{"10040": {"ApplNo": "10040", "Form": "SOLUTION;URETHRAL", "Drug": "CYSTOGRAFIN", "ActiveIngredient": "DIATRIZOATE MEGLUMINE", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/010040s171lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10040"}, "10104": {"ApplNo": "10104", "Form": "TABLET;ORAL", "Drug": "MEPHYTON", "ActiveIngredient": "PHYTONADIONE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/010104s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10104"}, "101063": {"ApplNo": "101063", "Form": "VIAL", "Drug": "ELSPAR", "ActiveIngredient": "ASPARAGINASE", "ApplType": "BLA", "Sponsor": "MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/101063s5169lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101063"}, "10187": {"ApplNo": "10187", "Form": "TABLET;ORAL", "Drug": "RITALIN", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/010187s093lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10187"}, "103000": {"ApplNo": "103000", "Form": "VIAL; SINGLE-USE", "Drug": "BOTOX", "ActiveIngredient": "OnabotulinumtoxinA", "ApplType": "BLA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103000s5322lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103000"}, "103132": {"ApplNo": "103132", "Form": "VIAL", "Drug": "INTRON A", "ActiveIngredient": "INTERFERON ALFA-2B", "ApplType": "BLA", "Sponsor": "SCHERING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103132s5202lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103132"}, "103172": {"ApplNo": "103172", "Form": "VIAL; SINGLE-USE", "Drug": "ACTIVASE", "ActiveIngredient": "ALTEPLASE", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103172s5268lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103172"}, "103234": {"ApplNo": "103234", "Form": "VIAL; SINGLE-USE", "Drug": "EPOGEN/PROCRIT", "ActiveIngredient": "EPOETIN ALFA", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103234s5369lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103234"}, "103293": {"ApplNo": "103293", "Form": "VIAL", "Drug": "PROLEUKIN", "ActiveIngredient": "ALDESLEUKIN", "ApplType": "BLA", "Sponsor": "CHIRON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103293s5130lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103293"}, "103353": {"ApplNo": "103353", "Form": "VIAL", "Drug": "NEUPOGEN", "ActiveIngredient": "FILGRASTIM", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103353s5197lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103353"}, "103362": {"ApplNo": "103362", "Form": "VIAL", "Drug": "LEUKINE", "ActiveIngredient": "SARGRAMOSTIM", "ApplType": "BLA", "Sponsor": "BERLEX LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103362s5249lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103362"}, "103411": {"ApplNo": "103411", "Form": "VIAL", "Drug": "ONCASPAR", "ActiveIngredient": "PEGASPARGASE", "ApplType": "BLA", "Sponsor": "SIGMA TAU", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103411s5205lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411"}, "103471": {"ApplNo": "103471", "Form": "VIAL; SUBCUTANEOUS", "Drug": "BETASERON", "ActiveIngredient": "INTERFERON BETA-1B", "ApplType": "BLA", "Sponsor": "BAYER HEALTHCARE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103471s5201lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471"}, "103532": {"ApplNo": "103532", "Form": "VIAL", "Drug": "PULMOZYME", "ActiveIngredient": "DORNASE ALFA", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103532s5191lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103532"}, "103575": {"ApplNo": "103575", "Form": "INJECTABLE; INJECTION", "Drug": "REOPRO", "ActiveIngredient": "ABCIXIMAB", "ApplType": "BLA", "Sponsor": "CENTOCOR INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103575s5138lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103575"}, "103608": {"ApplNo": "103608", "Form": "VIAL; INTRAVENOUS", "Drug": "PROSTASCINT", "ActiveIngredient": "CAPROMAB PENDETIDE", "ApplType": "BLA", "Sponsor": "CYTOGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103608s5043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103608"}, "103628": {"ApplNo": "103628", "Form": "VIAL", "Drug": "AVONEX", "ActiveIngredient": "INTERFERON BETA-1A", "ApplType": "BLA", "Sponsor": "BIOGEN", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103628s5266lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628"}, "103691": {"ApplNo": "103691", "Form": "GEL; TOPICAL", "Drug": "REGRANEX", "ActiveIngredient": "BECAPLERMIN", "ApplType": "BLA", "Sponsor": "SMITH AND NEPHEW", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103691"}, "103705": {"ApplNo": "103705", "Form": "SOLUTION;INTRAVENOUS", "Drug": "RITUXAN", "ActiveIngredient": "RITUXIMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5467lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103705"}, "103764": {"ApplNo": "103764", "Form": "VIAL; SINGLE-USE", "Drug": "SIMULECT", "ActiveIngredient": "BASILIXIMAB", "ApplType": "BLA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/basnov051298lb.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103764"}, "103767": {"ApplNo": "103767", "Form": "VIAL", "Drug": "ONTAK", "ActiveIngredient": "DENILEUKIN DIFTITOX", "ApplType": "BLA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103767s5144lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103767"}, "103770": {"ApplNo": "103770", "Form": "VIAL", "Drug": "SYNAGIS", "ActiveIngredient": "PALIVIZUMAB", "ApplType": "BLA", "Sponsor": "SWEDISH ORPHAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103770s5200lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103770"}, "103772": {"ApplNo": "103772", "Form": "VIAL", "Drug": "REMICADE", "ActiveIngredient": "INFLIXIMAB", "ApplType": "BLA", "Sponsor": "CENTOCOR INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103772"}, "103780": {"ApplNo": "103780", "Form": "SYRINGE", "Drug": "REBIF", "ActiveIngredient": "INTERFERON BETA-1A", "ApplType": "BLA", "Sponsor": "SERONO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103780s5210lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103780"}, "10379": {"ApplNo": "10379", "Form": "TABLET;ORAL", "Drug": "CYTOMEL", "ActiveIngredient": "LIOTHYRONINE SODIUM", "ApplType": "NDA", "Sponsor": "KING PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/010379s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10379"}, "103792": {"ApplNo": "103792", "Form": "VIAL; INTRAVENOUS", "Drug": "HERCEPTIN", "ActiveIngredient": "TRASTUZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103792s5345lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103792"}, "103795": {"ApplNo": "103795", "Form": "VIAL; SUBCUTANEOUS", "Drug": "ENBREL", "ActiveIngredient": "ETANERCEPT", "ApplType": "BLA", "Sponsor": "IMMUNEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103795s5591lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103795"}, "103836": {"ApplNo": "103836", "Form": "VIAL; SINGLE-USE", "Drug": "ACTIMMUNE", "ActiveIngredient": "INTERFERON GAMMA-1B", "ApplType": "BLA", "Sponsor": "VIDARA THERAPEUTICS RESEARCH LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103836"}, "103846": {"ApplNo": "103846", "Form": "VIAL", "Drug": "MYOBLOC", "ActiveIngredient": "Botulinum Toxin Type B", "ApplType": "BLA", "Sponsor": "ELAN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103846"}, "103909": {"ApplNo": "103909", "Form": "VIAL", "Drug": "TNKASE", "ActiveIngredient": "TENECTEPLASE", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103909s5187lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103909"}, "103946": {"ApplNo": "103946", "Form": "VIAL; INTRAVENOUS", "Drug": "ELITEK", "ActiveIngredient": "RASBURICASE", "ApplType": "BLA", "Sponsor": "SANOFI SYNTHELABO", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103946s5103lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103946"}, "103948": {"ApplNo": "103948", "Form": "VIAL; INTRAVENOUS", "Drug": "CAMPATH", "ActiveIngredient": "ALEMTUZUMAB", "ApplType": "BLA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5187lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103948"}, "103949": {"ApplNo": "103949", "Form": "VIAL", "Drug": "PEGINTRON", "ActiveIngredient": "PEGINTERFERON ALFA-2B", "ApplType": "BLA", "Sponsor": "SCHERING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103949"}, "103950": {"ApplNo": "103950", "Form": "VIAL; SUBCUTANEOUS", "Drug": "KINERET", "ActiveIngredient": "ANAKINRA", "ApplType": "BLA", "Sponsor": "BIOVITRUM AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103950s5189lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103950"}, "103951": {"ApplNo": "103951", "Form": "VIAL; INTRAVENOUS", "Drug": "ARANESP", "ActiveIngredient": "DARBEPOETIN ALFA", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103951s5363lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103951"}, "103964": {"ApplNo": "103964", "Form": "VIAL; SUBCUTANEOUS", "Drug": "PEGASYS", "ActiveIngredient": "PEGINTERFERON ALFA-2A", "ApplType": "BLA", "Sponsor": "zr pharma&", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103964s5275lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103964"}, "103976": {"ApplNo": "103976", "Form": "VIAL", "Drug": "XOLAIR", "ActiveIngredient": "OMALIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103976s5239lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103976"}, "103979": {"ApplNo": "103979", "Form": "VIAL; INTRAVENOUS", "Drug": "FABRAZYME", "ActiveIngredient": "AGALSIDASE BETA", "ApplType": "BLA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103979s5309lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103979"}, "10402": {"ApplNo": "10402", "Form": "INJECTABLE;INJECTION", "Drug": "PREMARIN", "ActiveIngredient": "ESTROGENS, CONJUGATED", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/010402s068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10402"}, "10515": {"ApplNo": "10515", "Form": "INJECTABLE;INJECTION", "Drug": "ISUPREL", "ActiveIngredient": "ISOPROTERENOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/010515Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10515"}, "10596": {"ApplNo": "10596", "Form": "CAPSULE;ORAL", "Drug": "CELONTIN", "ActiveIngredient": "METHSUXIMIDE", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010596s22lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10596"}, "10669": {"ApplNo": "10669", "Form": "TABLET;ORAL", "Drug": "LEUKERAN", "ActiveIngredient": "CHLORAMBUCIL", "ApplType": "NDA", "Sponsor": "WOODWARD SPECL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/010669s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10669"}, "10721": {"ApplNo": "10721", "Form": "TABLET;ORAL", "Drug": "ANTIVERT", "ActiveIngredient": "MECLIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CASPER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10721"}, "11153": {"ApplNo": "11153", "Form": "TABLET;ORAL", "Drug": "MEDROL", "ActiveIngredient": "METHYLPREDNISOLONE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011153Orig1s077lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11153"}, "11210": {"ApplNo": "11210", "Form": "CAPSULE;ORAL", "Drug": "TESSALON", "ActiveIngredient": "BENZONATATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011210s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11210"}, "11366": {"ApplNo": "11366", "Form": "TABLET;ORAL", "Drug": "KEVEYIS", "ActiveIngredient": "DICHLORPHENAMIDE", "ApplType": "NDA", "Sponsor": "XERIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011366s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11366"}, "11459": {"ApplNo": "11459", "Form": "CAPSULE;ORAL", "Drug": "VISTARIL", "ActiveIngredient": "HYDROXYZINE PAMOATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/011459s051_011795s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11459"}, "11525": {"ApplNo": "11525", "Form": "INJECTABLE;INJECTION", "Drug": "IC-GREEN", "ActiveIngredient": "INDOCYANINE GREEN", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011525Orig1s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11525"}, "11559": {"ApplNo": "11559", "Form": "INJECTABLE;INJECTION", "Drug": "BREVITAL SODIUM", "ActiveIngredient": "METHOHEXITAL SODIUM", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/011559s057lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11559"}, "11665": {"ApplNo": "11665", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MESTINON", "ActiveIngredient": "PYRIDOSTIGMINE BROMIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/15193s18lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11665"}, "11719": {"ApplNo": "11719", "Form": "INJECTABLE;INJECTION", "Drug": "METHOTREXATE SODIUM", "ActiveIngredient": "METHOTREXATE SODIUM", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011719Orig1s135lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11719"}, "11757": {"ApplNo": "11757", "Form": "INJECTABLE;INJECTION", "Drug": "DEPO-MEDROL", "ActiveIngredient": "METHYLPREDNISOLONE ACETATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/011757s120lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11757"}, "11790": {"ApplNo": "11790", "Form": "SOLUTION;IM-IV", "Drug": "ROBAXIN", "ActiveIngredient": "METHOCARBAMOL", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/11790slr046_robaxin_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11790"}, "11792": {"ApplNo": "11792", "Form": "TABLET;ORAL", "Drug": "SOMA", "ActiveIngredient": "CARISOPRODOL", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011792s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11792"}, "11839": {"ApplNo": "11839", "Form": "TABLET;ORAL", "Drug": "PROVERA", "ActiveIngredient": "MEDROXYPROGESTERONE ACETATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011839s079s080lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11839"}, "11856": {"ApplNo": "11856", "Form": "INJECTABLE;INJECTION", "Drug": "SOLU-MEDROL", "ActiveIngredient": "METHYLPREDNISOLONE SODIUM SUCCINATE", "ApplType": "NDA", "Sponsor": "PHARMACIA AND UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/011856s139lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11856"}, "11870": {"ApplNo": "11870", "Form": "SUSPENSION;ORAL", "Drug": "DIURIL", "ActiveIngredient": "CHLOROTHIAZIDE", "ApplType": "NDA", "Sponsor": "SALIX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/011870s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11870"}, "11909": {"ApplNo": "11909", "Form": "TABLET;ORAL", "Drug": "NARDIL", "ActiveIngredient": "PHENELZINE SULFATE", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011909s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11909"}, "11961": {"ApplNo": "11961", "Form": "TABLET;ORAL", "Drug": "MARPLAN", "ActiveIngredient": "ISOCARBOXAZID", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11961"}, "11963": {"ApplNo": "11963", "Form": "FOR SOLUTION;OPHTHALMIC", "Drug": "PHOSPHOLINE IODIDE", "ActiveIngredient": "ECHOTHIOPHATE IODIDE", "ApplType": "NDA", "Sponsor": "FERA PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/011963s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11963"}, "12041": {"ApplNo": "12041", "Form": "INJECTABLE;INJECTION", "Drug": "KENALOG-10", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "APOTHECON", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012041s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12041"}, "12093": {"ApplNo": "12093", "Form": "TABLET;ORAL", "Drug": "ISORDIL", "ActiveIngredient": "ISOSORBIDE DINITRATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/012093s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12093"}, "12104": {"ApplNo": "12104", "Form": "SPRAY;TOPICAL", "Drug": "KENALOG", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012104s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12104"}, "12141": {"ApplNo": "12141", "Form": "TABLET;ORAL", "Drug": "CYTOXAN", "ActiveIngredient": "CYCLOPHOSPHAMIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012141s090,012142s112lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12141"}, "12151": {"ApplNo": "12151", "Form": "TABLET;ORAL", "Drug": "ALDACTONE", "ActiveIngredient": "SPIRONOLACTONE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012151s079lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12151"}, "12250": {"ApplNo": "12250", "Form": "INJECTABLE;INJECTION", "Drug": "CARBOCAINE", "ActiveIngredient": "MEPIVACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012250s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12250"}, "12342": {"ApplNo": "12342", "Form": "TABLET;ORAL", "Drug": "PARNATE", "ActiveIngredient": "TRANYLCYPROMINE SULFATE", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12342"}, "12380": {"ApplNo": "12380", "Form": "CAPSULE;ORAL", "Drug": "ZARONTIN", "ActiveIngredient": "ETHOSUXIMIDE", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012380s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12380"}, "12429": {"ApplNo": "12429", "Form": "TABLET;ORAL", "Drug": "THIOGUANINE", "ActiveIngredient": "THIOGUANINE", "ApplType": "NDA", "Sponsor": "WOODWARD SPECL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012429s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12429"}, "12462": {"ApplNo": "12462", "Form": "TABLET;ORAL", "Drug": "LOMOTIL", "ActiveIngredient": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012462s048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12462"}, "125019": {"ApplNo": "125019", "Form": "INJECTABLE; INJECTION", "Drug": "ZEVALIN", "ActiveIngredient": "IBRITUMOMAB TIUXETAN", "ApplType": "BLA", "Sponsor": "SPECTRUM PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125019s227lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019"}, "125031": {"ApplNo": "125031", "Form": "SYRINGE", "Drug": "NEULASTA", "ActiveIngredient": "PEGFILGRASTIM", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125031s203lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125031"}, "125057": {"ApplNo": "125057", "Form": "SYRINGE", "Drug": "HUMIRA", "ActiveIngredient": "ADALIMUMAB", "ApplType": "BLA", "Sponsor": "ABBVIE INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125057"}, "125058": {"ApplNo": "125058", "Form": "VIAL", "Drug": "ALDURAZYME", "ActiveIngredient": "LARONIDASE", "ApplType": "BLA", "Sponsor": "BIOMARIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125058s244lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125058"}, "125084": {"ApplNo": "125084", "Form": "VIAL; INTRAVENOUS", "Drug": "ERBITUX", "ActiveIngredient": "CETUXIMAB", "ApplType": "BLA", "Sponsor": "IMCLONE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125084s279lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125084"}, "125085": {"ApplNo": "125085", "Form": "VIAL; INTRAVENOUS", "Drug": "AVASTIN", "ActiveIngredient": "BEVACIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125085s340lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125085"}, "125103": {"ApplNo": "125103", "Form": "INJECTABLE; INJECTION", "Drug": "KEPIVANCE", "ActiveIngredient": "PALIFERMIN", "ApplType": "BLA", "Sponsor": "BIOVITRUM AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125103s176lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125103"}, "125104": {"ApplNo": "125104", "Form": "VIAL; SINGLE-USE", "Drug": "TYSABRI", "ActiveIngredient": "NATALIZUMAB", "ApplType": "BLA", "Sponsor": "BIOGEN IDEC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125104s973s975lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125104"}, "125117": {"ApplNo": "125117", "Form": "INJECTABLE; INJECTION", "Drug": "NAGLAZYME", "ActiveIngredient": "GALSULFASE", "ApplType": "BLA", "Sponsor": "BIOMARIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125117s129lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125117"}, "125118": {"ApplNo": "125118", "Form": "INJECTABLE; IV (INFUSION)", "Drug": "ORENCIA", "ActiveIngredient": "ABATACEPT", "ApplType": "BLA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125118s240lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118"}, "125141": {"ApplNo": "125141", "Form": "INJECTABLE; IV (INFUSION)", "Drug": "MYOZYME", "ActiveIngredient": "ALGLUCOSIDASE ALFA", "ApplType": "BLA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125141s223lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125141"}, "125147": {"ApplNo": "125147", "Form": "INJECTABLE; IV (INFUSION)", "Drug": "VECTIBIX", "ActiveIngredient": "PANITUMUMAB", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125147s210lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147"}, "125151": {"ApplNo": "125151", "Form": "INJECTABLE; IV (INFUSION)", "Drug": "ELAPRASE", "ActiveIngredient": "IDURSULFASE", "ApplType": "BLA", "Sponsor": "SHIRE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125151s197lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125151"}, "125156": {"ApplNo": "125156", "Form": "INJECTABLE; INJECTION", "Drug": "LUCENTIS", "ActiveIngredient": "RANIBIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125156s117lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125156"}, "125160": {"ApplNo": "125160", "Form": "INJECTABLE; INJECTION", "Drug": "CIMZIA", "ActiveIngredient": "CERTOLIZUMAB PEGOL", "ApplType": "BLA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125160s305lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125160"}, "125164": {"ApplNo": "125164", "Form": "SOLUTION; INJECTION", "Drug": "MIRCERA", "ActiveIngredient": "METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA", "ApplType": "BLA", "Sponsor": "HOFFMAN-LA ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125164s086lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125164"}, "125166": {"ApplNo": "125166", "Form": "INJECTABLE; IV (INFUSION)", "Drug": "SOLIRIS", "ActiveIngredient": "ECULIZUMAB", "ApplType": "BLA", "Sponsor": "ALEXION PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125166s434lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125166"}, "125249": {"ApplNo": "125249", "Form": "VIAL; SINGLE-USE", "Drug": "ARCALYST", "ActiveIngredient": "RILONACEPT", "ApplType": "BLA", "Sponsor": "KINIKSA PHARMACEUTICALS (UK), LTD.", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125249s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125249"}, "125261": {"ApplNo": "125261", "Form": "INJECTABLE; INJECTION", "Drug": "STELARA", "ActiveIngredient": "USTEKINUMAB", "ApplType": "BLA", "Sponsor": "CENTOCOR ORTHO BIOTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125261s161lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125261"}, "125268": {"ApplNo": "125268", "Form": "INJECTABLE; SUBCUTANEOUS", "Drug": "NPLATE", "ActiveIngredient": "ROMIPLOSTIM", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125268s172lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125268"}, "125274": {"ApplNo": "125274", "Form": "INJECTABLE; INJECTION", "Drug": "DYSPORT", "ActiveIngredient": "abobotulinumtoxinA", "ApplType": "BLA", "Sponsor": "IPSEN BIOPHARM LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s123lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274"}, "125276": {"ApplNo": "125276", "Form": "INJECTABLE; INJECTION", "Drug": "ACTEMRA", "ActiveIngredient": "TOCILIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125276s138lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125276"}, "125277": {"ApplNo": "125277", "Form": "INJECTABLE; INJECTION", "Drug": "KALBITOR", "ActiveIngredient": "ECALLANTIDE", "ApplType": "BLA", "Sponsor": "DYAX CORP.", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125277"}, "125288": {"ApplNo": "125288", "Form": "INJECTABLE; INJECTION", "Drug": "NULOJIX", "ActiveIngredient": "BELATACEPT", "ApplType": "BLA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125288s101lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125288"}, "125289": {"ApplNo": "125289", "Form": "INJECTABLE; INJECTION", "Drug": "SIMPONI", "ActiveIngredient": "GOLIMUMAB", "ApplType": "BLA", "Sponsor": "CENTOCOR ORTHO BIOTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289"}, "125290": {"ApplNo": "125290", "Form": "INJECTABLE; SUBCUTANEOUS", "Drug": "EXTAVIA", "ActiveIngredient": "INTERFERON BETA-1B", "ApplType": "BLA", "Sponsor": "NOVARTIS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125290s073lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125290"}, "125291": {"ApplNo": "125291", "Form": "POWDER; IV (INFUSION)", "Drug": "LUMIZYME", "ActiveIngredient": "ALGLUCOSIDASE ALFA", "ApplType": "BLA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125291s156s157lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125291"}, "125293": {"ApplNo": "125293", "Form": "INJECTABLE; INJECTION", "Drug": "KRYSTEXXA", "ActiveIngredient": "PEGLOTICASE", "ApplType": "BLA", "Sponsor": "HORIZON PHARMA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125293"}, "125294": {"ApplNo": "125294", "Form": "INJECTABLE; INJECTION", "Drug": "GRANIX", "ActiveIngredient": "TBO-FILGRASTIM", "ApplType": "BLA", "Sponsor": "SICOR BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125294s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125294"}, "125319": {"ApplNo": "125319", "Form": "INJECTABLE; SUBCUTANEOUS", "Drug": "ILARIS", "ActiveIngredient": "CANAKINUMAB", "ApplType": "BLA", "Sponsor": "NOVARTIS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125319s100lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125319"}, "125320": {"ApplNo": "125320", "Form": "INJECTABLE; SUBCUTANEOUS", "Drug": "PROLIA", "ActiveIngredient": "DENOSUMAB", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125320s211lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125320"}, "125326": {"ApplNo": "125326", "Form": "INJECTABLE; INJECTION", "Drug": "ARZERRA", "ActiveIngredient": "OFATUMUMAB", "ApplType": "BLA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125326s075lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125326"}, "125327": {"ApplNo": "125327", "Form": "INJECTABLE; INJECTION", "Drug": "VORAXAZE", "ActiveIngredient": "GLUCARPIDASE", "ApplType": "BLA", "Sponsor": "BTG INTERNATIONAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125327s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125327"}, "125338": {"ApplNo": "125338", "Form": "SOLUTION; INJECTION", "Drug": "XIAFLEX", "ActiveIngredient": "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM", "ApplType": "BLA", "Sponsor": "AUXILIUM PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125338s129lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125338"}, "125349": {"ApplNo": "125349", "Form": "INJECTABLE; IV (INFUSION)", "Drug": "RAXIBACUMAB", "ActiveIngredient": "RAXIBACUMAB", "ApplType": "BLA", "Sponsor": "HUMAN GENOME SCIENCES INC.", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125349s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125349"}, "125360": {"ApplNo": "125360", "Form": "INJECTABLE;INJECTION", "Drug": "Xeomin", "ActiveIngredient": "incobotulinumtoxinA", "ApplType": "BLA", "Sponsor": "MERZ PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s093lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125360"}, "125370": {"ApplNo": "125370", "Form": "INJECTABLE; INJECTION", "Drug": "BENLYSTA", "ActiveIngredient": "BELIMUMAB", "ApplType": "BLA", "Sponsor": "HUMAN GENOME SCIENCES INC.", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s073,761043s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125370"}, "125377": {"ApplNo": "125377", "Form": "INJECTABLE; INJECTION", "Drug": "YERVOY", "ActiveIngredient": "IPILIMUMAB", "ApplType": "BLA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125377s130lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125377"}, "125387": {"ApplNo": "125387", "Form": "INJECTABLE; INJECTION", "Drug": "EYLEA", "ActiveIngredient": "AFLIBERCEPT", "ApplType": "BLA", "Sponsor": "REGENERON PHARMACEUTICALS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125387s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125387"}, "125388": {"ApplNo": "125388", "Form": "INJECTABLE; INJECTION", "Drug": "ADCETRIS", "ActiveIngredient": "BRENTUXIMAB VEDOTIN", "ApplType": "BLA", "Sponsor": "SEATTLE GENETICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125388s106lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125388"}, "125390": {"ApplNo": "125390", "Form": "INJECTABLE;INJECTION", "Drug": "MYALEPT", "ActiveIngredient": "METRELEPTIN", "ApplType": "BLA", "Sponsor": "AEGERION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390"}, "125399": {"ApplNo": "125399", "Form": "INJECTABLE; INJECTION", "Drug": "ADCETRIS", "ActiveIngredient": "BRENTUXIMAB VEDOTIN", "ApplType": "BLA", "Sponsor": "SEATTLE GENETICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125388s000,125399s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125399"}, "125409": {"ApplNo": "125409", "Form": "VIAL; SINGLE-USE", "Drug": "PERJETA", "ActiveIngredient": "PERTUZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125409s124lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125409"}, "125418": {"ApplNo": "125418", "Form": "INJECTABLE; INJECTION", "Drug": "ZALTRAP", "ActiveIngredient": "ZIV-AFLIBERCEPT", "ApplType": "BLA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125418s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125418"}, "125422": {"ApplNo": "125422", "Form": "INJECTABLE; INTRAVITREAL", "Drug": "JETREA", "ActiveIngredient": "OCRIPLASMIN", "ApplType": "BLA", "Sponsor": "THROMBOGENICS, INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125422s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125422"}, "125427": {"ApplNo": "125427", "Form": "VIAL; SINGLE-USE", "Drug": "KADCYLA", "ActiveIngredient": "ADO-TRASTUZUMAB EMTANSINE", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125427s111lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125427"}, "125433": {"ApplNo": "125433", "Form": "INJECTABLE; INJECTION", "Drug": "SIMPONI ARIA", "ActiveIngredient": "GOLIMUMAB", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125433"}, "125460": {"ApplNo": "125460", "Form": "INJECTABLE;INJECTION", "Drug": "VIMIZIM", "ActiveIngredient": "ELOSULFASE ALFA", "ApplType": "BLA", "Sponsor": "BIOMARIN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125460s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125460"}, "125469": {"ApplNo": "125469", "Form": "INJECTABLE;INJECTION", "Drug": "TRULICITY", "ActiveIngredient": "DULAGLUTIDE", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125469"}, "125472": {"ApplNo": "125472", "Form": "INJECTABLE;INTRAVENOUS, SUBCUTANEOUS", "Drug": "ACTEMRA", "ActiveIngredient": "TOCILIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125472s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125472"}, "125476": {"ApplNo": "125476", "Form": "INJECTABLE;INJECTION", "Drug": "ENTYVIO", "ActiveIngredient": "VEDOLIZUMAB", "ApplType": "BLA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125476Orig1s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125476"}, "125477": {"ApplNo": "125477", "Form": "INJECTABLE;INJECTION", "Drug": "CYRAMZA", "ActiveIngredient": "RAMUCIRUMAB", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125477s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125477"}, "125486": {"ApplNo": "125486", "Form": "INJECTABLE;INJECTION", "Drug": "GAZYVA", "ActiveIngredient": "OBINUTUZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125486s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125486"}, "125496": {"ApplNo": "125496", "Form": "INJECTABLE;INJECTION", "Drug": "SYLVANT", "ActiveIngredient": "SILTUXIMAB", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125496s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125496"}, "125499": {"ApplNo": "125499", "Form": "INJECTABLE;INJECTION", "Drug": "PLEGRIDY", "ActiveIngredient": "PEGINTERFERON BETA-1A", "ApplType": "BLA", "Sponsor": "BIOGEN IDEC INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125499s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125499"}, "125504": {"ApplNo": "125504", "Form": "INJECTABLE;INJECTION", "Drug": "COSENTYX", "ActiveIngredient": "SECUKINUMAB", "ApplType": "BLA", "Sponsor": "NOVARTIS PHARMS CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125504_S050_S051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125504"}, "125509": {"ApplNo": "125509", "Form": "INJECTABLE;INJECTION", "Drug": "ANTHIM", "ActiveIngredient": "OBILTOXAXIMAB", "ApplType": "BLA", "Sponsor": "ELUSYS THERAPEUTICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125509s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125509"}, "125511": {"ApplNo": "125511", "Form": "INJECTABLE;INJECTION", "Drug": "NATPARA", "ActiveIngredient": "PARATHYROID HORMONE", "ApplType": "BLA", "Sponsor": "NPS PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125511s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125511"}, "125513": {"ApplNo": "125513", "Form": "SOLUTION;INJECTION", "Drug": "STRENSIQ", "ActiveIngredient": "ASFOTASE ALFA", "ApplType": "BLA", "Sponsor": "ALEXION PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125513s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125513"}, "125514": {"ApplNo": "125514", "Form": "SOLUTION;INTRAVENOUS", "Drug": "KEYTRUDA", "ActiveIngredient": "PEMBROLIZUMAB", "ApplType": "BLA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125514s128lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514"}, "125516": {"ApplNo": "125516", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "UNITUXIN", "ActiveIngredient": "DINUTUXIMAB", "ApplType": "BLA", "Sponsor": "UNITED THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125516s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125516"}, "125521": {"ApplNo": "125521", "Form": "INJECTABLE;INJECTION", "Drug": "TALTZ", "ActiveIngredient": "IXEKIZUMAB", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125521"}, "125522": {"ApplNo": "125522", "Form": "INJECTABLE;INJECTION", "Drug": "REPATHA", "ActiveIngredient": "EVOLOCUMAB", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125522s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522"}, "125526": {"ApplNo": "125526", "Form": "INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER", "Drug": "NUCALA", "ActiveIngredient": "MEPOLIZUMAB", "ApplType": "BLA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761122s008,125526s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125526"}, "125527": {"ApplNo": "125527", "Form": "INJECTABLE;INJECTION", "Drug": "OPDIVO", "ActiveIngredient": "NIVOLUMAB", "ApplType": "BLA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125527s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125527"}, "125544": {"ApplNo": "125544", "Form": "INJECTABLE;INJECTION", "Drug": "INFLECTRA", "ActiveIngredient": "INFLIXIMAB-DYYB", "ApplType": "BLA", "Sponsor": "CELLTRION INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125544"}, "125545": {"ApplNo": "125545", "Form": "INJECTABLE;INJECTION", "Drug": "RETACRIT", "ActiveIngredient": "EPOETIN ALFA-EPBX", "ApplType": "BLA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125545"}, "125547": {"ApplNo": "125547", "Form": "INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL", "Drug": "PORTRAZZA", "ActiveIngredient": "NECITUMUMAB", "ApplType": "BLA", "Sponsor": "ELI LILLY CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125547s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125547"}, "125553": {"ApplNo": "125553", "Form": "INJECTABLE;INJECTION", "Drug": "ZARXIO", "ActiveIngredient": "FILGRASTIM-SNDZ", "ApplType": "BLA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125553s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125553"}, "125554": {"ApplNo": "125554", "Form": "INJECTABLE;INJECTION", "Drug": "OPDIVO", "ActiveIngredient": "NIVOLUMAB", "ApplType": "BLA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125554s114lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125554"}, "125557": {"ApplNo": "125557", "Form": "INJECTABLE;INJECTION", "Drug": "BLINCYTO", "ActiveIngredient": "BLINATUMOMAB", "ApplType": "BLA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125557s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557"}, "125559": {"ApplNo": "125559", "Form": "INJECTABLE;INJECTION", "Drug": "PRALUENT", "ActiveIngredient": "ALIROCUMAB", "ApplType": "BLA", "Sponsor": "REGENERON PHARMACEUTICALS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125559s029s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125559"}, "125561": {"ApplNo": "125561", "Form": "INJECTABLE;INJECTION", "Drug": "KANUMA", "ActiveIngredient": "SEBELIPASE ALFA", "ApplType": "BLA", "Sponsor": "ALEXION PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125561s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125561"}, "12616": {"ApplNo": "12616", "Form": "TABLET;ORAL", "Drug": "ALDACTAZIDE", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; SPIRONOLACTONE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012616s083lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12616"}, "12623": {"ApplNo": "12623", "Form": "TABLET;ORAL", "Drug": "FLAGYL", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012623s069lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12623"}, "12750": {"ApplNo": "12750", "Form": "CAPSULE;ORAL", "Drug": "LIBRAX", "ActiveIngredient": "CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12750"}, "12770": {"ApplNo": "12770", "Form": "SOLUTION/DROPS;OTIC", "Drug": "VOSOL HC", "ActiveIngredient": "ACETIC ACID, GLACIAL; HYDROCORTISONE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1997/012770s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12770"}, "12787": {"ApplNo": "12787", "Form": "CREAM;TOPICAL", "Drug": "SYNALAR", "ActiveIngredient": "FLUOCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "MEDIMETRIKS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012787s071lblrev.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12787"}, "12806": {"ApplNo": "12806", "Form": "OINTMENT;TOPICAL", "Drug": "CORDRAN", "ActiveIngredient": "FLURANDRENOLIDE", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012806s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12806"}, "12827": {"ApplNo": "12827", "Form": "TABLET;ORAL", "Drug": "ROBINUL", "ActiveIngredient": "GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "CASPER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012827s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12827"}, "12836": {"ApplNo": "12836", "Form": "TABLET;ORAL", "Drug": "PERSANTINE", "ActiveIngredient": "DIPYRIDAMOLE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/012836s061lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12836"}, "12911": {"ApplNo": "12911", "Form": "CAPSULE;ORAL", "Drug": "METOPIRONE", "ActiveIngredient": "METYRAPONE", "ApplType": "NDA", "Sponsor": "HRA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012911s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12911"}, "13025": {"ApplNo": "13025", "Form": "SOLUTION;INJECTION", "Drug": "THAM", "ActiveIngredient": "TROMETHAMINE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/013025s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13025"}, "13026": {"ApplNo": "13026", "Form": "TABLET;ORAL", "Drug": "TRECATOR", "ActiveIngredient": "ETHIONAMIDE", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013026s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13026"}, "13217": {"ApplNo": "13217", "Form": "TABLET;ORAL", "Drug": "SKELAXIN", "ActiveIngredient": "METAXALONE", "ApplType": "NDA", "Sponsor": "KING PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/013217s057lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13217"}, "13263": {"ApplNo": "13263", "Form": "TABLET;ORAL", "Drug": "VALIUM", "ActiveIngredient": "DIAZEPAM", "ApplType": "NDA", "Sponsor": "WAYLIS THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263s097lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13263"}, "13295": {"ApplNo": "13295", "Form": "INJECTABLE;INJECTION", "Drug": "CONRAY", "ActiveIngredient": "IOTHALAMATE MEGLUMINE", "ApplType": "NDA", "Sponsor": "LIEBEL-FLARSHEIM", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/013295s072lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13295"}, "13422": {"ApplNo": "13422", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "MAXIDEX", "ActiveIngredient": "DEXAMETHASONE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/013422s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13422"}, "13684": {"ApplNo": "13684", "Form": "INJECTABLE;INJECTION", "Drug": "OSMITROL 5% IN WATER", "ActiveIngredient": "MANNITOL", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/013684s106lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13684"}, "13790": {"ApplNo": "13790", "Form": "LOTION;TOPICAL", "Drug": "CORDRAN", "ActiveIngredient": "FLURANDRENOLIDE", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/013790s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13790"}, "14134": {"ApplNo": "14134", "Form": "INJECTABLE;INJECTION", "Drug": "PROTOPAM CHLORIDE", "ActiveIngredient": "PRALIDOXIME CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/014134s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14134"}, "14399": {"ApplNo": "14399", "Form": "TABLET;ORAL", "Drug": "NORPRAMIN", "ActiveIngredient": "DESIPRAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/014399s071lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14399"}, "14602": {"ApplNo": "14602", "Form": "INJECTABLE;INJECTION", "Drug": "CELESTONE SOLUSPAN", "ActiveIngredient": "BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/014602Orig1s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14602"}, "14879": {"ApplNo": "14879", "Form": "INJECTABLE;INJECTION", "Drug": "DOPRAM", "ActiveIngredient": "DOXAPRAM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/14879s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14879"}, "14901": {"ApplNo": "14901", "Form": "INJECTABLE;INJECTION", "Drug": "KENALOG-40", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "APOTHECON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/014901Orig1s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14901"}, "15034": {"ApplNo": "15034", "Form": "CAPSULE;ORAL", "Drug": "PONSTEL", "ActiveIngredient": "MEFENAMIC ACID", "ApplType": "NDA", "Sponsor": "AVION PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/015034s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15034"}, "15193": {"ApplNo": "15193", "Form": "SYRUP;ORAL", "Drug": "MESTINON", "ActiveIngredient": "PYRIDOSTIGMINE BROMIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/15193s18lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15193"}, "15197": {"ApplNo": "15197", "Form": "TABLET;ORAL", "Drug": "AMICAR", "ActiveIngredient": "AMINOCAPROIC ACID", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/015197s043,015230s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15197"}, "15230": {"ApplNo": "15230", "Form": "SOLUTION;ORAL", "Drug": "AMICAR", "ActiveIngredient": "AMINOCAPROIC ACID", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/015230s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15230"}, "15296": {"ApplNo": "15296", "Form": "SOLUTION;TOPICAL", "Drug": "SYNALAR", "ActiveIngredient": "FLUOCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "MEDIMETRIKS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/015296s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15296"}, "16084": {"ApplNo": "16084", "Form": "TABLET;ORAL", "Drug": "ZYLOPRIM", "ActiveIngredient": "ALLOPURINOL", "ApplType": "NDA", "Sponsor": "CASPER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016084Orig1s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16084"}, "16092": {"ApplNo": "16092", "Form": "TABLET;ORAL", "Drug": "EDECRIN", "ActiveIngredient": "ETHACRYNIC ACID", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/16092s042,16093s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16092"}, "16093": {"ApplNo": "16093", "Form": "INJECTABLE;INJECTION", "Drug": "EDECRIN", "ActiveIngredient": "ETHACRYNATE SODIUM", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/16092s042,16093s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16093"}, "16151": {"ApplNo": "16151", "Form": "TABLET;ORAL", "Drug": "UREX", "ActiveIngredient": "METHENAMINE HIPPURATE", "ApplType": "NDA", "Sponsor": "ALVOGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016151s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16151"}, "16199": {"ApplNo": "16199", "Form": "ENEMA;RECTAL", "Drug": "CORTENEMA", "ActiveIngredient": "HYDROCORTISONE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016199s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16199"}, "16267": {"ApplNo": "16267", "Form": "INJECTABLE;INJECTION", "Drug": "DESFERAL", "ActiveIngredient": "DEFEROXAMINE MESYLATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016267s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16267"}, "16269": {"ApplNo": "16269", "Form": "INJECTABLE;INJECTION", "Drug": "MANNITOL 25%", "ActiveIngredient": "MANNITOL", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016269s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16269"}, "16273": {"ApplNo": "16273", "Form": "TABLET;ORAL", "Drug": "LASIX", "ActiveIngredient": "FUROSEMIDE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016273s069lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16273"}, "16295": {"ApplNo": "16295", "Form": "CAPSULE;ORAL", "Drug": "HYDREA", "ActiveIngredient": "HYDROXYUREA", "ApplType": "NDA", "Sponsor": "CHEPLAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016295Orig1s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16295"}, "16320": {"ApplNo": "16320", "Form": "TABLET;ORAL", "Drug": "MYAMBUTOL", "ActiveIngredient": "ETHAMBUTOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "STI PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/016320s066lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16320"}, "16324": {"ApplNo": "16324", "Form": "TABLET;ORAL", "Drug": "IMURAN", "ActiveIngredient": "AZATHIOPRINE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016324s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16324"}, "16366": {"ApplNo": "16366", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/016366s214lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16366"}, "16367": {"ApplNo": "16367", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/016367s182lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16367"}, "16608": {"ApplNo": "16608", "Form": "TABLET;ORAL", "Drug": "TEGRETOL", "ActiveIngredient": "CARBAMAZEPINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16608"}, "16619": {"ApplNo": "16619", "Form": "INJECTABLE;INJECTION", "Drug": "SUBLIMAZE PRESERVATIVE FREE", "ActiveIngredient": "FENTANYL CITRATE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016619Orig1s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16619"}, "16620": {"ApplNo": "16620", "Form": "CAPSULE;ORAL", "Drug": "MACRODANTIN", "ActiveIngredient": "NITROFURANTOIN, MACROCRYSTALLINE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016620Orig1s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16620"}, "16673": {"ApplNo": "16673", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016673s149,016694s121lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16673"}, "16677": {"ApplNo": "16677", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016677s169,018016s067,020178s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16677"}, "16678": {"ApplNo": "16678", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16678"}, "16679": {"ApplNo": "16679", "Form": "INJECTABLE;INJECTION", "Drug": "LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016679s114lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16679"}, "16682": {"ApplNo": "16682", "Form": "INJECTABLE;INJECTION", "Drug": "LACTATED RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016682s117lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16682"}, "16683": {"ApplNo": "16683", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16683"}, "16687": {"ApplNo": "16687", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16687"}, "16689": {"ApplNo": "16689", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16689"}, "16693": {"ApplNo": "16693", "Form": "INJECTABLE;INJECTION", "Drug": "RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016693s101lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16693"}, "16694": {"ApplNo": "16694", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 10% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016673s149,016694s121lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16694"}, "16697": {"ApplNo": "16697", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16697"}, "16750": {"ApplNo": "16750", "Form": "INJECTABLE;INJECTION", "Drug": "CORTROSYN", "ActiveIngredient": "COSYNTROPIN", "ApplType": "NDA", "Sponsor": "AMPHASTAR PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016750Orig1s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16750"}, "16784": {"ApplNo": "16784", "Form": "SOLUTION;IRRIGATION", "Drug": "GLYCINE 1.5% IN PLASTIC CONTAINER", "ActiveIngredient": "GLYCINE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016784s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16784"}, "16812": {"ApplNo": "16812", "Form": "INJECTABLE;INJECTION", "Drug": "KETALAR", "ActiveIngredient": "KETAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016812s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16812"}, "16831": {"ApplNo": "16831", "Form": "SOLUTION;TOPICAL", "Drug": "EFUDEX", "ActiveIngredient": "FLUOROURACIL", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016831Orig1s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16831"}, "16851": {"ApplNo": "16851", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "FML", "ActiveIngredient": "FLUOROMETHOLONE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/016851s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16851"}, "16885": {"ApplNo": "16885", "Form": "TABLET;ORAL", "Drug": "LYSODREN", "ActiveIngredient": "MITOTANE", "ApplType": "NDA", "Sponsor": "HRA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016885s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16885"}, "16909": {"ApplNo": "16909", "Form": "OINTMENT;TOPICAL", "Drug": "LIDEX", "ActiveIngredient": "FLUOCINONIDE", "ApplType": "NDA", "Sponsor": "ALVOGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016909s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16909"}, "16931": {"ApplNo": "16931", "Form": "INJECTABLE;INJECTION", "Drug": "R-GENE 10", "ActiveIngredient": "ARGININE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PHARMACIA AND UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016931s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16931"}, "16964": {"ApplNo": "16964", "Form": "INJECTABLE;INJECTION", "Drug": "MARCAINE HYDROCHLORIDE", "ActiveIngredient": "BUPIVACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016964s082lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16964"}, "16968": {"ApplNo": "16968", "Form": "SOLUTION;INTRAOCULAR", "Drug": "MIOSTAT", "ActiveIngredient": "CARBACHOL", "ApplType": "NDA", "Sponsor": "ALCON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016968s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16968"}, "17001": {"ApplNo": "17001", "Form": "CAPSULE;ORAL", "Drug": "ANCOBON", "ActiveIngredient": "FLUCYTOSINE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017001Orig1s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17001"}, "17011": {"ApplNo": "17011", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "PRED FORTE", "ActiveIngredient": "PREDNISOLONE ACETATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017011s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17011"}, "17016": {"ApplNo": "17016", "Form": "INJECTABLE;INJECTION", "Drug": "CHORIONIC GONADOTROPIN", "ActiveIngredient": "GONADOTROPIN, CHORIONIC", "ApplType": "BLA", "Sponsor": "FERRING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017016s156lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17016"}, "17029": {"ApplNo": "17029", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017029s159lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17029"}, "17037": {"ApplNo": "17037", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017037Orig1s187lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17037"}, "17058": {"ApplNo": "17058", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "METHADONE HYDROCHLORIDE", "ActiveIngredient": "METHADONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017058s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17058"}, "17067": {"ApplNo": "17067", "Form": "INJECTABLE;INJECTION", "Drug": "CHORIONIC GONADOTROPIN", "ActiveIngredient": "GONADOTROPIN, CHORIONIC", "ApplType": "BLA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017067s057lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17067"}, "17078": {"ApplNo": "17078", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "DEXEDRINE", "ActiveIngredient": "DEXTROAMPHETAMINE SULFATE", "ApplType": "NDA", "Sponsor": "IMPAX LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017078s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17078"}, "17100": {"ApplNo": "17100", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "PRED MILD", "ActiveIngredient": "PREDNISOLONE ACETATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017100s048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17100"}, "17105": {"ApplNo": "17105", "Form": "TABLET;ORAL", "Drug": "TRANXENE", "ActiveIngredient": "CLORAZEPATE DIPOTASSIUM", "ApplType": "NDA", "Sponsor": "KEY THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17105"}, "17106": {"ApplNo": "17106", "Form": "SOLUTION;INTRAMUSCULAR", "Drug": "ATROPEN", "ActiveIngredient": "ATROPINE", "ApplType": "NDA", "Sponsor": "MMT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017106s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17106"}, "17116": {"ApplNo": "17116", "Form": "CONCENTRATE;ORAL", "Drug": "METHADOSE", "ActiveIngredient": "METHADONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SPECGX LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017116Orig1s043Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17116"}, "17243": {"ApplNo": "17243", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ULTRA-TECHNEKOW FM", "ActiveIngredient": "TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR", "ApplType": "NDA", "Sponsor": "CURIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017243Orig1s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17243"}, "17284": {"ApplNo": "17284", "Form": "GAS;INHALATION", "Drug": "XENON XE 133", "ActiveIngredient": "XENON XE-133", "ApplType": "NDA", "Sponsor": "LANTHEUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017284s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17284"}, "17340": {"ApplNo": "17340", "Form": "CREAM;TOPICAL", "Drug": "RETIN-A", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "VALEANT PHARMS NORTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17340"}, "17376": {"ApplNo": "17376", "Form": "TABLET;ORAL", "Drug": "SEPTRA", "ActiveIngredient": "SULFAMETHOXAZOLE; TRIMETHOPRIM", "ApplType": "NDA", "Sponsor": "MONARCH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017376s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17376"}, "17377": {"ApplNo": "17377", "Form": "TABLET;ORAL", "Drug": "BACTRIM", "ActiveIngredient": "SULFAMETHOXAZOLE; TRIMETHOPRIM", "ApplType": "NDA", "Sponsor": "SUN PHARM INDUSTRIES", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017377s083lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17377"}, "17378": {"ApplNo": "17378", "Form": "INJECTABLE;INJECTION", "Drug": "PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER", "ActiveIngredient": "MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017378s075lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17378"}, "17381": {"ApplNo": "17381", "Form": "CREAM;TOPICAL", "Drug": "SILVADENE", "ActiveIngredient": "SILVER SULFADIAZINE", "ApplType": "NDA", "Sponsor": "KING PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017381s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17381"}, "17398": {"ApplNo": "17398", "Form": "INJECTABLE;INJECTION", "Drug": "REGONOL", "ActiveIngredient": "PYRIDOSTIGMINE BROMIDE", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17398s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17398"}, "17422": {"ApplNo": "17422", "Form": "INJECTABLE;INJECTION", "Drug": "BICNU", "ActiveIngredient": "CARMUSTINE", "ApplType": "NDA", "Sponsor": "AVET LIFESCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017422s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17422"}, "17428": {"ApplNo": "17428", "Form": "LIQUID;IRRIGATION", "Drug": "STERILE WATER", "ActiveIngredient": "STERILE WATER FOR IRRIGATION", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017428s071_017866s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17428"}, "17441": {"ApplNo": "17441", "Form": "INJECTABLE;INJECTION", "Drug": "INFED", "ActiveIngredient": "FERRIC OXYHYDROXIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017441s179lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17441"}, "17442": {"ApplNo": "17442", "Form": "CAPSULE;ORAL", "Drug": "MINIPRESS", "ActiveIngredient": "PRAZOSIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017442 s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17442"}, "17443": {"ApplNo": "17443", "Form": "CAPSULE;ORAL", "Drug": "DANTRIUM", "ActiveIngredient": "DANTROLENE SODIUM", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/017443s043s046s048s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17443"}, "17450": {"ApplNo": "17450", "Form": "CREAM;VAGINAL", "Drug": "MONISTAT 7", "ActiveIngredient": "MICONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "MEDTECH PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017450Orig1s075,020670Orig1s036,021261Orig1s025,021308Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17450"}, "17453": {"ApplNo": "17453", "Form": "SUSPENSION;ORAL", "Drug": "PROGLYCEM", "ActiveIngredient": "DIAZOXIDE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017425s017,017453s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17453"}, "17469": {"ApplNo": "17469", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "OMNIPRED", "ActiveIngredient": "PREDNISOLONE ACETATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017469Orig1s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17469"}, "17478": {"ApplNo": "17478", "Form": "INJECTABLE;INJECTION", "Drug": "GALLIUM CITRATE GA 67", "ActiveIngredient": "GALLIUM CITRATE GA-67", "ApplType": "NDA", "Sponsor": "LANTHEUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017478s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17478"}, "17484": {"ApplNo": "17484", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017484s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17484"}, "17512": {"ApplNo": "17512", "Form": "SOLUTION;INTRAPERITONEAL", "Drug": "DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017512s122,020163s027,020183s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17512"}, "17522": {"ApplNo": "17522", "Form": "CREAM;TOPICAL", "Drug": "RETIN-A", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "VALEANT BERMUDA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17522"}, "17530": {"ApplNo": "17530", "Form": "INJECTABLE;INJECTION", "Drug": "TIGAN", "ActiveIngredient": "TRIMETHOBENZAMIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017530s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17530"}, "17532": {"ApplNo": "17532", "Form": "TABLET;ORAL", "Drug": "DIABETA", "ActiveIngredient": "GLYBURIDE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017532s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17532"}, "17533": {"ApplNo": "17533", "Form": "TABLET;ORAL", "Drug": "KLONOPIN", "ActiveIngredient": "CLONAZEPAM", "ApplType": "NDA", "Sponsor": "CHEPLAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17533"}, "17538": {"ApplNo": "17538", "Form": "INJECTABLE;INJECTION", "Drug": "TECHNESCAN PYP KIT", "ActiveIngredient": "TECHNETIUM TC-99M PYROPHOSPHATE KIT", "ApplType": "NDA", "Sponsor": "CURIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017538s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17538"}, "17555": {"ApplNo": "17555", "Form": "TABLET;ORAL", "Drug": "SINEMET", "ActiveIngredient": "CARBIDOPA; LEVODOPA", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017555s072lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17555"}, "17556": {"ApplNo": "17556", "Form": "CREAM;TOPICAL", "Drug": "HALOG", "ActiveIngredient": "HALCINONIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017556s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17556"}, "17563": {"ApplNo": "17563", "Form": "GRANULE;ORAL", "Drug": "FLAVORED COLESTID", "ActiveIngredient": "COLESTIPOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017563s023,020222s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17563"}, "17579": {"ApplNo": "17579", "Form": "GEL;TOPICAL", "Drug": "RETIN-A", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "VALEANT INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17579"}, "17581": {"ApplNo": "17581", "Form": "TABLET;ORAL", "Drug": "NAPROSYN", "ActiveIngredient": "NAPROXEN", "ApplType": "NDA", "Sponsor": "ATNAHS PHARMA US", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17581"}, "17588": {"ApplNo": "17588", "Form": "CAPSULE;ORAL", "Drug": "GLEOSTINE", "ActiveIngredient": "LOMUSTINE", "ApplType": "NDA", "Sponsor": "CORDEN PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017588Orig1s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17588"}, "17604": {"ApplNo": "17604", "Form": "CAPSULE;ORAL", "Drug": "NALFON", "ActiveIngredient": "FENOPROFEN CALCIUM", "ApplType": "NDA", "Sponsor": "XSPIRE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017604s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17604"}, "17607": {"ApplNo": "17607", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017607s123lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17607"}, "17624": {"ApplNo": "17624", "Form": "LIQUID;INHALATION", "Drug": "FORANE", "ActiveIngredient": "ISOFLURANE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017624s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17624"}, "17634": {"ApplNo": "17634", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; POTASSIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017634s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17634"}, "17643": {"ApplNo": "17643", "Form": "INJECTABLE;INJECTION", "Drug": "INTRALIPID 10%", "ActiveIngredient": "SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "FRESENIUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017643s082lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17643"}, "17648": {"ApplNo": "17648", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%", "ActiveIngredient": "POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017648s071lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17648"}, "17651": {"ApplNo": "17651", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017029s156,017651s066lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17651"}, "17681": {"ApplNo": "17681", "Form": "TABLET;ORAL", "Drug": "HIPREX", "ActiveIngredient": "METHENAMINE HIPPURATE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017681Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17681"}, "17692": {"ApplNo": "17692", "Form": "INJECTABLE;INJECTION", "Drug": "PREGNYL", "ActiveIngredient": "GONADOTROPIN, CHORIONIC", "ApplType": "BLA", "Sponsor": "ORGANON USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017692s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17692"}, "17697": {"ApplNo": "17697", "Form": "INJECTABLE;INJECTION", "Drug": "KINEVAC", "ActiveIngredient": "SINCALIDE", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017697s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17697"}, "17744": {"ApplNo": "17744", "Form": "TABLET;ORAL", "Drug": "MOTOFEN", "ActiveIngredient": "ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017744s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17744"}, "17765": {"ApplNo": "17765", "Form": "CREAM;TOPICAL", "Drug": "CLODERM", "ActiveIngredient": "CLOCORTOLONE PIVALATE", "ApplType": "NDA", "Sponsor": "EPI HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/17765scp024_cloderm_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17765"}, "17768": {"ApplNo": "17768", "Form": "SOLUTION;TOPICAL", "Drug": "HIBICLENS", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "MOLNLYCKE HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017768Orig1s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17768"}, "17771": {"ApplNo": "17771", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TECHNELITE", "ActiveIngredient": "TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR", "ApplType": "NDA", "Sponsor": "LANTHEUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017771Orig1s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17771"}, "17794": {"ApplNo": "17794", "Form": "TABLET;ORAL", "Drug": "ATIVAN", "ActiveIngredient": "LORAZEPAM", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17794"}, "17806": {"ApplNo": "17806", "Form": "INJECTABLE;INJECTION", "Drug": "THALLOUS CHLORIDE TL 201", "ActiveIngredient": "THALLOUS CHLORIDE TL-201", "ApplType": "NDA", "Sponsor": "LANTHEUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017806s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17806"}, "17808": {"ApplNo": "17808", "Form": "INJECTABLE;INJECTION", "Drug": "MIACALCIN", "ActiveIngredient": "CALCITONIN SALMON", "ApplType": "NDA", "Sponsor": "MYLAN IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017808s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17808"}, "17812": {"ApplNo": "17812", "Form": "CAPSULE;ORAL", "Drug": "LITHIUM CARBONATE", "ActiveIngredient": "LITHIUM CARBONATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17812"}, "17823": {"ApplNo": "17823", "Form": "SOLUTION;TOPICAL", "Drug": "HALOG", "ActiveIngredient": "HALCINONIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17823s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17823"}, "17824": {"ApplNo": "17824", "Form": "OINTMENT;TOPICAL", "Drug": "HALOG", "ActiveIngredient": "HALCINONIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17824s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17824"}, "17830": {"ApplNo": "17830", "Form": "TABLET;ORAL", "Drug": "LODOSYN", "ActiveIngredient": "CARBIDOPA", "ApplType": "NDA", "Sponsor": "ATON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017830s014s016s017s018s019s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17830"}, "17854": {"ApplNo": "17854", "Form": "TABLET;ORAL", "Drug": "REGLAN", "ActiveIngredient": "METOCLOPRAMIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017854s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17854"}, "17858": {"ApplNo": "17858", "Form": "SOLUTION;INJECTION, ORAL", "Drug": "AN-SULFUR COLLOID", "ActiveIngredient": "TECHNETIUM TC-99M SULFUR COLLOID KIT", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017858s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17858"}, "17866": {"ApplNo": "17866", "Form": "LIQUID;IRRIGATION", "Drug": "STERILE WATER IN PLASTIC CONTAINER", "ActiveIngredient": "STERILE WATER FOR IRRIGATION", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017428s071_017866s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17866"}, "17874": {"ApplNo": "17874", "Form": "SYSTEM;TRANSDERMAL", "Drug": "TRANSDERM SCOP", "ActiveIngredient": "SCOPOLAMINE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017874s043s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17874"}, "17881": {"ApplNo": "17881", "Form": "INJECTABLE;INJECTION", "Drug": "TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT", "ActiveIngredient": "TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT", "ApplType": "BLA", "Sponsor": "DRAXIMAGE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017881s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17881"}, "17892": {"ApplNo": "17892", "Form": "TABLET;ORAL", "Drug": "HALCION", "ActiveIngredient": "TRIAZOLAM", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17892"}, "17948": {"ApplNo": "17948", "Form": "TABLET;ORAL", "Drug": "NORMINEST FE", "ActiveIngredient": "ETHINYL ESTRADIOL;NORETHINDRONE; FERROUS FUMARATE", "ApplType": "NDA", "Sponsor": "GD SEARLE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017948s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17948"}, "17955": {"ApplNo": "17955", "Form": "GEL;TOPICAL", "Drug": "RETIN-A", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "VALEANT INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17955"}, "17962": {"ApplNo": "17962", "Form": "TABLET;ORAL", "Drug": "PARLODEL", "ActiveIngredient": "BROMOCRIPTINE MESYLATE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017962s083lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17962"}, "17963": {"ApplNo": "17963", "Form": "TABLET;ORAL", "Drug": "LOPRESSOR", "ActiveIngredient": "METOPROLOL TARTRATE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017963s068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17963"}, "17989": {"ApplNo": "17989", "Form": "INJECTABLE;INJECTION", "Drug": "HEMABATE", "ActiveIngredient": "CARBOPROST TROMETHAMINE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017989s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17989"}, "18008": {"ApplNo": "18008", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18008"}, "18013": {"ApplNo": "18013", "Form": "CAPSULE;ORAL", "Drug": "PAMELOR", "ActiveIngredient": "NORTRIPTYLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SPECGX LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18013"}, "18016": {"ApplNo": "18016", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016677s169,018016s067,020178s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18016"}, "18027": {"ApplNo": "18027", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "LITHOBID", "ActiveIngredient": "LITHIUM CARBONATE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18027"}, "18035": {"ApplNo": "18035", "Form": "INJECTABLE;INJECTION", "Drug": "DRAXIMAGE MDP-25", "ActiveIngredient": "TECHNETIUM TC-99M MEDRONATE", "ApplType": "NDA", "Sponsor": "JUBILANT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018035s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18035"}, "18037": {"ApplNo": "18037", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)", "ActiveIngredient": "DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18037"}, "18045": {"ApplNo": "18045", "Form": "CAPSULE;ORAL", "Drug": "EMCYT", "ActiveIngredient": "ESTRAMUSTINE PHOSPHATE SODIUM", "ApplType": "NDA", "Sponsor": "PHARMACIA AND UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018045s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18045"}, "18057": {"ApplNo": "18057", "Form": "INJECTABLE;INJECTION", "Drug": "CISPLATIN", "ActiveIngredient": "CISPLATIN", "ApplType": "NDA", "Sponsor": "HQ SPCLT PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018057s092lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18057"}, "18060": {"ApplNo": "18060", "Form": "SUPPOSITORY;RECTAL", "Drug": "ACEPHEN", "ActiveIngredient": "ACETAMINOPHEN", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018060Orig1s066lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18060"}, "18063": {"ApplNo": "18063", "Form": "TABLET;ORAL", "Drug": "CORGARD", "ActiveIngredient": "NADOLOL", "ApplType": "NDA", "Sponsor": "USWM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018063s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18063"}, "18066": {"ApplNo": "18066", "Form": "TABLET;ORAL", "Drug": "UNISOM", "ActiveIngredient": "DOXYLAMINE SUCCINATE", "ApplType": "NDA", "Sponsor": "CHATTEM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018066Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18066"}, "18074": {"ApplNo": "18074", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "PHENDIMETRAZINE TARTRATE", "ActiveIngredient": "PHENDIMETRAZINE TARTRATE", "ApplType": "NDA", "Sponsor": "VIRTUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018074Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18074"}, "18086": {"ApplNo": "18086", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "TIMOPTIC", "ActiveIngredient": "TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018086Orig1s080lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18086"}, "18090": {"ApplNo": "18090", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018090sS116lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18090"}, "18124": {"ApplNo": "18124", "Form": "INJECTABLE;INJECTION", "Drug": "CIS-MDP", "ActiveIngredient": "TECHNETIUM TC-99M MEDRONATE KIT", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018124s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18124"}, "18132": {"ApplNo": "18132", "Form": "INJECTABLE;INJECTION", "Drug": "DOPAMINE HYDROCHLORIDE", "ActiveIngredient": "DOPAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018132s067,018826s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18132"}, "18140": {"ApplNo": "18140", "Form": "INJECTABLE;INJECTION", "Drug": "ATIVAN", "ActiveIngredient": "LORAZEPAM", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018140s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18140"}, "18147": {"ApplNo": "18147", "Form": "CAPSULE;ORAL", "Drug": "FELDENE", "ActiveIngredient": "PIROXICAM", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018147_S052LBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18147"}, "18150": {"ApplNo": "18150", "Form": "INJECTABLE;INJECTION", "Drug": "THALLOUS CHLORIDE TL 201", "ActiveIngredient": "THALLOUS CHLORIDE TL-201", "ApplType": "NDA", "Sponsor": "CURIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018150s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18150"}, "18163": {"ApplNo": "18163", "Form": "CAPSULE;ORAL", "Drug": "RESTORIL", "ActiveIngredient": "TEMAZEPAM", "ApplType": "NDA", "Sponsor": "SPECGX LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18163"}, "18164": {"ApplNo": "18164", "Form": "TABLET;ORAL", "Drug": "ANAPROX DS", "ActiveIngredient": "NAPROXEN SODIUM", "ApplType": "NDA", "Sponsor": "ATNAHS PHARMA US", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18164"}, "18200": {"ApplNo": "18200", "Form": "TABLET;ORAL", "Drug": "MIDAMOR", "ActiveIngredient": "AMILORIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/18-200S024_Midamor_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18200"}, "18206": {"ApplNo": "18206", "Form": "TABLET;ORAL", "Drug": "LO/OVRAL FE", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL; FERROUS FUMARATE", "ApplType": "NDA", "Sponsor": "CADENCE HEALTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018206s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18206"}, "18225": {"ApplNo": "18225", "Form": "TABLET;ORAL", "Drug": "BUMEX", "ActiveIngredient": "BUMETANIDE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018225s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18225"}, "18227": {"ApplNo": "18227", "Form": "INJECTABLE;INJECTION", "Drug": "AMIDATE", "ActiveIngredient": "ETOMIDATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018227s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18227"}, "18240": {"ApplNo": "18240", "Form": "TABLET;ORAL", "Drug": "TENORMIN", "ActiveIngredient": "ATENOLOL", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018240s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18240"}, "18248": {"ApplNo": "18248", "Form": "INJECTABLE;INJECTION", "Drug": "OXYTOCIN", "ActiveIngredient": "OXYTOCIN", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018248s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18248"}, "18261": {"ApplNo": "18261", "Form": "INJECTABLE;INJECTION", "Drug": "PITOCIN", "ActiveIngredient": "OXYTOCIN", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018261Orig1s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18261"}, "18264": {"ApplNo": "18264", "Form": "INJECTABLE;INJECTION", "Drug": "DANTRIUM", "ActiveIngredient": "DANTROLENE SODIUM", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018264s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18264"}, "18276": {"ApplNo": "18276", "Form": "TABLET;ORAL", "Drug": "XANAX", "ActiveIngredient": "ALPRAZOLAM", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18276"}, "18279": {"ApplNo": "18279", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "K-TAB", "ActiveIngredient": "POTASSIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018279Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18279"}, "18300": {"ApplNo": "18300", "Form": "SOLUTION;TOPICAL", "Drug": "HIBISTAT", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "MOLNLYCKE HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018300Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18300"}, "18303": {"ApplNo": "18303", "Form": "TABLET;ORAL", "Drug": "LOPRESSOR HCT", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018303s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18303"}, "18304": {"ApplNo": "18304", "Form": "INJECTABLE;INJECTION", "Drug": "SENSORCAINE", "ActiveIngredient": "BUPIVACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018304s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18304"}, "18321": {"ApplNo": "18321", "Form": "INJECTABLE;INJECTION", "Drug": "TECHNESCAN", "ActiveIngredient": "TECHNETIUM TC-99M OXIDRONATE KIT", "ApplType": "NDA", "Sponsor": "CURIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018321s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18321"}, "18327": {"ApplNo": "18327", "Form": "GAS;INHALATION", "Drug": "XENON XE 133", "ActiveIngredient": "XENON XE-133", "ApplType": "NDA", "Sponsor": "CURIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018327s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18327"}, "18332": {"ApplNo": "18332", "Form": "SUSPENSION;ORAL", "Drug": "INDOCIN", "ActiveIngredient": "INDOMETHACIN", "ApplType": "NDA", "Sponsor": "EGALET", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018332s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18332"}, "18333": {"ApplNo": "18333", "Form": "TABLET;ORAL", "Drug": "CARAFATE", "ActiveIngredient": "SUCRALFATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018333s034,019183s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18333"}, "18337": {"ApplNo": "18337", "Form": "SUPPOSITORY;RECTAL", "Drug": "ACETAMINOPHEN", "ActiveIngredient": "ACETAMINOPHEN", "ApplType": "NDA", "Sponsor": "TARO PHARM INDS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018337Orig1s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18337"}, "18401": {"ApplNo": "18401", "Form": "INJECTABLE;INJECTION", "Drug": "BUPRENEX", "ActiveIngredient": "BUPRENORPHINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "INDIVIOR INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018401s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18401"}, "18422": {"ApplNo": "18422", "Form": "TABLET;ORAL", "Drug": "LOPID", "ActiveIngredient": "GEMFIBROZIL", "ApplType": "NDA", "Sponsor": "PFIZER PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018422s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18422"}, "18449": {"ApplNo": "18449", "Form": "INJECTABLE;INJECTION", "Drug": "INTRALIPID 20%", "ActiveIngredient": "SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "FRESENIUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018449s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18449"}, "18461": {"ApplNo": "18461", "Form": "INJECTABLE;INJECTION", "Drug": "LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "LIDOCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018461s058lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18461"}, "18469": {"ApplNo": "18469", "Form": "SOLUTION;IRRIGATION", "Drug": "BSS PLUS", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE", "ApplType": "NDA", "Sponsor": "ALCON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018469s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18469"}, "18482": {"ApplNo": "18482", "Form": "CAPSULE;ORAL", "Drug": "PROCARDIA", "ActiveIngredient": "NIFEDIPINE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018482s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18482"}, "18484": {"ApplNo": "18484", "Form": "INJECTABLE;INJECTION", "Drug": "PROSTIN VR PEDIATRIC", "ActiveIngredient": "ALPROSTADIL", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018484Orig1s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18484"}, "18487": {"ApplNo": "18487", "Form": "TABLET;ORAL", "Drug": "FUROSEMIDE", "ActiveIngredient": "FUROSEMIDE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018487s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18487"}, "18511": {"ApplNo": "18511", "Form": "INJECTABLE;INJECTION", "Drug": "DRAXIMAGE DTPA", "ActiveIngredient": "TECHNETIUM TC-99M PENTETATE KIT", "ApplType": "NDA", "Sponsor": "JUBILANT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018511Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18511"}, "18514": {"ApplNo": "18514", "Form": "CREAM;TOPICAL", "Drug": "LOCOID", "ActiveIngredient": "HYDROCORTISONE BUTYRATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018514s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18514"}, "18553": {"ApplNo": "18553", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "INDERAL LA", "ActiveIngredient": "PROPRANOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018553s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18553"}, "18558": {"ApplNo": "18558", "Form": "TABLET;ORAL", "Drug": "LITHIUM CARBONATE", "ActiveIngredient": "LITHIUM CARBONATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18558"}, "18561": {"ApplNo": "18561", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 70% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18561"}, "18562": {"ApplNo": "18562", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 40% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18562"}, "18563": {"ApplNo": "18563", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 50% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18563"}, "18564": {"ApplNo": "18564", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 20% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18564"}, "18565": {"ApplNo": "18565", "Form": "INJECTABLE;INJECTION", "Drug": "DURAMORPH PF", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018565s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18565"}, "18569": {"ApplNo": "18569", "Form": "TABLET;ORAL", "Drug": "FUROSEMIDE", "ActiveIngredient": "FUROSEMIDE", "ApplType": "NDA", "Sponsor": "EPIC PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018569s066lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18569"}, "18594": {"ApplNo": "18594", "Form": "OINTMENT;TOPICAL", "Drug": "TOPICORT", "ActiveIngredient": "DESOXIMETASONE", "ApplType": "NDA", "Sponsor": "TARO PHARM INDS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018594Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18594"}, "18602": {"ApplNo": "18602", "Form": "TABLET;ORAL", "Drug": "CARDIZEM", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018602Orig1s069lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18602"}, "18604": {"ApplNo": "18604", "Form": "OINTMENT;TOPICAL", "Drug": "ZOVIRAX", "ActiveIngredient": "ACYCLOVIR", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/018604s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18604"}, "18609": {"ApplNo": "18609", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018609s058lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18609"}, "18612": {"ApplNo": "18612", "Form": "GUM, CHEWING;BUCCAL", "Drug": "NICORETTE", "ActiveIngredient": "NICOTINE POLACRILEX", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018612Orig1s083,020066Orig1s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18612"}, "18615": {"ApplNo": "18615", "Form": "SUSPENSION;ORAL", "Drug": "SULFATRIM PEDIATRIC", "ActiveIngredient": "SULFAMETHOXAZOLE; TRIMETHOPRIM", "ApplType": "NDA", "Sponsor": "PHARM ASSOC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018615s080lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18615"}, "18629": {"ApplNo": "18629", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18629"}, "18632": {"ApplNo": "18632", "Form": "LIQUID;N/A", "Drug": "STERILE WATER FOR INJECTION IN PLASTIC CONTAINER", "ActiveIngredient": "STERILE WATER FOR INJECTION", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018632s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18632"}, "18651": {"ApplNo": "18651", "Form": "CAPSULE;ORAL", "Drug": "MARINOL", "ActiveIngredient": "DRONABINOL", "ApplType": "NDA", "Sponsor": "ALKEM LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018651s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18651"}, "18652": {"ApplNo": "18652", "Form": "OINTMENT;TOPICAL", "Drug": "LOCOID", "ActiveIngredient": "HYDROCORTISONE BUTYRATE", "ApplType": "NDA", "Sponsor": "PRECISION DERMAT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018652s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18652"}, "18657": {"ApplNo": "18657", "Form": "INJECTABLE;INJECTION", "Drug": "FLAGYL I.V. RTU IN PLASTIC CONTAINER", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018657s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18657"}, "18658": {"ApplNo": "18658", "Form": "SUSPENSION, EXTENDED RELEASE;ORAL", "Drug": "DELSYM", "ActiveIngredient": "DEXTROMETHORPHAN POLISTIREX", "ApplType": "NDA", "Sponsor": "RB HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018658Orig1s030lbl_replacement.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18658"}, "18667": {"ApplNo": "18667", "Form": "INJECTABLE;INJECTION", "Drug": "FUROSEMIDE", "ActiveIngredient": "FUROSEMIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018667s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18667"}, "18671": {"ApplNo": "18671", "Form": "CAPSULE;ORAL", "Drug": "SODIUM IODIDE I 123", "ActiveIngredient": "SODIUM IODIDE I-123", "ApplType": "NDA", "Sponsor": "CARDINAL HEALTH 418", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018671s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18671"}, "18677": {"ApplNo": "18677", "Form": "CAPSULE;ORAL", "Drug": "CESAMET", "ActiveIngredient": "NABILONE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018677Orig1s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18677"}, "18679": {"ApplNo": "18679", "Form": "TABLET;ORAL", "Drug": "TRIMETHOPRIM", "ActiveIngredient": "TRIMETHOPRIM", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018679s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18679"}, "18680": {"ApplNo": "18680", "Form": "INTRAUTERINE DEVICE;INTRAUTERINE", "Drug": "PARAGARD T 380A", "ActiveIngredient": "COPPER", "ApplType": "NDA", "Sponsor": "COOPERSURGICAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018680s069s070lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18680"}, "18681": {"ApplNo": "18681", "Form": "SOLUTION;IRRIGATION", "Drug": "LACTATED RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018681s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18681"}, "18692": {"ApplNo": "18692", "Form": "INJECTABLE;SPINAL", "Drug": "MARCAINE", "ActiveIngredient": "BUPIVACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018692s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18692"}, "18701": {"ApplNo": "18701", "Form": "INJECTABLE;INJECTION", "Drug": "HALDOL", "ActiveIngredient": "HALOPERIDOL DECANOATE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/015923s093s098,018701s071s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18701"}, "18705": {"ApplNo": "18705", "Form": "SPRAY, METERED;SUBLINGUAL", "Drug": "NITROLINGUAL PUMPSPRAY", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "NDA", "Sponsor": "POHL BOSKAMP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018705s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18705"}, "18708": {"ApplNo": "18708", "Form": "TABLET;ORAL", "Drug": "DORAL", "ActiveIngredient": "QUAZEPAM", "ApplType": "NDA", "Sponsor": "GALT PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18708"}, "18714": {"ApplNo": "18714", "Form": "TABLET;ORAL", "Drug": "BILTRICIDE", "ActiveIngredient": "PRAZIQUANTEL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018714s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18714"}, "18716": {"ApplNo": "18716", "Form": "TABLET;ORAL", "Drug": "TRANDATE", "ActiveIngredient": "LABETALOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALVOGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018716s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18716"}, "18723": {"ApplNo": "18723", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "DEPAKOTE", "ActiveIngredient": "DIVALPROEX SODIUM", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018723s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18723"}, "18735": {"ApplNo": "18735", "Form": "INJECTABLE;INJECTION", "Drug": "ISOVUE-M 200", "ActiveIngredient": "IOPAMIDOL", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018735s067lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18735"}, "18737": {"ApplNo": "18737", "Form": "CREAM;TOPICAL", "Drug": "EXELDERM", "ActiveIngredient": "SULCONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "JOURNEY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/18737slr003_exelderm_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18737"}, "18738": {"ApplNo": "18738", "Form": "SOLUTION;TOPICAL", "Drug": "EXELDERM", "ActiveIngredient": "SULCONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "JOURNEY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018738s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18738"}, "18741": {"ApplNo": "18741", "Form": "OINTMENT, AUGMENTED;TOPICAL", "Drug": "DIPROLENE", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018741s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18741"}, "18748": {"ApplNo": "18748", "Form": "CREAM;TOPICAL", "Drug": "LOPROX", "ActiveIngredient": "CICLOPIROX", "ApplType": "NDA", "Sponsor": "MEDIMETRIKS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018748s024,019824s023,020519s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18748"}, "18760": {"ApplNo": "18760", "Form": "TABLET;ORAL", "Drug": "TENORETIC 100", "ActiveIngredient": "ATENOLOL; CHLORTHALIDONE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018760s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18760"}, "18771": {"ApplNo": "18771", "Form": "INSERT;OPHTHALMIC", "Drug": "LACRISERT", "ActiveIngredient": "HYDROXYPROPYL CELLULOSE", "ApplType": "NDA", "Sponsor": "VALEANT PHARMS INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018771s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18771"}, "18780": {"ApplNo": "18780", "Form": "INJECTABLE;INJECTION", "Drug": "HUMULIN R", "ActiveIngredient": "INSULIN RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018780s180lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18780"}, "18781": {"ApplNo": "18781", "Form": "INJECTABLE;INJECTION", "Drug": "HUMULIN N", "ActiveIngredient": "INSULIN SUSP ISOPHANE RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018781s193lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18781"}, "18823": {"ApplNo": "18823", "Form": "TABLET;ORAL", "Drug": "FUROSEMIDE", "ActiveIngredient": "FUROSEMIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018823s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18823"}, "18826": {"ApplNo": "18826", "Form": "INJECTABLE;INJECTION", "Drug": "DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DOPAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018826s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18826"}, "18827": {"ApplNo": "18827", "Form": "CREAM;TOPICAL", "Drug": "LOTRISONE", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018827s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18827"}, "18841": {"ApplNo": "18841", "Form": "TABLET;ORAL", "Drug": "DAYPRO", "ActiveIngredient": "OXAPROZIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018841s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18841"}, "18883": {"ApplNo": "18883", "Form": "SOLUTION;INTRAPERITONEAL", "Drug": "DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "FRESENIUS MEDCL", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018883Orig1s057,020171Orig1s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18883"}, "18890": {"ApplNo": "18890", "Form": "INJECTABLE;INJECTION", "Drug": "METRONIDAZOLE IN PLASTIC CONTAINER", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018890s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18890"}, "18891": {"ApplNo": "18891", "Form": "SYSTEM;TRANSDERMAL", "Drug": "CATAPRES-TTS-1", "ActiveIngredient": "CLONIDINE", "ApplType": "NDA", "Sponsor": "LAVIPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018891s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18891"}, "18893": {"ApplNo": "18893", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM ACETATE", "ActiveIngredient": "SODIUM ACETATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018893s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18893"}, "18897": {"ApplNo": "18897", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SODIUM CHLORIDE 14.6%", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018897Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18897"}, "18900": {"ApplNo": "18900", "Form": "INJECTABLE;INJECTION", "Drug": "METRO I.V. IN PLASTIC CONTAINER", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018900s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18900"}, "18902": {"ApplNo": "18902", "Form": "INJECTABLE;INJECTION", "Drug": "FUROSEMIDE", "ActiveIngredient": "FUROSEMIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018902Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18902"}, "18916": {"ApplNo": "18916", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018916s071lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18916"}, "18921": {"ApplNo": "18921", "Form": "SOLUTION;IRRIGATION", "Drug": "LACTATED RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018921s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18921"}, "18925": {"ApplNo": "18925", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VERAPAMIL HYDROCHLORIDE", "ActiveIngredient": "VERAPAMIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018925s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18925"}, "18927": {"ApplNo": "18927", "Form": "SUSPENSION;ORAL", "Drug": "TEGRETOL", "ActiveIngredient": "CARBAMAZEPINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18927"}, "18931": {"ApplNo": "18931", "Form": "INJECTABLE;INJECTION", "Drug": "TRAVASOL 5.5% IN PLASTIC CONTAINER", "ActiveIngredient": "AMINO ACIDS", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018931s055,020849s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18931"}, "18936": {"ApplNo": "18936", "Form": "CAPSULE;ORAL", "Drug": "PROZAC", "ActiveIngredient": "FLUOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018936s111lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18936"}, "18938": {"ApplNo": "18938", "Form": "INJECTABLE;INJECTION", "Drug": "DDAVP", "ActiveIngredient": "DESMOPRESSIN ACETATE", "ApplType": "NDA", "Sponsor": "FERRING PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018938Orig1s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18938"}, "18948": {"ApplNo": "18948", "Form": "TABLET;ORAL", "Drug": "CARNITOR", "ActiveIngredient": "LEVOCARNITINE", "ApplType": "NDA", "Sponsor": "LEADIANT BIOSCI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018948s028,019257s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18948"}, "18956": {"ApplNo": "18956", "Form": "SOLUTION;INJECTION, ORAL, RECTAL", "Drug": "OMNIPAQUE 180", "ActiveIngredient": "IOHEXOL", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018956s113,020608s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18956"}, "18961": {"ApplNo": "18961", "Form": "INJECTABLE;INJECTION", "Drug": "CHROMIC CHLORIDE IN PLASTIC CONTAINER", "ActiveIngredient": "CHROMIC CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/18961s12lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18961"}, "18962": {"ApplNo": "18962", "Form": "INJECTABLE;INJECTION", "Drug": "MANGANESE CHLORIDE IN PLASTIC CONTAINER", "ActiveIngredient": "MANGANESE CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/18962slr011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18962"}, "18965": {"ApplNo": "18965", "Form": "SUSPENSION;ORAL", "Drug": "NAPROSYN", "ActiveIngredient": "NAPROXEN", "ApplType": "NDA", "Sponsor": "ATNAHS PHARMA US", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018965s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18965"}, "18977": {"ApplNo": "18977", "Form": "TABLET;ORAL-28", "Drug": "TRI-NORINYL 28-DAY", "ActiveIngredient": "ETHINYL ESTRADIOL; NORETHINDRONE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018977s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18977"}, "18983": {"ApplNo": "18983", "Form": "FOR SOLUTION;ORAL", "Drug": "COLYTE WITH FLAVOR PACKS", "ActiveIngredient": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018983s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18983"}, "18989": {"ApplNo": "18989", "Form": "TABLET;ORAL", "Drug": "ADVIL", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018989Orig1s099lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18989"}, "18998": {"ApplNo": "18998", "Form": "TABLET;ORAL", "Drug": "VASOTEC", "ActiveIngredient": "ENALAPRIL MALEATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018998s083lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18998"}, "19011": {"ApplNo": "19011", "Form": "FOR SOLUTION;ORAL", "Drug": "GOLYTELY", "ActiveIngredient": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS", "ApplType": "NDA", "Sponsor": "BRAINTREE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19011"}, "19012": {"ApplNo": "19012", "Form": "TABLET;ORAL", "Drug": "MOTRIN IB", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019012Orig1s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19012"}, "19018": {"ApplNo": "19018", "Form": "INJECTABLE;INJECTION", "Drug": "TROPHAMINE", "ActiveIngredient": "AMINO ACIDS", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019018Orig1s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19018"}, "19022": {"ApplNo": "19022", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 3% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019022s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19022"}, "19028": {"ApplNo": "19028", "Form": "SOLUTION;DENTAL", "Drug": "PERIDEX", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "3M", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019028s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19028"}, "19034": {"ApplNo": "19034", "Form": "INJECTABLE;INJECTION", "Drug": "DILAUDID", "ActiveIngredient": "HYDROMORPHONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019034s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19034"}, "19044": {"ApplNo": "19044", "Form": "INJECTABLE;INJECTION", "Drug": "INDIUM IN 111 OXYQUINOLINE", "ActiveIngredient": "INDIUM IN-111 OXYQUINOLINE", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019044Orig1s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19044"}, "19049": {"ApplNo": "19049", "Form": "CREAM;TOPICAL", "Drug": "RETIN-A", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19049"}, "19050": {"ApplNo": "19050", "Form": "INJECTABLE;INJECTION", "Drug": "SUFENTA PRESERVATIVE FREE", "ActiveIngredient": "SUFENTANIL CITRATE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019050s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19050"}, "19071": {"ApplNo": "19071", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "UROCIT-K", "ActiveIngredient": "POTASSIUM CITRATE", "ApplType": "NDA", "Sponsor": "MISSION PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019071s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19071"}, "19079": {"ApplNo": "19079", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "FLAREX", "ActiveIngredient": "FLUOROMETHOLONE ACETATE", "ApplType": "NDA", "Sponsor": "EYEVANCE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019079s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19079"}, "19090": {"ApplNo": "19090", "Form": "INJECTABLE;INJECTION", "Drug": "ZANTAC", "ActiveIngredient": "RANITIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PAI HOLDINGS PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019090s053,019593s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19090"}, "19101": {"ApplNo": "19101", "Form": "INJECTABLE;INJECTION", "Drug": "FENTANYL CITRATE PRESERVATIVE FREE", "ActiveIngredient": "FENTANYL CITRATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019101s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19101"}, "19115": {"ApplNo": "19115", "Form": "INJECTABLE;INJECTION", "Drug": "FENTANYL CITRATE", "ActiveIngredient": "FENTANYL CITRATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019115s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19115"}, "19116": {"ApplNo": "19116", "Form": "SOLUTION;TOPICAL", "Drug": "LOCOID", "ActiveIngredient": "HYDROCORTISONE BUTYRATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019116s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19116"}, "19123": {"ApplNo": "19123", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "KLOR-CON", "ActiveIngredient": "POTASSIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019123s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19123"}, "19125": {"ApplNo": "19125", "Form": "SOLUTION;TOPICAL", "Drug": "EXIDINE", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "XTTRIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019125Orig1s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19125"}, "19127": {"ApplNo": "19127", "Form": "AEROSOL, METERED;TOPICAL", "Drug": "EXIDINE", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "XTTRIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019127Orig1s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19127"}, "19129": {"ApplNo": "19129", "Form": "TABLET;ORAL", "Drug": "MAXZIDE", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; TRIAMTERENE", "ApplType": "NDA", "Sponsor": "AUROBINDO PHARMA USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019129s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19129"}, "19152": {"ApplNo": "19152", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CALAN SR", "ActiveIngredient": "VERAPAMIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019152Orig1s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19152"}, "19157": {"ApplNo": "19157", "Form": "SOLUTION;ORAL", "Drug": "PEDIAPRED", "ActiveIngredient": "PREDNISOLONE SODIUM PHOSPHATE", "ApplType": "NDA", "Sponsor": "SETON PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019157s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19157"}, "19183": {"ApplNo": "19183", "Form": "SUSPENSION;ORAL", "Drug": "CARAFATE", "ActiveIngredient": "SUCRALFATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019183s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19183"}, "19193": {"ApplNo": "19193", "Form": "FOR SOLUTION;INHALATION", "Drug": "PROVOCHOLINE", "ActiveIngredient": "METHACHOLINE CHLORIDE", "ApplType": "NDA", "Sponsor": "METHAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019193s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19193"}, "19216": {"ApplNo": "19216", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "FML FORTE", "ActiveIngredient": "FLUOROMETHOLONE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019216s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19216"}, "19219": {"ApplNo": "19219", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "BETAGAN", "ActiveIngredient": "LEVOBUNOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019219s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19219"}, "19221": {"ApplNo": "19221", "Form": "TABLET;ORAL", "Drug": "VASERETIC", "ActiveIngredient": "ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019221s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19221"}, "19257": {"ApplNo": "19257", "Form": "SOLUTION;ORAL", "Drug": "CARNITOR", "ActiveIngredient": "LEVOCARNITINE", "ApplType": "NDA", "Sponsor": "LEADIANT BIOSCI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018948s028,019257s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19257"}, "19258": {"ApplNo": "19258", "Form": "SOLUTION;TOPICAL", "Drug": "CIDA-STAT", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "ECOLAB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019258Orig1s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19258"}, "19261": {"ApplNo": "19261", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PAREMYD", "ActiveIngredient": "HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/19261s8lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19261"}, "19268": {"ApplNo": "19268", "Form": "TABLET;ORAL", "Drug": "CYTOTEC", "ActiveIngredient": "MISOPROSTOL", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019268s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19268"}, "19270": {"ApplNo": "19270", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "BETOPTIC", "ActiveIngredient": "BETAXOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/19270s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19270"}, "19281": {"ApplNo": "19281", "Form": "INJECTABLE;INJECTION", "Drug": "CYKLOKAPRON", "ActiveIngredient": "TRANEXAMIC ACID", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019281Orig1s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19281"}, "19308": {"ApplNo": "19308", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19308"}, "19316": {"ApplNo": "19316", "Form": "SOLUTION;INTRAMUSCULAR, INTRAVENOUS", "Drug": "MAGNESIUM SULFATE", "ActiveIngredient": "MAGNESIUM SULFATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019316s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19316"}, "19339": {"ApplNo": "19339", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018916s063,019339s052,019805s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19339"}, "19345": {"ApplNo": "19345", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 30% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19345"}, "19353": {"ApplNo": "19353", "Form": "INJECTABLE;INJECTION", "Drug": "ALFENTA", "ActiveIngredient": "ALFENTANIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019353s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19353"}, "19356": {"ApplNo": "19356", "Form": "GEL;TOPICAL", "Drug": "NAFTIN", "ActiveIngredient": "NAFTIFINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019356s008,019599s014,204286s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19356"}, "19367": {"ApplNo": "19367", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019367s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19367"}, "19386": {"ApplNo": "19386", "Form": "INJECTABLE;INJECTION", "Drug": "BREVIBLOC IN PLASTIC CONTAINER", "ActiveIngredient": "ESMOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019386s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19386"}, "19389": {"ApplNo": "19389", "Form": "SPRAY, METERED;NASAL", "Drug": "BECONASE AQ", "ActiveIngredient": "BECLOMETHASONE DIPROPIONATE MONOHYDRATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019389Orig1s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19389"}, "19414": {"ApplNo": "19414", "Form": "INJECTABLE;INJECTION", "Drug": "CARDIOGEN-82", "ActiveIngredient": "RUBIDIUM CHLORIDE RB-82", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019414Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19414"}, "19422": {"ApplNo": "19422", "Form": "SOLUTION;TOPICAL", "Drug": "EXIDINE", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "XTTRIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019422Orig1s049Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19422"}, "19430": {"ApplNo": "19430", "Form": "INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS", "Drug": "EPIPEN", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019430Orig1s091lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19430"}, "19452": {"ApplNo": "19452", "Form": "OIL;TOPICAL", "Drug": "DERMA-SMOOTHE/FS", "ActiveIngredient": "FLUOCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "HILL DERMAC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019452Orig1s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19452"}, "19463": {"ApplNo": "19463", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "TIMOPTIC IN OCUDOSE", "ActiveIngredient": "TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019463s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19463"}, "19465": {"ApplNo": "19465", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019465s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19465"}, "19480": {"ApplNo": "19480", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019480s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19480"}, "19481": {"ApplNo": "19481", "Form": "SOLUTION;IRRIGATION", "Drug": "RENACIDIN", "ActiveIngredient": "CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE", "ApplType": "NDA", "Sponsor": "UNITED GUARDIAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019481s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19481"}, "19487": {"ApplNo": "19487", "Form": "SOLUTION;ORAL", "Drug": "IMODIUM A-D", "ActiveIngredient": "LOPERAMIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019487Orig1s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19487"}, "19501": {"ApplNo": "19501", "Form": "SOLUTION;TOPICAL", "Drug": "ROGAINE (FOR MEN)", "ActiveIngredient": "MINOXIDIL", "ApplType": "NDA", "Sponsor": "JOHNSON AND JOHNSON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019501Orig1s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19501"}, "19516": {"ApplNo": "19516", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MS CONTIN", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "NDA", "Sponsor": "PURDUE PHARMA LP", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019516s057lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19516"}, "19531": {"ApplNo": "19531", "Form": "INJECTABLE;INJECTION", "Drug": "NUTRILIPID 10%", "ActiveIngredient": "SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019531s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19531"}, "19537": {"ApplNo": "19537", "Form": "TABLET;ORAL", "Drug": "CIPRO", "ActiveIngredient": "CIPROFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019537s092lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19537"}, "19569": {"ApplNo": "19569", "Form": "TABLET;ORAL", "Drug": "THIOLA", "ActiveIngredient": "TIOPRONIN", "ApplType": "NDA", "Sponsor": "MISSION PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019569s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19569"}, "19574": {"ApplNo": "19574", "Form": "TABLET;ORAL", "Drug": "THALITONE", "ActiveIngredient": "CHLORTHALIDONE", "ApplType": "NDA", "Sponsor": "CASPER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019574s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19574"}, "19594": {"ApplNo": "19594", "Form": "CAPSULE;ORAL", "Drug": "ACTIGALL", "ActiveIngredient": "URSODIOL", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019594s21lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19594"}, "19599": {"ApplNo": "19599", "Form": "CREAM;TOPICAL", "Drug": "NAFTIN", "ActiveIngredient": "NAFTIFINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019356s008,019599s014,204286s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19599"}, "19600": {"ApplNo": "19600", "Form": "CAPSULE;ORAL", "Drug": "OXSORALEN-ULTRA", "ActiveIngredient": "METHOXSALEN", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19600slr006,009_oxsoralen-ultra_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19600"}, "19603": {"ApplNo": "19603", "Form": "INJECTABLE;INJECTION", "Drug": "MANNITOL 20% IN PLASTIC CONTAINER", "ActiveIngredient": "MANNITOL", "ApplType": "NDA", "Sponsor": "ICU MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019603s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19603"}, "19614": {"ApplNo": "19614", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "VERELAN", "ActiveIngredient": "VERAPAMIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SOCIETAL CDMO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019614s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19614"}, "19615": {"ApplNo": "19615", "Form": "INJECTABLE;INJECTION", "Drug": "DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DOPAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019615s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19615"}, "19617": {"ApplNo": "19617", "Form": "GEL;ENDOCERVICAL", "Drug": "PREPIDIL", "ActiveIngredient": "DINOPROSTONE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019617s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19617"}, "19618": {"ApplNo": "19618", "Form": "ENEMA;RECTAL", "Drug": "ROWASA", "ActiveIngredient": "MESALAMINE", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019618s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19618"}, "19626": {"ApplNo": "19626", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019626s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19626"}, "19627": {"ApplNo": "19627", "Form": "INJECTABLE;INJECTION", "Drug": "DIPRIVAN", "ActiveIngredient": "PROPOFOL", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019627s069lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19627"}, "19630": {"ApplNo": "19630", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19630s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19630"}, "19631": {"ApplNo": "19631", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19631s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19631"}, "19632": {"ApplNo": "19632", "Form": "INJECTABLE;INJECTION", "Drug": "LACTATED RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019632s050,019634s050,020002s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19632"}, "19634": {"ApplNo": "19634", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019632s050,019634s050,020002s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19634"}, "19635": {"ApplNo": "19635", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019635s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19635"}, "19640": {"ApplNo": "19640", "Form": "INJECTABLE;INJECTION", "Drug": "HUMATROPE", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19640s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19640"}, "19649": {"ApplNo": "19649", "Form": "TABLET;ORAL", "Drug": "FLUMADINE", "ActiveIngredient": "RIMANTADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019649s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19649"}, "19655": {"ApplNo": "19655", "Form": "CAPSULE;ORAL", "Drug": "RETROVIR", "ActiveIngredient": "ZIDOVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019655Orig1s059,019910Orig1s046,019951Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19655"}, "19658": {"ApplNo": "19658", "Form": "TABLET;ORAL", "Drug": "CLARITIN", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019658Orig1s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19658"}, "19667": {"ApplNo": "19667", "Form": "INJECTABLE;INJECTION", "Drug": "SANDOSTATIN", "ActiveIngredient": "OCTREOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019667s073lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19667"}, "19668": {"ApplNo": "19668", "Form": "TABLET;ORAL", "Drug": "CARDURA", "ActiveIngredient": "DOXAZOSIN MESYLATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019668Orig1s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19668"}, "19670": {"ApplNo": "19670", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CLARITIN-D", "ActiveIngredient": "LORATADINE; PSEUDOEPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019670Orig1s034,020470Orig1s047Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19670"}, "19676": {"ApplNo": "19676", "Form": "Injectable; Injection", "Drug": "NUTROPIN", "ActiveIngredient": "SOMATROPIN [rDNA origin]", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019676s020,021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19676"}, "19680": {"ApplNo": "19680", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "DEPAKOTE", "ActiveIngredient": "DIVALPROEX SODIUM", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19680"}, "19684": {"ApplNo": "19684", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "PROCARDIA XL", "ActiveIngredient": "NIFEDIPINE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019684s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19684"}, "19699": {"ApplNo": "19699", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE; POTASSIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019699s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19699"}, "19700": {"ApplNo": "19700", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ACULAR", "ActiveIngredient": "KETOROLAC TROMETHAMINE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019700s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19700"}, "19708": {"ApplNo": "19708", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19708s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19708"}, "19710": {"ApplNo": "19710", "Form": "INJECTABLE;INJECTION", "Drug": "OPTIRAY 320", "ActiveIngredient": "IOVERSOL", "ApplType": "NDA", "Sponsor": "LIEBEL-FLARSHEIM", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019710Orig1s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19710"}, "19715": {"ApplNo": "19715", "Form": "CAPSULE;ORAL", "Drug": "DIPENTUM", "ActiveIngredient": "OLSALAZINE SODIUM", "ApplType": "NDA", "Sponsor": "MYLAN SPCLT VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019715s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19715"}, "19717": {"ApplNo": "19717", "Form": "INJECTABLE;INJECTION", "Drug": "HUMULIN 70/30", "ActiveIngredient": "INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019717s174lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19717"}, "19726": {"ApplNo": "19726", "Form": "IMPLANT;IMPLANTATION", "Drug": "ZOLADEX", "ActiveIngredient": "GOSERELIN ACETATE", "ApplType": "NDA", "Sponsor": "TERSERA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019726s059,020578s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19726"}, "19732": {"ApplNo": "19732", "Form": "INJECTABLE;INJECTION", "Drug": "LUPRON DEPOT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "ABBVIE ENDOCRINE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019732s045,020517s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19732"}, "19734": {"ApplNo": "19734", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER", "ActiveIngredient": "NICARDIPINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019734Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19734"}, "19758": {"ApplNo": "19758", "Form": "TABLET;ORAL", "Drug": "CLOZARIL", "ActiveIngredient": "CLOZAPINE", "ApplType": "NDA", "Sponsor": "HERITAGE LIFE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019758s101lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19758"}, "19759": {"ApplNo": "19759", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019759s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19759"}, "19763": {"ApplNo": "19763", "Form": "INJECTABLE;INJECTION", "Drug": "IFEX", "ActiveIngredient": "IFOSFAMIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019763s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19763"}, "19764": {"ApplNo": "19764", "Form": "INJECTABLE;INJECTION", "Drug": "SAIZEN", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "EMD SERONO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19764s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19764"}, "19766": {"ApplNo": "19766", "Form": "TABLET;ORAL", "Drug": "ZOCOR", "ActiveIngredient": "SIMVASTATIN", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019766s102lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19766"}, "19771": {"ApplNo": "19771", "Form": "TABLET;ORAL", "Drug": "ADVIL COLD AND SINUS", "ActiveIngredient": "IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019771orig1s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19771"}, "19774": {"ApplNo": "19774", "Form": "INJECTABLE;INJECTION", "Drug": "ZOMACTON", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "FERRING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/19774s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19774"}, "19777": {"ApplNo": "19777", "Form": "TABLET;ORAL", "Drug": "ZESTRIL", "ActiveIngredient": "LISINOPRIL", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019777s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19777"}, "19779": {"ApplNo": "19779", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "IOPIDINE", "ActiveIngredient": "APRACLONIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "IMPRIMIS PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019779s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19779"}, "19781": {"ApplNo": "19781", "Form": "CAPSULE;ORAL", "Drug": "PROMETRIUM", "ActiveIngredient": "PROGESTERONE", "ApplType": "NDA", "Sponsor": "VIRTUS PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019781Orig1s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19781"}, "19785": {"ApplNo": "19785", "Form": "INJECTABLE;INJECTION", "Drug": "CARDIOLITE", "ActiveIngredient": "TECHNETIUM TC-99M SESTAMIBI KIT", "ApplType": "NDA", "Sponsor": "LANTHEUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019785s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19785"}, "19787": {"ApplNo": "19787", "Form": "TABLET;ORAL", "Drug": "NORVASC", "ActiveIngredient": "AMLODIPINE BESYLATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19787"}, "19796": {"ApplNo": "19796", "Form": "LOTION;TOPICAL", "Drug": "ELOCON", "ActiveIngredient": "MOMETASONE FUROATE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019796s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19796"}, "19797": {"ApplNo": "19797", "Form": "FOR SOLUTION;ORAL", "Drug": "NULYTELY", "ActiveIngredient": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BRAINTREE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019797s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19797"}, "19822": {"ApplNo": "19822", "Form": "SPONGE;TOPICAL", "Drug": "BIOSCRUB", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "GRIFFEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019822Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19822"}, "19824": {"ApplNo": "19824", "Form": "SUSPENSION;TOPICAL", "Drug": "LOPROX", "ActiveIngredient": "CICLOPIROX", "ApplType": "NDA", "Sponsor": "MEDIMETRIKS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018748s024,019824s023,020519s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19824"}, "19826": {"ApplNo": "19826", "Form": "INJECTABLE;INJECTION", "Drug": "THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "THEOPHYLLINE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019826s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19826"}, "19828": {"ApplNo": "19828", "Form": "CREAM;TOPICAL", "Drug": "OXISTAT", "ActiveIngredient": "OXICONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "FOUGERA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19828slr009,20209slr005_oxistat_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19828"}, "19829": {"ApplNo": "19829", "Form": "INJECTABLE;INJECTION", "Drug": "CERETEC", "ActiveIngredient": "TECHNETIUM TC-99M EXAMETAZIME KIT", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019829s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19829"}, "19830": {"ApplNo": "19830", "Form": "INJECTABLE;INJECTION", "Drug": "LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "LIDOCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019830s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19830"}, "19835": {"ApplNo": "19835", "Form": "TABLET;ORAL", "Drug": "ZYRTEC ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019835Orig1s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19835"}, "19839": {"ApplNo": "19839", "Form": "TABLET;ORAL", "Drug": "ZOLOFT", "ActiveIngredient": "SERTRALINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s102,020990s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19839"}, "19841": {"ApplNo": "19841", "Form": "INJECTABLE;INJECTION", "Drug": "INDIUM IN 111 CHLORIDE", "ActiveIngredient": "INDIUM IN-111 CHLORIDE", "ApplType": "NDA", "Sponsor": "CURIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/in111mal021902LB.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19841"}, "19845": {"ApplNo": "19845", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "BETOPTIC S", "ActiveIngredient": "BETAXOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019845s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19845"}, "19851": {"ApplNo": "19851", "Form": "TABLET;ORAL", "Drug": "LOTENSIN", "ActiveIngredient": "BENAZEPRIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019851s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19851"}, "19853": {"ApplNo": "19853", "Form": "CAPSULE;ORAL", "Drug": "CUPRIMINE", "ActiveIngredient": "PENICILLAMINE", "ApplType": "NDA", "Sponsor": "VALEANT PHARMS INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19853s012,014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19853"}, "19860": {"ApplNo": "19860", "Form": "TABLET;ORAL", "Drug": "IMODIUM A-D", "ActiveIngredient": "LOPERAMIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019860Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19860"}, "19865": {"ApplNo": "19865", "Form": "TABLET;ORAL", "Drug": "BETAPACE", "ActiveIngredient": "SOTALOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LEGACY PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019865s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19865"}, "19872": {"ApplNo": "19872", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "TYLENOL", "ActiveIngredient": "ACETAMINOPHEN", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019872Orig1s048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19872"}, "19884": {"ApplNo": "19884", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "MESNEX", "ActiveIngredient": "MESNA", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019884s016,020855s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19884"}, "19886": {"ApplNo": "19886", "Form": "SPRAY, METERED;NASAL", "Drug": "SYNAREL", "ActiveIngredient": "NAFARELIN ACETATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019886s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19886"}, "19887": {"ApplNo": "19887", "Form": "FOR SOLUTION;INHALATION", "Drug": "NEBUPENT", "ActiveIngredient": "PENTAMIDINE ISETHIONATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19887"}, "19888": {"ApplNo": "19888", "Form": "TABLET;ORAL", "Drug": "ZESTORETIC", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; LISINOPRIL", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019888s069lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19888"}, "19891": {"ApplNo": "19891", "Form": "SOLUTION;ORAL", "Drug": "DILAUDID", "ActiveIngredient": "HYDROMORPHONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "RHODES PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019891s029,019892s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19891"}, "19892": {"ApplNo": "19892", "Form": "TABLET;ORAL", "Drug": "DILAUDID", "ActiveIngredient": "HYDROMORPHONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "RHODES PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019891s029,019892s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19892"}, "19899": {"ApplNo": "19899", "Form": "TABLET;ORAL", "Drug": "SINE-AID IB", "ActiveIngredient": "IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019899Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19899"}, "19901": {"ApplNo": "19901", "Form": "CAPSULE;ORAL", "Drug": "ALTACE", "ActiveIngredient": "RAMIPRIL", "ApplType": "NDA", "Sponsor": "KING PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019901s067lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19901"}, "19904": {"ApplNo": "19904", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER", "ActiveIngredient": "POTASSIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019904s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19904"}, "19906": {"ApplNo": "19906", "Form": "CAPSULE;ORAL", "Drug": "ANAFRANIL", "ActiveIngredient": "CLOMIPRAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SPECGX LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19906"}, "19908": {"ApplNo": "19908", "Form": "TABLET;ORAL", "Drug": "AMBIEN", "ActiveIngredient": "ZOLPIDEM TARTRATE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19908"}, "19909": {"ApplNo": "19909", "Form": "SUSPENSION;ORAL", "Drug": "ZOVIRAX", "ActiveIngredient": "ACYCLOVIR", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018828s030,020089s019,019909s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19909"}, "19910": {"ApplNo": "19910", "Form": "SOLUTION;ORAL", "Drug": "RETROVIR", "ActiveIngredient": "ZIDOVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019655Orig1s059,019910Orig1s046,019951Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19910"}, "19921": {"ApplNo": "19921", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "OCUFLOX", "ActiveIngredient": "OFLOXACIN", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019921s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19921"}, "19922": {"ApplNo": "19922", "Form": "INJECTABLE;INJECTION", "Drug": "CORLOPAM", "ActiveIngredient": "FENOLDOPAM MESYLATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019922s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19922"}, "19931": {"ApplNo": "19931", "Form": "LOTION;TOPICAL", "Drug": "KLARON", "ActiveIngredient": "SULFACETAMIDE SODIUM", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019931s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19931"}, "19938": {"ApplNo": "19938", "Form": "INJECTABLE;INJECTION", "Drug": "NOVOLIN R", "ActiveIngredient": "INSULIN RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019938s082lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19938"}, "19942": {"ApplNo": "19942", "Form": "INJECTABLE;INJECTION", "Drug": "INTRALIPID 30%", "ActiveIngredient": "SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "FRESENIUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019942s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19942"}, "19943": {"ApplNo": "19943", "Form": "INJECTABLE; INJECTION", "Drug": "LUPRON DEPOT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "ABBVIE ENDOCRINE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020011s042,019943s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19943"}, "19949": {"ApplNo": "19949", "Form": "TABLET;ORAL", "Drug": "DIFLUCAN", "ActiveIngredient": "FLUCONAZOLE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019949s073,020090s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19949"}, "19951": {"ApplNo": "19951", "Form": "INJECTABLE;INJECTION", "Drug": "RETROVIR", "ActiveIngredient": "ZIDOVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019655Orig1s059,019910Orig1s046,019951Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19951"}, "19952": {"ApplNo": "19952", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019952s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19952"}, "19953": {"ApplNo": "19953", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019953s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19953"}, "19955": {"ApplNo": "19955", "Form": "TABLET;ORAL", "Drug": "DDAVP", "ActiveIngredient": "DESMOPRESSIN ACETATE", "ApplType": "NDA", "Sponsor": "FERRING PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017922s038,018938s027,019955s013lbl.pdf#page=33", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19955"}, "19959": {"ApplNo": "19959", "Form": "INJECTABLE;INJECTION", "Drug": "NOVOLIN N", "ActiveIngredient": "INSULIN SUSP ISOPHANE RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019959s085lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19959"}, "19962": {"ApplNo": "19962", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "TOPROL-XL", "ActiveIngredient": "METOPROLOL SUCCINATE", "ApplType": "NDA", "Sponsor": "TOPROL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019962s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19962"}, "19970": {"ApplNo": "19970", "Form": "INJECTABLE;INJECTION", "Drug": "NITROGLYCERIN IN DEXTROSE 5%", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019970s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19970"}, "19991": {"ApplNo": "19991", "Form": "INJECTABLE;INJECTION", "Drug": "NOVOLIN 70/30", "ActiveIngredient": "INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019991s085lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19991"}, "19992": {"ApplNo": "19992", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "CILOXAN", "ActiveIngredient": "CIPROFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019992s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19992"}, "19998": {"ApplNo": "19998", "Form": "CAPSULE;ORAL", "Drug": "CHEMET", "ActiveIngredient": "SUCCIMER", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019998s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19998"}, "20002": {"ApplNo": "20002", "Form": "INJECTABLE;INJECTION", "Drug": "RINGER'S IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019632s050,019634s050,020002s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20002"}, "20006": {"ApplNo": "20006", "Form": "INJECTABLE;INJECTION", "Drug": "MANNITOL 5% IN PLASTIC CONTAINER", "ActiveIngredient": "MANNITOL", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020006s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20006"}, "200063": {"ApplNo": "200063", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CONTRAVE", "ActiveIngredient": "BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NALPROPION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200063s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200063"}, "20011": {"ApplNo": "20011", "Form": "INJECTABLE;INJECTION", "Drug": "LUPRON DEPOT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "ABBVIE ENDOCRINE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020011s042,019943s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20011"}, "200175": {"ApplNo": "200175", "Form": "TABLET;ORAL", "Drug": "TRIBENZOR", "ActiveIngredient": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200175s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200175"}, "20021": {"ApplNo": "20021", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "SUDAFED 24 HOUR", "ActiveIngredient": "PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020021Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20021"}, "200271": {"ApplNo": "200271", "Form": "SOLUTION;INTRAMUSCULAR", "Drug": "HYDROXYPROGESTERONE CAPROATE", "ActiveIngredient": "HYDROXYPROGESTERONE CAPROATE", "ApplType": "ANDA", "Sponsor": "ASPEN GLOBAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200271lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200271"}, "20031": {"ApplNo": "20031", "Form": "TABLET;ORAL", "Drug": "PAXIL", "ActiveIngredient": "PAROXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020031s012,020710s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20031"}, "20032": {"ApplNo": "20032", "Form": "SUSPENSION;INTRATRACHEAL", "Drug": "SURVANTA", "ActiveIngredient": "BERACTANT", "ApplType": "BLA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020032Orig1s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20032"}, "200327": {"ApplNo": "200327", "Form": "POWDER;INTRAVENOUS", "Drug": "TEFLARO", "ActiveIngredient": "CEFTAROLINE FOSAMIL", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200327Orig1s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200327"}, "20033": {"ApplNo": "20033", "Form": "TABLET;ORAL", "Drug": "LOTENSIN HCT", "ActiveIngredient": "BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020033s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20033"}, "200403": {"ApplNo": "200403", "Form": "INJECTABLE;INJECTION", "Drug": "HYDROMORPHONE HYDROCHLORIDE", "ActiveIngredient": "HYDROMORPHONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200403s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200403"}, "20047": {"ApplNo": "20047", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 50% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020047s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20047"}, "20049": {"ApplNo": "20049", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "PENTASA", "ActiveIngredient": "MESALAMINE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020049s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20049"}, "20051": {"ApplNo": "20051", "Form": "TABLET;ORAL", "Drug": "GLYNASE", "ActiveIngredient": "GLYBURIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020051s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20051"}, "200533": {"ApplNo": "200533", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "NUCYNTA ER", "ActiveIngredient": "TAPENTADOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "COLLEGIUM PHARM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200533s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200533"}, "200534": {"ApplNo": "200534", "Form": "CAPSULE;ORAL", "Drug": "OXYCODONE HYDROCHLORIDE", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GENUS LIFESCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200534s010,200535s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200534"}, "200535": {"ApplNo": "200535", "Form": "SOLUTION;ORAL", "Drug": "OXYCODONE HYDROCHLORIDE", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GENUS LIFESCIENCES", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200534s010,200535s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200535"}, "200582": {"ApplNo": "200582", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TOPOTECAN HYDROCHLORIDE", "ActiveIngredient": "TOPOTECAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200582s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200582"}, "200603": {"ApplNo": "200603", "Form": "TABLET;ORAL", "Drug": "LATUDA", "ActiveIngredient": "LURASIDONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SUNOVION PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200603"}, "20062": {"ApplNo": "20062", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "CARDIZEM CD", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020062s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20062"}, "20064": {"ApplNo": "20064", "Form": "CAPSULE;ORAL", "Drug": "MACROBID", "ActiveIngredient": "NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20064"}, "20065": {"ApplNo": "20065", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "OPCON-A", "ActiveIngredient": "NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020065Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20065"}, "200652": {"ApplNo": "200652", "Form": "TABLET;ORAL", "Drug": "ALOSETRON HYDROCHLORIDE", "ActiveIngredient": "ALOSETRON HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200652Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200652"}, "200655": {"ApplNo": "200655", "Form": "SOLUTION;INTRAVENOUS", "Drug": "FLUORODOPA F18", "ActiveIngredient": "FLUORODOPA F-18", "ApplType": "NDA", "Sponsor": "FEINSTEIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200655s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200655"}, "200656": {"ApplNo": "200656", "Form": "EMULSION;INTRAVENOUS", "Drug": "PERIKABIVEN IN PLASTIC CONTAINER", "ActiveIngredient": "AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/200656s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200656"}, "20066": {"ApplNo": "20066", "Form": "GUM, CHEWING;BUCCAL", "Drug": "NICORETTE", "ActiveIngredient": "NICOTINE POLACRILEX", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018612Orig1s083,020066Orig1s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20066"}, "20067": {"ApplNo": "20067", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "EC-NAPROSYN", "ActiveIngredient": "NAPROXEN", "ApplType": "NDA", "Sponsor": "ATNAHS PHARMA US", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20067"}, "200671": {"ApplNo": "200671", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "DURLAZA", "ActiveIngredient": "ASPIRIN", "ApplType": "NDA", "Sponsor": "ESPERO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200671s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200671"}, "200677": {"ApplNo": "200677", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "SIGNIFOR", "ActiveIngredient": "PASIREOTIDE DIASPARTATE", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200677"}, "200678": {"ApplNo": "200678", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "KOMBIGLYZE XR", "ActiveIngredient": "METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200678"}, "20068": {"ApplNo": "20068", "Form": "INJECTABLE;INJECTION", "Drug": "FOSCAVIR", "ActiveIngredient": "FOSCARNET SODIUM", "ApplType": "NDA", "Sponsor": "CLINIGEN HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020068Orig1s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20068"}, "200738": {"ApplNo": "200738", "Form": "OINTMENT;OPHTHALMIC", "Drug": "LOTEMAX", "ActiveIngredient": "LOTEPREDNOL ETABONATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200738s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200738"}, "200740": {"ApplNo": "200740", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "CYSTARAN", "ActiveIngredient": "CYSTEAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LEADIANT BIOSCI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/200740s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200740"}, "20075": {"ApplNo": "20075", "Form": "INJECTABLE;INTRATHECAL", "Drug": "LIORESAL", "ActiveIngredient": "BACLOFEN", "ApplType": "NDA", "Sponsor": "AMNEAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020075Orig1s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20075"}, "20076": {"ApplNo": "20076", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "HABITROL", "ActiveIngredient": "NICOTINE", "ApplType": "NDA", "Sponsor": "DR REDDYS LABS SA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020076Orig1s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20076"}, "200795": {"ApplNo": "200795", "Form": "INJECTABLE;INJECTION", "Drug": "GEMCITABINE HYDROCHLORIDE", "ActiveIngredient": "GEMCITABINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200795Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200795"}, "200796": {"ApplNo": "200796", "Form": "TABLET;ORAL", "Drug": "EDARBI", "ActiveIngredient": "AZILSARTAN KAMEDOXOMIL", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200796s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200796"}, "20080": {"ApplNo": "20080", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "IMITREX", "ActiveIngredient": "SUMATRIPTAN SUCCINATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020080s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20080"}, "20083": {"ApplNo": "20083", "Form": "CAPSULE;ORAL", "Drug": "SPORANOX", "ActiveIngredient": "ITRACONAZOLE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020083s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20083"}, "200890": {"ApplNo": "200890", "Form": "SOLUTION;OPHTHALMIC", "Drug": "ISOPTO CARPINE", "ActiveIngredient": "PILOCARPINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200890s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200890"}, "20090": {"ApplNo": "20090", "Form": "FOR SUSPENSION;ORAL", "Drug": "DIFLUCAN", "ActiveIngredient": "FLUCONAZOLE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019949s073,020090s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20090"}, "200936": {"ApplNo": "200936", "Form": "GEL;TOPICAL", "Drug": "DICLOFENAC SODIUM ", "ActiveIngredient": "DICLOFENAC SODIUM", "ApplType": "ANDA", "Sponsor": "TOLMAR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200936Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200936"}, "201023": {"ApplNo": "201023", "Form": "SOLUTION;INTRAVENOUS", "Drug": "JEVTANA KIT", "ActiveIngredient": "CABAZITAXEL", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201023Orig1s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201023"}, "20105": {"ApplNo": "20105", "Form": "INJECTABLE;INJECTION", "Drug": "TRIOSTAT", "ActiveIngredient": "LIOTHYRONINE SODIUM", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20105s2lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20105"}, "201107": {"ApplNo": "201107", "Form": "SOLUTION;ORAL", "Drug": "ABACAVIR SULFATE", "ActiveIngredient": "ABACAVIR SULFATE", "ApplType": "ANDA", "Sponsor": "HETERO LABS LTD III", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201107Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201107"}, "20111": {"ApplNo": "20111", "Form": "SOLUTION;TOPICAL", "Drug": "CHLORHEXIDINE GLUCONATE", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "BAJAJ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020111Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20111"}, "201152": {"ApplNo": "201152", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "VIRAMUNE XR", "ActiveIngredient": "NEVIRAPINE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201152"}, "201153": {"ApplNo": "201153", "Form": "CREAM; TOPICAL", "Drug": "ZYCLARA", "ActiveIngredient": "IMIQUIMOD", "ApplType": "NDA", "Sponsor": "GRACEWAY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201153s000,022483s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201153"}, "20118": {"ApplNo": "20118", "Form": "LIQUID;INHALATION", "Drug": "SUPRANE", "ActiveIngredient": "DESFLURANE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020118s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20118"}, "201194": {"ApplNo": "201194", "Form": "SOLUTION;ORAL", "Drug": "OXYCODONE HYDROCHLORIDE", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "VISTAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201194s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201194"}, "201195": {"ApplNo": "201195", "Form": "INJECTABLE;INJECTION", "Drug": "DOCETAXEL", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201195s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201195"}, "20122": {"ApplNo": "20122", "Form": "INJECTABLE;INJECTION", "Drug": "NIPENT", "ActiveIngredient": "PENTOSTATIN", "ApplType": "NDA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020122s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20122"}, "20123": {"ApplNo": "20123", "Form": "INJECTABLE;INJECTION", "Drug": "OMNISCAN", "ActiveIngredient": "GADODIAMIDE", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s047,022066s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20123"}, "20126": {"ApplNo": "20126", "Form": "CREAM;TOPICAL", "Drug": "ZONALON", "ActiveIngredient": "DOXEPIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20126slr006_Zonalon_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20126"}, "201277": {"ApplNo": "201277", "Form": "SOLUTION;INTRAVENOUS", "Drug": "GADAVIST", "ActiveIngredient": "GADOBUTROL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201277s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201277"}, "201280": {"ApplNo": "201280", "Form": "TABLET;ORAL", "Drug": "TRADJENTA", "ActiveIngredient": "LINAGLIPTIN", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201280s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201280"}, "201281": {"ApplNo": "201281", "Form": "TABLET;ORAL", "Drug": "JENTADUETO", "ActiveIngredient": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201281s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201281"}, "201292": {"ApplNo": "201292", "Form": "TABLET;ORAL", "Drug": "GILOTRIF", "ActiveIngredient": "AFATINIB DIMALEATE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201292s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201292"}, "20131": {"ApplNo": "20131", "Form": "INJECTABLE;INJECTION", "Drug": "PROHANCE", "ActiveIngredient": "GADOTERIDOL", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020131Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20131"}, "20132": {"ApplNo": "20132", "Form": "TABLET;ORAL", "Drug": "IMITREX", "ActiveIngredient": "SUMATRIPTAN SUCCINATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020132s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20132"}, "20134": {"ApplNo": "20134", "Form": "INJECTABLE;INJECTION", "Drug": "METASTRON", "ActiveIngredient": "STRONTIUM CHLORIDE SR-89", "ApplType": "NDA", "Sponsor": "Q BIOMED", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020134s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20134"}, "201361": {"ApplNo": "201361", "Form": "CAPSULE;ORAL", "Drug": "OMEPRAZOLE AND SODIUM BICARBONATE", "ActiveIngredient": "OMEPRAZOLE; SODIUM BICARBONATE", "ApplType": "ANDA", "Sponsor": "PERRIGO R AND D", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201361Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201361"}, "201367": {"ApplNo": "201367", "Form": "SUSPENSION;ORAL", "Drug": "BANZEL", "ActiveIngredient": "RUFINAMIDE", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201367"}, "201370": {"ApplNo": "201370", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201370s013s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201370"}, "201373": {"ApplNo": "201373", "Form": "SUSPENSION;ORAL", "Drug": "CHILDREN'S ALLEGRA ALLERGY", "ActiveIngredient": "FEXOFENADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201373Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201373"}, "20140": {"ApplNo": "20140", "Form": "POWDER;INTRAVENOUS", "Drug": "FUSILEV", "ActiveIngredient": "LEVOLEUCOVORIN CALCIUM", "ApplType": "NDA", "Sponsor": "ACROTECH BIOPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020140s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20140"}, "201444": {"ApplNo": "201444", "Form": "SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS", "Drug": "NITHIODOTE", "ActiveIngredient": "SODIUM NITRITE; SODIUM THIOSULFATE", "ApplType": "NDA", "Sponsor": "HOPE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201444s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201444"}, "20145": {"ApplNo": "20145", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "NITRO-DUR", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "NDA", "Sponsor": "USPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020145s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20145"}, "20148": {"ApplNo": "20148", "Form": "SPRAY, METERED;NASAL", "Drug": "MIGRANAL", "ActiveIngredient": "DIHYDROERGOTAMINE MESYLATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020148s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20148"}, "201525": {"ApplNo": "201525", "Form": "INJECTABLE;INJECTION", "Drug": "DOCETAXEL", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201525s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201525"}, "201532": {"ApplNo": "201532", "Form": "SOLUTION;INTRAVENOUS", "Drug": "HALAVEN", "ActiveIngredient": "ERIBULIN MESYLATE", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201532s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201532"}, "201573": {"ApplNo": "201573", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "FENOFIBRIC ACID", "ActiveIngredient": "CHOLINE FENOFIBRATE", "ApplType": "ANDA", "Sponsor": "ANCHEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201573Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201573"}, "20162": {"ApplNo": "20162", "Form": "INJECTABLE;INJECTION", "Drug": "ACTHREL", "ActiveIngredient": "CORTICORELIN OVINE TRIFLUTATE", "ApplType": "BLA", "Sponsor": "FERRING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020162s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20162"}, "20163": {"ApplNo": "20163", "Form": "SOLUTION;INTRAPERITONEAL", "Drug": "DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017512s123,020163s028,020183s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20163"}, "201635": {"ApplNo": "201635", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "TROKENDI XR", "ActiveIngredient": "TOPIRAMATE", "ApplType": "NDA", "Sponsor": "SUPERNUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201635s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201635"}, "20164": {"ApplNo": "20164", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "LOVENOX (PRESERVATIVE FREE)", "ActiveIngredient": "ENOXAPARIN SODIUM", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020164Orig1s131lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20164"}, "20165": {"ApplNo": "20165", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "NICODERM CQ", "ActiveIngredient": "NICOTINE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020165Orig1s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20165"}, "201657": {"ApplNo": "201657", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PARICALCITOL", "ActiveIngredient": "PARICALCITOL", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201657s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201657"}, "201688": {"ApplNo": "201688", "Form": "POWDER;INHALATION", "Drug": "TOBI PODHALER", "ActiveIngredient": "TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201688s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201688"}, "20169": {"ApplNo": "20169", "Form": "TABLET;ORAL", "Drug": "NILANDRON", "ActiveIngredient": "NILUTAMIDE", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020169s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20169"}, "201691": {"ApplNo": "201691", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "ALKALOIDA ZRT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201691Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201691"}, "201699": {"ApplNo": "201699", "Form": "TABLET;ORAL", "Drug": "DIFICID", "ActiveIngredient": "FIDAXOMICIN", "ApplType": "NDA", "Sponsor": "CUBIST PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201699s013,213138s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201699"}, "20171": {"ApplNo": "20171", "Form": "SOLUTION;INTRAPERITONEAL", "Drug": "DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "FRESENIUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018883Orig1s057,020171Orig1s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20171"}, "201739": {"ApplNo": "201739", "Form": "SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS", "Drug": "AUVI-Q", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "KALEO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201739s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201739"}, "20178": {"ApplNo": "20178", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016677s169,018016s067,020178s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20178"}, "20179": {"ApplNo": "20179", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020179s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20179"}, "20180": {"ApplNo": "20180", "Form": "TABLET;ORAL", "Drug": "PROSCAR", "ActiveIngredient": "FINASTERIDE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020180s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20180"}, "201803": {"ApplNo": "201803", "Form": "TABLET;ORAL", "Drug": "ADVIL", "ActiveIngredient": "IBUPROFEN SODIUM", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201803Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201803"}, "201811": {"ApplNo": "201811", "Form": "INJECTABLE;INJECTION", "Drug": "ARGATROBAN", "ActiveIngredient": "ARGATROBAN", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201811s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201811"}, "20182": {"ApplNo": "20182", "Form": "INJECTABLE;INJECTION", "Drug": "CARNITOR", "ActiveIngredient": "LEVOCARNITINE", "ApplType": "NDA", "Sponsor": "LEADIANT BIOSCI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020182s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20182"}, "201820": {"ApplNo": "201820", "Form": "SOLUTION;INHALATION", "Drug": "BETHKIS", "ActiveIngredient": "TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201820s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201820"}, "20183": {"ApplNo": "20183", "Form": "SOLUTION;INTRAPERITONEAL", "Drug": "DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017512s123,020163s028,020183s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20183"}, "201849": {"ApplNo": "201849", "Form": "POWDER;INTRAMUSCULAR, INTRAVENOUS", "Drug": "GLUCAGON", "ActiveIngredient": "GLUCAGON HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201849s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201849"}, "20186": {"ApplNo": "20186", "Form": "TABLET;ORAL", "Drug": "ZIAC", "ActiveIngredient": "BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020186s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20186"}, "20189": {"ApplNo": "20189", "Form": "TABLET;ORAL", "Drug": "FELBATOL", "ActiveIngredient": "FELBAMATE", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20189"}, "20191": {"ApplNo": "20191", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ALOMIDE", "ActiveIngredient": "LODOXAMIDE TROMETHAMINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20191slr018_alomide_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20191"}, "201922": {"ApplNo": "201922", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "XIMINO", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JOURNEY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/201922s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201922"}, "201923": {"ApplNo": "201923", "Form": "IMPLANT;INTRAVITREAL", "Drug": "ILUVIEN", "ActiveIngredient": "FLUOCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "ALIMERA SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201923s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201923"}, "20193": {"ApplNo": "20193", "Form": "CAPSULE;ORAL", "Drug": "ELMIRON", "ActiveIngredient": "PENTOSAN POLYSULFATE SODIUM", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193Orig1s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20193"}, "201971": {"ApplNo": "201971", "Form": "TABLET;ORAL", "Drug": "RASAGILINE MESYLATE", "ActiveIngredient": "RASAGILINE MESYLATE", "ApplType": "ANDA", "Sponsor": "AUROBINDO PHARMA USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201971Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201971"}, "202008": {"ApplNo": "202008", "Form": "SOLUTION;INTRAVENOUS", "Drug": "AMYVID", "ActiveIngredient": "FLORBETAPIR F-18", "ApplType": "NDA", "Sponsor": "AVID RADIOPHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202008s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202008"}, "20201": {"ApplNo": "20201", "Form": "INJECTABLE;INJECTION", "Drug": "DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DOBUTAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021201s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20201"}, "202020": {"ApplNo": "202020", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "RAYOS", "ActiveIngredient": "PREDNISONE", "ApplType": "NDA", "Sponsor": "HORIZON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202020s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202020"}, "202022": {"ApplNo": "202022", "Form": "TABLET;ORAL", "Drug": "EDURANT", "ActiveIngredient": "RILPIVIRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PRODS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202022s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202022"}, "20204": {"ApplNo": "20204", "Form": "TABLET;ORAL", "Drug": "ALEVE", "ActiveIngredient": "NAPROXEN SODIUM", "ApplType": "NDA", "Sponsor": "BAYER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020204Orig1s083Lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20204"}, "202049": {"ApplNo": "202049", "Form": "POWDER;INHALATION", "Drug": "BRONCHITOL", "ActiveIngredient": "MANNITOL", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202049s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202049"}, "202051": {"ApplNo": "202051", "Form": "TABLET;ORAL", "Drug": "ADEFOVIR DIPIVOXIL", "ActiveIngredient": "ADEFOVIR DIPIVOXIL", "ApplType": "ANDA", "Sponsor": "SIGMAPHARM LABS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202051Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202051"}, "202053": {"ApplNo": "202053", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "DORZOLAMIDE HYDROCHLORIDE", "ActiveIngredient": "DORZOLAMIDE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "INDOCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202053Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202053"}, "202057": {"ApplNo": "202057", "Form": "CAPSULE;ORAL", "Drug": "VASCEPA", "ActiveIngredient": "ICOSAPENT ETHYL", "ApplType": "NDA", "Sponsor": "AMARIN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202057"}, "202067": {"ApplNo": "202067", "Form": "TABLET;ORAL", "Drug": "ONFI", "ActiveIngredient": "CLOBAZAM", "ApplType": "NDA", "Sponsor": "LUNDBECK PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202067"}, "202080": {"ApplNo": "202080", "Form": "TABLET;ORAL", "Drug": "OXAYDO", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ZYLA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202080s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202080"}, "20209": {"ApplNo": "20209", "Form": "LOTION;TOPICAL", "Drug": "OXISTAT", "ActiveIngredient": "OXICONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020209Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20209"}, "202091": {"ApplNo": "202091", "Form": "FOR SUSPENSION;ORAL", "Drug": "SUPRAX", "ActiveIngredient": "CEFIXIME", "ApplType": "NDA", "Sponsor": "LUPIN LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202091s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202091"}, "202100": {"ApplNo": "202100", "Form": "FOR SUSPENSION, EXTENDED RELEASE;ORAL", "Drug": "QUILLIVANT XR", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NEXTWAVE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202100"}, "202101": {"ApplNo": "202101", "Form": "TABLET;ORAL", "Drug": "ARIPIPRAZOLE", "ActiveIngredient": "ARIPIPRAZOLE", "ApplType": "ANDA", "Sponsor": "ALEMBIC PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202101s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202101"}, "202102": {"ApplNo": "202102", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "ARIPIPRAZOLE", "ActiveIngredient": "ARIPIPRAZOLE", "ApplType": "ANDA", "Sponsor": "ALEMBIC PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202102s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202102"}, "202106": {"ApplNo": "202106", "Form": "POWDER;INTRAVENOUS", "Drug": "MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER", "ActiveIngredient": "MEROPENEM", "ApplType": "NDA", "Sponsor": "B BRAUN MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202106s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202106"}, "202107": {"ApplNo": "202107", "Form": "TABLET;ORAL", "Drug": "KORLYM", "ActiveIngredient": "MIFEPRISTONE", "ApplType": "NDA", "Sponsor": "CORCEPT THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202107"}, "202123": {"ApplNo": "202123", "Form": "TABLET;ORAL", "Drug": "COMPLERA", "ActiveIngredient": "EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202123s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202123"}, "202129": {"ApplNo": "202129", "Form": "AEROSOL, METERED;NASAL", "Drug": "ZETONNA", "ActiveIngredient": "CICLESONIDE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202129s004s005s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202129"}, "20213": {"ApplNo": "20213", "Form": "FOR SOLUTION;OPHTHALMIC", "Drug": "MIOCHOL-E", "ActiveIngredient": "ACETYLCHOLINE CHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020213s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20213"}, "202133": {"ApplNo": "202133", "Form": "TABLET;ORAL", "Drug": "FLUOXETINE HYDROCHLORIDE", "ActiveIngredient": "FLUOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202133s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202133"}, "202145": {"ApplNo": "202145", "Form": "CREAM;TOPICAL", "Drug": "HYDROCORTISONE BUTYRATE", "ActiveIngredient": "HYDROCORTISONE BUTYRATE", "ApplType": "ANDA", "Sponsor": "GLENMARK GENERICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202145Orig1lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202145"}, "20215": {"ApplNo": "20215", "Form": "TABLET;ORAL", "Drug": "MONOKET", "ActiveIngredient": "ISOSORBIDE MONONITRATE", "ApplType": "NDA", "Sponsor": "ECI PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020215s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20215"}, "202153": {"ApplNo": "202153", "Form": "SOLUTION;INTRAVENOUS", "Drug": "RUBY-FILL", "ActiveIngredient": "RUBIDIUM CHLORIDE RB-82", "ApplType": "NDA", "Sponsor": "JUBILANT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202153s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202153"}, "202155": {"ApplNo": "202155", "Form": "TABLET;ORAL", "Drug": "ELIQUIS", "ActiveIngredient": "APIXABAN", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202155"}, "202158": {"ApplNo": "202158", "Form": "SOLUTION;INTRAVENOUS, INTRAVESICULAR, OPHTHALMIC", "Drug": "RADIOGENIX SYSTEM", "ActiveIngredient": "TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR", "ApplType": "NDA", "Sponsor": "NORTHSTAR MEDICAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202158s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202158"}, "20216": {"ApplNo": "20216", "Form": "CREAM;TOPICAL, VAGINAL", "Drug": "PREMARIN", "ActiveIngredient": "ESTROGENS, CONJUGATED", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020216s083lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20216"}, "202192": {"ApplNo": "202192", "Form": "TABLET;ORAL", "Drug": "JAKAFI", "ActiveIngredient": "RUXOLITINIB PHOSPHATE", "ApplType": "NDA", "Sponsor": "INCYTE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202192s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202192"}, "20220": {"ApplNo": "20220", "Form": "INJECTABLE;INJECTION", "Drug": "ULTRAVIST 370", "ActiveIngredient": "IOPROMIDE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020220s052,021425s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20220"}, "202207": {"ApplNo": "202207", "Form": "INJECTABLE;INJECTION", "Drug": "LYMPHOSEEK KIT", "ActiveIngredient": "TECHNETIUM TC-99M TILMANOCEPT", "ApplType": "NDA", "Sponsor": "CARDINAL HEALTH 414", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202207s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202207"}, "20221": {"ApplNo": "20221", "Form": "INJECTABLE;INJECTION", "Drug": "ETHYOL", "ActiveIngredient": "AMIFOSTINE", "ApplType": "NDA", "Sponsor": "CLINIGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020221s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20221"}, "202211": {"ApplNo": "202211", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "OXYTROL FOR WOMEN", "ActiveIngredient": "OXYBUTYNIN", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202211Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202211"}, "20222": {"ApplNo": "20222", "Form": "TABLET;ORAL", "Drug": "COLESTID", "ActiveIngredient": "COLESTIPOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020222Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20222"}, "202231": {"ApplNo": "202231", "Form": "POWDER;INTRAVENOUS", "Drug": "LEVOTHYROXINE SODIUM", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202231s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202231"}, "202236": {"ApplNo": "202236", "Form": "SPRAY, METERED;NASAL", "Drug": "DYMISTA", "ActiveIngredient": "AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202236s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202236"}, "202240": {"ApplNo": "202240", "Form": "CAPSULE;ORAL", "Drug": "CELECOXIB", "ActiveIngredient": "CELECOXIB", "ApplType": "ANDA", "Sponsor": "LUPIN LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202240Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202240"}, "20226": {"ApplNo": "20226", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "NAPHCON-A", "ActiveIngredient": "NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE", "ApplType": "NDA", "Sponsor": "ALCON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020226Orig1s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20226"}, "202270": {"ApplNo": "202270", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "JANUMET XR", "ActiveIngredient": "METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202270"}, "202276": {"ApplNo": "202276", "Form": "TABLET;ORAL", "Drug": "STENDRA", "ActiveIngredient": "AVANAFIL", "ApplType": "NDA", "Sponsor": "METUCHEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202276s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202276"}, "202292": {"ApplNo": "202292", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "MYTESI", "ActiveIngredient": "CROFELEMER", "ApplType": "NDA", "Sponsor": "NAPO PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202292s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202292"}, "202293": {"ApplNo": "202293", "Form": "TABLET;ORAL", "Drug": "FARXIGA", "ActiveIngredient": "DAPAGLIFLOZIN", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202293Orig1s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202293"}, "202294": {"ApplNo": "202294", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "DEXLANSOPRAZOLE", "ActiveIngredient": "DEXLANSOPRAZOLE", "ApplType": "ANDA", "Sponsor": "PAR PHARM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202294Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202294"}, "202317": {"ApplNo": "202317", "Form": "GEL;TOPICAL", "Drug": "VALCHLOR", "ActiveIngredient": "MECHLORETHAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HELSINN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202317"}, "20232": {"ApplNo": "20232", "Form": "CAPSULE;ORAL", "Drug": "FIORICET W/ CODEINE", "ActiveIngredient": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE", "ApplType": "NDA", "Sponsor": "ACTAVIS LABS UT INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020232s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20232"}, "202324": {"ApplNo": "202324", "Form": "TABLET;ORAL", "Drug": "INLYTA", "ActiveIngredient": "AXITINIB", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202324Orig1s014CorrectedLbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202324"}, "202331": {"ApplNo": "202331", "Form": "TABLET;ORAL", "Drug": "EDARBYCLOR", "ActiveIngredient": "AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202331s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202331"}, "20234": {"ApplNo": "20234", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "TEGRETOL-XR", "ActiveIngredient": "CARBAMAZEPINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20234"}, "202344": {"ApplNo": "202344", "Form": "TABLET, EFFERVESCENT;ORAL", "Drug": "BINOSTO", "ActiveIngredient": "ALENDRONATE SODIUM", "ApplType": "NDA", "Sponsor": "ASCEND THERAPS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202344s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202344"}, "20235": {"ApplNo": "20235", "Form": "CAPSULE;ORAL", "Drug": "NEURONTIN", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20235"}, "20237": {"ApplNo": "20237", "Form": "TABLET;ORAL", "Drug": "SALAGEN", "ActiveIngredient": "PILOCARPINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020237s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20237"}, "202379": {"ApplNo": "202379", "Form": "TABLET;ORAL", "Drug": "ZYTIGA", "ActiveIngredient": "ABIRATERONE ACETATE", "ApplType": "NDA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202379s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202379"}, "20238": {"ApplNo": "20238", "Form": "TABLET;ORAL", "Drug": "TAGAMET HB", "ActiveIngredient": "CIMETIDINE", "ApplType": "NDA", "Sponsor": "MEDTECH PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020238Orig1s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20238"}, "202402": {"ApplNo": "202402", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "IBUPROFEN LYSINE", "ActiveIngredient": "IBUPROFEN LYSINE", "ApplType": "ANDA", "Sponsor": "XGEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202402Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202402"}, "20241": {"ApplNo": "20241", "Form": "TABLET;ORAL", "Drug": "LAMICTAL", "ActiveIngredient": "LAMOTRIGINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20241"}, "202428": {"ApplNo": "202428", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "FABIOR", "ActiveIngredient": "TAZAROTENE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202428lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202428"}, "202429": {"ApplNo": "202429", "Form": "TABLET;ORAL", "Drug": "ZELBORAF", "ActiveIngredient": "VEMURAFENIB", "ApplType": "NDA", "Sponsor": "HOFFMANN LA ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202429s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202429"}, "202439": {"ApplNo": "202439", "Form": "TABLET;ORAL", "Drug": "XARELTO", "ActiveIngredient": "RIVAROXABAN", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406Orig1s039,202439Orig1s038correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202439"}, "202450": {"ApplNo": "202450", "Form": "POWDER, METERED;INHALATION", "Drug": "TUDORZA PRESSAIR", "ActiveIngredient": "ACLIDINIUM BROMIDE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202450s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202450"}, "20246": {"ApplNo": "20246", "Form": "INJECTABLE;INJECTION", "Drug": "DEPO-PROVERA", "ActiveIngredient": "MEDROXYPROGESTERONE ACETATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020246s060s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20246"}, "20248": {"ApplNo": "20248", "Form": "INJECTABLE;INJECTION", "Drug": "INTRALIPID 20%", "ActiveIngredient": "SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "FRESENIUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020248s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20248"}, "202489": {"ApplNo": "202489", "Form": "TABLET;ORAL", "Drug": "TINIDAZOLE", "ActiveIngredient": "TINIDAZOLE", "ApplType": "ANDA", "Sponsor": "UNIQUE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202489Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202489"}, "202511": {"ApplNo": "202511", "Form": "SOLUTION;ORAL", "Drug": "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ", "ActiveIngredient": "MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE", "ApplType": "ANDA", "Sponsor": "NOVEL LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202511Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202511"}, "202514": {"ApplNo": "202514", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ZIOPTAN", "ActiveIngredient": "TAFLUPROST", "ApplType": "NDA", "Sponsor": "THEA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202514s003s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202514"}, "202515": {"ApplNo": "202515", "Form": "INJECTABLE;INJECTION", "Drug": "MORPHINE SULFATE", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "NDA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202515Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202515"}, "202543": {"ApplNo": "202543", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "LEVETIRACETAM IN SODIUM CHLORIDE", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "NDA", "Sponsor": "HQ SPECIALITY PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202543s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202543"}, "20255": {"ApplNo": "20255", "Form": "INJECTABLE;INJECTION", "Drug": "DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DOBUTAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020255s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20255"}, "202565": {"ApplNo": "202565", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "BIMATOPROST", "ActiveIngredient": "BIMATOPROST", "ApplType": "ANDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202565Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202565"}, "202570": {"ApplNo": "202570", "Form": "CAPSULE;ORAL", "Drug": "XALKORI", "ActiveIngredient": "CRIZOTINIB", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202570s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202570"}, "202573": {"ApplNo": "202573", "Form": "TABLET;ORAL", "Drug": "RITONAVIR", "ActiveIngredient": "RITONAVIR", "ApplType": "ANDA", "Sponsor": "CIPLA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202573Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202573"}, "20258": {"ApplNo": "20258", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "IOPIDINE", "ActiveIngredient": "APRACLONIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "IMPRIMIS PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020258s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20258"}, "202595": {"ApplNo": "202595", "Form": "CAPSULE;ORAL", "Drug": "OSELTAMIVIR PHOSPHATE", "ActiveIngredient": "OSELTAMIVIR PHOSPHATE", "ApplType": "ANDA", "Sponsor": "NATCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202595Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202595"}, "202611": {"ApplNo": "202611", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MYRBETRIQ", "ActiveIngredient": "MIRABEGRON", "ApplType": "NDA", "Sponsor": "APGDI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202611Orig1s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202611"}, "20263": {"ApplNo": "20263", "Form": "POWDER;INTRAMUSCULAR", "Drug": "LUPRON DEPOT-PED KIT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "ABBVIE ENDOCRINE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020263s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20263"}, "202662": {"ApplNo": "202662", "Form": "TABLET;ORAL", "Drug": "OXYCODONE HYDROCHLORIDE", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "EPIC PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202662Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202662"}, "202667": {"ApplNo": "202667", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "COSOPT PF", "ActiveIngredient": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "THEA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202667s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202667"}, "20267": {"ApplNo": "20267", "Form": "TABLET;ORAL", "Drug": "JUNIOR STRENGTH ADVIL", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020267Orig1s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20267"}, "202688": {"ApplNo": "202688", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "PROPAFENONE HYDROCHLORIDE", "ActiveIngredient": "PROPAFENONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "WATSON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202688Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202688"}, "202714": {"ApplNo": "202714", "Form": "POWDER;INTRAVENOUS", "Drug": "KYPROLIS", "ActiveIngredient": "CARFILZOMIB", "ApplType": "NDA", "Sponsor": "ONYX THERAP", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202714s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202714"}, "20272": {"ApplNo": "20272", "Form": "TABLET;ORAL", "Drug": "RISPERDAL", "ActiveIngredient": "RISPERIDONE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020272s087,021444s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20272"}, "202723": {"ApplNo": "202723", "Form": "TABLET;ORAL", "Drug": "DONEPEZIL HYDROCHLORIDE", "ActiveIngredient": "DONEPEZIL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "DR REDDYS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202723Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202723"}, "20273": {"ApplNo": "20273", "Form": "OINTMENT;TOPICAL", "Drug": "DOVONEX", "ActiveIngredient": "CALCIPOTRIENE", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020273s013,020554s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20273"}, "202736": {"ApplNo": "202736", "Form": "LOTION;TOPICAL", "Drug": "SKLICE", "ActiveIngredient": "IVERMECTIN", "ApplType": "NDA", "Sponsor": "ARBOR PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202736Orig1s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202736"}, "202784": {"ApplNo": "202784", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "ESOMEPRAZOLE MAGNESIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "ANDA", "Sponsor": "HETERO LABS LTD III", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202784Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202784"}, "20280": {"ApplNo": "20280", "Form": "INJECTABLE;INJECTION", "Drug": "GENOTROPIN PRESERVATIVE FREE", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "PHARMACIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20280S23LTR.PDF", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20280"}, "202806": {"ApplNo": "202806", "Form": "CAPSULE;ORAL", "Drug": "TAFINLAR", "ActiveIngredient": "DABRAFENIB MESYLATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202806s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202806"}, "202810": {"ApplNo": "202810", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "OXTELLAR XR", "ActiveIngredient": "OXCARBAZEPINE", "ApplType": "NDA", "Sponsor": "SUPERNUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202810s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202810"}, "202811": {"ApplNo": "202811", "Form": "CAPSULE;ORAL", "Drug": "LINZESS", "ActiveIngredient": "LINACLOTIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202811s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202811"}, "202813": {"ApplNo": "202813", "Form": "AEROSOL, METERED;NASAL", "Drug": "QNASL", "ActiveIngredient": "BECLOMETHASONE DIPROPIONATE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202813Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202813"}, "202832": {"ApplNo": "202832", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.9%", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "MEDEFIL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202832Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202832"}, "202834": {"ApplNo": "202834", "Form": "TABLET;ORAL", "Drug": "FYCOMPA", "ActiveIngredient": "PERAMPANEL", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202834"}, "202860": {"ApplNo": "202860", "Form": "GAS;INHALATION", "Drug": "GENOSYL", "ActiveIngredient": "NITRIC OXIDE", "ApplType": "NDA", "Sponsor": "VERO BIOTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202860s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202860"}, "20287": {"ApplNo": "20287", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "FRAGMIN", "ActiveIngredient": "DALTEPARIN SODIUM", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020287Orig1s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20287"}, "202872": {"ApplNo": "202872", "Form": "GEL;OPHTHALMIC", "Drug": "LOTEMAX", "ActiveIngredient": "LOTEPREDNOL ETABONATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202872s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202872"}, "202895": {"ApplNo": "202895", "Form": "SUSPENSION;ORAL", "Drug": "PREZISTA", "ActiveIngredient": "DARUNAVIR", "ApplType": "NDA", "Sponsor": "JANSSEN PRODS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021976s067,202895s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202895"}, "202939": {"ApplNo": "202939", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "QUETIAPINE FUMARATE", "ActiveIngredient": "QUETIAPINE FUMARATE", "ApplType": "ANDA", "Sponsor": "INTELLIPHARMACEUTICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202939Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202939"}, "202941": {"ApplNo": "202941", "Form": "TABLET;ORAL", "Drug": "LAMIVUDINE", "ActiveIngredient": "LAMIVUDINE", "ApplType": "ANDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202941Orig1s000_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202941"}, "202958": {"ApplNo": "202958", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "LEVETIRACETAM", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "ANDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202958Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202958"}, "202964": {"ApplNo": "202964", "Form": "FOR SOLUTION;ORAL", "Drug": "DICLOFENAC POTASSIUM", "ActiveIngredient": "DICLOFENAC POTASSIUM", "ApplType": "ANDA", "Sponsor": "PAR FORM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202964Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202964"}, "20297": {"ApplNo": "20297", "Form": "TABLET;ORAL", "Drug": "COREG", "ActiveIngredient": "CARVEDILOL", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20297"}, "202971": {"ApplNo": "202971", "Form": "FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "ABILIFY MAINTENA KIT", "ActiveIngredient": "ARIPIPRAZOLE", "ApplType": "NDA", "Sponsor": "OTSUKA PHARM CO LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202971"}, "20298": {"ApplNo": "20298", "Form": "INJECTABLE;INJECTION", "Drug": "ALOPRIM", "ActiveIngredient": "ALLOPURINOL SODIUM", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020298s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20298"}, "202992": {"ApplNo": "202992", "Form": "TABLET;ORAL", "Drug": "AUBAGIO", "ActiveIngredient": "TERIFLUNOMIDE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202992"}, "203039": {"ApplNo": "203039", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "CLOZAPINE", "ActiveIngredient": "CLOZAPINE", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203039Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203039"}, "203045": {"ApplNo": "203045", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "ISENTRESS", "ActiveIngredient": "RALTEGRAVIR POTASSIUM", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022145s044,203045s017,205786s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203045"}, "203049": {"ApplNo": "203049", "Form": "INJECTABLE;INJECTION", "Drug": "ARGATROBAN", "ActiveIngredient": "ARGATROBAN", "ApplType": "NDA", "Sponsor": "HIKMA PHARM CO LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203049s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203049"}, "203058": {"ApplNo": "203058", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE", "ActiveIngredient": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE", "ApplType": "ANDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203058Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203058"}, "203085": {"ApplNo": "203085", "Form": "TABLET;ORAL", "Drug": "STIVARGA", "ActiveIngredient": "REGORAFENIB", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203085Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203085"}, "20309": {"ApplNo": "20309", "Form": "INJECTABLE;INJECTION", "Drug": "MAGNESIUM SULFATE IN PLASTIC CONTAINER", "ActiveIngredient": "MAGNESIUM SULFATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020309Orig1s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20309"}, "203094": {"ApplNo": "203094", "Form": "TABLET;ORAL", "Drug": "TYBOST", "ActiveIngredient": "COBICISTAT", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203094s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203094"}, "20310": {"ApplNo": "20310", "Form": "SHAMPOO;TOPICAL", "Drug": "NIZORAL ANTI-DANDRUFF", "ActiveIngredient": "KETOCONAZOLE", "ApplType": "NDA", "Sponsor": "KRAMER", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020310Orig1s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20310"}, "203100": {"ApplNo": "203100", "Form": "TABLET;ORAL", "Drug": "STRIBILD", "ActiveIngredient": "COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203100s036lblet.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203100"}, "203108": {"ApplNo": "203108", "Form": "SPRAY, METERED;INHALATION", "Drug": "STRIVERDI RESPIMAT", "ActiveIngredient": "OLODATEROL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203108s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203108"}, "203109": {"ApplNo": "203109", "Form": "FOR SUSPENSION;ORAL", "Drug": "REVATIO", "ActiveIngredient": "SILDENAFIL CITRATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203109Orig1s015lblrpl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203109"}, "203137": {"ApplNo": "203137", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "VIZAMYL", "ActiveIngredient": "FLUTEMETAMOL F-18", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203137s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203137"}, "20314": {"ApplNo": "20314", "Form": "INJECTABLE;INJECTION", "Drug": "OCTREOSCAN", "ActiveIngredient": "INDIUM IN-111 PENTETREOTIDE KIT", "ApplType": "NDA", "Sponsor": "CURIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020314Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20314"}, "203152": {"ApplNo": "203152", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "OLOPATADINE HYDROCHLORIDE", "ActiveIngredient": "OLOPATADINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "USV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203152Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203152"}, "203155": {"ApplNo": "203155", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "CHOLINE C-11", "ActiveIngredient": "CHOLINE C-11", "ApplType": "NDA", "Sponsor": "MCPRF", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203155s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155"}, "203159": {"ApplNo": "203159", "Form": "INTRAUTERINE DEVICE;INTRAUTERINE", "Drug": "SKYLA", "ActiveIngredient": "LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203159s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203159"}, "203168": {"ApplNo": "203168", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PROLENSA", "ActiveIngredient": "BROMFENAC SODIUM", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203168s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203168"}, "203188": {"ApplNo": "203188", "Form": "TABLET;ORAL", "Drug": "KALYDECO", "ActiveIngredient": "IVACAFTOR", "ApplType": "NDA", "Sponsor": "VERTEX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203188s034,207925s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203188"}, "203195": {"ApplNo": "203195", "Form": "CAPSULE;ORAL", "Drug": "SUPRAX", "ActiveIngredient": "CEFIXIME", "ApplType": "NDA", "Sponsor": "LUPIN LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202091S007_203195_S008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203195"}, "203202": {"ApplNo": "203202", "Form": "CAPSULE;ORAL", "Drug": "NORTHERA", "ActiveIngredient": "DROXIDOPA", "ApplType": "NDA", "Sponsor": "LUNDBECK NA LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203202s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203202"}, "203214": {"ApplNo": "203214", "Form": "TABLET;ORAL", "Drug": "XELJANZ", "ActiveIngredient": "TOFACITINIB CITRATE", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203214s028,208246s013,213082s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203214"}, "203231": {"ApplNo": "203231", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ZOLEDRONIC ACID", "ActiveIngredient": "ZOLEDRONIC ACID", "ApplType": "NDA", "Sponsor": "INFORLIFE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203231"}, "20325": {"ApplNo": "20325", "Form": "TABLET;ORAL", "Drug": "PEPCID AC", "ActiveIngredient": "FAMOTIDINE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020325Orig1s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20325"}, "203255": {"ApplNo": "203255", "Form": "FOR SUSPENSION;INTRAMUSCULAR", "Drug": "SIGNIFOR LAR KIT", "ActiveIngredient": "PASIREOTIDE PAMOATE", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203255s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203255"}, "203260": {"ApplNo": "203260", "Form": "TABLET;ORAL", "Drug": "LAMIVUDINE", "ActiveIngredient": "LAMIVUDINE", "ApplType": "ANDA", "Sponsor": "HETERO LABS LTD V", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203260Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203260"}, "203263": {"ApplNo": "203263", "Form": "INJECTABLE, LIPOSOMAL;INJECTION", "Drug": "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)", "ActiveIngredient": "DOXORUBICIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203263lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203263"}, "20327": {"ApplNo": "20327", "Form": "INJECTABLE;INJECTION", "Drug": "ISOVUE-250", "ActiveIngredient": "IOPAMIDOL", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020327s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20327"}, "203284": {"ApplNo": "203284", "Form": "LIQUID;ORAL", "Drug": "RAVICTI", "ActiveIngredient": "GLYCEROL PHENYLBUTYRATE", "ApplType": "NDA", "Sponsor": "HORIZON THERAP US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203284"}, "20329": {"ApplNo": "20329", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "GLUCOTROL XL", "ActiveIngredient": "GLIPIZIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020329Orig1s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20329"}, "20330": {"ApplNo": "20330", "Form": "SOLUTION, GEL FORMING/DROPS;OPHTHALMIC", "Drug": "TIMOPTIC-XE", "ActiveIngredient": "TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020330s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20330"}, "203312": {"ApplNo": "203312", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "RYTARY", "ActiveIngredient": "CARBIDOPA; LEVODOPA", "ApplType": "NDA", "Sponsor": "IMPAX LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203312s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203312"}, "203314": {"ApplNo": "203314", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "TRESIBA", "ActiveIngredient": "INSULIN DEGLUDEC", "ApplType": "BLA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203314s018s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203314"}, "203324": {"ApplNo": "203324", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PHOTREXA", "ActiveIngredient": "RIBOFLAVIN 5'-PHOSPHATE SODIUM", "ApplType": "NDA", "Sponsor": "GLAUKOS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203324s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203324"}, "20333": {"ApplNo": "20333", "Form": "CAPSULE;ORAL", "Drug": "AGRYLIN", "ActiveIngredient": "ANAGRELIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020333s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20333"}, "20334": {"ApplNo": "20334", "Form": "CAPSULE;ORAL", "Drug": "FLAGYL", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020334s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20334"}, "203340": {"ApplNo": "203340", "Form": "SOLUTION;ORAL", "Drug": "NYMALIZE", "ActiveIngredient": "NIMODIPINE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203340Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203340"}, "203341": {"ApplNo": "203341", "Form": "TABLET;ORAL", "Drug": "BOSULIF", "ActiveIngredient": "BOSUTINIB MONOHYDRATE", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203341s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203341"}, "203388": {"ApplNo": "203388", "Form": "CAPSULE;ORAL", "Drug": "ERIVEDGE", "ActiveIngredient": "VISMODEGIB", "ApplType": "NDA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203388s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203388"}, "203389": {"ApplNo": "203389", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "PROCYSBI", "ActiveIngredient": "CYSTEAMINE BITARTRATE", "ApplType": "NDA", "Sponsor": "HORIZON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203389s027,213491s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203389"}, "203414": {"ApplNo": "203414", "Form": "TABLET;ORAL", "Drug": "KAZANO", "ActiveIngredient": "ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203414s013lbl.pdf#page=32", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203414"}, "203415": {"ApplNo": "203415", "Form": "CAPSULE;ORAL", "Drug": "XTANDI", "ActiveIngredient": "ENZALUTAMIDE", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203415s019,213674s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203415"}, "203441": {"ApplNo": "203441", "Form": "POWDER;SUBCUTANEOUS", "Drug": "GATTEX KIT", "ActiveIngredient": "TEDUGLUTIDE RECOMBINANT", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203441Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203441"}, "203469": {"ApplNo": "203469", "Form": "TABLET;ORAL", "Drug": "ICLUSIG", "ActiveIngredient": "PONATINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203469s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203469"}, "203479": {"ApplNo": "203479", "Form": "SUSPENSION;ORAL", "Drug": "VERSACLOZ", "ActiveIngredient": "CLOZAPINE", "ApplType": "NDA", "Sponsor": "TASMAN PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203479s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203479"}, "203491": {"ApplNo": "203491", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "ILEVRO", "ActiveIngredient": "NEPAFENAC", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203491s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203491"}, "203496": {"ApplNo": "203496", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ORENITRAM", "ActiveIngredient": "TREPROSTINIL DIOLAMINE", "ApplType": "NDA", "Sponsor": "UNITED THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203496Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203496"}, "203505": {"ApplNo": "203505", "Form": "TABLET;ORAL", "Drug": "OSPHENA", "ActiveIngredient": "OSPEMIFENE", "ApplType": "NDA", "Sponsor": "DUCHESNAY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203505s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203505"}, "20351": {"ApplNo": "20351", "Form": "INJECTABLE;INJECTION", "Drug": "VISIPAQUE 270", "ActiveIngredient": "IODIXANOL", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020351s054,020808s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20351"}, "203510": {"ApplNo": "203510", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PHENYLEPHRINE HYDROCHLORIDE", "ActiveIngredient": "PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PARAGON BIOTECK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203510s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203510"}, "20353": {"ApplNo": "20353", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "NAPRELAN", "ActiveIngredient": "NAPROXEN SODIUM", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020353s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20353"}, "203551": {"ApplNo": "203551", "Form": "INJECTABLE;INJECTION", "Drug": "DOCETAXEL", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "ACTAVIS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203551s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203551"}, "20356": {"ApplNo": "20356", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "SULAR", "ActiveIngredient": "NISOLDIPINE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020356s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20356"}, "203560": {"ApplNo": "203560", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "DEFERASIROX", "ActiveIngredient": "DEFERASIROX", "ApplType": "ANDA", "Sponsor": "ACTAVIS ELIZABETH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203560Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203560"}, "203563": {"ApplNo": "203563", "Form": "SOLUTION;INTRAVENOUS", "Drug": "LEVOLEUCOVORIN CALCIUM", "ActiveIngredient": "LEVOLEUCOVORIN CALCIUM", "ApplType": "ANDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203563Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203563"}, "203565": {"ApplNo": "203565", "Form": "SOLUTION;INTRAVENOUS", "Drug": "INJECTAFER", "ActiveIngredient": "FERRIC CARBOXYMALTOSE", "ApplType": "NDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203565Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203565"}, "203567": {"ApplNo": "203567", "Form": "SOLUTION;TOPICAL", "Drug": "JUBLIA", "ActiveIngredient": "EFINACONAZOLE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203567s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203567"}, "20358": {"ApplNo": "20358", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "WELLBUTRIN SR", "ActiveIngredient": "BUPROPION HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020358s066lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20358"}, "203585": {"ApplNo": "203585", "Form": "POWDER;SUBCUTANEOUS", "Drug": "SYNRIBO", "ActiveIngredient": "OMACETAXINE MEPESUCCINATE", "ApplType": "NDA", "Sponsor": "TEVA PHARMS INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203585"}, "203593": {"ApplNo": "203593", "Form": "TABLET;ORAL", "Drug": "DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM", "ApplType": "ANDA", "Sponsor": "WATSON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203593Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203593"}, "203594": {"ApplNo": "203594", "Form": "TABLET;ORAL", "Drug": "DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM", "ApplType": "ANDA", "Sponsor": "WATSON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203594Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203594"}, "203629": {"ApplNo": "203629", "Form": "SOLUTION;INTRAVENOUS", "Drug": "NEOSTIGMINE METHYLSULFATE", "ActiveIngredient": "NEOSTIGMINE METHYLSULFATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203629s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203629"}, "203634": {"ApplNo": "203634", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "UCERIS", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203634s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203634"}, "20364": {"ApplNo": "20364", "Form": "CAPSULE;ORAL", "Drug": "LOTREL", "ActiveIngredient": "AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020364Orig1s068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20364"}, "203649": {"ApplNo": "203649", "Form": "INJECTABLE;IV (INFUSION), SUBCUTANEOUS", "Drug": "TREPROSTINIL", "ActiveIngredient": "TREPROSTINIL", "ApplType": "ANDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203649Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203649"}, "203655": {"ApplNo": "203655", "Form": "INJECTABLE;INJECTION", "Drug": "MELPHALAN HYDROCHLORIDE", "ActiveIngredient": "MELPHALAN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "DR REDDYS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203655Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203655"}, "203667": {"ApplNo": "203667", "Form": "TABLET;ORAL", "Drug": "MINASTRIN 24 FE", "ActiveIngredient": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE", "ApplType": "NDA", "Sponsor": "APIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203667s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203667"}, "20367": {"ApplNo": "20367", "Form": "INJECTABLE;INJECTION", "Drug": "CEREZYME", "ActiveIngredient": "IMIGLUCERASE", "ApplType": "BLA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020367_S119lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20367"}, "203684": {"ApplNo": "203684", "Form": "FOR SUSPENSION;INTRAVENOUS", "Drug": "LUMASON", "ActiveIngredient": "SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203684s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203684"}, "20369": {"ApplNo": "20369", "Form": "OINTMENT;OPHTHALMIC", "Drug": "CILOXAN", "ActiveIngredient": "CIPROFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020369s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20369"}, "203697": {"ApplNo": "203697", "Form": "CAPSULE;ORAL", "Drug": "VAZALORE", "ActiveIngredient": "ASPIRIN", "ApplType": "NDA", "Sponsor": "PLX PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203697Orig1s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203697"}, "203711": {"ApplNo": "203711", "Form": "INJECTABLE;INJECTION", "Drug": "ONDANSETRON HYDROCHLORIDE", "ActiveIngredient": "ONDANSETRON HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "QILU PHARM HAINAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203711Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203711"}, "20372": {"ApplNo": "20372", "Form": "INJECTABLE;INJECTION", "Drug": "MYOVIEW", "ActiveIngredient": "TECHNETIUM TC-99M TETROFOSMIN KIT", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020372Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20372"}, "20375": {"ApplNo": "20375", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "CLIMARA", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020375Orig1s045,s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20375"}, "203752": {"ApplNo": "203752", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "MINIVELLE", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "NOVEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203752Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203752"}, "203756": {"ApplNo": "203756", "Form": "CAPSULE;ORAL", "Drug": "COMETRIQ", "ActiveIngredient": "CABOZANTINIB S-MALATE", "ApplType": "NDA", "Sponsor": "EXELIXIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203756s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203756"}, "20378": {"ApplNo": "20378", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "GONAL-F", "ActiveIngredient": "FOLLITROPIN ALFA/BETA", "ApplType": "BLA", "Sponsor": "EMD SERONO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020378s045,s067,s075lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20378"}, "20379": {"ApplNo": "20379", "Form": "INJECTABLE;INJECTION", "Drug": "CAVERJECT", "ActiveIngredient": "ALPROSTADIL", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020379s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20379"}, "203791": {"ApplNo": "203791", "Form": "TABLET;BUCCAL", "Drug": "SITAVIG", "ActiveIngredient": "ACYCLOVIR", "ApplType": "NDA", "Sponsor": "EPI HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203791s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203791"}, "20380": {"ApplNo": "20380", "Form": "GEL;TOPICAL", "Drug": "DIFFERIN", "ActiveIngredient": "ADAPALENE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020380Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20380"}, "203826": {"ApplNo": "203826", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PHENYLEPHRINE HYDROCHLORIDE", "ActiveIngredient": "PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203826s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203826"}, "203849": {"ApplNo": "203849", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MORPHINE SULFATE", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "ANDA", "Sponsor": "ACTAVIS ELIZABETH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203849Orig1s000MG.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203849"}, "20385": {"ApplNo": "20385", "Form": "SPRAY, METERED;NASAL", "Drug": "NICOTROL", "ActiveIngredient": "NICOTINE", "ApplType": "NDA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020385s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20385"}, "203856": {"ApplNo": "203856", "Form": "CAPSULE;ORAL", "Drug": "CYCLOPHOSPHAMIDE", "ActiveIngredient": "CYCLOPHOSPHAMIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203856s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203856"}, "203858": {"ApplNo": "203858", "Form": "CAPSULE;ORAL", "Drug": "JUXTAPID", "ActiveIngredient": "LOMITAPIDE MESYLATE", "ApplType": "NDA", "Sponsor": "AMRYT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203858s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203858"}, "20386": {"ApplNo": "20386", "Form": "TABLET;ORAL", "Drug": "COZAAR", "ActiveIngredient": "LOSARTAN POTASSIUM", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020386s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20386"}, "20387": {"ApplNo": "20387", "Form": "TABLET;ORAL", "Drug": "HYZAAR", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020387s067lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20387"}, "20392": {"ApplNo": "20392", "Form": "CAPSULE;ORAL", "Drug": "CYSTAGON", "ActiveIngredient": "CYSTEAMINE BITARTRATE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020392s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20392"}, "203922": {"ApplNo": "203922", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SODIUM NITRITE", "ActiveIngredient": "SODIUM NITRITE", "ApplType": "NDA", "Sponsor": "HOPE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203922s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203922"}, "203923": {"ApplNo": "203923", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SODIUM THIOSULFATE", "ActiveIngredient": "SODIUM THIOSULFATE", "ApplType": "NDA", "Sponsor": "HOPE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203923s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203923"}, "203952": {"ApplNo": "203952", "Form": "SUSPENSION;ENTERAL", "Drug": "DUOPA", "ActiveIngredient": "CARBIDOPA; LEVODOPA", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203952s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203952"}, "20397": {"ApplNo": "20397", "Form": "TABLET;ORAL", "Drug": "ZANAFLEX", "ActiveIngredient": "TIZANIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LEGACY PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021447s011_020397s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20397"}, "203971": {"ApplNo": "203971", "Form": "SOLUTION;INTRAVENOUS", "Drug": "XOFIGO", "ActiveIngredient": "RADIUM RA-223 DICHLORIDE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203971s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203971"}, "203975": {"ApplNo": "203975", "Form": "POWDER;INHALATION", "Drug": "ANORO ELLIPTA", "ActiveIngredient": "UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203975s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203975"}, "203985": {"ApplNo": "203985", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "AFINITOR DISPERZ", "ActiveIngredient": "EVEROLIMUS", "ApplType": "NDA", "Sponsor": "NOVARTIS PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203985s023,022334s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203985"}, "203993": {"ApplNo": "203993", "Form": "SUSPENSION;ORAL", "Drug": "ONFI", "ActiveIngredient": "CLOBAZAM", "ApplType": "NDA", "Sponsor": "LUNDBECK PHARMS LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203993"}, "20400": {"ApplNo": "20400", "Form": "GEL;TOPICAL", "Drug": "AVITA", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020400s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20400"}, "20401": {"ApplNo": "20401", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "TIAZAC", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020401s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20401"}, "204016": {"ApplNo": "204016", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ZOLEDRONIC ACID", "ActiveIngredient": "ZOLEDRONIC ACID", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204016s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204016"}, "204017": {"ApplNo": "204017", "Form": "SYSTEM;TRANSDERMAL", "Drug": "TWIRLA", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "AGILE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204017s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204017"}, "20402": {"ApplNo": "20402", "Form": "CAPSULE;ORAL", "Drug": "ADVIL LIQUI-GELS", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020402Orig1s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20402"}, "204026": {"ApplNo": "204026", "Form": "CAPSULE;ORAL", "Drug": "POMALYST", "ActiveIngredient": "POMALIDOMIDE", "ApplType": "NDA", "Sponsor": "BRISTOL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204026s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204026"}, "204029": {"ApplNo": "204029", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CLOFARABINE", "ActiveIngredient": "CLOFARABINE", "ApplType": "ANDA", "Sponsor": "ABON PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204029Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204029"}, "204042": {"ApplNo": "204042", "Form": "TABLET;ORAL", "Drug": "INVOKANA", "ActiveIngredient": "CANAGLIFLOZIN", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204042s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204042"}, "20405": {"ApplNo": "20405", "Form": "TABLET;ORAL", "Drug": "LANOXIN", "ActiveIngredient": "DIGOXIN", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020405s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20405"}, "20406": {"ApplNo": "20406", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "PREVACID", "ActiveIngredient": "LANSOPRAZOLE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020406s094,021428s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20406"}, "204060": {"ApplNo": "204060", "Form": "TABLET;ORAL", "Drug": "FOSAMPRENAVIR CALCIUM", "ActiveIngredient": "FOSAMPRENAVIR CALCIUM", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204060lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204060"}, "204061": {"ApplNo": "204061", "Form": "TABLET;ORAL", "Drug": "QUARTETTE", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204061s005s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204061"}, "204063": {"ApplNo": "204063", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "TECFIDERA", "ActiveIngredient": "DIMETHYL FUMARATE", "ApplType": "NDA", "Sponsor": "BIOGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204063s028s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204063"}, "204078": {"ApplNo": "204078", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BLOXIVERZ", "ActiveIngredient": "NEOSTIGMINE METHYLSULFATE", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204078s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204078"}, "204096": {"ApplNo": "204096", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "ASTAGRAF XL", "ActiveIngredient": "TACROLIMUS", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204096"}, "20411": {"ApplNo": "20411", "Form": "INSERT, EXTENDED RELEASE;VAGINAL", "Drug": "CERVIDIL", "ActiveIngredient": "DINOPROSTONE", "ApplType": "NDA", "Sponsor": "FERRING PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020411Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20411"}, "204114": {"ApplNo": "204114", "Form": "TABLET;ORAL", "Drug": "MEKINIST", "ActiveIngredient": "TRAMETINIB DIMETHYL SULFOXIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204114s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204114"}, "204141": {"ApplNo": "204141", "Form": "SPRAY;TOPICAL", "Drug": "TOPICORT", "ActiveIngredient": "DESOXIMETASONE", "ApplType": "NDA", "Sponsor": "TARO PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204141s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204141"}, "20415": {"ApplNo": "20415", "Form": "TABLET;ORAL", "Drug": "REMERON", "ActiveIngredient": "MIRTAZAPINE", "ApplType": "NDA", "Sponsor": "ORGANON USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20415"}, "204150": {"ApplNo": "204150", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "DESVENLAFAXINE", "ActiveIngredient": "DESVENLAFAXINE", "ApplType": "NDA", "Sponsor": "ALEMBIC PHARMS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204150s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204150"}, "204153": {"ApplNo": "204153", "Form": "CREAM;TOPICAL", "Drug": "LUZU", "ActiveIngredient": "LULICONAZOLE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204153s004s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204153"}, "204154": {"ApplNo": "204154", "Form": "TABLET;ORAL", "Drug": "IVERMECTIN", "ActiveIngredient": "IVERMECTIN", "ApplType": "ANDA", "Sponsor": "EDENBRIDGE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204154Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204154"}, "204168": {"ApplNo": "204168", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "FETZIMA", "ActiveIngredient": "LEVOMILNACIPRAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204168s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204168"}, "204200": {"ApplNo": "204200", "Form": "SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS", "Drug": "ADRENALIN", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204200Orig1s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204200"}, "204223": {"ApplNo": "204223", "Form": "SOLUTION;INTRAMUSCULAR, INTRAVENOUS", "Drug": "MORPHINE SULFATE", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204223s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204223"}, "204242": {"ApplNo": "204242", "Form": "TABLET;SUBLINGUAL", "Drug": "ZUBSOLV", "ActiveIngredient": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "OREXO US INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204242s021s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204242"}, "204251": {"ApplNo": "204251", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "SIMBRINZA", "ActiveIngredient": "BRIMONIDINE TARTRATE; BRINZOLAMIDE", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204251s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204251"}, "204255": {"ApplNo": "204255", "Form": "SOLUTION, METERED;TRANSDERMAL", "Drug": "TESTOSTERONE", "ActiveIngredient": "TESTOSTERONE", "ApplType": "ANDA", "Sponsor": "PADAGIS ISRAEL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204255Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204255"}, "20427": {"ApplNo": "20427", "Form": "TABLET;ORAL", "Drug": "SABRIL", "ActiveIngredient": "VIGABATRIN", "ApplType": "NDA", "Sponsor": "LUNDBECK PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20427"}, "204275": {"ApplNo": "204275", "Form": "POWDER;INHALATION", "Drug": "BREO ELLIPTA", "ActiveIngredient": "FLUTICASONE FUROATE; VILANTEROL TRIFENATATE", "ApplType": "NDA", "Sponsor": "GLAXO GRP LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204275s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204275"}, "20428": {"ApplNo": "20428", "Form": "CREAM;TOPICAL", "Drug": "AZELEX", "ActiveIngredient": "AZELAIC ACID", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20428slr016_azelex_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20428"}, "204286": {"ApplNo": "204286", "Form": "GEL;TOPICAL", "Drug": "NAFTIN", "ActiveIngredient": "NAFTIFINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204286s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204286"}, "204300": {"ApplNo": "204300", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VAZCULEP", "ActiveIngredient": "PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204300Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204300"}, "204312": {"ApplNo": "204312", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "LEVETIRACETAM", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "ANDA", "Sponsor": "EUGIA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204312Origs000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204312"}, "204326": {"ApplNo": "204326", "Form": "TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL", "Drug": "ADZENYS XR-ODT", "ActiveIngredient": "AMPHETAMINE", "ApplType": "NDA", "Sponsor": "NEOS THERAPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204326s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204326"}, "204353": {"ApplNo": "204353", "Form": "TABLET;ORAL", "Drug": "INVOKAMET", "ActiveIngredient": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204353s041,205879s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204353"}, "204354": {"ApplNo": "204354", "Form": "SUPPOSITORY;RECTAL", "Drug": "MESALAMINE", "ActiveIngredient": "MESALAMINE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204354Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204354"}, "204369": {"ApplNo": "204369", "Form": "TABLET; ORAL", "Drug": "STIVARGA", "ActiveIngredient": "REGORAFENIB", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204369lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204369"}, "204370": {"ApplNo": "204370", "Form": "CAPSULE;ORAL", "Drug": "VRAYLAR", "ActiveIngredient": "CARIPRAZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204370s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204370"}, "204384": {"ApplNo": "204384", "Form": "TABLET;ORAL", "Drug": "SIRTURO", "ActiveIngredient": "BEDAQUILINE FUMARATE", "ApplType": "NDA", "Sponsor": "JANSSEN THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204384s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204384"}, "20439": {"ApplNo": "20439", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "BETIMOL", "ActiveIngredient": "TIMOLOL", "ApplType": "NDA", "Sponsor": "THEA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20439s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20439"}, "204399": {"ApplNo": "204399", "Form": "GEL;TRANSDERMAL", "Drug": "VOGELXO", "ActiveIngredient": "TESTOSTERONE", "ApplType": "NDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204399"}, "204410": {"ApplNo": "204410", "Form": "TABLET;ORAL", "Drug": "OPSUMIT", "ActiveIngredient": "MACITENTAN", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204410s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204410"}, "204412": {"ApplNo": "204412", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "DELZICOL", "ActiveIngredient": "MESALAMINE", "ApplType": "NDA", "Sponsor": "APIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204412s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204412"}, "204417": {"ApplNo": "204417", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ELEPSIA XR", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "NDA", "Sponsor": "TRIPOINT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204417"}, "204426": {"ApplNo": "204426", "Form": "CAPSULE;ORAL", "Drug": "TAYTULLA", "ActiveIngredient": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE", "ApplType": "NDA", "Sponsor": "APIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204426s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204426"}, "204427": {"ApplNo": "204427", "Form": "SOLUTION;TOPICAL", "Drug": "KERYDIN", "ActiveIngredient": "TAVABOROLE", "ApplType": "NDA", "Sponsor": "ANACOR PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204427s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204427"}, "204431": {"ApplNo": "204431", "Form": "TABLET;SUBLINGUAL", "Drug": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE", "ActiveIngredient": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "ETHYPHARM USA CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204431Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204431"}, "20444": {"ApplNo": "20444", "Form": "INJECTABLE;INJECTION", "Drug": "FLOLAN", "ActiveIngredient": "EPOPROSTENOL SODIUM", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020444s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20444"}, "204441": {"ApplNo": "204441", "Form": "TABLET;ORAL", "Drug": "JYNARQUE", "ActiveIngredient": "TOLVAPTAN", "ApplType": "NDA", "Sponsor": "OTSUKA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204441s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204441"}, "204447": {"ApplNo": "204447", "Form": "TABLET;ORAL", "Drug": "TRINTELLIX", "ActiveIngredient": "VORTIOXETINE HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204447s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204447"}, "204475": {"ApplNo": "204475", "Form": "TABLET;ORAL", "Drug": "FENOFIBRATE", "ActiveIngredient": "FENOFIBRATE", "ApplType": "ANDA", "Sponsor": "MYLAN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204475Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204475"}, "204485": {"ApplNo": "204485", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VASOSTRICT", "ActiveIngredient": "VASOPRESSIN", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204485Orig1s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204485"}, "20449": {"ApplNo": "20449", "Form": "INJECTABLE;INJECTION", "Drug": "TAXOTERE", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020449s086lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20449"}, "20450": {"ApplNo": "20450", "Form": "INJECTABLE;INJECTION", "Drug": "CEREBYX", "ActiveIngredient": "FOSPHENYTOIN SODIUM", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020450s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20450"}, "204508": {"ApplNo": "204508", "Form": "EMULSION;INTRAVENOUS", "Drug": "CLINOLIPID 20%", "ActiveIngredient": "OLIVE OIL; SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204508s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204508"}, "20451": {"ApplNo": "20451", "Form": "INJECTABLE;INJECTION", "Drug": "PHOTOFRIN", "ActiveIngredient": "PORFIMER SODIUM", "ApplType": "NDA", "Sponsor": "PINNACLE BIOLGS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020451s029,021525s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20451"}, "204516": {"ApplNo": "204516", "Form": "CAPSULE;ORAL", "Drug": "BRISDELLE", "ActiveIngredient": "PAROXETINE MESYLATE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204516s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204516"}, "20453": {"ApplNo": "20453", "Form": "CREAM;TOPICAL", "Drug": "PANDEL", "ActiveIngredient": "HYDROCORTISONE PROBUTATE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020453s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20453"}, "204569": {"ApplNo": "204569", "Form": "TABLET;ORAL", "Drug": "BELSOMRA", "ActiveIngredient": "SUVOREXANT", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204569"}, "20457": {"ApplNo": "20457", "Form": "INJECTABLE;INJECTION", "Drug": "ETOPOPHOS PRESERVATIVE FREE", "ActiveIngredient": "ETOPOSIDE PHOSPHATE", "ApplType": "NDA", "Sponsor": "CHEPLAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020457s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20457"}, "204623": {"ApplNo": "204623", "Form": "SOLUTION;TOPICAL", "Drug": "PENNSAID", "ActiveIngredient": "DICLOFENAC SODIUM", "ApplType": "NDA", "Sponsor": "HORIZON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204623s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204623"}, "204629": {"ApplNo": "204629", "Form": "TABLET;ORAL", "Drug": "JARDIANCE", "ActiveIngredient": "EMPAGLIFLOZIN", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204629s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204629"}, "204630": {"ApplNo": "204630", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PROVAYBLUE", "ActiveIngredient": "METHYLENE BLUE", "ApplType": "NDA", "Sponsor": "PROVEPHARM SAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204630Orig1s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204630"}, "204640": {"ApplNo": "204640", "Form": "SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS", "Drug": "ADRENALIN", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204640Orig1s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204640"}, "20465": {"ApplNo": "20465", "Form": "TABLET; ORAL", "Drug": "AZULFIDINE", "ActiveIngredient": "SULFASALAZINE ", "ApplType": "NDA", "Sponsor": "PHARMACIA AND UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/007073s133,020465s000,021243s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20465"}, "204655": {"ApplNo": "204655", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "NEXIUM 24HR", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "NDA", "Sponsor": "ASTRAZENECA LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204655Orig1s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204655"}, "204671": {"ApplNo": "204671", "Form": "TABLET;ORAL", "Drug": "SOVALDI", "ActiveIngredient": "SOFOSBUVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204671s017,212480s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204671"}, "204677": {"ApplNo": "204677", "Form": "SOLUTION;INTRAVENOUS", "Drug": "NEURACEQ", "ActiveIngredient": "FLORBETABEN F-18", "ApplType": "NDA", "Sponsor": "LIFE MOLECULAR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204677Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204677"}, "20468": {"ApplNo": "20468", "Form": "SPRAY, METERED;NASAL", "Drug": "NASACORT ALLERGY 24 HOUR", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020468Orig1s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20468"}, "204684": {"ApplNo": "204684", "Form": "CAPSULE;ORAL", "Drug": "IMPAVIDO", "ActiveIngredient": "MILTEFOSINE", "ApplType": "NDA", "Sponsor": "KNIGHT THERAPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204684s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204684"}, "20470": {"ApplNo": "20470", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CLARITIN-D 24 HOUR", "ActiveIngredient": "LORATADINE; PSEUDOEPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019670Orig1s034,020470Orig1s047Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20470"}, "204708": {"ApplNo": "204708", "Form": "GEL;TOPICAL", "Drug": "MIRVASO", "ActiveIngredient": "BRIMONIDINE TARTRATE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204708s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204708"}, "20471": {"ApplNo": "20471", "Form": "TABLET;ORAL", "Drug": "ZYFLO", "ActiveIngredient": "ZILEUTON", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020471s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20471"}, "20472": {"ApplNo": "20472", "Form": "INSERT, EXTENDED RELEASE;VAGINAL", "Drug": "ESTRING", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020472Orig1s019Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20472"}, "204734": {"ApplNo": "204734", "Form": "POWDER;ORAL", "Drug": "FOSRENOL", "ActiveIngredient": "LANTHANUM CARBONATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021468s023,204734s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204734"}, "20475": {"ApplNo": "20475", "Form": "GEL;TOPICAL", "Drug": "RETIN-A MICRO", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "VALEANT INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020475s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20475"}, "204760": {"ApplNo": "204760", "Form": "TABLET;ORAL", "Drug": "MOVANTIK", "ActiveIngredient": "NALOXEGOL OXALATE", "ApplType": "NDA", "Sponsor": "REDHILL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204760"}, "204767": {"ApplNo": "204767", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ACETAMINOPHEN", "ActiveIngredient": "ACETAMINOPHEN", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204767s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204767"}, "20478": {"ApplNo": "20478", "Form": "LIQUID;INHALATION", "Drug": "ULTANE", "ActiveIngredient": "SEVOFLURANE", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020478s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20478"}, "204781": {"ApplNo": "204781", "Form": "SOLUTION;INTRAVENOUS", "Drug": "DOTAREM", "ActiveIngredient": "GADOTERATE MEGLUMINE", "ApplType": "NDA", "Sponsor": "GUERBET", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781"}, "204785": {"ApplNo": "204785", "Form": "CAPSULE;ORAL", "Drug": "TREZIX", "ActiveIngredient": "ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE", "ApplType": "ANDA", "Sponsor": "XSPIRE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204785Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204785"}, "204790": {"ApplNo": "204790", "Form": "TABLET;ORAL", "Drug": "TIVICAY", "ActiveIngredient": "DOLUTEGRAVIR SODIUM", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204790s030,213983s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204790"}, "204803": {"ApplNo": "204803", "Form": "SOLUTION, EXTENDED RELEASE;INFILTRATION", "Drug": "POSIMIR", "ActiveIngredient": "BUPIVACAINE", "ApplType": "NDA", "Sponsor": "INNOCOLL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204803Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204803"}, "204819": {"ApplNo": "204819", "Form": "TABLET;ORAL", "Drug": "ADEMPAS", "ActiveIngredient": "RIOCIGUAT", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204819"}, "204820": {"ApplNo": "204820", "Form": "CAPSULE;ORAL", "Drug": "MITIGARE", "ActiveIngredient": "COLCHICINE", "ApplType": "NDA", "Sponsor": "HIKMA INTL PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204820"}, "204824": {"ApplNo": "204824", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "OTREXUP", "ActiveIngredient": "METHOTREXATE", "ApplType": "NDA", "Sponsor": "OTTER PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204824s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204824"}, "20485": {"ApplNo": "20485", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "VISINE", "ActiveIngredient": "NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE", "ApplType": "NDA", "Sponsor": "JOHNSON AND JOHNSON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020485Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20485"}, "20487": {"ApplNo": "20487", "Form": "TABLET;ORAL", "Drug": "VALTREX", "ActiveIngredient": "VALACYCLOVIR HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020487s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20487"}, "20488": {"ApplNo": "20488", "Form": "INJECTABLE;INJECTION", "Drug": "MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "MAGNESIUM SULFATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020488Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20488"}, "204886": {"ApplNo": "204886", "Form": "TABLET;ORAL", "Drug": "ZONTIVITY", "ActiveIngredient": "VORAPAXAR SULFATE", "ApplType": "NDA", "Sponsor": "XSPIRE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204886s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204886"}, "20489": {"ApplNo": "20489", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "ANDRODERM", "ActiveIngredient": "TESTOSTERONE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020489s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20489"}, "20491": {"ApplNo": "20491", "Form": "INJECTABLE;INJECTION", "Drug": "CORVERT", "ActiveIngredient": "IBUTILIDE FUMARATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-491S003.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20491"}, "204957": {"ApplNo": "204957", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ACETAMINOPHEN", "ActiveIngredient": "ACETAMINOPHEN", "ApplType": "NDA", "Sponsor": "B BRAUN MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204957s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204957"}, "204958": {"ApplNo": "204958", "Form": "POWDER;INTRAVENOUS", "Drug": "KENGREAL", "ActiveIngredient": "CANGRELOR", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204958s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204958"}, "20496": {"ApplNo": "20496", "Form": "TABLET;ORAL", "Drug": "AMARYL", "ActiveIngredient": "GLIMEPIRIDE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020496s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20496"}, "20497": {"ApplNo": "20497", "Form": "TABLET;ORAL", "Drug": "FARESTON", "ActiveIngredient": "TOREMIFENE CITRATE", "ApplType": "NDA", "Sponsor": "KYOWA KIRIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020497s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20497"}, "20498": {"ApplNo": "20498", "Form": "TABLET;ORAL", "Drug": "CASODEX", "ActiveIngredient": "BICALUTAMIDE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020498s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20498"}, "204988": {"ApplNo": "204988", "Form": "TABLET;ORAL", "Drug": "RUFINAMIDE", "ActiveIngredient": "RUFINAMIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204988Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204988"}, "20500": {"ApplNo": "20500", "Form": "SUSPENSION;ORAL", "Drug": "MEPRON", "ActiveIngredient": "ATOVAQUONE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020500s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20500"}, "205003": {"ApplNo": "205003", "Form": "TABLET;ORAL", "Drug": "PRESTALIA", "ActiveIngredient": "AMLODIPINE BESYLATE; PERINDOPRIL ARGININE", "ApplType": "NDA", "Sponsor": "ADHERA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205003s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205003"}, "205004": {"ApplNo": "205004", "Form": "POWDER;INTRAVENOUS", "Drug": "BORTEZOMIB", "ActiveIngredient": "BORTEZOMIB", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205004s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205004"}, "205029": {"ApplNo": "205029", "Form": "SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS", "Drug": "EPINEPHRINE", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "BPI LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205029s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205029"}, "20503": {"ApplNo": "20503", "Form": "AEROSOL, METERED;INHALATION", "Drug": "PROVENTIL-HFA", "ActiveIngredient": "ALBUTEROL SULFATE", "ApplType": "NDA", "Sponsor": "KINDEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020503s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20503"}, "20504": {"ApplNo": "20504", "Form": "CAPSULE;ORAL", "Drug": "MICROZIDE", "ActiveIngredient": "HYDROCHLOROTHIAZIDE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020504s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20504"}, "20505": {"ApplNo": "20505", "Form": "TABLET;ORAL", "Drug": "TOPAMAX", "ActiveIngredient": "TOPIRAMATE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020505s064,020844s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20505"}, "205053": {"ApplNo": "205053", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "NOXAFIL", "ActiveIngredient": "POSACONAZOLE", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205053Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205053"}, "205054": {"ApplNo": "205054", "Form": "FOR SUSPENSION;INTRAMUSCULAR", "Drug": "LUTRATE DEPOT KIT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "INVAGEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205054s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205054"}, "205065": {"ApplNo": "205065", "Form": "POWDER;ORAL", "Drug": "KUVAN", "ActiveIngredient": "SAPROPTERIN DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BIOMARIN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022181s020,205065s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205065"}, "205075": {"ApplNo": "205075", "Form": "TABLET;ORAL", "Drug": "RUFINAMIDE", "ActiveIngredient": "RUFINAMIDE", "ApplType": "ANDA", "Sponsor": "GLENMARK PHARMS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205075Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205075"}, "205076": {"ApplNo": "205076", "Form": "CREAM;TOPICAL", "Drug": "OXICONAZOLE NITRATE", "ActiveIngredient": "OXICONAZOLE NITRATE", "ApplType": "ANDA", "Sponsor": "TARO PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205076Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205076"}, "205095": {"ApplNo": "205095", "Form": "TABLET;ORAL", "Drug": "RUFINAMIDE", "ActiveIngredient": "RUFINAMIDE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205095Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205095"}, "205098": {"ApplNo": "205098", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VARITHENA", "ActiveIngredient": "POLIDOCANOL", "ApplType": "NDA", "Sponsor": "PROVENSIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205098s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205098"}, "205108": {"ApplNo": "205108", "Form": "SOLUTION;ORAL", "Drug": "SOTYLIZE", "ActiveIngredient": "SOTALOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205108s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205108"}, "205109": {"ApplNo": "205109", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "VELPHORO", "ActiveIngredient": "FERRIC OXYHYDROXIDE", "ApplType": "NDA", "Sponsor": "VIFOR FRESENIUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205109s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205109"}, "205122": {"ApplNo": "205122", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "QUDEXY XR", "ActiveIngredient": "TOPIRAMATE", "ApplType": "NDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205122"}, "20516": {"ApplNo": "20516", "Form": "SUSPENSION;ORAL", "Drug": "CHILDREN'S MOTRIN", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020516Orig1s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20516"}, "20517": {"ApplNo": "20517", "Form": "INJECTABLE;INJECTION", "Drug": "LUPRON DEPOT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "ABBVIE ENDOCRINE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019732s045,020517s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20517"}, "205175": {"ApplNo": "205175", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "ECOZA", "ActiveIngredient": "ECONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "RESILIA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205175s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205175"}, "20521": {"ApplNo": "20521", "Form": "SUSPENSION;INTRATRACHEAL", "Drug": "INFASURF PRESERVATIVE FREE", "ActiveIngredient": "CALFACTANT", "ApplType": "BLA", "Sponsor": "ONY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20521lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20521"}, "20522": {"ApplNo": "20522", "Form": "INJECTABLE;INJECTION", "Drug": "NUTROPIN AQ NUSPIN", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-522S013_Somatropin_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20522"}, "205223": {"ApplNo": "205223", "Form": "GEL;VAGINAL", "Drug": "NUVESSA", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "CHEMO RESEARCH SL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205223s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205223"}, "20524": {"ApplNo": "20524", "Form": "CREAM;TOPICAL", "Drug": "MENTAX", "ActiveIngredient": "BUTENAFINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20524s5lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20524"}, "205266": {"ApplNo": "205266", "Form": "CAPSULE;ORAL", "Drug": "ODOMZO", "ActiveIngredient": "SONIDEGIB PHOSPHATE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205266s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205266"}, "20527": {"ApplNo": "20527", "Form": "TABLET;ORAL-28", "Drug": "PREMPRO", "ActiveIngredient": "ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020527s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20527"}, "20529": {"ApplNo": "20529", "Form": "GEL;TOPICAL", "Drug": "CONDYLOX", "ActiveIngredient": "PODOFILOX", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1997/020529s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20529"}, "205327": {"ApplNo": "205327", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "METHYLPHENIDATE HYDROCHLORIDE", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "OSMOTICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205327Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205327"}, "20533": {"ApplNo": "20533", "Form": "SOLUTION;INJECTION", "Drug": "NAROPIN", "ActiveIngredient": "ROPIVACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020533Orig1s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20533"}, "205352": {"ApplNo": "205352", "Form": "TABLET;ORAL", "Drug": "ALEVE PM", "ActiveIngredient": "DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205352Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205352"}, "205379": {"ApplNo": "205379", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ESOMEPRAZOLE SODIUM", "ActiveIngredient": "ESOMEPRAZOLE SODIUM", "ApplType": "ANDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205379Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205379"}, "20538": {"ApplNo": "20538", "Form": "SYSTEM;TRANSDERMAL", "Drug": "VIVELLE-DOT", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020538Orig1s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20538"}, "205382": {"ApplNo": "205382", "Form": "POWDER;INHALATION", "Drug": "INCRUSE ELLIPTA", "ActiveIngredient": "UMECLIDINIUM BROMIDE", "ApplType": "NDA", "Sponsor": "GLAXO GRP ENGLAND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205382s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205382"}, "205388": {"ApplNo": "205388", "Form": "SOLUTION;IRRIGATION", "Drug": "OMIDRIA", "ActiveIngredient": "KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "RAYNER SURGICAL", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205388s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205388"}, "205395": {"ApplNo": "205395", "Form": "TABLET;ORAL", "Drug": "PREZCOBIX", "ActiveIngredient": "COBICISTAT; DARUNAVIR", "ApplType": "NDA", "Sponsor": "JANSSEN PRODS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205395s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205395"}, "20541": {"ApplNo": "20541", "Form": "TABLET;ORAL", "Drug": "ARIMIDEX", "ActiveIngredient": "ANASTROZOLE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020541s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20541"}, "205410": {"ApplNo": "205410", "Form": "SOLUTION;ORAL", "Drug": "HEMANGEOL", "ActiveIngredient": "PROPRANOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PIERRE FABRE DERMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205410"}, "205422": {"ApplNo": "205422", "Form": "TABLET;ORAL", "Drug": "REXULTI", "ActiveIngredient": "BREXPIPRAZOLE", "ApplType": "NDA", "Sponsor": "OTSUKA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205422Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205422"}, "205433": {"ApplNo": "205433", "Form": "SOLUTION;INHALATION", "Drug": "KITABIS PAK", "ActiveIngredient": "TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "PULMOFLOW INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205433s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205433"}, "205434": {"ApplNo": "205434", "Form": "SPRAY, METERED;NASAL", "Drug": "FLONASE ALLERGY RELIEF", "ActiveIngredient": "FLUTICASONE PROPIONATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205434Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205434"}, "205435": {"ApplNo": "205435", "Form": "TABLET;ORAL", "Drug": "SIVEXTRO", "ActiveIngredient": "TEDIZOLID PHOSPHATE", "ApplType": "NDA", "Sponsor": "CUBIST PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205435s014,205435s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205435"}, "205436": {"ApplNo": "205436", "Form": "POWDER;INTRAVENOUS", "Drug": "SIVEXTRO", "ActiveIngredient": "TEDIZOLID PHOSPHATE", "ApplType": "NDA", "Sponsor": "CUBIST PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205435s014,205435s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205436"}, "205437": {"ApplNo": "205437", "Form": "TABLET;ORAL", "Drug": "OTEZLA", "ActiveIngredient": "APREMILAST", "ApplType": "NDA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205437s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205437"}, "20547": {"ApplNo": "20547", "Form": "TABLET;ORAL", "Drug": "ACCOLATE", "ActiveIngredient": "ZAFIRLUKAST", "ApplType": "NDA", "Sponsor": "STRIDES PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020547s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20547"}, "205476": {"ApplNo": "205476", "Form": "POWDER;IV (INFUSION)", "Drug": "BENDAMUSTINE HYDROCHLORIDE", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "INNOPHARMA LICENSING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205476Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205476"}, "205488": {"ApplNo": "205488", "Form": "GEL, METERED;NASAL", "Drug": "NATESTO", "ActiveIngredient": "TESTOSTERONE", "ApplType": "NDA", "Sponsor": "ACERUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205488s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205488"}, "205489": {"ApplNo": "205489", "Form": "TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL", "Drug": "COTEMPLA XR-ODT", "ActiveIngredient": "METHYLPHENIDATE", "ApplType": "NDA", "Sponsor": "NEOS THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205489s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205489"}, "205490": {"ApplNo": "205490", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "PERRIGO R AND D", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205490Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205490"}, "205494": {"ApplNo": "205494", "Form": "CAPSULE;ORAL", "Drug": "CERDELGA", "ActiveIngredient": "ELIGLUSTAT TARTRATE", "ApplType": "NDA", "Sponsor": "GENZYME CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205494"}, "20550": {"ApplNo": "20550", "Form": "Tablet; Oral", "Drug": "VALTREX", "ActiveIngredient": "VALACYCLOVIR HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020550s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20550"}, "20551": {"ApplNo": "20551", "Form": "INJECTABLE;INJECTION", "Drug": "NIMBEX", "ActiveIngredient": "CISATRACURIUM BESYLATE", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020551s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20551"}, "205525": {"ApplNo": "205525", "Form": "SOLUTION;ORAL", "Drug": "SYNDROS", "ActiveIngredient": "DRONABINOL", "ApplType": "NDA", "Sponsor": "BENUVIA OPERATIONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205525s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205525"}, "20554": {"ApplNo": "20554", "Form": "CREAM;TOPICAL", "Drug": "DOVONEX", "ActiveIngredient": "CALCIPOTRIENE", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020273s013,020554s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20554"}, "20555": {"ApplNo": "20555", "Form": "TABLET;ORAL", "Drug": "AXID AR", "ActiveIngredient": "NIZATIDINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020555Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20555"}, "205551": {"ApplNo": "205551", "Form": "TABLET;ORAL", "Drug": "TRIUMEQ", "ActiveIngredient": "ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205551s029,215413s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205551"}, "205552": {"ApplNo": "205552", "Form": "CAPSULE;ORAL", "Drug": "IMBRUVICA", "ActiveIngredient": "IBRUTINIB", "ApplType": "NDA", "Sponsor": "PHARMACYCLICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205552s036,210563s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205552"}, "205555": {"ApplNo": "205555", "Form": "POWDER;INTRAPLEURAL", "Drug": "STERITALC", "ActiveIngredient": "TALC", "ApplType": "NDA", "Sponsor": "NOVATECH SA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205555s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205555"}, "205572": {"ApplNo": "205572", "Form": "SOLUTION;INTRAVENOUS", "Drug": "MOXIFLOXACIN HYDROCHLORIDE", "ActiveIngredient": "MOXIFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205572"}, "205574": {"ApplNo": "205574", "Form": "POWDER;IV (INFUSION)", "Drug": "BENDAMUSTINE HYDROCHLORIDE", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205574Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205574"}, "205579": {"ApplNo": "205579", "Form": "FOR SUSPENSION;INTRAVENOUS", "Drug": "RYANODEX", "ActiveIngredient": "DANTROLENE SODIUM", "ApplType": "NDA", "Sponsor": "EAGLE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205579s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205579"}, "205580": {"ApplNo": "205580", "Form": "SOLUTION;IV (INFUSION)", "Drug": "BELRAPZO", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EAGLE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205580Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205580"}, "205582": {"ApplNo": "205582", "Form": "POWDER;INTRAVENOUS", "Drug": "DECITABINE", "ActiveIngredient": "DECITABINE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205582s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205582"}, "205596": {"ApplNo": "205596", "Form": "SOLUTION;INTRAVENOUS", "Drug": "NOXAFIL", "ActiveIngredient": "POSACONAZOLE", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205596Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205596"}, "205598": {"ApplNo": "205598", "Form": "FOR SOLUTION;ORAL", "Drug": "MACRILEN", "ActiveIngredient": "MACIMORELIN ACETATE", "ApplType": "NDA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205598s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205598"}, "20560": {"ApplNo": "20560", "Form": "TABLET;ORAL", "Drug": "FOSAMAX", "ActiveIngredient": "ALENDRONATE SODIUM", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020560s070lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20560"}, "205609": {"ApplNo": "205609", "Form": "TABLET;ORAL", "Drug": "ETHACRYNIC ACID", "ActiveIngredient": "ETHACRYNIC ACID", "ApplType": "ANDA", "Sponsor": "EDENBRIDGE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205609Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205609"}, "205612": {"ApplNo": "205612", "Form": "SOLUTION;INJECTION", "Drug": "ROPIVACAINE HYDROCHLORIDE", "ActiveIngredient": "ROPIVACAINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "EUGIA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205612Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205612"}, "205613": {"ApplNo": "205613", "Form": "AEROSOL, FOAM;RECTAL", "Drug": "UCERIS", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205613s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205613"}, "205625": {"ApplNo": "205625", "Form": "POWDER;INHALATION", "Drug": "ARNUITY ELLIPTA", "ActiveIngredient": "FLUTICASONE FUROATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205625s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205625"}, "20563": {"ApplNo": "20563", "Form": "INJECTABLE;INJECTION", "Drug": "HUMALOG", "ActiveIngredient": "INSULIN LISPRO RECOMBINANT", "ApplType": "BLA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20563S10-11-12-13LBL.PDF", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20563"}, "205636": {"ApplNo": "205636", "Form": "POWDER, METERED;INHALATION", "Drug": "PROAIR RESPICLICK", "ActiveIngredient": "ALBUTEROL SULFATE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205636s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205636"}, "20564": {"ApplNo": "20564", "Form": "TABLET;ORAL", "Drug": "EPIVIR", "ActiveIngredient": "LAMIVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020564s039,020596s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20564"}, "205641": {"ApplNo": "205641", "Form": "AEROSOL, METERED;INHALATION", "Drug": "ASMANEX HFA", "ActiveIngredient": "MOMETASONE FUROATE", "ApplType": "NDA", "Sponsor": "ORGANON LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205641s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205641"}, "205645": {"ApplNo": "205645", "Form": "POWDER;INTRAVENOUS", "Drug": "TIGECYCLINE", "ActiveIngredient": "TIGECYCLINE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205645s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205645"}, "205649": {"ApplNo": "205649", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "XIGDUO XR", "ActiveIngredient": "DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205649s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205649"}, "205677": {"ApplNo": "205677", "Form": "CAPSULE;ORAL", "Drug": "HETLIOZ", "ActiveIngredient": "TASIMELTEON", "ApplType": "NDA", "Sponsor": "VANDA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205677Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205677"}, "205692": {"ApplNo": "205692", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "BASAGLAR", "ActiveIngredient": "INSULIN GLARGINE", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205692s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205692"}, "205703": {"ApplNo": "205703", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER", "ActiveIngredient": "ESMOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HQ SPCLT PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205703s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205703"}, "20571": {"ApplNo": "20571", "Form": "INJECTABLE;INJECTION", "Drug": "CAMPTOSAR", "ActiveIngredient": "IRINOTECAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020571Orig1s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20571"}, "205718": {"ApplNo": "205718", "Form": "CAPSULE;ORAL", "Drug": "AKYNZEO", "ActiveIngredient": "NETUPITANT; PALONOSETRON HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HELSINN HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205718s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205718"}, "20572": {"ApplNo": "20572", "Form": "TABLET;ORAL", "Drug": "BUPHENYL", "ActiveIngredient": "SODIUM PHENYLBUTYRATE", "ApplType": "NDA", "Sponsor": "HORIZON THERAP US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020572s025,020573s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20572"}, "20573": {"ApplNo": "20573", "Form": "POWDER;ORAL", "Drug": "BUPHENYL", "ActiveIngredient": "SODIUM PHENYLBUTYRATE", "ApplType": "NDA", "Sponsor": "HORIZON THERAP US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020572s025,020573s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20573"}, "205739": {"ApplNo": "205739", "Form": "POWDER;ORAL", "Drug": "VELTASSA", "ActiveIngredient": "PATIROMER SORBITEX CALCIUM", "ApplType": "NDA", "Sponsor": "VIFOR PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205739s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205739"}, "205747": {"ApplNo": "205747", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "HUMALOG KWIKPEN", "ActiveIngredient": "INSULIN LISPRO RECOMBINANT", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205747s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205747"}, "205750": {"ApplNo": "205750", "Form": "CAPSULE;ORAL", "Drug": "CHOLBAM", "ActiveIngredient": "CHOLIC ACID", "ApplType": "NDA", "Sponsor": "TRAVERE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205750s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205750"}, "20576": {"ApplNo": "20576", "Form": "FOR SOLUTION;ORAL", "Drug": "CYSTADANE", "ActiveIngredient": "BETAINE", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020576s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20576"}, "205776": {"ApplNo": "205776", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "RASUVO", "ActiveIngredient": "METHOTREXATE", "ApplType": "NDA", "Sponsor": "MEDEXUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205776s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205776"}, "20578": {"ApplNo": "20578", "Form": "IMPLANT;IMPLANTATION", "Drug": "ZOLADEX", "ActiveIngredient": "GOSERELIN ACETATE", "ApplType": "NDA", "Sponsor": "TERSERA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019726s059,020578s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20578"}, "205781": {"ApplNo": "205781", "Form": "GEL;TRANSDERMAL", "Drug": "TESTOSTERONE", "ActiveIngredient": "TESTOSTERONE", "ApplType": "ANDA", "Sponsor": "PADAGIS ISRAEL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205781Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205781"}, "205786": {"ApplNo": "205786", "Form": "POWDER;ORAL", "Drug": "ISENTRESS", "ActiveIngredient": "RALTEGRAVIR POTASSIUM", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022145s044,203045s017,205786s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205786"}, "20579": {"ApplNo": "20579", "Form": "CAPSULE;ORAL", "Drug": "FLOMAX", "ActiveIngredient": "TAMSULOSIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020579s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20579"}, "205811": {"ApplNo": "205811", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE", "ActiveIngredient": "DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "ACTAVIS LABS FL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205811Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205811"}, "20583": {"ApplNo": "20583", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "LOTEMAX", "ActiveIngredient": "LOTEPREDNOL ETABONATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20583lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20583"}, "205831": {"ApplNo": "205831", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "APTENSIO XR", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "RHODES PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205831s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205831"}, "205832": {"ApplNo": "205832", "Form": "CAPSULE;ORAL", "Drug": "OFEV", "ActiveIngredient": "NINTEDANIB ESYLATE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205832Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205832"}, "205834": {"ApplNo": "205834", "Form": "TABLET;ORAL", "Drug": "HARVONI", "ActiveIngredient": "LEDIPASVIR; SOFOSBUVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205834s032,212477s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205834"}, "205836": {"ApplNo": "205836", "Form": "TABLET;ORAL", "Drug": "BRIVIACT", "ActiveIngredient": "BRIVARACETAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205836Orig1s011;205837Orig1s009;205838Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205836"}, "205837": {"ApplNo": "205837", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BRIVIACT", "ActiveIngredient": "BRIVARACETAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205836Orig1s011;205837Orig1s009;205838Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205837"}, "205838": {"ApplNo": "205838", "Form": "SOLUTION;ORAL", "Drug": "BRIVIACT", "ActiveIngredient": "BRIVARACETAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205836Orig1s011;205837Orig1s009;205838Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205838"}, "205858": {"ApplNo": "205858", "Form": "TABLET;ORAL", "Drug": "ZYDELIG", "ActiveIngredient": "IDELALISIB", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205858"}, "20587": {"ApplNo": "20587", "Form": "AEROSOL;INTRAPLEURAL", "Drug": "SCLEROSOL", "ActiveIngredient": "TALC", "ApplType": "NDA", "Sponsor": "SCIARRA LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020587s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20587"}, "205874": {"ApplNo": "205874", "Form": "TABLET;ORAL", "Drug": "AURYXIA", "ActiveIngredient": "FERRIC CITRATE", "ApplType": "NDA", "Sponsor": "KERYX BIOPHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205874s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205874"}, "205879": {"ApplNo": "205879", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "INVOKAMET XR", "ActiveIngredient": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204353s041,205879s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205879"}, "20588": {"ApplNo": "20588", "Form": "SOLUTION;ORAL", "Drug": "RISPERDAL", "ActiveIngredient": "RISPERIDONE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020588s073lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20588"}, "205880": {"ApplNo": "205880", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SODIUM PHENYLACETATE AND SODIUM BENZOATE", "ActiveIngredient": "SODIUM BENZOATE; SODIUM PHENYLACETATE", "ApplType": "ANDA", "Sponsor": "NAVINTA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205880Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205880"}, "205883": {"ApplNo": "205883", "Form": "INJECTABLE;INJECTION", "Drug": "MEROPENEM", "ActiveIngredient": "MEROPENEM", "ApplType": "ANDA", "Sponsor": "AMNEAL PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205883Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205883"}, "20589": {"ApplNo": "20589", "Form": "SUSPENSION;ORAL", "Drug": "CHILDREN'S ADVIL", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020589Orig1s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20589"}, "205901": {"ApplNo": "205901", "Form": "TABLET;ORAL", "Drug": "TELMISARTAN", "ActiveIngredient": "TELMISARTAN", "ApplType": "ANDA", "Sponsor": "HETERO LABS LTD V", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205901Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205901"}, "205917": {"ApplNo": "205917", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PARICALCITOL", "ActiveIngredient": "PARICALCITOL", "ApplType": "NDA", "Sponsor": "HIKMA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205917s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205917"}, "205919": {"ApplNo": "205919", "Form": "SUSPENSION;ORAL", "Drug": "PURIXAN", "ActiveIngredient": "MERCAPTOPURINE", "ApplType": "NDA", "Sponsor": "NOVA LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205919s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205919"}, "20592": {"ApplNo": "20592", "Form": "TABLET;ORAL", "Drug": "ZYPREXA", "ActiveIngredient": "OLANZAPINE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20592"}, "205920": {"ApplNo": "205920", "Form": "AEROSOL, METERED;INHALATION", "Drug": "PRIMATENE MIST", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "ARMSTRONG PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205920Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205920"}, "205927": {"ApplNo": "205927", "Form": "TABLET;ORAL", "Drug": "PRASUGREL", "ActiveIngredient": "PRASUGREL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205927Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205927"}, "205931": {"ApplNo": "205931", "Form": "TABLET;ORAL", "Drug": "ACTICLATE", "ActiveIngredient": "DOXYCYCLINE HYCLATE", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205931s005,208253s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205931"}, "205934": {"ApplNo": "205934", "Form": "INJECTABLE;INJECTION", "Drug": "DOCETAXEL", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "SHILPA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205934s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205934"}, "20596": {"ApplNo": "20596", "Form": "SOLUTION;ORAL", "Drug": "EPIVIR", "ActiveIngredient": "LAMIVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020564s039,020596s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20596"}, "20597": {"ApplNo": "20597", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "XALATAN", "ActiveIngredient": "LATANOPROST", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020597s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20597"}, "20599": {"ApplNo": "20599", "Form": "TABLET;ORAL", "Drug": "RILUTEK", "ActiveIngredient": "RILUZOLE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020599s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20599"}, "20600": {"ApplNo": "20600", "Form": "GEL;TOPICAL", "Drug": "TAZORAC", "ActiveIngredient": "TAZAROTENE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020600s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20600"}, "206015": {"ApplNo": "206015", "Form": "TABLET;ORAL", "Drug": "PITAVASTATIN CALCIUM", "ActiveIngredient": "PITAVASTATIN CALCIUM", "ApplType": "ANDA", "Sponsor": "AUROBINDO PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206015Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206015"}, "20602": {"ApplNo": "20602", "Form": "TABLET;ORAL", "Drug": "JUNIOR STRENGTH MOTRIN", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020602Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20602"}, "206028": {"ApplNo": "206028", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "MEMANTINE HYDROCHLORIDE", "ActiveIngredient": "MEMANTINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "LUPIN LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206028Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206028"}, "20603": {"ApplNo": "20603", "Form": "SUSPENSION/DROPS;ORAL", "Drug": "CHILDREN'S MOTRIN", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020603Orig1s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20603"}, "206038": {"ApplNo": "206038", "Form": "TABLET;ORAL", "Drug": "ORKAMBI", "ActiveIngredient": "IVACAFTOR; LUMACAFTOR", "ApplType": "NDA", "Sponsor": "VERTEX PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206038s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206038"}, "20604": {"ApplNo": "20604", "Form": "INJECTABLE;INJECTION", "Drug": "SEROSTIM", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "EMD SERONO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020604s093lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20604"}, "20607": {"ApplNo": "20607", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "ARTHROTEC", "ActiveIngredient": "DICLOFENAC SODIUM; MISOPROSTOL", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020607s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20607"}, "206073": {"ApplNo": "206073", "Form": "TABLET;ORAL", "Drug": "GLYXAMBI", "ActiveIngredient": "EMPAGLIFLOZIN; LINAGLIPTIN", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206073s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206073"}, "20608": {"ApplNo": "20608", "Form": "SOLUTION;INJECTION, ORAL, RECTAL", "Drug": "OMNIPAQUE 300", "ActiveIngredient": "IOHEXOL", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018956s113,020608s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20608"}, "206088": {"ApplNo": "206088", "Form": "TABLET;ORAL", "Drug": "OTEZLA", "ActiveIngredient": "APREMILAST", "ApplType": "NDA", "Sponsor": "CELGENE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206088s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206088"}, "206089": {"ApplNo": "206089", "Form": "CAPSULE;ORAL", "Drug": "JATENZO", "ActiveIngredient": "TESTOSTERONE UNDECANOATE", "ApplType": "NDA", "Sponsor": "TOLMAR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206089s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206089"}, "206099": {"ApplNo": "206099", "Form": "POWDER;NASAL", "Drug": "ONZETRA XSAIL", "ActiveIngredient": "SUMATRIPTAN SUCCINATE", "ApplType": "NDA", "Sponsor": "CURRAX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206099s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206099"}, "20610": {"ApplNo": "20610", "Form": "CAPSULE;ORAL", "Drug": "COLAZAL", "ActiveIngredient": "BALSALAZIDE DISODIUM", "ApplType": "NDA", "Sponsor": "VALEANT PHARMS INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020610s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20610"}, "206110": {"ApplNo": "206110", "Form": "POWDER;INTRAVENOUS", "Drug": "CASPOFUNGIN ACETATE", "ActiveIngredient": "CASPOFUNGIN ACETATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206110s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206110"}, "206111": {"ApplNo": "206111", "Form": "TABLET;ORAL", "Drug": "SYNJARDY", "ActiveIngredient": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206111s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206111"}, "20612": {"ApplNo": "20612", "Form": "PATCH;TOPICAL", "Drug": "LIDODERM", "ActiveIngredient": "LIDOCAINE", "ApplType": "NDA", "Sponsor": "TEIKOKU PHARMA USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020612s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20612"}, "206137": {"ApplNo": "206137", "Form": "TABLET;ORAL", "Drug": "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE", "ActiveIngredient": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL", "ApplType": "ANDA", "Sponsor": "PAR PHARM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206137s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206137"}, "206143": {"ApplNo": "206143", "Form": "TABLET;ORAL", "Drug": "CORLANOR", "ActiveIngredient": "IVABRADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206143"}, "20615": {"ApplNo": "20615", "Form": "INJECTABLE;INJECTION", "Drug": "DURACLON", "ActiveIngredient": "CLONIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MYLAN INSTITUTIONAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020615s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20615"}, "206163": {"ApplNo": "206163", "Form": "POWDER;INTRAVENOUS", "Drug": "LEVOTHYROXINE SODIUM", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "ANDA", "Sponsor": "PIRAMAL CRITICAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206163ORig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206163"}, "206185": {"ApplNo": "206185", "Form": "EMULSION;OPHTHALMIC", "Drug": "XELPROS", "ActiveIngredient": "LATANOPROST", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/2016185s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206185"}, "206192": {"ApplNo": "206192", "Form": "TABLET;ORAL", "Drug": "COTELLIC", "ActiveIngredient": "COBIMETINIB FUMARATE", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206192s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206192"}, "206197": {"ApplNo": "206197", "Form": "POWDER;INTRAVENOUS", "Drug": "FOSAPREPITANT DIMEGLUMINE", "ActiveIngredient": "FOSAPREPITANT DIMEGLUMINE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206197Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206197"}, "206214": {"ApplNo": "206214", "Form": "CAPSULE;ORAL", "Drug": "LORATADINE", "ActiveIngredient": "LORATADINE", "ApplType": "ANDA", "Sponsor": "MARKSANS PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206214Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206214"}, "20622": {"ApplNo": "20622", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "COPAXONE", "ActiveIngredient": "GLATIRAMER ACETATE", "ApplType": "NDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020622s115lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20622"}, "206229": {"ApplNo": "206229", "Form": "INTRAUTERINE DEVICE;INTRAUTERINE", "Drug": "LILETTA", "ActiveIngredient": "LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "MEDICINES360", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206229s011s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206229"}, "20623": {"ApplNo": "20623", "Form": "TABLET;ORAL", "Drug": "ANZEMET", "ActiveIngredient": "DOLASETRON MESYLATE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020623s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20623"}, "206255": {"ApplNo": "206255", "Form": "CREAM;TOPICAL", "Drug": "SOOLANTRA", "ActiveIngredient": "IVERMECTIN", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206255s005s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206255"}, "206256": {"ApplNo": "206256", "Form": "POWDER;INTRAVENOUS", "Drug": "BELEODAQ", "ActiveIngredient": "BELINOSTAT", "ApplType": "NDA", "Sponsor": "ACROTECH BIOPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206256s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206256"}, "20626": {"ApplNo": "20626", "Form": "SPRAY;NASAL", "Drug": "IMITREX", "ActiveIngredient": "SUMATRIPTAN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020626s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20626"}, "206260": {"ApplNo": "206260", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "QUETIAPINE FUMARATE", "ActiveIngredient": "QUETIAPINE FUMARATE", "ApplType": "ANDA", "Sponsor": "PHARMADAX INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206260Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206260"}, "206276": {"ApplNo": "206276", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PATADAY ONCE DAILY RELIEF", "ActiveIngredient": "OLOPATADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206276Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206276"}, "206289": {"ApplNo": "206289", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ATROPINE SULFATE", "ActiveIngredient": "ATROPINE SULFATE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206289Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206289"}, "20629": {"ApplNo": "20629", "Form": "CREAM;TOPICAL", "Drug": "DENAVIR", "ActiveIngredient": "PENCICLOVIR", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020629s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20629"}, "20630": {"ApplNo": "20630", "Form": "INJECTABLE;INJECTION", "Drug": "ULTIVA", "ActiveIngredient": "REMIFENTANIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MYLAN INSTITUTIONAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020630s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20630"}, "206316": {"ApplNo": "206316", "Form": "TABLET;ORAL", "Drug": "SAVAYSA", "ActiveIngredient": "EDOXABAN TOSYLATE", "ApplType": "NDA", "Sponsor": "DAIICHI SANKYO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206316s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206316"}, "206321": {"ApplNo": "206321", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "SAXENDA", "ActiveIngredient": "LIRAGLUTIDE RECOMBINANT", "ApplType": "NDA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206321s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206321"}, "206323": {"ApplNo": "206323", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "TUXARIN ER", "ActiveIngredient": "CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE", "ApplType": "NDA", "Sponsor": "MAINPOINTE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206323s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206323"}, "206333": {"ApplNo": "206333", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "KYBELLA", "ActiveIngredient": "DEOXYCHOLIC ACID", "ApplType": "NDA", "Sponsor": "KYTHERA BIOPHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206333s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206333"}, "206334": {"ApplNo": "206334", "Form": "POWDER;INTRAVENOUS", "Drug": "ORBACTIV", "ActiveIngredient": "ORITAVANCIN DIPHOSPHATE", "ApplType": "NDA", "Sponsor": "MELINTA THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206334s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206334"}, "206352": {"ApplNo": "206352", "Form": "POWDER;ORAL", "Drug": "REYATAZ", "ActiveIngredient": "ATAZANAVIR SULFATE", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021567s044,206352s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206352"}, "206353": {"ApplNo": "206353", "Form": "TABLET;ORAL", "Drug": "EVOTAZ", "ActiveIngredient": "ATAZANAVIR SULFATE; COBICISTAT", "ApplType": "NDA", "Sponsor": "BRISTOL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206353s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206353"}, "206356": {"ApplNo": "206356", "Form": "SUSPENSION;ORAL", "Drug": "ORFADIN", "ActiveIngredient": "NITISINONE", "ApplType": "NDA", "Sponsor": "SWEDISH ORPHAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021232s023,206356s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206356"}, "206369": {"ApplNo": "206369", "Form": "LIQUID;N/A", "Drug": "STERILE WATER FOR INJECTION", "ActiveIngredient": "STERILE WATER FOR INJECTION", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206369Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206369"}, "20637": {"ApplNo": "20637", "Form": "IMPLANT;INTRACRANIAL", "Drug": "GLIADEL", "ActiveIngredient": "CARMUSTINE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020637s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20637"}, "20639": {"ApplNo": "20639", "Form": "TABLET;ORAL", "Drug": "SEROQUEL", "ActiveIngredient": "QUETIAPINE FUMARATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20639"}, "206406": {"ApplNo": "206406", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ENVARSUS XR", "ActiveIngredient": "TACROLIMUS", "ApplType": "NDA", "Sponsor": "VELOXIS PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206406s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206406"}, "20641": {"ApplNo": "20641", "Form": "SYRUP;ORAL", "Drug": "CLARITIN", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020641Orig1s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20641"}, "206426": {"ApplNo": "206426", "Form": "SOLUTION;INTRAVENOUS", "Drug": "RAPIVAB", "ActiveIngredient": "PERAMIVIR", "ApplType": "NDA", "Sponsor": "BIOCRYST", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206426s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206426"}, "206439": {"ApplNo": "206439", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "NAMZARIC", "ActiveIngredient": "DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206439s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206439"}, "20645": {"ApplNo": "20645", "Form": "SOLUTION;INTRAVENOUS", "Drug": "AMMONUL", "ActiveIngredient": "SODIUM BENZOATE; SODIUM PHENYLACETATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020645s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20645"}, "20646": {"ApplNo": "20646", "Form": "TABLET;ORAL", "Drug": "GABITRIL", "ActiveIngredient": "TIAGABINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020646s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20646"}, "206473": {"ApplNo": "206473", "Form": "SOLUTION;INTRAVENOUS", "Drug": "LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "LINEZOLID", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206473s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206473"}, "20648": {"ApplNo": "20648", "Form": "GEL;RECTAL", "Drug": "DIASTAT", "ActiveIngredient": "DIAZEPAM", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020648s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20648"}, "206488": {"ApplNo": "206488", "Form": "SOLUTION;INTRAVENOUS", "Drug": "EXONDYS 51", "ActiveIngredient": "ETEPLIRSEN", "ApplType": "NDA", "Sponsor": "SAREPTA THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206488s027s028s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206488"}, "20649": {"ApplNo": "20649", "Form": "INJECTABLE;INJECTION", "Drug": "EDEX", "ActiveIngredient": "ALPROSTADIL", "ApplType": "NDA", "Sponsor": "AUXILIUM PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020649s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20649"}, "206494": {"ApplNo": "206494", "Form": "POWDER;INTRAVENOUS", "Drug": "AVYCAZ", "ActiveIngredient": "AVIBACTAM SODIUM; CEFTAZIDIME", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206494s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206494"}, "206500": {"ApplNo": "206500", "Form": "TABLET;ORAL", "Drug": "VARUBI", "ActiveIngredient": "ROLAPITANT HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TERSERA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206500s008,208399s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206500"}, "206538": {"ApplNo": "206538", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "TOUJEO SOLOSTAR", "ActiveIngredient": "INSULIN GLARGINE RECOMBINANT", "ApplType": "BLA", "Sponsor": "SANOFI US SERVICES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206538s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206538"}, "206545": {"ApplNo": "206545", "Form": "TABLET;ORAL", "Drug": "ZYDELIG", "ActiveIngredient": "IDELALISIB", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206545lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206545"}, "206552": {"ApplNo": "206552", "Form": "INJECTABLE;INJECTION", "Drug": "HEPARIN SODIUM", "ActiveIngredient": "HEPARIN SODIUM", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206552Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206552"}, "206561": {"ApplNo": "206561", "Form": "INJECTABLE;INJECTION", "Drug": "INDOMETHACIN SODIUM", "ActiveIngredient": "INDOMETHACIN SODIUM", "ApplType": "ANDA", "Sponsor": "NAVINTA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206561Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206561"}, "20657": {"ApplNo": "20657", "Form": "SOLUTION;ORAL", "Drug": "SPORANOX", "ActiveIngredient": "ITRACONAZOLE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020657s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20657"}, "20659": {"ApplNo": "20659", "Form": "SOLUTION;ORAL", "Drug": "NORVIR", "ActiveIngredient": "RITONAVIR", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022417Orig1s025,020659Orig1s073,209512Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20659"}, "206627": {"ApplNo": "206627", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "HYSINGLA ER", "ActiveIngredient": "HYDROCODONE BITARTRATE", "ApplType": "NDA", "Sponsor": "PURDUE PHARMA LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206627s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206627"}, "206628": {"ApplNo": "206628", "Form": "SOLUTION;INTRAVENOUS", "Drug": "DEXMEDETOMIDINE HYDROCHLORIDE", "ActiveIngredient": "DEXMEDETOMIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HQ SPCLT PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206628s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206628"}, "206679": {"ApplNo": "206679", "Form": "SUSPENSION;ORAL", "Drug": "FLOLIPID", "ActiveIngredient": "SIMVASTATIN", "ApplType": "NDA", "Sponsor": "TCG FLUENT PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206679s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206679"}, "206685": {"ApplNo": "206685", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "ESTRADIOL", "ActiveIngredient": "ESTRADIOL", "ApplType": "ANDA", "Sponsor": "MYLAN TECHNOLOGIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206685Orig1s000Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206685"}, "20670": {"ApplNo": "20670", "Form": "CREAM, SUPPOSITORY;TOPICAL, VAGINAL", "Drug": "MONISTAT 3 COMBINATION PACK", "ActiveIngredient": "MICONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "MEDTECH PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017450Orig1s075,020670Orig1s036,021261Orig1s025,021308Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20670"}, "206709": {"ApplNo": "206709", "Form": "CAPSULE;ORAL", "Drug": "DIACOMIT", "ActiveIngredient": "STIRIPENTOL", "ApplType": "NDA", "Sponsor": "BIOCODEX SA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206709s003,207223s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206709"}, "20671": {"ApplNo": "20671", "Form": "INJECTABLE;INJECTION", "Drug": "HYCAMTIN", "ActiveIngredient": "TOPOTECAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020671s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20671"}, "20675": {"ApplNo": "20675", "Form": "TABLET;ORAL", "Drug": "URSO 250", "ActiveIngredient": "URSODIOL", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020675s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20675"}, "206756": {"ApplNo": "206756", "Form": "SPRAY, METERED;INHALATION", "Drug": "STIOLTO RESPIMAT", "ActiveIngredient": "OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206756s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206756"}, "20676": {"ApplNo": "20676", "Form": "OINTMENT;VAGINAL", "Drug": "VAGISTAT-1", "ActiveIngredient": "TIOCONAZOLE", "ApplType": "NDA", "Sponsor": "COMBE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020676Orig1s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20676"}, "20678": {"ApplNo": "20678", "Form": "INJECTABLE;INJECTION", "Drug": "CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER", "ActiveIngredient": "AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020678s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20678"}, "206814": {"ApplNo": "206814", "Form": "SOLUTION;ORAL", "Drug": "POTASSIUM CHLORIDE", "ActiveIngredient": "POTASSIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "GENUS LIFESCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206814s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206814"}, "20682": {"ApplNo": "20682", "Form": "TABLET;ORAL", "Drug": "GLYSET", "ActiveIngredient": "MIGLITOL", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020682s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20682"}, "206827": {"ApplNo": "206827", "Form": "CAPSULE;ORAL", "Drug": "CELECOXIB", "ActiveIngredient": "CELECOXIB", "ApplType": "ANDA", "Sponsor": "AUROBINDO PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206827Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206827"}, "206829": {"ApplNo": "206829", "Form": "POWDER;INTRAVENOUS", "Drug": "ZERBAXA", "ActiveIngredient": "CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM", "ApplType": "NDA", "Sponsor": "CUBIST PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206829s011s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206829"}, "20687": {"ApplNo": "20687", "Form": "TABLET;ORAL", "Drug": "MIFEPREX", "ActiveIngredient": "MIFEPRISTONE", "ApplType": "NDA", "Sponsor": "DANCO LABS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s025Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20687"}, "20688": {"ApplNo": "20688", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PATADAY TWICE DAILY RELIEF", "ActiveIngredient": "OLOPATADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020688s032,021545s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20688"}, "20690": {"ApplNo": "20690", "Form": "TABLET;ORAL", "Drug": "ARICEPT", "ActiveIngredient": "DONEPEZIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20690"}, "206910": {"ApplNo": "206910", "Form": "TABLET;ORAL", "Drug": "JADENU", "ActiveIngredient": "DEFERASIROX", "ApplType": "NDA", "Sponsor": "NOVARTIS PHARMS CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206910"}, "206911": {"ApplNo": "206911", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "BROMSITE", "ActiveIngredient": "BROMFENAC SODIUM", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206911s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206911"}, "20692": {"ApplNo": "20692", "Form": "POWDER;INHALATION", "Drug": "SEREVENT", "ActiveIngredient": "SALMETEROL XINAFOATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20692"}, "206927": {"ApplNo": "206927", "Form": "POWDER;INTRAVENOUS", "Drug": "BORTEZOMIB", "ActiveIngredient": "BORTEZOMIB", "ApplType": "NDA", "Sponsor": "DR REDDYS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206927s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206927"}, "206939": {"ApplNo": "206939", "Form": "FOR SUSPENSION;ORAL", "Drug": "CEFIXIME", "ActiveIngredient": "CEFIXIME", "ApplType": "ANDA", "Sponsor": "BELCHER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206939Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206939"}, "206940": {"ApplNo": "206940", "Form": "TABLET;ORAL", "Drug": "VIBERZI", "ActiveIngredient": "ELUXADOLINE", "ApplType": "NDA", "Sponsor": "ALLERGAN HOLDINGS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206940"}, "206947": {"ApplNo": "206947", "Form": "CAPSULE;ORAL", "Drug": "LENVIMA", "ActiveIngredient": "LENVATINIB MESYLATE", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206947s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206947"}, "206968": {"ApplNo": "206968", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ACETAMINOPHEN", "ActiveIngredient": "ACETAMINOPHEN", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206968s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206968"}, "20697": {"ApplNo": "20697", "Form": "TABLET;ORAL", "Drug": "TASMAR", "ActiveIngredient": "TOLCAPONE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020697s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20697"}, "206976": {"ApplNo": "206976", "Form": "SYSTEM;TOPICAL", "Drug": "LICART", "ActiveIngredient": "DICLOFENAC EPOLAMINE", "ApplType": "NDA", "Sponsor": "IBSA INST BIO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206976s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206976"}, "206977": {"ApplNo": "206977", "Form": "SOLUTION;ORAL", "Drug": "TIROSINT-SOL", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "INSTITUT BIOCHIMIQUE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206977Orig1s009Corrected_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206977"}, "20699": {"ApplNo": "20699", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "EFFEXOR XR", "ActiveIngredient": "VENLAFAXINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020699s112lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20699"}, "206995": {"ApplNo": "206995", "Form": "TABLET;ORAL", "Drug": "IRESSA", "ActiveIngredient": "GEFITINIB", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206995s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206995"}, "20701": {"ApplNo": "20701", "Form": "GEL;VAGINAL", "Drug": "CRINONE", "ActiveIngredient": "PROGESTERONE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020701s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20701"}, "20702": {"ApplNo": "20702", "Form": "TABLET;ORAL", "Drug": "LIPITOR", "ActiveIngredient": "ATORVASTATIN CALCIUM", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020702Orig1s079correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20702"}, "207026": {"ApplNo": "207026", "Form": "INJECTABLE;INJECTION", "Drug": "PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021703Orig1s020, 207026Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207026"}, "207027": {"ApplNo": "207027", "Form": "FOR SUSPENSION;ORAL", "Drug": "PROMACTA KIT", "ActiveIngredient": "ELTROMBOPAG OLAMINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022291s033,207027s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207027"}, "20704": {"ApplNo": "20704", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "CLARITIN REDITABS", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020704Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20704"}, "207042": {"ApplNo": "207042", "Form": "SOLUTION;INTRAVENOUS", "Drug": "NEOSTIGMINE METHYLSULFATE", "ActiveIngredient": "NEOSTIGMINE METHYLSULFATE", "ApplType": "ANDA", "Sponsor": "EUROHLTH INTL SARL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207042"}, "207058": {"ApplNo": "207058", "Form": "CAPSULE;ORAL", "Drug": "DOFETILIDE", "ActiveIngredient": "DOFETILIDE", "ApplType": "ANDA", "Sponsor": "MAYNE PHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207058Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207058"}, "207070": {"ApplNo": "207070", "Form": "SPRAY;INHALATION", "Drug": "SPIRIVA RESPIMAT", "ActiveIngredient": "TIOTROPIUM BROMIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207070s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207070"}, "207071": {"ApplNo": "207071", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "FINACEA", "ActiveIngredient": "AZELAIC ACID", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207071s002s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207071"}, "207078": {"ApplNo": "207078", "Form": "FOR SUSPENSION;ORAL", "Drug": "LOKELMA", "ActiveIngredient": "SODIUM ZIRCONIUM CYCLOSILICATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207078s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207078"}, "20708": {"ApplNo": "20708", "Form": "INJECTABLE;INJECTION", "Drug": "LUPRON DEPOT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "ABBVIE ENDOCRINE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020708s038lblrpl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20708"}, "207096": {"ApplNo": "207096", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SODIUM PHENYLACETATE AND SODIUM BENZOATE", "ActiveIngredient": "SODIUM BENZOATE; SODIUM PHENYLACETATE", "ApplType": "ANDA", "Sponsor": "AILEX PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207096Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207096"}, "20710": {"ApplNo": "20710", "Form": "SUSPENSION;ORAL", "Drug": "PAXIL", "ActiveIngredient": "PAROXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "APOTEX", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020031s079,020710s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20710"}, "207103": {"ApplNo": "207103", "Form": "CAPSULE;ORAL", "Drug": "IBRANCE", "ActiveIngredient": "PALBOCICLIB", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207103s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207103"}, "20712": {"ApplNo": "20712", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "CARBATROL", "ActiveIngredient": "CARBAMAZEPINE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020712s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20712"}, "207131": {"ApplNo": "207131", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CEFAZOLIN IN PLASTIC CONTAINER", "ActiveIngredient": "CEFAZOLIN SODIUM", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207131s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207131"}, "207139": {"ApplNo": "207139", "Form": "CAPSULE;ORAL", "Drug": "PAROXETINE MESYLATE", "ActiveIngredient": "PAROXETINE MESYLATE", "ApplType": "ANDA", "Sponsor": "ACTAVIS LABS FL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207139Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207139"}, "20714": {"ApplNo": "20714", "Form": "INHALANT;ORAL", "Drug": "NICOTROL", "ActiveIngredient": "NICOTINE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020714s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20714"}, "207145": {"ApplNo": "207145", "Form": "TABLET;ORAL", "Drug": "XADAGO", "ActiveIngredient": "SAFINAMIDE MESYLATE", "ApplType": "NDA", "Sponsor": "MDD US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207145s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207145"}, "20715": {"ApplNo": "20715", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "TRELSTAR", "ActiveIngredient": "TRIPTORELIN PAMOATE", "ApplType": "NDA", "Sponsor": "VERITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020715s040,021288s035,022427s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20715"}, "207154": {"ApplNo": "207154", "Form": "GEL;TOPICAL", "Drug": "ACZONE", "ActiveIngredient": "DAPSONE", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207154s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207154"}, "207155": {"ApplNo": "207155", "Form": "POWDER;INTRAVENOUS", "Drug": "EVOMELA", "ActiveIngredient": "MELPHALAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ACROTECH BIOPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207155Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207155"}, "207160": {"ApplNo": "207160", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "LEVETIRACETAM IN SODIUM CHLORIDE", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "ANDA", "Sponsor": "EUGIA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207160Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207160"}, "20717": {"ApplNo": "20717", "Form": "TABLET;ORAL", "Drug": "PROVIGIL", "ActiveIngredient": "MODAFINIL", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20717"}, "207174": {"ApplNo": "207174", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PARICALCITOL", "ActiveIngredient": "PARICALCITOL", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207174s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207174"}, "207193": {"ApplNo": "207193", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "ESOMEPRAZOLE MAGNESIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "ANDA", "Sponsor": "PERRIGO R AND D", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207193Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207193"}, "207202": {"ApplNo": "207202", "Form": "TABLET;ORAL", "Drug": "ABILIFY MYCITE KIT", "ActiveIngredient": "ARIPIPRAZOLE", "ApplType": "NDA", "Sponsor": "OTSUKA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207202s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207202"}, "207223": {"ApplNo": "207223", "Form": "FOR SUSPENSION;ORAL", "Drug": "DIACOMIT", "ActiveIngredient": "STIRIPENTOL", "ApplType": "NDA", "Sponsor": "BIOCODEX SA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206709s003,207223s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207223"}, "20723": {"ApplNo": "20723", "Form": "CREAM;TOPICAL", "Drug": "ALDARA", "ActiveIngredient": "IMIQUIMOD", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020723s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20723"}, "207238": {"ApplNo": "207238", "Form": "SOLUTION;TOPICAL", "Drug": "DICLOFENAC SODIUM", "ActiveIngredient": "DICLOFENAC SODIUM", "ApplType": "ANDA", "Sponsor": "ACTAVIS LABS UT INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207238ORig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207238"}, "20725": {"ApplNo": "20725", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "CREON", "ActiveIngredient": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)", "ApplType": "BLA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020725s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20725"}, "20726": {"ApplNo": "20726", "Form": "TABLET;ORAL", "Drug": "FEMARA", "ActiveIngredient": "LETROZOLE", "ApplType": "NDA", "Sponsor": "NOVARTIS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020726s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20726"}, "20727": {"ApplNo": "20727", "Form": "TABLET;ORAL", "Drug": "BIDIL", "ActiveIngredient": "HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020727Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20727"}, "207318": {"ApplNo": "207318", "Form": "TABLET;ORAL", "Drug": "NUPLAZID", "ActiveIngredient": "PIMAVANSERIN TARTRATE", "ApplType": "NDA", "Sponsor": "ACADIA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207318s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207318"}, "20734": {"ApplNo": "20734", "Form": "INJECTABLE;INJECTION", "Drug": "CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "AMINO ACIDS; DEXTROSE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020734s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20734"}, "207356": {"ApplNo": "207356", "Form": "SUSPENSION, LIPOSOMAL;INHALATION", "Drug": "ARIKAYCE KIT", "ActiveIngredient": "AMIKACIN SULFATE", "ApplType": "NDA", "Sponsor": "INSMED INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207356"}, "207407": {"ApplNo": "207407", "Form": "SOLUTION;ORAL", "Drug": "LOPINAVIR AND RITONAVIR", "ActiveIngredient": "LOPINAVIR; RITONAVIR", "ApplType": "ANDA", "Sponsor": "LANNETT CO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207407Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207407"}, "20742": {"ApplNo": "20742", "Form": "SOLUTION;IRRIGATION", "Drug": "BSS", "ActiveIngredient": "CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE", "ApplType": "NDA", "Sponsor": "ALCON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020742s025s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20742"}, "207426": {"ApplNo": "207426", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM NITROPRUSSIDE", "ActiveIngredient": "SODIUM NITROPRUSSIDE", "ApplType": "ANDA", "Sponsor": "SAGENT PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207426Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207426"}, "20743": {"ApplNo": "20743", "Form": "CREAM;TOPICAL", "Drug": "NORITATE", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020743s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20743"}, "20744": {"ApplNo": "20744", "Form": "SUSPENSION;INTRATRACHEAL", "Drug": "CUROSURF", "ActiveIngredient": "PORACTANT ALFA", "ApplType": "BLA", "Sponsor": "CHIESI USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020744s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20744"}, "207449": {"ApplNo": "207449", "Form": "INJECTABLE;INJECTION", "Drug": "DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "DEXTROSE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207449Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207449"}, "20746": {"ApplNo": "20746", "Form": "SPRAY, METERED;NASAL", "Drug": "RHINOCORT", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020746Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20746"}, "20747": {"ApplNo": "20747", "Form": "TROCHE/LOZENGE;TRANSMUCOSAL", "Drug": "ACTIQ", "ActiveIngredient": "FENTANYL CITRATE", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020747s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20747"}, "20748": {"ApplNo": "20748", "Form": "CREAM;TOPICAL", "Drug": "DIFFERIN", "ActiveIngredient": "ADAPALENE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20748lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20748"}, "207500": {"ApplNo": "207500", "Form": "CAPSULE;ORAL", "Drug": "CRESEMBA", "ActiveIngredient": "ISAVUCONAZONIUM SULFATE", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207500s011,207501s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207500"}, "207501": {"ApplNo": "207501", "Form": "POWDER;INTRAVENOUS", "Drug": "CRESEMBA", "ActiveIngredient": "ISAVUCONAZONIUM SULFATE", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207500s011,207501s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207501"}, "20753": {"ApplNo": "20753", "Form": "TABLET;ORAL", "Drug": "AROMASIN", "ActiveIngredient": "EXEMESTANE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020753s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20753"}, "207533": {"ApplNo": "207533", "Form": "SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "ARISTADA", "ActiveIngredient": "ARIPIPRAZOLE LAUROXIL", "ApplType": "NDA", "Sponsor": "ALKERMES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207533"}, "207534": {"ApplNo": "207534", "Form": "SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS", "Drug": "SYMJEPI", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "ADAMIS PHARMS CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207534s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207534"}, "207549": {"ApplNo": "207549", "Form": "INJECTABLE;INJECTION", "Drug": "METHYLPREDNISOLONE SODIUM SUCCINATE", "ActiveIngredient": "METHYLPREDNISOLONE SODIUM SUCCINATE", "ApplType": "ANDA", "Sponsor": "AMNEAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207549Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207549"}, "207561": {"ApplNo": "207561", "Form": "TABLET;ORAL", "Drug": "GENVOYA", "ActiveIngredient": "COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207561s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207561"}, "20757": {"ApplNo": "20757", "Form": "TABLET;ORAL", "Drug": "AVAPRO", "ActiveIngredient": "IRBESARTAN", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020757s074lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20757"}, "20758": {"ApplNo": "20758", "Form": "TABLET;ORAL", "Drug": "AVALIDE", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; IRBESARTAN", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020758s080lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20758"}, "207589": {"ApplNo": "207589", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "ENSTILAR", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207589s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207589"}, "207620": {"ApplNo": "207620", "Form": "TABLET;ORAL", "Drug": "ENTRESTO", "ActiveIngredient": "SACUBITRIL; VALSARTAN", "ApplType": "NDA", "Sponsor": "NOVARTIS PHARMS CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207620s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207620"}, "207624": {"ApplNo": "207624", "Form": "FOR SUSPENSION;ORAL", "Drug": "SEVELAMER CARBONATE", "ActiveIngredient": "SEVELAMER CARBONATE", "ApplType": "ANDA", "Sponsor": "AUROBINDO PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207624Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207624"}, "20763": {"ApplNo": "20763", "Form": "TABLET;ORAL", "Drug": "AMERGE", "ActiveIngredient": "NARATRIPTAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020763s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20763"}, "207631": {"ApplNo": "207631", "Form": "TABLET;ORAL", "Drug": "NILUTAMIDE", "ActiveIngredient": "NILUTAMIDE", "ApplType": "ANDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207631Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207631"}, "20764": {"ApplNo": "20764", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "LAMICTAL CD", "ActiveIngredient": "LAMOTRIGINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20764"}, "207648": {"ApplNo": "207648", "Form": "EMULSION;INTRAVENOUS", "Drug": "SMOFLIPID 20%", "ActiveIngredient": "FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207648s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207648"}, "20766": {"ApplNo": "20766", "Form": "CAPSULE;ORAL", "Drug": "XENICAL", "ActiveIngredient": "ORLISTAT", "ApplType": "NDA", "Sponsor": "CHEPLAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020766s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20766"}, "20768": {"ApplNo": "20768", "Form": "TABLET;ORAL", "Drug": "ZOMIG", "ActiveIngredient": "ZOLMITRIPTAN", "ApplType": "NDA", "Sponsor": "IPR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020768s023,021231s014,021450s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20768"}, "20769": {"ApplNo": "20769", "Form": "CREAM;TOPICAL", "Drug": "LOCOID LIPOCREAM", "ActiveIngredient": "HYDROCORTISONE BUTYRATE", "ApplType": "NDA", "Sponsor": "PRECISION DERMAT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020769s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20769"}, "207695": {"ApplNo": "207695", "Form": "OINTMENT;TOPICAL", "Drug": "EUCRISA", "ActiveIngredient": "CRISABOROLE", "ApplType": "NDA", "Sponsor": "ANACOR PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207695s007s009s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207695"}, "20771": {"ApplNo": "20771", "Form": "TABLET;ORAL", "Drug": "DETROL", "ActiveIngredient": "TOLTERODINE TARTRATE", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020771s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20771"}, "20772": {"ApplNo": "20772", "Form": "SOLUTION;ORAL", "Drug": "SUCRAID", "ActiveIngredient": "SACROSIDASE", "ApplType": "BLA", "Sponsor": "QOL MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020772Orig1s027Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20772"}, "20779": {"ApplNo": "20779", "Form": "TABLET;ORAL", "Drug": "VIRACEPT", "ActiveIngredient": "NELFINAVIR MESYLATE", "ApplType": "NDA", "Sponsor": "AGOURON PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020778s042,020779s063,021503s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20779"}, "207793": {"ApplNo": "207793", "Form": "INJECTABLE, LIPOSOMAL;INTRAVENOUS", "Drug": "ONIVYDE", "ActiveIngredient": "IRINOTECAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "IPSEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207793lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207793"}, "207795": {"ApplNo": "207795", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "VYZULTA", "ActiveIngredient": "LATANOPROSTENE BUNOD", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207795s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207795"}, "20780": {"ApplNo": "20780", "Form": "FOR SUSPENSION;ORAL", "Drug": "CIPRO", "ActiveIngredient": "CIPROFLOXACIN", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019537s093,020780s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20780"}, "20782": {"ApplNo": "20782", "Form": "Tablet, Extended Release; Oral", "Drug": "DEPAKOTE ER", "ActiveIngredient": "DIVALPROEX SODIUM", "ApplType": "NDA", "Sponsor": "ABBOTT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20782_depakote_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20782"}, "20785": {"ApplNo": "20785", "Form": "CAPSULE;ORAL", "Drug": "THALOMID", "ActiveIngredient": "THALIDOMIDE", "ApplType": "NDA", "Sponsor": "CELGENE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020785s069lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20785"}, "20786": {"ApplNo": "20786", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION", "ActiveIngredient": "FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020786Origs035,021704Orig1s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20786"}, "207865": {"ApplNo": "207865", "Form": "FOR SUSPENSION;ORAL", "Drug": "EMEND", "ActiveIngredient": "APREPITANT", "ApplType": "NDA", "Sponsor": "MSD MERCK CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021549s030,207865s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207865"}, "20788": {"ApplNo": "20788", "Form": "TABLET;ORAL", "Drug": "PROPECIA", "ActiveIngredient": "FINASTERIDE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20788"}, "20789": {"ApplNo": "20789", "Form": "CAPSULE;ORAL", "Drug": "ZONEGRAN", "ActiveIngredient": "ZONISAMIDE", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20789"}, "207917": {"ApplNo": "207917", "Form": "GEL;TOPICAL", "Drug": "EPIDUO FORTE", "ActiveIngredient": "ADAPALENE; BENZOYL PEROXIDE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207917Orig1s004s008Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207917"}, "207920": {"ApplNo": "207920", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "NEXIUM 24HR", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "NDA", "Sponsor": "ASTRAZENECA LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207920Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207920"}, "207921": {"ApplNo": "207921", "Form": "AEROSOL, METERED;INHALATION", "Drug": "QVAR REDIHALER", "ActiveIngredient": "BECLOMETHASONE DIPROPIONATE", "ApplType": "NDA", "Sponsor": "NORTON WATERFORD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207921Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207921"}, "207924": {"ApplNo": "207924", "Form": "TABLET;ORAL", "Drug": "OLUMIANT", "ActiveIngredient": "BARICITINIB", "ApplType": "NDA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207924s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207924"}, "207925": {"ApplNo": "207925", "Form": "GRANULE;ORAL", "Drug": "KALYDECO", "ActiveIngredient": "IVACAFTOR", "ApplType": "NDA", "Sponsor": "VERTEX PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203188s034,207925s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207925"}, "207926": {"ApplNo": "207926", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PHENYLEPHRINE HYDROCHLORIDE", "ActiveIngredient": "PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207926s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207926"}, "20793": {"ApplNo": "20793", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CAFCIT", "ActiveIngredient": "CAFFEINE CITRATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020793s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20793"}, "207932": {"ApplNo": "207932", "Form": "FILM;BUCCAL", "Drug": "BELBUCA", "ActiveIngredient": "BUPRENORPHINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BDSI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207932s019s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207932"}, "207946": {"ApplNo": "207946", "Form": "SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "INVEGA TRINZA", "ActiveIngredient": "PALIPERIDONE PALMITATE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207946Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207946"}, "207947": {"ApplNo": "207947", "Form": "TABLET;ORAL", "Drug": "UPTRAVI", "ActiveIngredient": "SELEXIPAG", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207947s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207947"}, "207953": {"ApplNo": "207953", "Form": "POWDER;INTRAVENOUS", "Drug": "YONDELIS", "ActiveIngredient": "TRABECTEDIN", "ApplType": "NDA", "Sponsor": "JANSSEN PRODS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207953s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207953"}, "207958": {"ApplNo": "207958", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "SPRITAM", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "NDA", "Sponsor": "APRECIA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207958s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207958"}, "20796": {"ApplNo": "20796", "Form": "TABLET;ORAL", "Drug": "COMTAN", "ActiveIngredient": "ENTACAPONE", "ApplType": "NDA", "Sponsor": "ORION PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020796s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20796"}, "207960": {"ApplNo": "207960", "Form": "TABLET, EXTENDED RELEASE, CHEWABLE;ORAL", "Drug": "QUILLICHEW ER", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NEXTWAVE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207960s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207960"}, "207962": {"ApplNo": "207962", "Form": "PATCH;TOPICAL", "Drug": "ZTLIDO", "ActiveIngredient": "LIDOCAINE", "ApplType": "NDA", "Sponsor": "SCILEX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207962s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207962"}, "207963": {"ApplNo": "207963", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PALONOSETRON HYDROCHLORIDE", "ActiveIngredient": "PALONOSETRON HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207963s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207963"}, "207964": {"ApplNo": "207964", "Form": "CLOTH;TOPICAL", "Drug": "READYPREP CHG", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "MEDLINE INDUSTRIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207964Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207964"}, "207968": {"ApplNo": "207968", "Form": "GRANULE;ORAL", "Drug": "JADENU SPRINKLE", "ActiveIngredient": "DEFERASIROX", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207968"}, "207981": {"ApplNo": "207981", "Form": "TABLET;ORAL", "Drug": "LONSURF", "ActiveIngredient": "TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE", "ApplType": "NDA", "Sponsor": "TAIHO ONCOLOGY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207981s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207981"}, "207987": {"ApplNo": "207987", "Form": "SOLUTION;INTRA-ARTERIAL", "Drug": "ABLYSINOL", "ActiveIngredient": "ALCOHOL", "ApplType": "NDA", "Sponsor": "BPI LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207987lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207987"}, "207997": {"ApplNo": "207997", "Form": "CAPSULE;ORAL", "Drug": "RYDAPT", "ActiveIngredient": "MIDOSTAURIN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207997s008lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207997"}, "207999": {"ApplNo": "207999", "Form": "TABLET;ORAL", "Drug": "OCALIVA", "ActiveIngredient": "OBETICHOLIC ACID", "ApplType": "NDA", "Sponsor": "INTERCEPT PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207999s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207999"}, "20800": {"ApplNo": "20800", "Form": "INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS", "Drug": "ADRENACLICK", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "IMPAX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020800s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20800"}, "20801": {"ApplNo": "20801", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "PEPCID AC", "ActiveIngredient": "FAMOTIDINE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020801Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20801"}, "208010": {"ApplNo": "208010", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "RAYALDEE", "ActiveIngredient": "CALCIFEDIOL", "ApplType": "NDA", "Sponsor": "EIRGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208010s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208010"}, "208019": {"ApplNo": "208019", "Form": "FOR SOLUTION;ORAL", "Drug": "POTASSIUM CHLORIDE", "ActiveIngredient": "POTASSIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "PHARMA RES SOFTWARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208019s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208019"}, "20802": {"ApplNo": "20802", "Form": "TABLET;ORAL", "Drug": "EXCEDRIN (MIGRAINE)", "ActiveIngredient": "ACETAMINOPHEN; ASPIRIN; CAFFEINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020802Orig1s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20802"}, "208025": {"ApplNo": "208025", "Form": "TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL", "Drug": "LANSOPRAZOLE", "ActiveIngredient": "LANSOPRAZOLE", "ApplType": "NDA", "Sponsor": "DEXCEL", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208025s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208025"}, "208026": {"ApplNo": "208026", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "JENTADUETO XR", "ActiveIngredient": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208026s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208026"}, "20803": {"ApplNo": "20803", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "ALREX", "ActiveIngredient": "LOTEPREDNOL ETABONATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20803lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20803"}, "208030": {"ApplNo": "208030", "Form": "SOLUTION;ORAL", "Drug": "FERRIPROX", "ActiveIngredient": "DEFERIPRONE", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208030"}, "208032": {"ApplNo": "208032", "Form": "SPRAY, METERED;NASAL", "Drug": "KOVANAZE", "ActiveIngredient": "OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ST RENATUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208032s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208032"}, "208036": {"ApplNo": "208036", "Form": "FOR SUSPENSION;ORAL", "Drug": "E-Z-HD", "ActiveIngredient": "BARIUM SULFATE", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208036s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208036"}, "20805": {"ApplNo": "20805", "Form": "SUSPENSION/DROPS;OTIC", "Drug": "CIPRO HC", "ActiveIngredient": "CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020805s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20805"}, "208051": {"ApplNo": "208051", "Form": "TABLET;ORAL", "Drug": "NERLYNX", "ActiveIngredient": "NERATINIB MALEATE", "ApplType": "NDA", "Sponsor": "PUMA BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208051s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208051"}, "208054": {"ApplNo": "208054", "Form": "SOLUTION;INTRAVENOUS", "Drug": "AXUMIN", "ActiveIngredient": "FLUCICLOVINE F-18", "ApplType": "NDA", "Sponsor": "BLUE EARTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208054s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208054"}, "208065": {"ApplNo": "208065", "Form": "TABLET;ORAL", "Drug": "TAGRISSO", "ActiveIngredient": "OSIMERTINIB MESYLATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208065s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208065"}, "208073": {"ApplNo": "208073", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "XIIDRA", "ActiveIngredient": "LIFITEGRAST", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208073s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208073"}, "208078": {"ApplNo": "208078", "Form": "TABLET;ORAL", "Drug": "FIRDAPSE", "ActiveIngredient": "AMIFAMPRIDINE PHOSPHATE", "ApplType": "NDA", "Sponsor": "CATALYST PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208078s008lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208078"}, "208079": {"ApplNo": "208079", "Form": "SPRAY;TOPICAL", "Drug": "SERNIVO", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE", "ApplType": "NDA", "Sponsor": "PRIMUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208079s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208079"}, "20808": {"ApplNo": "20808", "Form": "INJECTABLE;INJECTION", "Drug": "VISIPAQUE 320", "ActiveIngredient": "IODIXANOL", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020351s054,020808s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20808"}, "208081": {"ApplNo": "208081", "Form": "GEL;TOPICAL", "Drug": "AMELUZ", "ActiveIngredient": "AMINOLEVULINIC ACID HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BIOFRONTERA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208081s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208081"}, "208082": {"ApplNo": "208082", "Form": "TABLET;ORAL", "Drug": "AUSTEDO", "ActiveIngredient": "DEUTETRABENAZINE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208082s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208082"}, "208083": {"ApplNo": "208083", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208083s006s007s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208083"}, "208088": {"ApplNo": "208088", "Form": "CAPSULE;ORAL", "Drug": "TLANDO", "ActiveIngredient": "TESTOSTERONE UNDECANOATE", "ApplType": "NDA", "Sponsor": "ANTARES PHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208088s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208088"}, "208090": {"ApplNo": "208090", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "XTAMPZA ER", "ActiveIngredient": "OXYCODONE", "ApplType": "NDA", "Sponsor": "COLLEGIUM PHARM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208090s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208090"}, "208114": {"ApplNo": "208114", "Form": "SOLUTION;INTRAVENOUS", "Drug": "DEFITELIO", "ActiveIngredient": "DEFIBROTIDE SODIUM", "ApplType": "NDA", "Sponsor": "JAZZ PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208114Orig1s000Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208114"}, "20812": {"ApplNo": "20812", "Form": "SUSPENSION/DROPS;ORAL", "Drug": "INFANT'S ADVIL", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020812Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20812"}, "208135": {"ApplNo": "208135", "Form": "SOLUTION;OPHTHALMIC", "Drug": "TETRACAINE HYDROCHLORIDE", "ActiveIngredient": "TETRACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALCON LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208135s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208135"}, "208143": {"ApplNo": "208143", "Form": "SUSPENSION;ORAL", "Drug": "READI-CAT 2", "ActiveIngredient": "BARIUM SULFATE", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208143s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208143"}, "208144": {"ApplNo": "208144", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "LUMIFY", "ActiveIngredient": "BRIMONIDINE TARTRATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208144Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208144"}, "208147": {"ApplNo": "208147", "Form": "SUSPENSION, EXTENDED RELEASE;ORAL", "Drug": "DYANAVEL XR", "ActiveIngredient": "AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE", "ApplType": "NDA", "Sponsor": "TRIS PHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208147Orig1s012,210526Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208147"}, "20815": {"ApplNo": "20815", "Form": "TABLET;ORAL", "Drug": "EVISTA", "ActiveIngredient": "RALOXIFENE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020815s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20815"}, "208151": {"ApplNo": "208151", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ISOPTO ATROPINE", "ActiveIngredient": "ATROPINE SULFATE", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208151Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208151"}, "208157": {"ApplNo": "208157", "Form": "SOLUTION;INTRAVENOUS", "Drug": "MYXREDLIN", "ActiveIngredient": "INSULIN HUMAN", "ApplType": "BLA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208157s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208157"}, "208159": {"ApplNo": "208159", "Form": "GRANULE;ORAL", "Drug": "VISTOGARD", "ActiveIngredient": "URIDINE TRIACETATE", "ApplType": "NDA", "Sponsor": "WELLSTAT THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208159s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208159"}, "20816": {"ApplNo": "20816", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "AZOPT", "ActiveIngredient": "BRINZOLAMIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020816s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20816"}, "208169": {"ApplNo": "208169", "Form": "GRANULE;ORAL", "Drug": "XURIDEN", "ActiveIngredient": "URIDINE TRIACETATE", "ApplType": "NDA", "Sponsor": "WELLSTAT THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208169s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208169"}, "208171": {"ApplNo": "208171", "Form": "SOLUTION;INTRAVENOUS", "Drug": "MONOFERRIC", "ActiveIngredient": "FERRIC DERISOMALTOSE", "ApplType": "NDA", "Sponsor": "PHARMACOSMOS AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208171Orig1s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208171"}, "20818": {"ApplNo": "20818", "Form": "TABLET;ORAL", "Drug": "DIOVAN HCT", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; VALSARTAN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020818s080lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20818"}, "208183": {"ApplNo": "208183", "Form": "LOTION;TOPICAL", "Drug": "ULTRAVATE", "ActiveIngredient": "HALOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDUSTRIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208183s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208183"}, "20819": {"ApplNo": "20819", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ZEMPLAR", "ActiveIngredient": "PARICALCITOL", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020819Orig1s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20819"}, "208193": {"ApplNo": "208193", "Form": "SOLUTION;ORAL", "Drug": "OZOBAX", "ActiveIngredient": "BACLOFEN", "ApplType": "NDA", "Sponsor": "METACEL PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208193s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208193"}, "208194": {"ApplNo": "208194", "Form": "SOLUTION;IV (INFUSION)", "Drug": "BENDEKA", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EAGLE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208194s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208194"}, "208215": {"ApplNo": "208215", "Form": "TABLET;ORAL", "Drug": "DESCOVY", "ActiveIngredient": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208215s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208215"}, "208216": {"ApplNo": "208216", "Form": "POWDER;INTRAVENOUS, SUBCUTANEOUS", "Drug": "AZACITIDINE", "ActiveIngredient": "AZACITIDINE", "ApplType": "NDA", "Sponsor": "ACTAVIS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208216s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208216"}, "208219": {"ApplNo": "208219", "Form": "GEL;OPHTHALMIC", "Drug": "LOTEMAX SM", "ActiveIngredient": "LOTEPREDNOL ETABONATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208219s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208219"}, "20822": {"ApplNo": "20822", "Form": "TABLET;ORAL", "Drug": "CELEXA", "ActiveIngredient": "CITALOPRAM HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020822s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20822"}, "208223": {"ApplNo": "208223", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "ZEMBRACE SYMTOUCH", "ActiveIngredient": "SUMATRIPTAN SUCCINATE", "ApplType": "NDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208223s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208223"}, "208224": {"ApplNo": "208224", "Form": "INTRAUTERINE DEVICE;INTRAUTERINE", "Drug": "KYLEENA", "ActiveIngredient": "LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208224s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208224"}, "208232": {"ApplNo": "208232", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "MYCAPSSA", "ActiveIngredient": "OCTREOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "AMRYT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208232s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208232"}, "208246": {"ApplNo": "208246", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "XELJANZ XR", "ActiveIngredient": "TOFACITINIB CITRATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203214s028,208246s013,213082s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208246"}, "20825": {"ApplNo": "20825", "Form": "CAPSULE;ORAL", "Drug": "GEODON", "ActiveIngredient": "ZIPRASIDONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020825s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20825"}, "208251": {"ApplNo": "208251", "Form": "SOLUTION/DROPS;OTIC", "Drug": "OTOVEL", "ActiveIngredient": "CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "LABORATORIOS SALVAT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208251orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208251"}, "208254": {"ApplNo": "208254", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "RHOPRESSA", "ActiveIngredient": "NETARSUDIL MESYLATE", "ApplType": "NDA", "Sponsor": "AERIE PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208254s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208254"}, "208255": {"ApplNo": "208255", "Form": "TABLET;ORAL", "Drug": "SYMFI LO", "ActiveIngredient": "EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208255s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208255"}, "208258": {"ApplNo": "208258", "Form": "CREAM;TOPICAL", "Drug": "TAZAROTENE", "ActiveIngredient": "TAZAROTENE", "ApplType": "ANDA", "Sponsor": "TARO PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208258Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208258"}, "208259": {"ApplNo": "208259", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ROCKLATAN", "ActiveIngredient": "LATANOPROST; NETARSUDIL DIMESYLATE", "ApplType": "NDA", "Sponsor": "AERIE PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208259s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208259"}, "208261": {"ApplNo": "208261", "Form": "TABLET;ORAL", "Drug": "ZEPATIER", "ActiveIngredient": "ELBASVIR; GRAZOPREVIR", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208261s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208261"}, "208264": {"ApplNo": "208264", "Form": "POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL", "Drug": "TEPADINA", "ActiveIngredient": "THIOTEPA", "ApplType": "NDA", "Sponsor": "ADIENNE SA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208264s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208264"}, "20827": {"ApplNo": "20827", "Form": "CREAM;VAGINAL", "Drug": "MONISTAT 3", "ActiveIngredient": "MICONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "MEDTECH PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017450Orig1s073,020670Orig1s035,020827Orig1s031,021261Orig1s024,021308Orig1s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20827"}, "208271": {"ApplNo": "208271", "Form": "TABLET;ORAL", "Drug": "RELISTOR", "ActiveIngredient": "METHYLNALTREXONE BROMIDE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208271"}, "208277": {"ApplNo": "208277", "Form": "SUSPENSION;ORAL", "Drug": "FYCOMPA", "ActiveIngredient": "PERAMPANEL", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208277"}, "208288": {"ApplNo": "208288", "Form": "SOLUTION;TOPICAL", "Drug": "SOLUPREP", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL", "ApplType": "NDA", "Sponsor": "3M HEALTH CARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208288Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208288"}, "208289": {"ApplNo": "208289", "Form": "SOLUTION;INTRAVENOUS", "Drug": "AKOVAZ", "ActiveIngredient": "EPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208289Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208289"}, "20829": {"ApplNo": "20829", "Form": "TABLET;ORAL", "Drug": "SINGULAIR", "ActiveIngredient": "MONTELUKAST SODIUM", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20829"}, "208294": {"ApplNo": "208294", "Form": "AEROSOL, METERED;INHALATION", "Drug": "BEVESPI AEROSPHERE", "ActiveIngredient": "FORMOTEROL FUMARATE; GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208294s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208294"}, "20830": {"ApplNo": "20830", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "SINGULAIR", "ActiveIngredient": "MONTELUKAST SODIUM", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20830"}, "208313": {"ApplNo": "208313", "Form": "SOLUTION;INTRAVENOUS", "Drug": "INFUGEM", "ActiveIngredient": "GEMCITABINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208313s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208313"}, "20832": {"ApplNo": "20832", "Form": "SPONGE;TOPICAL", "Drug": "CHLORAPREP ONE-STEP", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL", "ApplType": "NDA", "Sponsor": "BECTON DICKINSON CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020832Orig1s036_REPLACEMENT_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20832"}, "208325": {"ApplNo": "208325", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PARSABIV", "ActiveIngredient": "ETELCALCETIDE", "ApplType": "NDA", "Sponsor": "KAI PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208325s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208325"}, "20833": {"ApplNo": "20833", "Form": "POWDER;INHALATION", "Drug": "FLOVENT DISKUS 50", "ActiveIngredient": "FLUTICASONE PROPIONATE", "ApplType": "NDA", "Sponsor": "GLAXO GRP LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020833s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20833"}, "20834": {"ApplNo": "20834", "Form": "SOLUTION;TOPICAL", "Drug": "ROGAINE EXTRA STRENGTH (FOR MEN)", "ActiveIngredient": "MINOXIDIL", "ApplType": "NDA", "Sponsor": "JOHNSON AND JOHNSON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020834Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20834"}, "208341": {"ApplNo": "208341", "Form": "TABLET;ORAL", "Drug": "EPCLUSA", "ActiveIngredient": "SOFOSBUVIR; VELPATASVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208341s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208341"}, "20835": {"ApplNo": "20835", "Form": "TABLET;ORAL", "Drug": "ACTONEL", "ActiveIngredient": "RISEDRONATE SODIUM", "ApplType": "NDA", "Sponsor": "APIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20835"}, "208351": {"ApplNo": "208351", "Form": "TABLET;ORAL", "Drug": "ODEFSEY", "ActiveIngredient": "EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208351s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208351"}, "208352": {"ApplNo": "208352", "Form": "GEL;VAGINAL", "Drug": "PHEXXI", "ActiveIngredient": "CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE", "ApplType": "NDA", "Sponsor": "EVOFEM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208352s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208352"}, "20837": {"ApplNo": "20837", "Form": "SOLUTION;INHALATION", "Drug": "XOPENEX", "ActiveIngredient": "LEVALBUTEROL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020837s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20837"}, "208379": {"ApplNo": "208379", "Form": "TABLET;ORAL", "Drug": "ZYPITAMAG", "ActiveIngredient": "PITAVASTATIN MAGNESIUM", "ApplType": "NDA", "Sponsor": "MEDICURE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208379s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208379"}, "20838": {"ApplNo": "20838", "Form": "TABLET;ORAL", "Drug": "ATACAND", "ActiveIngredient": "CANDESARTAN CILEXETIL", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020838s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20838"}, "208385": {"ApplNo": "208385", "Form": "POWDER;INTRAVENOUS", "Drug": "DAPTOMYCIN", "ActiveIngredient": "DAPTOMYCIN", "ApplType": "NDA", "Sponsor": "SAGENT PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208385s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208385"}, "20839": {"ApplNo": "20839", "Form": "TABLET;ORAL", "Drug": "PLAVIX", "ActiveIngredient": "CLOPIDOGREL BISULFATE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020839s078lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20839"}, "208400": {"ApplNo": "208400", "Form": "SOLUTION;ORAL", "Drug": "XATMEP", "ActiveIngredient": "METHOTREXATE SODIUM", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208004s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208400"}, "208401": {"ApplNo": "208401", "Form": "SOLUTION;ORAL", "Drug": "QBRELIS", "ActiveIngredient": "LISINOPRIL", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208401s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208401"}, "208411": {"ApplNo": "208411", "Form": "SPRAY, METERED;NASAL", "Drug": "NARCAN", "ActiveIngredient": "NALOXONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EMERGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208411Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208411"}, "208418": {"ApplNo": "208418", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CALCIUM GLUCONATE", "ActiveIngredient": "CALCIUM GLUCONATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208418Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208418"}, "208419": {"ApplNo": "208419", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PEMETREXED", "ActiveIngredient": "PEMETREXED", "ApplType": "NDA", "Sponsor": "ACTAVIS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208419s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208419"}, "20843": {"ApplNo": "20843", "Form": "CAPSULE; ORAL", "Drug": "PROMETRIUM", "ActiveIngredient": "PROGESTERONE", "ApplType": "NDA", "Sponsor": "VIRTUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019781s017,020843s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20843"}, "208434": {"ApplNo": "208434", "Form": "CAPSULE;ORAL", "Drug": "ALECENSA", "ActiveIngredient": "ALECTINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOFFMANN-LA ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208434s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208434"}, "208437": {"ApplNo": "208437", "Form": "SOLUTION;INHALATION", "Drug": "LONHALA MAGNAIR KIT", "ActiveIngredient": "GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "SUNOVION RESP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208437s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208437"}, "20844": {"ApplNo": "20844", "Form": "CAPSULE;ORAL", "Drug": "TOPAMAX", "ActiveIngredient": "TOPIRAMATE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020505s062,020844s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20844"}, "208447": {"ApplNo": "208447", "Form": "CAPSULE;ORAL", "Drug": "ZEJULA", "ActiveIngredient": "NIRAPARIB TOSYLATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208447s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208447"}, "20845": {"ApplNo": "20845", "Form": "GAS;INHALATION", "Drug": "INOMAX", "ActiveIngredient": "NITRIC OXIDE", "ApplType": "NDA", "Sponsor": "MALLINCKRODT HOSP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020845s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20845"}, "208462": {"ApplNo": "208462", "Form": "CAPSULE;ORAL", "Drug": "NINLARO", "ActiveIngredient": "IXAZOMIB CITRATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208462s012s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208462"}, "208464": {"ApplNo": "208464", "Form": "TABLET;ORAL", "Drug": "VEMLIDY", "ActiveIngredient": "TENOFOVIR ALAFENAMIDE FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208464s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208464"}, "208470": {"ApplNo": "208470", "Form": "INSERT;VAGINAL", "Drug": "INTRAROSA", "ActiveIngredient": "PRASTERONE", "ApplType": "NDA", "Sponsor": "MILLICENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208470s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208470"}, "208471": {"ApplNo": "208471", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "ADLYXIN", "ActiveIngredient": "LIXISENATIDE", "ApplType": "BLA", "Sponsor": "SANOFI-AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208471s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208471"}, "208477": {"ApplNo": "208477", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "LORATADINE", "ActiveIngredient": "LORATADINE", "ApplType": "ANDA", "Sponsor": "AUROBINDO PHARMA LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208477s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208477"}, "20849": {"ApplNo": "20849", "Form": "INJECTABLE;INJECTION", "Drug": "PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER", "ActiveIngredient": "AMINO ACIDS", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018931s055,020849s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20849"}, "20850": {"ApplNo": "20850", "Form": "TABLET;ORAL", "Drug": "MICARDIS", "ActiveIngredient": "TELMISARTAN", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020850s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20850"}, "208510": {"ApplNo": "208510", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "VYVANSE", "ActiveIngredient": "LISDEXAMFETAMINE DIMESYLATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021977s048,208510s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208510"}, "208547": {"ApplNo": "208547", "Form": "POWDER;INTRAVENOUS", "Drug": "NETSPOT", "ActiveIngredient": "GALLIUM DOTATATE GA-68", "ApplType": "NDA", "Sponsor": "AAA USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208547s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208547"}, "20855": {"ApplNo": "20855", "Form": "TABLET;ORAL", "Drug": "MESNEX", "ActiveIngredient": "MESNA", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019884s016,020855s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20855"}, "208552": {"ApplNo": "208552", "Form": "CREAM;TOPICAL", "Drug": "RHOFADE", "ActiveIngredient": "OXYMETAZOLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EPI HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208552s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208552"}, "208558": {"ApplNo": "208558", "Form": "TABLET;ORAL", "Drug": "LYNPARZA", "ActiveIngredient": "OLAPARIB", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208558s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208558"}, "208562": {"ApplNo": "208562", "Form": "POWDER;INTRAVENOUS", "Drug": "VORICONAZOLE", "ActiveIngredient": "VORICONAZOLE", "ApplType": "NDA", "Sponsor": "XELLIA PHARMS APS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208562s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208562"}, "208564": {"ApplNo": "208564", "Form": "INSERT;VAGINAL", "Drug": "IMVEXXY", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208564s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208564"}, "20857": {"ApplNo": "20857", "Form": "TABLET;ORAL", "Drug": "COMBIVIR", "ActiveIngredient": "LAMIVUDINE; ZIDOVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020857s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20857"}, "208573": {"ApplNo": "208573", "Form": "TABLET;ORAL", "Drug": "VENCLEXTA", "ActiveIngredient": "VENETOCLAX", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208573s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208573"}, "208582": {"ApplNo": "208582", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ALTAFLUOR BENOX", "ActiveIngredient": "BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM", "ApplType": "NDA", "Sponsor": "ALTAIRE PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208582Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208582"}, "208583": {"ApplNo": "208583", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "XULTOPHY 100/3.6", "ActiveIngredient": "INSULIN DEGLUDEC; LIRAGLUTIDE", "ApplType": "BLA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208583s018s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208583"}, "208587": {"ApplNo": "208587", "Form": "FOR SOLUTION;ORAL", "Drug": "ENDARI", "ActiveIngredient": "L-GLUTAMINE", "ApplType": "NDA", "Sponsor": "EMMAUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208587s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208587"}, "20859": {"ApplNo": "20859", "Form": "CAPSULE;ORAL", "Drug": "SONATA", "ActiveIngredient": "ZALEPLON", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20859"}, "208609": {"ApplNo": "208609", "Form": "SOLUTION;INTRAVENOUS", "Drug": "EPHEDRINE SULFATE", "ActiveIngredient": "EPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208609s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208609"}, "208610": {"ApplNo": "208610", "Form": "TABLET;ORAL", "Drug": "BAXDELA", "ActiveIngredient": "DELAFLOXACIN MEGLUMINE", "ApplType": "NDA", "Sponsor": "MELINTA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208610"}, "208611": {"ApplNo": "208611", "Form": "POWDER;INTRAVENOUS", "Drug": "BAXDELA", "ActiveIngredient": "DELAFLOXACIN MEGLUMINE", "ApplType": "NDA", "Sponsor": "MELINTA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208611"}, "208612": {"ApplNo": "208612", "Form": "TABLET;ORAL", "Drug": "BALCOLTRA", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "AVION PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208612s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208612"}, "208614": {"ApplNo": "208614", "Form": "INJECTABLE;INJECTION", "Drug": "DOXERCALCIFEROL", "ActiveIngredient": "DOXERCALCIFEROL", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208614s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208614"}, "20862": {"ApplNo": "20862", "Form": "CAPSULE;ORAL", "Drug": "HECTOROL", "ActiveIngredient": "DOXERCALCIFEROL", "ApplType": "NDA", "Sponsor": "SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020862s031,021027s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20862"}, "208623": {"ApplNo": "208623", "Form": "CAPSULE;ORAL", "Drug": "GALAFOLD", "ActiveIngredient": "MIGALASTAT HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AMICUS THERAP US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208623s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208623"}, "208627": {"ApplNo": "208627", "Form": "CAPSULE;ORAL", "Drug": "TPOXX", "ActiveIngredient": "TECOVIRIMAT", "ApplType": "NDA", "Sponsor": "SIGA TECHNOLOGIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208627s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208627"}, "208630": {"ApplNo": "208630", "Form": "FOR SOLUTION;ORAL", "Drug": "GLEOLAN", "ActiveIngredient": "AMINOLEVULINIC ACID HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NXDC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208630s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208630"}, "20864": {"ApplNo": "20864", "Form": "TABLET;ORAL", "Drug": "MAXALT", "ActiveIngredient": "RIZATRIPTAN BENZOATE", "ApplType": "NDA", "Sponsor": "ORGANON LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20864"}, "208647": {"ApplNo": "208647", "Form": "CAPSULE;ORAL", "Drug": "EZALLOR SPRINKLE", "ActiveIngredient": "ROSUVASTATIN CALCIUM", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208647s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208647"}, "20865": {"ApplNo": "20865", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "MAXALT-MLT", "ActiveIngredient": "RIZATRIPTAN BENZOATE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20865"}, "208653": {"ApplNo": "208653", "Form": "TABLET;ORAL", "Drug": "APADAZ", "ActiveIngredient": "ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "KVK TECH INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208653s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208653"}, "208658": {"ApplNo": "208658", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "SYNJARDY XR", "ActiveIngredient": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208658s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208658"}, "20866": {"ApplNo": "20866", "Form": "TABLET;ORAL", "Drug": "CYCLOSET", "ActiveIngredient": "BROMOCRIPTINE MESYLATE", "ApplType": "NDA", "Sponsor": "VEROSCIENCE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020866s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20866"}, "208673": {"ApplNo": "208673", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "SOLIQUA 100/33", "ActiveIngredient": "INSULIN GLARGINE; LIXISENATIDE", "ApplType": "BLA", "Sponsor": "SANOFI-AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208673s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208673"}, "208684": {"ApplNo": "208684", "Form": "TABLET;ORAL", "Drug": "EMFLAZA", "ActiveIngredient": "DEFLAZACORT", "ApplType": "NDA", "Sponsor": "PTC THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208684s005,208685s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208684"}, "208685": {"ApplNo": "208685", "Form": "SUSPENSION;ORAL", "Drug": "EMFLAZA", "ActiveIngredient": "DEFLAZACORT", "ApplType": "NDA", "Sponsor": "PTC THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208684s005,208685s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208685"}, "208686": {"ApplNo": "208686", "Form": "SOLUTION;ORAL", "Drug": "EPANED", "ActiveIngredient": "ENALAPRIL MALEATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208686s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208686"}, "20869": {"ApplNo": "20869", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "COSOPT", "ActiveIngredient": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "THEA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020869s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20869"}, "208692": {"ApplNo": "208692", "Form": "TABLET;ORAL", "Drug": "CABOMETYX", "ActiveIngredient": "CABOZANTINIB S-MALATE", "ApplType": "NDA", "Sponsor": "EXELIXIS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208692s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208692"}, "208694": {"ApplNo": "208694", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ZERVIATE", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EYEVANCE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208694s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208694"}, "20870": {"ApplNo": "20870", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "COMBIPATCH", "ActiveIngredient": "ESTRADIOL; NORETHINDRONE ACETATE", "ApplType": "NDA", "Sponsor": "NOVEN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020870s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20870"}, "208700": {"ApplNo": "208700", "Form": "SOLUTION;INTRAVENOUS", "Drug": "LUTATHERA", "ActiveIngredient": "LUTETIUM LU 177 DOTATATE", "ApplType": "NDA", "Sponsor": "AAA USA INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208700s019s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208700"}, "208711": {"ApplNo": "208711", "Form": "TABLET;ORAL", "Drug": "EGATEN", "ActiveIngredient": "TRICLABENDAZOLE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208711s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208711"}, "208712": {"ApplNo": "208712", "Form": "CAPSULE;ORAL", "Drug": "VONJO", "ActiveIngredient": "PACRITINIB CITRATE", "ApplType": "NDA", "Sponsor": "CTI BIOPHARMA CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208712s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208712"}, "208715": {"ApplNo": "208715", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CABAZITAXEL", "ActiveIngredient": "CABAZITAXEL", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208715s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208715"}, "208716": {"ApplNo": "208716", "Form": "TABLET;ORAL", "Drug": "VERZENIO", "ActiveIngredient": "ABEMACICLIB", "ApplType": "NDA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208716s006s007s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208716"}, "20872": {"ApplNo": "20872", "Form": "TABLET;ORAL", "Drug": "ALLEGRA ALLERGY", "ActiveIngredient": "FEXOFENADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020872s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20872"}, "20873": {"ApplNo": "20873", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ANGIOMAX", "ActiveIngredient": "BIVALIRUDIN", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020873s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20873"}, "208742": {"ApplNo": "208742", "Form": "INSERT;OPHTHALMIC", "Drug": "DEXTENZA", "ActiveIngredient": "DEXAMETHASONE", "ApplType": "NDA", "Sponsor": "OCULAR THERAPEUTIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208742s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208742"}, "208743": {"ApplNo": "208743", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "TYMLOS", "ActiveIngredient": "ABALOPARATIDE", "ApplType": "NDA", "Sponsor": "RADIUS HEALTH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208743s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208743"}, "208744": {"ApplNo": "208744", "Form": "POWDER;INTRAVENOUS", "Drug": "TIGECYCLINE", "ActiveIngredient": "TIGECYCLINE", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208744s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208744"}, "208745": {"ApplNo": "208745", "Form": "TABLET;ORAL", "Drug": "TRULANCE", "ActiveIngredient": "PLECANATIDE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208745"}, "208746": {"ApplNo": "208746", "Form": "POWDER;INTRAVENOUS", "Drug": "PEMETREXED DITROMETHAMINE", "ActiveIngredient": "PEMETREXED DITROMETHAMINE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208746s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208746"}, "208751": {"ApplNo": "208751", "Form": "SOLUTION;INTRAVENOUS, SUBCUTANEOUS", "Drug": "FIASP", "ActiveIngredient": "INSULIN ASPART", "ApplType": "BLA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208751s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208751"}, "208772": {"ApplNo": "208772", "Form": "TABLET;ORAL", "Drug": "ALUNBRIG", "ActiveIngredient": "BRIGATINIB", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208772s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208772"}, "208780": {"ApplNo": "208780", "Form": "TABLET;ORAL", "Drug": "ESBRIET", "ActiveIngredient": "PIRFENIDONE", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022535s015,208780s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208780"}, "208791": {"ApplNo": "208791", "Form": "SOLUTION;INTRATHECAL", "Drug": "CLOROTEKAL", "ActiveIngredient": "CHLOROPROCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN MEDICAL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208791s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208791"}, "208794": {"ApplNo": "208794", "Form": "TABLET;ORAL", "Drug": "XERMELO", "ActiveIngredient": "TELOTRISTAT ETIPRATE", "ApplType": "NDA", "Sponsor": "TERSERA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208794s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208794"}, "208798": {"ApplNo": "208798", "Form": "POWDER;INHALATION", "Drug": "ARMONAIR DIGIHALER", "ActiveIngredient": "FLUTICASONE PROPIONATE", "ApplType": "NDA", "Sponsor": "TEVA PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208798s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208798"}, "208799": {"ApplNo": "208799", "Form": "POWDER;INHALATION", "Drug": "AIRDUO RESPICLICK", "ActiveIngredient": "FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE", "ApplType": "NDA", "Sponsor": "TEVA PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208799Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208799"}, "20882": {"ApplNo": "20882", "Form": "TABLET;ORAL", "Drug": "NEURONTIN", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20882"}, "20883": {"ApplNo": "20883", "Form": "INJECTABLE;INJECTION", "Drug": "ARGATROBAN", "ActiveIngredient": "ARGATROBAN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020883s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20883"}, "208843": {"ApplNo": "208843", "Form": "TABLET;ORAL", "Drug": "SIKLOS", "ActiveIngredient": "HYDROXYUREA", "ApplType": "NDA", "Sponsor": "ADDMEDICA SAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208843s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208843"}, "208844": {"ApplNo": "208844", "Form": "PASTE;ORAL", "Drug": "VARIBAR PUDDING", "ActiveIngredient": "BARIUM SULFATE", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208844lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208844"}, "208845": {"ApplNo": "208845", "Form": "FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR", "Drug": "ZILRETTA", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "PACIRA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208845s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208845"}, "208854": {"ApplNo": "208854", "Form": "TABLET;ORAL", "Drug": "SYMPROIC", "ActiveIngredient": "NALDEMEDINE TOSYLATE", "ApplType": "NDA", "Sponsor": "BDSI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208854"}, "208855": {"ApplNo": "208855", "Form": "TABLET;ORAL", "Drug": "VERZENIO", "ActiveIngredient": "ABEMACICLIB", "ApplType": "NDA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208855s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208855"}, "20886": {"ApplNo": "20886", "Form": "GEL;TOPICAL", "Drug": "PANRETIN", "ActiveIngredient": "ALITRETINOIN", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20886lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20886"}, "208870": {"ApplNo": "208870", "Form": "POWDER;INTRAVENOUS", "Drug": "DRAX EXAMETAZIME", "ActiveIngredient": "TECHNETIUM TC-99M EXAMETAZIME KIT", "ApplType": "NDA", "Sponsor": "JUBILANT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208870s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208870"}, "208878": {"ApplNo": "208878", "Form": "INJECTABLE;INJECTION", "Drug": "MIDAZOLAM HYDROCHLORIDE", "ActiveIngredient": "MIDAZOLAM HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208878Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208878"}, "20888": {"ApplNo": "20888", "Form": "Cream; Topical", "Drug": "LOTRIMIN AF", "ActiveIngredient": "CLOTRIMAZOLE", "ApplType": "NDA", "Sponsor": "SCHERING PLOUGH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20888s2lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20888"}, "20889": {"ApplNo": "20889", "Form": "Lotion; Topical", "Drug": "LOTRIMIN AF", "ActiveIngredient": "CLOTRIMAZOLE", "ApplType": "NDA", "Sponsor": "SCHERING PLOUGH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20889s2lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20889"}, "208891": {"ApplNo": "208891", "Form": "POWDER;INHALATION", "Drug": "WIXELA INHUB", "ActiveIngredient": "FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208891Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208891"}, "20890": {"ApplNo": "20890", "Form": "Solution; Topical", "Drug": "LOTRIMIN AF", "ActiveIngredient": "CLOTRIMAZOLE", "ApplType": "NDA", "Sponsor": "SCHERING PLOUGH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20890s2lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20890"}, "208901": {"ApplNo": "208901", "Form": "CAPSULE;ORAL", "Drug": "TOLSURA", "ActiveIngredient": "ITRACONAZOLE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208901s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208901"}, "208910": {"ApplNo": "208910", "Form": "FOR SOLUTION;ORAL", "Drug": "FIRVANQ KIT", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208910s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208910"}, "208912": {"ApplNo": "208912", "Form": "SUSPENSION;INTRAOCULAR", "Drug": "DEXYCU KIT", "ActiveIngredient": "DEXAMETHASONE", "ApplType": "NDA", "Sponsor": "EYEPOINT PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208912s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208912"}, "20892": {"ApplNo": "20892", "Form": "SOLUTION;INTRAVESICAL", "Drug": "VALSTAR PRESERVATIVE FREE", "ActiveIngredient": "VALRUBICIN", "ApplType": "NDA", "Sponsor": "ENDO PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020892s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20892"}, "208943": {"ApplNo": "208943", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CORPHEDRA", "ActiveIngredient": "EPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208943s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208943"}, "208944": {"ApplNo": "208944", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "GOCOVRI", "ActiveIngredient": "AMANTADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ADAMAS OPERATIONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208944s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208944"}, "208945": {"ApplNo": "208945", "Form": "CREAM;TOPICAL", "Drug": "XEPI", "ActiveIngredient": "OZENOXACIN", "ApplType": "NDA", "Sponsor": "FERRER INTERNACIONAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208945s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208945"}, "20895": {"ApplNo": "20895", "Form": "TABLET;ORAL", "Drug": "VIAGRA", "ActiveIngredient": "SILDENAFIL CITRATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020895s048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20895"}, "208956": {"ApplNo": "208956", "Form": "FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "TRIPTODUR KIT", "ActiveIngredient": "TRIPTORELIN PAMOATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208956s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208956"}, "20896": {"ApplNo": "20896", "Form": "TABLET;ORAL", "Drug": "XELODA", "ActiveIngredient": "CAPECITABINE", "ApplType": "NDA", "Sponsor": "HOFFMANN LA ROCHE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020896s044s045s046s047s048s049s050s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20896"}, "20897": {"ApplNo": "20897", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "DITROPAN XL", "ActiveIngredient": "OXYBUTYNIN CHLORIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020897s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20897"}, "20898": {"ApplNo": "20898", "Form": "INJECTABLE;INJECTION", "Drug": "THYROGEN", "ActiveIngredient": "THYROTROPIN ALFA", "ApplType": "BLA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20898slr021_Thyrogen_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20898"}, "208984": {"ApplNo": "208984", "Form": "SOLUTION;ORAL", "Drug": "SELZENTRY", "ActiveIngredient": "MARAVIROC", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128Orig1s019,208984Orig1s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208984"}, "20899": {"ApplNo": "20899", "Form": "INJECTABLE;INJECTION", "Drug": "OPTISON", "ActiveIngredient": "ALBUMIN HUMAN", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020899s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20899"}, "20901": {"ApplNo": "20901", "Form": "LOTION;TOPICAL", "Drug": "METROLOTION", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20901slr002_metrolotion_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20901"}, "20902": {"ApplNo": "20902", "Form": "TABLET;ORAL", "Drug": "PEPCID AC", "ActiveIngredient": "FAMOTIDINE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/020902A_Pepcid_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20902"}, "209022": {"ApplNo": "209022", "Form": "SPRAY, METERED;NASAL", "Drug": "XHANCE", "ActiveIngredient": "FLUTICASONE PROPIONATE", "ApplType": "NDA", "Sponsor": "OPTINOSE US INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209022s013s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209022"}, "20905": {"ApplNo": "20905", "Form": "TABLET;ORAL", "Drug": "ARAVA", "ActiveIngredient": "LEFLUNOMIDE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020905s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20905"}, "20907": {"ApplNo": "20907", "Form": "TABLET;ORAL", "Drug": "ACTIVELLA", "ActiveIngredient": "ESTRADIOL; NORETHINDRONE ACETATE", "ApplType": "NDA", "Sponsor": "AMNEAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020907s020s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20907"}, "20908": {"ApplNo": "20908", "Form": "TABLET;VAGINAL", "Drug": "VAGIFEM", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020908s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20908"}, "209080": {"ApplNo": "209080", "Form": "SUSPENSION;ORAL", "Drug": "TIGLUTIK KIT", "ActiveIngredient": "RILUZOLE", "ApplType": "NDA", "Sponsor": "ITALFARMACO SA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209080s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209080"}, "209089": {"ApplNo": "209089", "Form": "TABLET;ORAL", "Drug": "XYZAL ALLERGY 24HR", "ActiveIngredient": "LEVOCETIRIZINE DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209089Orig1s000,209090Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209089"}, "209090": {"ApplNo": "209090", "Form": "SOLUTION;ORAL", "Drug": "XYZAL ALLERGY 24HR", "ActiveIngredient": "LEVOCETIRIZINE DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209090Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209090"}, "209091": {"ApplNo": "209091", "Form": "TABLET;ORAL", "Drug": "QTERN", "ActiveIngredient": "DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209091s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209091"}, "209092": {"ApplNo": "209092", "Form": "TABLET;ORAL", "Drug": "KISQALI", "ActiveIngredient": "RIBOCICLIB SUCCINATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209092s013,209935s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209092"}, "209112": {"ApplNo": "209112", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ASCOR", "ActiveIngredient": "ASCORBIC ACID", "ApplType": "NDA", "Sponsor": "MCGUFF", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209112s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209112"}, "209113": {"ApplNo": "209113", "Form": "FOR SUSPENSION;ORAL", "Drug": "OSELTAMIVIR PHOSPHATE", "ActiveIngredient": "OSELTAMIVIR PHOSPHATE", "ApplType": "ANDA", "Sponsor": "ZYDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209113Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209113"}, "209115": {"ApplNo": "209115", "Form": "TABLET;ORAL", "Drug": "RUBRACA", "ActiveIngredient": "RUCAPARIB CAMSYLATE", "ApplType": "NDA", "Sponsor": "CLOVIS ONCOLOGY INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209115s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209115"}, "20912": {"ApplNo": "20912", "Form": "SOLUTION;INJECTION", "Drug": "AGGRASTAT", "ActiveIngredient": "TIROFIBAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MEDICURE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020912s027,020913s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20912"}, "209128": {"ApplNo": "209128", "Form": "TABLET;SUBLINGUAL", "Drug": "DSUVIA", "ActiveIngredient": "SUFENTANIL CITRATE", "ApplType": "NDA", "Sponsor": "ACELRX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209128s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209128"}, "20913": {"ApplNo": "20913", "Form": "SOLUTION;INTRAVENOUS", "Drug": "AGGRASTAT", "ActiveIngredient": "TIROFIBAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MEDICURE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020913Orig1s028ReplacementLbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20913"}, "209176": {"ApplNo": "209176", "Form": "SOLUTION;INTRAVENOUS", "Drug": "RADICAVA", "ActiveIngredient": "EDARAVONE", "ApplType": "NDA", "Sponsor": "MITSUBISHI TANABE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209176s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209176"}, "20918": {"ApplNo": "20918", "Form": "INJECTABLE;INJECTION", "Drug": "GLUCAGEN", "ActiveIngredient": "GLUCAGON HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVO NORDISK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020918s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20918"}, "209184": {"ApplNo": "209184", "Form": "POWDER;INHALATION", "Drug": "INBRIJA", "ActiveIngredient": "LEVODOPA", "ApplType": "NDA", "Sponsor": "ACORDA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209184s005,s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209184"}, "20919": {"ApplNo": "20919", "Form": "POWDER;INTRAMUSCULAR", "Drug": "GEODON", "ActiveIngredient": "ZIPRASIDONE MESYLATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020825s062,020919s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20919"}, "209191": {"ApplNo": "209191", "Form": "POWDER;INTRAVENOUS, SUBCUTANEOUS", "Drug": "BORTEZOMIB", "ActiveIngredient": "BORTEZOMIB", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209191s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209191"}, "209195": {"ApplNo": "209195", "Form": "TABLET;ORAL", "Drug": "VOSEVI", "ActiveIngredient": "SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209195s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209195"}, "209196": {"ApplNo": "209196", "Form": "SOLUTION;INTRAVENOUS, SUBCUTANEOUS", "Drug": "ADMELOG", "ActiveIngredient": "INSULIN LISPRO", "ApplType": "BLA", "Sponsor": "SANOFI-AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209196s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209196"}, "209210": {"ApplNo": "209210", "Form": "SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS", "Drug": "BYDUREON BCISE", "ActiveIngredient": "EXENATIDE SYNTHETIC", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209210s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209210"}, "209229": {"ApplNo": "209229", "Form": "TABLET;ORAL", "Drug": "LUCEMYRA", "ActiveIngredient": "LOFEXIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "USWM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209229s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209229"}, "20923": {"ApplNo": "20923", "Form": "INJECTABLE;INJECTION", "Drug": "OPTIRAY 320", "ActiveIngredient": "IOVERSOL", "ApplType": "NDA", "Sponsor": "LIEBEL-FLARSHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019710s065,020923s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20923"}, "209241": {"ApplNo": "209241", "Form": "CAPSULE;ORAL", "Drug": "INGREZZA", "ActiveIngredient": "VALBENAZINE TOSYLATE", "ApplType": "NDA", "Sponsor": "NEUROCRINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209241Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209241"}, "209260": {"ApplNo": "209260", "Form": "SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL", "Drug": "ATROPINE SULFATE", "ActiveIngredient": "ATROPINE SULFATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209260s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209260"}, "20927": {"ApplNo": "20927", "Form": "INJECTABLE; INJECTION", "Drug": "AREDIA", "ActiveIngredient": "PAMIDRONATE DISODIUM", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20927lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20927"}, "209279": {"ApplNo": "209279", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "TRACLEER", "ActiveIngredient": "BOSENTAN", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209279Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209279"}, "20928": {"ApplNo": "20928", "Form": "INJECTABLE;INJECTION", "Drug": "GLUCAGON", "ActiveIngredient": "GLUCAGON", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020928s060lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20928"}, "20929": {"ApplNo": "20929", "Form": "SUSPENSION;INHALATION", "Drug": "PULMICORT RESPULES", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020929s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20929"}, "209296": {"ApplNo": "209296", "Form": "EMULSION;INTRAVENOUS", "Drug": "CINVANTI", "ActiveIngredient": "APREPITANT", "ApplType": "NDA", "Sponsor": "HERON THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209296Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209296"}, "209299": {"ApplNo": "209299", "Form": "TABLET;ORAL", "Drug": "TAVALISSE", "ActiveIngredient": "FOSTAMATINIB DISODIUM", "ApplType": "NDA", "Sponsor": "RIGEL PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209299lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209299"}, "20931": {"ApplNo": "20931", "Form": "CAPSULE;ORAL", "Drug": "TIKOSYN", "ActiveIngredient": "DOFETILIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20931"}, "209310": {"ApplNo": "209310", "Form": "IMPLANT;IMPLANTATION", "Drug": "SINUVA", "ActiveIngredient": "MOMETASONE FUROATE", "ApplType": "NDA", "Sponsor": "INTERSECT ENT INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209310s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209310"}, "209311": {"ApplNo": "209311", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "JORNAY PM", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "IRONSHORE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209311s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209311"}, "20933": {"ApplNo": "20933", "Form": "SUSPENSION;ORAL", "Drug": "VIRAMUNE", "ActiveIngredient": "NEVIRAPINE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20933"}, "20934": {"ApplNo": "20934", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "LUXIQ", "ActiveIngredient": "BETAMETHASONE VALERATE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020934s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20934"}, "209347": {"ApplNo": "209347", "Form": "SOLUTION;INTRAVENOUS", "Drug": "GANZYK-RTU", "ActiveIngredient": "GANCICLOVIR", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209347s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209347"}, "209353": {"ApplNo": "209353", "Form": "LOTION;TOPICAL", "Drug": "ALTRENO", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "DOW PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209353s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209353"}, "209354": {"ApplNo": "209354", "Form": "LOTION;TOPICAL", "Drug": "DUOBRII", "ActiveIngredient": "HALOBETASOL PROPIONATE; TAZAROTENE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209354s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209354"}, "209355": {"ApplNo": "209355", "Form": "LOTION;TOPICAL", "Drug": "BRYHALI", "ActiveIngredient": "HALOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209355s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209355"}, "209359": {"ApplNo": "209359", "Form": "SOLUTION;INTRAVENOUS", "Drug": "EPINEPHRINE", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209359Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209359"}, "20936": {"ApplNo": "20936", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "PAXIL CR", "ActiveIngredient": "PAROXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020936s060lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20936"}, "209360": {"ApplNo": "209360", "Form": "SOLUTION;INTRAVENOUS", "Drug": "GIAPREZA", "ActiveIngredient": "ANGIOTENSIN II ACETATE", "ApplType": "NDA", "Sponsor": "LA JOLLA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209360s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209360"}, "209363": {"ApplNo": "209363", "Form": "GRANULE;ORAL", "Drug": "SOLOSEC", "ActiveIngredient": "SECNIDAZOLE", "ApplType": "NDA", "Sponsor": "LUPIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209363Orig1s014s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209363"}, "209376": {"ApplNo": "209376", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TRALEMENT", "ActiveIngredient": "CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE", "ApplType": "NDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209376s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209376"}, "209377": {"ApplNo": "209377", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ZINC SULFATE", "ActiveIngredient": "ZINC SULFATE", "ApplType": "NDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209377s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209377"}, "209379": {"ApplNo": "209379", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SELENIOUS ACID", "ActiveIngredient": "SELENIOUS ACID", "ApplType": "NDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209379s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209379"}, "20938": {"ApplNo": "20938", "Form": "TABLET;ORAL", "Drug": "MOBIC", "ActiveIngredient": "MELOXICAM", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020938s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20938"}, "209381": {"ApplNo": "209381", "Form": "FOR SOLUTION;ORAL", "Drug": "PLENVU", "ActiveIngredient": "ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209381s009lbledt02.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209381"}, "209387": {"ApplNo": "209387", "Form": "SOLUTION;INTRAVENOUS", "Drug": "NIPRIDE RTU IN SODIUM CHLORIDE 0.9%", "ActiveIngredient": "SODIUM NITROPRUSSIDE", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209387s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209387"}, "209388": {"ApplNo": "209388", "Form": "SPRAY, METERED;NASAL", "Drug": "GIMOTI", "ActiveIngredient": "METOCLOPRAMIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EVOKE PHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209388"}, "209394": {"ApplNo": "209394", "Form": "TABLET;ORAL", "Drug": "MAVYRET", "ActiveIngredient": "GLECAPREVIR; PIBRENTASVIR", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209394s014,215110s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209394"}, "209400": {"ApplNo": "209400", "Form": "TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL", "Drug": "OMEPRAZOLE", "ActiveIngredient": "OMEPRAZOLE", "ApplType": "NDA", "Sponsor": "DEXCEL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209400Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209400"}, "209401": {"ApplNo": "209401", "Form": "POWDER;INTRAVENOUS", "Drug": "VYXEOS", "ActiveIngredient": "CYTARABINE; DAUNORUBICIN", "ApplType": "NDA", "Sponsor": "CELATOR PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209401s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209401"}, "209405": {"ApplNo": "209405", "Form": "TABLET;ORAL", "Drug": "TYBLUME", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "EXELTIS USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209405s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209405"}, "20941": {"ApplNo": "20941", "Form": "CREAM;TOPICAL", "Drug": "ABREVA", "ActiveIngredient": "DOCOSANOL", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020941Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20941"}, "209410": {"ApplNo": "209410", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "OSMOLEX ER", "ActiveIngredient": "AMANTADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ADAMAS OPERATIONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209410s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209410"}, "20943": {"ApplNo": "20943", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "VERELAN PM", "ActiveIngredient": "VERAPAMIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SOCIETAL CDMO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20943"}, "20944": {"ApplNo": "20944", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "CHILDREN'S ADVIL", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020944Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20944"}, "209445": {"ApplNo": "209445", "Form": "POWDER;INTRAVENOUS", "Drug": "FETROJA", "ActiveIngredient": "CEFIDEROCOL SULFATE TOSYLATE", "ApplType": "NDA", "Sponsor": "SHIONOGI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209445s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209445"}, "209449": {"ApplNo": "209449", "Form": "TABLET;ORAL", "Drug": "NITYR", "ActiveIngredient": "NITISINONE", "ApplType": "NDA", "Sponsor": "CYCLE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209449s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209449"}, "209463": {"ApplNo": "209463", "Form": "POWDER;INTRAVENOUS", "Drug": "PANTOPRAZOLE SODIUM", "ActiveIngredient": "PANTOPRAZOLE SODIUM", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209463s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209463"}, "209472": {"ApplNo": "209472", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PEMFEXY", "ActiveIngredient": "PEMETREXED", "ApplType": "NDA", "Sponsor": "EAGLE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209472s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209472"}, "209478": {"ApplNo": "209478", "Form": "SUSPENSION;ORAL", "Drug": "CAROSPIR", "ActiveIngredient": "SPIRONOLACTONE", "ApplType": "NDA", "Sponsor": "CMP DEV LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209478Orig1s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209478"}, "209481": {"ApplNo": "209481", "Form": "POWDER;INTRAVENOUS", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MYLAN LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209481s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209481"}, "209482": {"ApplNo": "209482", "Form": "POWDER;INHALATION", "Drug": "TRELEGY ELLIPTA", "ActiveIngredient": "FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209482s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209482"}, "209483": {"ApplNo": "209483", "Form": "CREAM;TOPICAL", "Drug": "IMPOYZ", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "PRIMUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209483s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209483"}, "20949": {"ApplNo": "20949", "Form": "SOLUTION;INHALATION", "Drug": "ACCUNEB", "ActiveIngredient": "ALBUTEROL SULFATE", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020949Orig1s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20949"}, "209500": {"ApplNo": "209500", "Form": "CAPSULE;ORAL", "Drug": "CAPLYTA", "ActiveIngredient": "LUMATEPERONE TOSYLATE", "ApplType": "NDA", "Sponsor": "INTRA-CELLULAR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209500s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209500"}, "209501": {"ApplNo": "209501", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "LYRICA CR", "ActiveIngredient": "PREGABALIN", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209501s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209501"}, "209506": {"ApplNo": "209506", "Form": "GEL;TOPICAL", "Drug": "DAPSONE", "ActiveIngredient": "DAPSONE", "ApplType": "ANDA", "Sponsor": "TARO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209506Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209506"}, "209510": {"ApplNo": "209510", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BARHEMSYS", "ActiveIngredient": "AMISULPRIDE", "ApplType": "NDA", "Sponsor": "ACACIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209510s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209510"}, "209511": {"ApplNo": "209511", "Form": "IMPLANT;IMPLANTATION", "Drug": "XARACOLL", "ActiveIngredient": "BUPIVACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "INNOCOLL PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209511s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209511"}, "209512": {"ApplNo": "209512", "Form": "POWDER;ORAL", "Drug": "NORVIR", "ActiveIngredient": "RITONAVIR", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022417Orig1s025,020659Orig1s073,209512Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209512"}, "209521": {"ApplNo": "209521", "Form": "TABLET;ORAL", "Drug": "SEYSARA", "ActiveIngredient": "SARECYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209521s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209521"}, "209529": {"ApplNo": "209529", "Form": "SUSPENSION;ORAL", "Drug": "VESICARE LS", "ActiveIngredient": "SOLIFENACIN SUCCINATE", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209529s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209529"}, "209531": {"ApplNo": "209531", "Form": "SOLUTION;INTRATHECAL", "Drug": "SPINRAZA", "ActiveIngredient": "NUSINERSEN SODIUM", "ApplType": "NDA", "Sponsor": "BIOGEN IDEC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209531s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209531"}, "20954": {"ApplNo": "20954", "Form": "INJECTABLE;INJECTION", "Drug": "BUSULFEX", "ActiveIngredient": "BUSULFAN", "ApplType": "NDA", "Sponsor": "OTSUKA PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020954Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20954"}, "20955": {"ApplNo": "20955", "Form": "INJECTABLE;INJECTION", "Drug": "FERRLECIT", "ActiveIngredient": "FERRIC OXYHYDROXIDE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020955s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20955"}, "209550": {"ApplNo": "209550", "Form": "TABLET;ORAL", "Drug": "TENOFOVIR DISOPROXIL FUMARATE", "ActiveIngredient": "TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "ANDA", "Sponsor": "CASI PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209550lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209550"}, "209566": {"ApplNo": "209566", "Form": "SOLUTION;INTRAMUSCULAR", "Drug": "SEIZALAM", "ActiveIngredient": "MIDAZOLAM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MMT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209566s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209566"}, "209569": {"ApplNo": "209569", "Form": "SOLUTION;OPHTHALMIC", "Drug": "TISSUEBLUE", "ActiveIngredient": "BRILLIANT BLUE G", "ApplType": "NDA", "Sponsor": "DUTCH OPHTHALMIC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209569Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209569"}, "209570": {"ApplNo": "209570", "Form": "TABLET;ORAL", "Drug": "BENZNIDAZOLE", "ActiveIngredient": "BENZNIDAZOLE", "ApplType": "NDA", "Sponsor": "CHEMO RESEARCH SL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209570s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209570"}, "209575": {"ApplNo": "209575", "Form": "SOLUTION;NASAL", "Drug": "NUMBRINO", "ActiveIngredient": "COCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CODY LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209575s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209575"}, "20958": {"ApplNo": "20958", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "PEPCID COMPLETE", "ActiveIngredient": "CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020958Orig1s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20958"}, "209589": {"ApplNo": "209589", "Form": "SOLUTION;ORAL", "Drug": "CLENPIQ", "ActiveIngredient": "CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE", "ApplType": "NDA", "Sponsor": "FERRING PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209589s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209589"}, "209592": {"ApplNo": "209592", "Form": "INJECTABLE;INTRATHECAL", "Drug": "BACLOFEN", "ActiveIngredient": "BACLOFEN", "ApplType": "ANDA", "Sponsor": "MYLAN LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209592Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209592"}, "209604": {"ApplNo": "209604", "Form": "SOLUTION;INTRAVENOUS", "Drug": "GEMCITABINE HYDROCHLORIDE", "ActiveIngredient": "GEMCITABINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209604s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209604"}, "209606": {"ApplNo": "209606", "Form": "TABLET;ORAL", "Drug": "IDHIFA", "ActiveIngredient": "ENASIDENIB MESYLATE", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209606s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209606"}, "209607": {"ApplNo": "209607", "Form": "SOLUTION;INTRAVENOUS", "Drug": "AZEDRA", "ActiveIngredient": "IOBENGUANE I-131", "ApplType": "NDA", "Sponsor": "PROGENICS PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209607s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209607"}, "209627": {"ApplNo": "209627", "Form": "RING;VAGINAL", "Drug": "ANNOVERA", "ActiveIngredient": "ETHINYL ESTRADIOL; SEGESTERONE ACETATE", "ApplType": "NDA", "Sponsor": "THERAPEUTICSMD INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209627s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209627"}, "20963": {"ApplNo": "20963", "Form": "SOLUTION, GEL FORMING/DROPS;OPHTHALMIC", "Drug": "TIMOLOL MALEATE", "ActiveIngredient": "TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020963s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20963"}, "209637": {"ApplNo": "209637", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "OZEMPIC", "ActiveIngredient": "SEMAGLUTIDE", "ApplType": "NDA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637"}, "20965": {"ApplNo": "20965", "Form": "SOLUTION;TOPICAL", "Drug": "LEVULAN", "ActiveIngredient": "AMINOLEVULINIC ACID HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "DUSA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020965s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20965"}, "209661": {"ApplNo": "209661", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "BONJESTA", "ActiveIngredient": "DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "DUCHESNAY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209661s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209661"}, "20969": {"ApplNo": "20969", "Form": "INJECTABLE;INJECTION", "Drug": "UVADEX", "ActiveIngredient": "METHOXSALEN", "ApplType": "NDA", "Sponsor": "MALLINCKRODT HOSP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020969s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20969"}, "20971": {"ApplNo": "20971", "Form": "INJECTABLE;INJECTION", "Drug": "SEPTOCAINE", "ActiveIngredient": "ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE", "ApplType": "NDA", "Sponsor": "DEPROCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020971s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20971"}, "20972": {"ApplNo": "20972", "Form": "CAPSULE;ORAL", "Drug": "SUSTIVA", "ActiveIngredient": "EFAVIRENZ", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020972s057,021360s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20972"}, "20973": {"ApplNo": "20973", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "ACIPHEX", "ActiveIngredient": "RABEPRAZOLE SODIUM", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020973s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20973"}, "20977": {"ApplNo": "20977", "Form": "TABLET;ORAL", "Drug": "ZIAGEN", "ActiveIngredient": "ABACAVIR SULFATE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20977"}, "209776": {"ApplNo": "209776", "Form": "POWDER;INTRAVENOUS", "Drug": "VABOMERE", "ActiveIngredient": "MEROPENEM; VABORBACTAM", "ApplType": "NDA", "Sponsor": "REMPEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209776s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209776"}, "209777": {"ApplNo": "209777", "Form": "TABLET;ORAL", "Drug": "ROXYBOND", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PROTEGA PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209777s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209777"}, "20978": {"ApplNo": "20978", "Form": "SOLUTION;ORAL", "Drug": "ZIAGEN", "ActiveIngredient": "ABACAVIR SULFATE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20978"}, "20980": {"ApplNo": "20980", "Form": "CREAM;TOPICAL", "Drug": "LAMISIL", "ActiveIngredient": "TERBINAFINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020980Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20980"}, "209803": {"ApplNo": "209803", "Form": "TABLET;ORAL", "Drug": "STEGLATRO", "ActiveIngredient": "ERTUGLIFLOZIN", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209803s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209803"}, "209805": {"ApplNo": "209805", "Form": "TABLET;ORAL", "Drug": "STEGLUJAN", "ActiveIngredient": "ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209805s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209805"}, "209806": {"ApplNo": "209806", "Form": "TABLET;ORAL", "Drug": "SEGLUROMET", "ActiveIngredient": "ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209806s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209806"}, "20981": {"ApplNo": "20981", "Form": "CAPSULE;ORAL", "Drug": "HYCAMTIN", "ActiveIngredient": "TOPOTECAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020981s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20981"}, "209816": {"ApplNo": "209816", "Form": "TABLET;ORAL", "Drug": "NUZYRA", "ActiveIngredient": "OMADACYCLINE TOSYLATE", "ApplType": "NDA", "Sponsor": "PARATEK PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209816s011,209817s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209816"}, "209817": {"ApplNo": "209817", "Form": "POWDER;INTRAVENOUS", "Drug": "NUZYRA", "ActiveIngredient": "OMADACYCLINE TOSYLATE", "ApplType": "NDA", "Sponsor": "PARATEK PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209816s011,209817s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209817"}, "209819": {"ApplNo": "209819", "Form": "SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS", "Drug": "SUBLOCADE", "ActiveIngredient": "BUPRENORPHINE", "ApplType": "NDA", "Sponsor": "INDIVIOR INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209819s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209819"}, "20983": {"ApplNo": "20983", "Form": "AEROSOL, METERED;INHALATION", "Drug": "VENTOLIN HFA", "ActiveIngredient": "ALBUTEROL SULFATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020983s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20983"}, "209830": {"ApplNo": "209830", "Form": "SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "ARISTADA INITIO KIT", "ActiveIngredient": "ARIPIPRAZOLE LAUROXIL", "ApplType": "NDA", "Sponsor": "ALKERMES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209830"}, "20985": {"ApplNo": "20985", "Form": "CREAM;TOPICAL", "Drug": "CARAC", "ActiveIngredient": "FLUOROURACIL", "ApplType": "NDA", "Sponsor": "VALEANT PHARMS NORTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020985Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20985"}, "20986": {"ApplNo": "20986", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "NOVOLOG", "ActiveIngredient": "INSULIN ASPART RECOMBINANT", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020986Orig1s095lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20986"}, "209863": {"ApplNo": "209863", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "XYOSTED (AUTOINJECTOR)", "ActiveIngredient": "TESTOSTERONE ENANTHATE", "ApplType": "NDA", "Sponsor": "ANTARES PHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209863s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209863"}, "20987": {"ApplNo": "20987", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "PROTONIX", "ActiveIngredient": "PANTOPRAZOLE SODIUM", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020987s058,022020s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20987"}, "20988": {"ApplNo": "20988", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "PROTONIX IV", "ActiveIngredient": "PANTOPRAZOLE SODIUM", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020988s064lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20988"}, "209884": {"ApplNo": "209884", "Form": "TABLET;ORAL", "Drug": "MAYZENT", "ActiveIngredient": "SIPONIMOD FUMARIC ACID", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209884Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209884"}, "209885": {"ApplNo": "209885", "Form": "TABLET;ORAL", "Drug": "AUSTEDO", "ActiveIngredient": "DEUTETRABENAZINE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209885lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209885"}, "20989": {"ApplNo": "20989", "Form": "CAPSULE;ORAL", "Drug": "EVOXAC", "ActiveIngredient": "CEVIMELINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020989s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20989"}, "209899": {"ApplNo": "209899", "Form": "CAPSULE;ORAL", "Drug": "ZEPOSIA", "ActiveIngredient": "OZANIMOD HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CELGENE INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209899s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209899"}, "20990": {"ApplNo": "20990", "Form": "CONCENTRATE;ORAL", "Drug": "ZOLOFT", "ActiveIngredient": "SERTRALINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s102,020990s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20990"}, "209905": {"ApplNo": "209905", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "EVEKEO ODT", "ActiveIngredient": "AMPHETAMINE SULFATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209905s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209905"}, "209935": {"ApplNo": "209935", "Form": "TABLET;ORAL", "Drug": "KISQALI FEMARA CO-PACK (COPACKAGED)", "ActiveIngredient": "LETROZOLE; RIBOCICLIB SUCCINATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209092s013,209935s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209935"}, "209936": {"ApplNo": "209936", "Form": "POWDER;INTRAVENOUS", "Drug": "ALIQOPA", "ActiveIngredient": "COPANLISIB DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209936s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209936"}, "209939": {"ApplNo": "209939", "Form": "TABLET;ORAL", "Drug": "PREVYMIS", "ActiveIngredient": "LETERMOVIR", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209939s008,209940s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209939"}, "209940": {"ApplNo": "209940", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PREVYMIS", "ActiveIngredient": "LETERMOVIR", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209939s008,209940s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209940"}, "209949": {"ApplNo": "209949", "Form": "POWDER;INTRAVENOUS", "Drug": "DAPTOMYCIN", "ActiveIngredient": "DAPTOMYCIN", "ApplType": "NDA", "Sponsor": "XELLIA PHARMS APS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209949s006s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209949"}, "209963": {"ApplNo": "209963", "Form": "SOLUTION;NASAL", "Drug": "GOPRELTO", "ActiveIngredient": "COCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GENUS LIFESCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209963s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209963"}, "209964": {"ApplNo": "209964", "Form": "SOLUTION;ORAL", "Drug": "CORLANOR", "ActiveIngredient": "IVABRADINE", "ApplType": "NDA", "Sponsor": "AMGEN INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209964"}, "20998": {"ApplNo": "20998", "Form": "CAPSULE;ORAL", "Drug": "CELEBREX", "ActiveIngredient": "CELECOXIB", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020998s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20998"}, "209988": {"ApplNo": "209988", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "FUROSCIX", "ActiveIngredient": "FUROSEMIDE", "ApplType": "NDA", "Sponsor": "SCPHARMACEUTICALS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209988Orig1s000Correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209988"}, "21003": {"ApplNo": "21003", "Form": "TABLET;ORAL", "Drug": "EPIVIR-HBV", "ActiveIngredient": "LAMIVUDINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021003_021004_S023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21003"}, "21004": {"ApplNo": "21004", "Form": "SOLUTION;ORAL", "Drug": "EPIVIR-HBV", "ActiveIngredient": "LAMIVUDINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021003_021004_S023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21004"}, "21006": {"ApplNo": "21006", "Form": "TABLET;ORAL", "Drug": "FROVA", "ActiveIngredient": "FROVATRIPTAN SUCCINATE", "ApplType": "NDA", "Sponsor": "ENDO PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021006s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21006"}, "210063": {"ApplNo": "210063", "Form": "SOLUTION;INTRAMUSCULAR", "Drug": "FULVESTRANT", "ActiveIngredient": "FULVESTRANT", "ApplType": "NDA", "Sponsor": "TEVA PHARMS USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210063s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210063"}, "210064": {"ApplNo": "210064", "Form": "POWDER;INTRAVENOUS", "Drug": "FOSAPREPITANT DIMEGLUMINE", "ActiveIngredient": "FOSAPREPITANT DIMEGLUMINE", "ApplType": "NDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210064s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210064"}, "21008": {"ApplNo": "21008", "Form": "INJECTABLE;INJECTION", "Drug": "SANDOSTATIN LAR", "ActiveIngredient": "OCTREOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021008s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21008"}, "210089": {"ApplNo": "210089", "Form": "INJECTABLE;INJECTION", "Drug": "PULMOTECH MAA", "ActiveIngredient": "TECHNETIUM TC99M ALBUMIN AGGREGATED", "ApplType": "BLA", "Sponsor": "CIS BIO INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210089s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210089"}, "21011": {"ApplNo": "21011", "Form": "TABLET;ORAL", "Drug": "ROXICODONE", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SPECGX LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021011s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21011"}, "210115": {"ApplNo": "210115", "Form": "FOR SUSPENSION;ORAL", "Drug": "PROGRAF", "ActiveIngredient": "TACROLIMUS", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210115s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210115"}, "210132": {"ApplNo": "210132", "Form": "CAPSULE;ORAL", "Drug": "BIJUVA", "ActiveIngredient": "ESTRADIOL; PROGESTERONE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210132s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210132"}, "210134": {"ApplNo": "210134", "Form": "POWDER;NASAL", "Drug": "BAQSIMI", "ActiveIngredient": "GLUCAGON", "ApplType": "NDA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210134s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210134"}, "21014": {"ApplNo": "21014", "Form": "TABLET;ORAL", "Drug": "TRILEPTAL", "ActiveIngredient": "OXCARBAZEPINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021014s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21014"}, "21016": {"ApplNo": "21016", "Form": "TABLET;ORAL", "Drug": "RELPAX", "ActiveIngredient": "ELETRIPTAN HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/21016s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21016"}, "210166": {"ApplNo": "210166", "Form": "TABLET;ORAL", "Drug": "MOTEGRITY", "ActiveIngredient": "PRUCALOPRIDE SUCCINATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210166s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210166"}, "21017": {"ApplNo": "21017", "Form": "INJECTABLE;INJECTION", "Drug": "HUMALOG MIX 75/25", "ActiveIngredient": "INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT", "ApplType": "BLA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21017scm013_humalog_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21017"}, "21018": {"ApplNo": "21018", "Form": "INJECTABLE;INJECTION", "Drug": "HUMALOG MIX 50/50", "ActiveIngredient": "INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT", "ApplType": "BLA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021018s077lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21018"}, "210192": {"ApplNo": "210192", "Form": "TABLET;ORAL", "Drug": "JULUCA", "ActiveIngredient": "DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210192s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210192"}, "210238": {"ApplNo": "210238", "Form": "TABLET;ORAL", "Drug": "DOPTELET", "ActiveIngredient": "AVATROMBOPAG MALEATE", "ApplType": "NDA", "Sponsor": "AKARX INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210238s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210238"}, "21024": {"ApplNo": "21024", "Form": "TABLET;ORAL", "Drug": "PRIFTIN", "ActiveIngredient": "RIFAPENTINE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21024"}, "210251": {"ApplNo": "210251", "Form": "TABLET;ORAL", "Drug": "BIKTARVY", "ActiveIngredient": "BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210251s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210251"}, "210259": {"ApplNo": "210259", "Form": "CAPSULE;ORAL", "Drug": "CALQUENCE", "ActiveIngredient": "ACALABRUTINIB", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210259s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210259"}, "21026": {"ApplNo": "21026", "Form": "OINTMENT;TOPICAL", "Drug": "VUSION", "ActiveIngredient": "MICONAZOLE NITRATE; WHITE PETROLATUM; ZINC OXIDE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021026s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21026"}, "21027": {"ApplNo": "21027", "Form": "INJECTABLE;INJECTION", "Drug": "HECTOROL", "ActiveIngredient": "DOXERCALCIFEROL", "ApplType": "NDA", "Sponsor": "SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021027Orig1s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21027"}, "210274": {"ApplNo": "210274", "Form": "INJECTABLE;INJECTION", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ZHEJAING NOVUS PHARMACEUTICALS CO. LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210274s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210274"}, "210282": {"ApplNo": "210282", "Form": "POWDER;INTRAVENOUS", "Drug": "DAPTOMYCIN", "ActiveIngredient": "DAPTOMYCIN", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210282s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210282"}, "210296": {"ApplNo": "210296", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "BAFIERTAM", "ActiveIngredient": "MONOMETHYL FUMARATE", "ApplType": "NDA", "Sponsor": "BANNER LIFE SCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210296s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210296"}, "210303": {"ApplNo": "210303", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ZEMDRI", "ActiveIngredient": "PLAZOMICIN SULFATE", "ApplType": "NDA", "Sponsor": "CIPLA USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210303Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210303"}, "210308": {"ApplNo": "210308", "Form": "TABLET;ORAL", "Drug": "YONSA", "ActiveIngredient": "ABIRATERONE ACETATE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210308s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210308"}, "210326": {"ApplNo": "210326", "Form": "SOLUTION;INTRAMUSCULAR", "Drug": "FULVESTRANT", "ActiveIngredient": "FULVESTRANT", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210326s001s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210326"}, "21035": {"ApplNo": "21035", "Form": "TABLET;ORAL", "Drug": "KEPPRA", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021035s104,021505s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21035"}, "21036": {"ApplNo": "21036", "Form": "POWDER;INHALATION", "Drug": "RELENZA", "ActiveIngredient": "ZANAMIVIR", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021036s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21036"}, "210361": {"ApplNo": "210361", "Form": "CLOTH;TOPICAL", "Drug": "QBREXZA", "ActiveIngredient": "GLYCOPYRRONIUM TOSYLATE", "ApplType": "NDA", "Sponsor": "JOURNEY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210361Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210361"}, "210365": {"ApplNo": "210365", "Form": "SOLUTION;ORAL", "Drug": "EPIDIOLEX", "ActiveIngredient": "CANNABIDIOL", "ApplType": "NDA", "Sponsor": "GW RES LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210365s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210365"}, "21038": {"ApplNo": "21038", "Form": "INJECTABLE;INJECTION", "Drug": "PRECEDEX", "ActiveIngredient": "DEXMEDETOMIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021038s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21038"}, "210428": {"ApplNo": "210428", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "KAPSPARGO SPRINKLE", "ActiveIngredient": "METOPROLOL SUCCINATE", "ApplType": "NDA", "Sponsor": "SPIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210428s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210428"}, "210441": {"ApplNo": "210441", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "APPCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210441Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210441"}, "210450": {"ApplNo": "210450", "Form": "TABLET;ORAL", "Drug": "ORILISSA", "ActiveIngredient": "ELAGOLIX SODIUM", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210450s004s005s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210450"}, "210455": {"ApplNo": "210455", "Form": "TABLET;ORAL", "Drug": "SYMTUZA", "ActiveIngredient": "COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE", "ApplType": "NDA", "Sponsor": "JANSSEN PRODS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210455s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210455"}, "210491": {"ApplNo": "210491", "Form": "TABLET;ORAL", "Drug": "SYMDEKO (COPACKAGED)", "ActiveIngredient": "IVACAFTOR; IVACAFTOR, TEZACAFTOR", "ApplType": "NDA", "Sponsor": "VERTEX PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210491s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210491"}, "210493": {"ApplNo": "210493", "Form": "POWDER;INTRAVENOUS", "Drug": "AKYNZEO", "ActiveIngredient": "FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HELSINN HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210493s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210493"}, "210496": {"ApplNo": "210496", "Form": "CAPSULE;ORAL", "Drug": "BRAFTOVI", "ActiveIngredient": "ENCORAFENIB", "ApplType": "NDA", "Sponsor": "ARRAY BIOPHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210496s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210496"}, "210498": {"ApplNo": "210498", "Form": "TABLET;ORAL", "Drug": "MEKTOVI", "ActiveIngredient": "BINIMETINIB", "ApplType": "NDA", "Sponsor": "ARRAY BIOPHARMA INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210498lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210498"}, "210526": {"ApplNo": "210526", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "DYANAVEL XR 5", "ActiveIngredient": "AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE", "ApplType": "NDA", "Sponsor": "TRIS PHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208147Orig1s012,210526Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210526"}, "210543": {"ApplNo": "210543", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "LUPIN LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210543Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210543"}, "21055": {"ApplNo": "21055", "Form": "CAPSULE;ORAL", "Drug": "TARGRETIN", "ActiveIngredient": "BEXAROTENE", "ApplType": "NDA", "Sponsor": "VALEANT LUXEMBOURG", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021055s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21055"}, "210557": {"ApplNo": "210557", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "VYLEESI (AUTOINJECTOR)", "ActiveIngredient": "BREMELANOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "PALATIN TECHNOLOGIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210557s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557"}, "21056": {"ApplNo": "21056", "Form": "GEL;TOPICAL", "Drug": "TARGRETIN", "ActiveIngredient": "BEXAROTENE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021056s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21056"}, "210563": {"ApplNo": "210563", "Form": "TABLET;ORAL", "Drug": "IMBRUVICA", "ActiveIngredient": "IBRUTINIB", "ApplType": "NDA", "Sponsor": "PHARMACYCLICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205552s036,210563s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210563"}, "210565": {"ApplNo": "210565", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "INVELTYS", "ActiveIngredient": "LOTEPREDNOL ETABONATE", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210565s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210565"}, "210566": {"ApplNo": "210566", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "LEXETTE", "ActiveIngredient": "HALOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210566Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210566"}, "21057": {"ApplNo": "21057", "Form": "INJECTABLE;INJECTION", "Drug": "GANIRELIX ACETATE", "ActiveIngredient": "GANIRELIX ACETATE", "ApplType": "NDA", "Sponsor": "ORGANON USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021057Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21057"}, "210589": {"ApplNo": "210589", "Form": "EMULSION;INTRAVENOUS", "Drug": "OMEGAVEN", "ActiveIngredient": "FISH OIL TRIGLYCERIDES", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210589s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210589"}, "210595": {"ApplNo": "210595", "Form": "POWDER, METERED;INHALATION", "Drug": "DUAKLIR PRESSAIR", "ActiveIngredient": "ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210595lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210595"}, "210598": {"ApplNo": "210598", "Form": "SOLUTION;INHALATION", "Drug": "YUPELRI", "ActiveIngredient": "REVEFENACIN", "ApplType": "NDA", "Sponsor": "MYLAN IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210598s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210598"}, "21060": {"ApplNo": "21060", "Form": "INJECTABLE;INTRATHECAL", "Drug": "PRIALT", "ActiveIngredient": "ZICONOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "TERSERA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021060s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21060"}, "210605": {"ApplNo": "210605", "Form": "INJECTABLE;INJECTION", "Drug": "SEMGLEE", "ActiveIngredient": "INSULIN GLARGINE", "ApplType": "BLA", "Sponsor": "MYLAN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210605s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210605"}, "210607": {"ApplNo": "210607", "Form": "TABLET;ORAL", "Drug": "ARAKODA", "ActiveIngredient": "TAFENOQUINE SUCCINATE", "ApplType": "NDA", "Sponsor": "60 DEGREES PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210607lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210607"}, "210632": {"ApplNo": "210632", "Form": "SOLUTION;INTRAVENOUS", "Drug": "LEVOTHYROXINE SODIUM", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210632s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210632"}, "21064": {"ApplNo": "21064", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "DEFINITY", "ActiveIngredient": "PERFLUTREN", "ApplType": "NDA", "Sponsor": "LANTHEUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021064s025s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21064"}, "210655": {"ApplNo": "210655", "Form": "FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS", "Drug": "PERSERIS KIT", "ActiveIngredient": "RISPERIDONE", "ApplType": "NDA", "Sponsor": "INDIVIOR INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210655s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210655"}, "210656": {"ApplNo": "210656", "Form": "TABLET;ORAL", "Drug": "DAURISMO", "ActiveIngredient": "GLASDEGIB MALEATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210656s002s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210656"}, "210660": {"ApplNo": "210660", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ELCYS", "ActiveIngredient": "CYSTEINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210660lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210660"}, "21067": {"ApplNo": "21067", "Form": "POWDER;INHALATION", "Drug": "ASMANEX TWISTHALER", "ActiveIngredient": "MOMETASONE FUROATE", "ApplType": "NDA", "Sponsor": "ORGANON LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021067s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21067"}, "21068": {"ApplNo": "21068", "Form": "SOLUTION;ORAL", "Drug": "ROCALTROL", "ActiveIngredient": "CALCITRIOL", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21068"}, "21071": {"ApplNo": "21071", "Form": "TABLET;ORAL", "Drug": "AVANDIA", "ActiveIngredient": "ROSIGLITAZONE MALEATE", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21071"}, "21073": {"ApplNo": "21073", "Form": "TABLET;ORAL", "Drug": "ACTOS", "ActiveIngredient": "PIOGLITAZONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21073"}, "210730": {"ApplNo": "210730", "Form": "SOLUTION;INTRAVENOUS", "Drug": "OLINVYK", "ActiveIngredient": "OLICERIDINE", "ApplType": "NDA", "Sponsor": "TREVENA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210730s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210730"}, "210737": {"ApplNo": "210737", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "REDITREX", "ActiveIngredient": "METHOTREXATE", "ApplType": "NDA", "Sponsor": "NORDIC GRP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210737"}, "21074": {"ApplNo": "21074", "Form": "SOLUTION;TOPICAL", "Drug": "AVAGARD", "ActiveIngredient": "ALCOHOL; CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "3M", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021074Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21074"}, "21077": {"ApplNo": "21077", "Form": "POWDER;INHALATION", "Drug": "ADVAIR DISKUS 100/50", "ActiveIngredient": "FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE", "ApplType": "NDA", "Sponsor": "GLAXO GRP LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021077s061lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21077"}, "21078": {"ApplNo": "21078", "Form": "TABLET;ORAL", "Drug": "MALARONE", "ActiveIngredient": "ATOVAQUONE; PROGUANIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021078s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21078"}, "210793": {"ApplNo": "210793", "Form": "CAPSULE;ORAL", "Drug": "NUPLAZID", "ActiveIngredient": "PIMAVANSERIN TARTRATE", "ApplType": "NDA", "Sponsor": "ACADIA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207318s010,210793s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210793"}, "210795": {"ApplNo": "210795", "Form": "TABLET;ORAL", "Drug": "KRINTAFEL", "ActiveIngredient": "TAFENOQUINE SUCCINATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210795s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210795"}, "210797": {"ApplNo": "210797", "Form": "IMPLANT;SUBCUTANEOUS", "Drug": "SCENESSE", "ActiveIngredient": "AFAMELANOTIDE", "ApplType": "NDA", "Sponsor": "CLIVUNEL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210797s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210797"}, "210806": {"ApplNo": "210806", "Form": "TABLET;ORAL", "Drug": "PIFELTRO", "ActiveIngredient": "DORAVIRINE", "ApplType": "NDA", "Sponsor": "MSD MERCK CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210806s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210806"}, "210807": {"ApplNo": "210807", "Form": "TABLET;ORAL", "Drug": "DELSTRIGO", "ActiveIngredient": "DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "MSD MERCK CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210807s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210807"}, "21081": {"ApplNo": "21081", "Form": "INJECTABLE;INJECTION", "Drug": "LANTUS", "ActiveIngredient": "INSULIN GLARGINE RECOMBINANT", "ApplType": "BLA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021081s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21081"}, "210821": {"ApplNo": "210821", "Form": "SOLUTION;OPHTHALMIC", "Drug": "TETRACAINE HYDROCHLORIDE", "ActiveIngredient": "TETRACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH LOMB IRELAND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210821s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210821"}, "210828": {"ApplNo": "210828", "Form": "SOLUTION;INTRAVENOUS", "Drug": "GALLIUM GA 68 DOTATOC", "ActiveIngredient": "GALLIUM GA-68 DOTATOC", "ApplType": "NDA", "Sponsor": "UIHC PET IMAGING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210828s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210828"}, "21083": {"ApplNo": "21083", "Form": "SOLUTION;ORAL", "Drug": "RAPAMUNE", "ActiveIngredient": "SIROLIMUS", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021083s069s070,021110s087s088lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21083"}, "210833": {"ApplNo": "210833", "Form": "FILM;ORAL", "Drug": "SYMPAZAN", "ActiveIngredient": "CLOBAZAM", "ApplType": "NDA", "Sponsor": "OTTER PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210833s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210833"}, "210850": {"ApplNo": "210850", "Form": "POWDER;INTRAVENOUS", "Drug": "SINCALIDE", "ActiveIngredient": "SINCALIDE", "ApplType": "NDA", "Sponsor": "MAIA PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210850s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210850"}, "210854": {"ApplNo": "210854", "Form": "TABLET;ORAL", "Drug": "XOFLUZA", "ActiveIngredient": "BALOXAVIR MARBOXIL", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210854s005s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210854"}, "21086": {"ApplNo": "21086", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "ZYPREXA ZYDIS", "ActiveIngredient": "OLANZAPINE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21086"}, "210861": {"ApplNo": "210861", "Form": "CAPSULE;ORAL", "Drug": "VITRAKVI", "ActiveIngredient": "LAROTRECTINIB SULFATE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210861s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210861"}, "210867": {"ApplNo": "210867", "Form": "TABLET;ORAL", "Drug": "MOXIDECTIN", "ActiveIngredient": "MOXIDECTIN", "ApplType": "NDA", "Sponsor": "MDGH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210867s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210867"}, "210868": {"ApplNo": "210868", "Form": "TABLET;ORAL", "Drug": "LORBRENA", "ActiveIngredient": "LORLATINIB", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210868s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210868"}, "21087": {"ApplNo": "21087", "Form": "CAPSULE;ORAL", "Drug": "TAMIFLU", "ActiveIngredient": "OSELTAMIVIR PHOSPHATE", "ApplType": "NDA", "Sponsor": "ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021087s071,021246s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21087"}, "210872": {"ApplNo": "210872", "Form": "SOLUTION;TOPICAL", "Drug": "ZURAGARD", "ActiveIngredient": "ISOPROPYL ALCOHOL", "ApplType": "NDA", "Sponsor": "ZUREX PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210872Orig1s001Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210872"}, "210875": {"ApplNo": "210875", "Form": "FILM;SUBLINGUAL", "Drug": "KYNMOBI", "ActiveIngredient": "APOMORPHINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SUNOVION PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210875s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210875"}, "210884": {"ApplNo": "210884", "Form": "SPRAY;NASAL", "Drug": "TOSYMRA", "ActiveIngredient": "SUMATRIPTAN", "ApplType": "NDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210884s000lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210884"}, "21090": {"ApplNo": "21090", "Form": "TABLET;ORAL-28", "Drug": "CYCLESSA", "ActiveIngredient": "DESOGESTREL; ETHINYL ESTRADIOL", "ApplType": "NDA", "Sponsor": "ASPEN GLOBAL INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021090s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21090"}, "210906": {"ApplNo": "210906", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CALCIUM GLUCONATE IN SODIUM CHLORIDE", "ActiveIngredient": "CALCIUM GLUCONATE", "ApplType": "NDA", "Sponsor": "HQ SPCLT PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210906s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210906"}, "210910": {"ApplNo": "210910", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "AEMCOLO", "ActiveIngredient": "RIFAMYCIN SODIUM", "ApplType": "NDA", "Sponsor": "REDHILL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210910s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210910"}, "210913": {"ApplNo": "210913", "Form": "SOLUTION;OPHTHALMIC", "Drug": "CEQUA", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210913s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210913"}, "210922": {"ApplNo": "210922", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ONPATTRO", "ActiveIngredient": "PATISIRAN SODIUM", "ApplType": "NDA", "Sponsor": "ALNYLAM PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210922s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210922"}, "210923": {"ApplNo": "210923", "Form": "TABLET;ORAL", "Drug": "MULPLETA", "ActiveIngredient": "LUSUTROMBOPAG", "ApplType": "NDA", "Sponsor": "SHIONOGI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210923s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210923"}, "21093": {"ApplNo": "21093", "Form": "TABLET;ORAL", "Drug": "ATACAND HCT", "ActiveIngredient": "CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021093s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21093"}, "210933": {"ApplNo": "210933", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "EYSUVIS", "ActiveIngredient": "LOTEPREDNOL ETABONATE", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210933s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210933"}, "210942": {"ApplNo": "210942", "Form": "SOLUTION;ORAL", "Drug": "GLOPERBA", "ActiveIngredient": "COLCHICINE", "ApplType": "NDA", "Sponsor": "SCILEX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210942Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210942"}, "210951": {"ApplNo": "210951", "Form": "TABLET;ORAL", "Drug": "ERLEADA", "ActiveIngredient": "APALUTAMIDE", "ApplType": "NDA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210951s009s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210951"}, "210959": {"ApplNo": "210959", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "LAURUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210959Orig1s001,s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210959"}, "21098": {"ApplNo": "21098", "Form": "TABLET;ORAL-28", "Drug": "YASMIN", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021098s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21098"}, "210997": {"ApplNo": "210997", "Form": "SOLUTION;INTRAMUSCULAR, INTRAVENOUS", "Drug": "GLYRX-PF", "ActiveIngredient": "GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210997s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210997"}, "21103": {"ApplNo": "21103", "Form": "TABLET; ORAL", "Drug": "ACTIVELLA", "ActiveIngredient": "ESTRADIOL; NORETHINDRONE ACETATE", "ApplType": "NDA", "Sponsor": "NOVO NORDISK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21103lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21103"}, "211039": {"ApplNo": "211039", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE", "ActiveIngredient": "BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM", "ApplType": "NDA", "Sponsor": "BAUSCH LOMB IRELAND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211039Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211039"}, "21106": {"ApplNo": "21106", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "SOMAVERT", "ActiveIngredient": "PEGVISOMANT", "ApplType": "BLA", "Sponsor": "PHARMACIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021106s067s068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21106"}, "21107": {"ApplNo": "21107", "Form": "TABLET;ORAL", "Drug": "LOTRONEX", "ActiveIngredient": "ALOSETRON HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021107s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21107"}, "21108": {"ApplNo": "21108", "Form": "CREAM;TOPICAL", "Drug": "RENOVA", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "VALEANT PHARMS NORTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021108s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21108"}, "21110": {"ApplNo": "21110", "Form": "TABLET;ORAL", "Drug": "RAPAMUNE", "ActiveIngredient": "SIROLIMUS", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021083s069s070,021110s087s088lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21110"}, "211109": {"ApplNo": "211109", "Form": "POWDER;INTRAVENOUS", "Drug": "XERAVA", "ActiveIngredient": "ERAVACYCLINE DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TETRAPHASE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211109lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211109"}, "21112": {"ApplNo": "21112", "Form": "CREAM;TOPICAL", "Drug": "TRI-LUMA", "ActiveIngredient": "FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021112s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21112"}, "21113": {"ApplNo": "21113", "Form": "INJECTABLE;INJECTION", "Drug": "PAMIDRONATE DISODIUM", "ActiveIngredient": "PAMIDRONATE DISODIUM", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021113s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21113"}, "211150": {"ApplNo": "211150", "Form": "TABLET;ORAL", "Drug": "WAKIX", "ActiveIngredient": "PITOLISANT HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HARMONY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211150s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211150"}, "211155": {"ApplNo": "211155", "Form": "CAPSULE;ORAL", "Drug": "COPIKTRA", "ActiveIngredient": "DUVELISIB", "ApplType": "NDA", "Sponsor": "SECURA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211155s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211155"}, "211158": {"ApplNo": "211158", "Form": "POWDER;INTRAVENOUS", "Drug": "TIGECYCLINE", "ActiveIngredient": "TIGECYCLINE", "ApplType": "NDA", "Sponsor": "AMNEAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211158s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211158"}, "21116": {"ApplNo": "21116", "Form": "TABLET;ORAL", "Drug": "THYRO-TABS", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "ALVOGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021116s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21116"}, "21117": {"ApplNo": "21117", "Form": "INJECTABLE;INJECTION", "Drug": "CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021117s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21117"}, "211172": {"ApplNo": "211172", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "TEGSEDI", "ActiveIngredient": "INOTERSEN SODIUM", "ApplType": "NDA", "Sponsor": "AKCEA THERAPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211172s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211172"}, "21119": {"ApplNo": "21119", "Form": "INJECTABLE;INJECTION", "Drug": "VISUDYNE", "ActiveIngredient": "VERTEPORFIN", "ApplType": "NDA", "Sponsor": "VALEANT LUXEMBOURG", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021119s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21119"}, "211192": {"ApplNo": "211192", "Form": "TABLET;ORAL", "Drug": "TIBSOVO", "ActiveIngredient": "IVOSIDENIB", "ApplType": "NDA", "Sponsor": "SERVIER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211192s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211192"}, "21121": {"ApplNo": "21121", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CONCERTA", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021121s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21121"}, "211215": {"ApplNo": "211215", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ANGIOMAX RTU", "ActiveIngredient": "BIVALIRUDIN", "ApplType": "NDA", "Sponsor": "MAIA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211215s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211215"}, "211225": {"ApplNo": "211225", "Form": "TABLET;ORAL", "Drug": "ZYKADIA", "ActiveIngredient": "CERITINIB", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211225s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211225"}, "211226": {"ApplNo": "211226", "Form": "POWDER;INTRAVENOUS", "Drug": "KHAPZORY", "ActiveIngredient": "LEVOLEUCOVORIN", "ApplType": "NDA", "Sponsor": "ACROTECH BIOPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211226s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211226"}, "21123": {"ApplNo": "21123", "Form": "TABLET;ORAL", "Drug": "ULTRACET", "ActiveIngredient": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021123s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21123"}, "211230": {"ApplNo": "211230", "Form": "TABLET;ORAL", "Drug": "SUNOSI", "ActiveIngredient": "SOLRIAMFETOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AXSOME MALTA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211230Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211230"}, "21124": {"ApplNo": "21124", "Form": "SOLUTION;TOPICAL", "Drug": "LAMISIL AT", "ActiveIngredient": "TERBINAFINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021124Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21124"}, "211243": {"ApplNo": "211243", "Form": "SPRAY;NASAL", "Drug": "SPRAVATO", "ActiveIngredient": "ESKETAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211243s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243"}, "21128": {"ApplNo": "21128", "Form": "SUSPENSION;ORAL", "Drug": "CHILDREN'S MOTRIN COLD", "ActiveIngredient": "IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021228Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21128"}, "211280": {"ApplNo": "211280", "Form": "TABLET;ORAL", "Drug": "REYVOW", "ActiveIngredient": "LASMIDITAN SUCCINATE", "ApplType": "NDA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211280s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211280"}, "211281": {"ApplNo": "211281", "Form": "SOLUTION;ORAL", "Drug": "PIZENSY", "ActiveIngredient": "LACTITOL", "ApplType": "NDA", "Sponsor": "BRAINTREE LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211281s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211281"}, "211288": {"ApplNo": "211288", "Form": "TABLET;ORAL", "Drug": "VIZIMPRO", "ActiveIngredient": "DACOMITINIB", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211288s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211288"}, "21129": {"ApplNo": "21129", "Form": "SOLUTION;ORAL", "Drug": "NEURONTIN", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21129"}, "21130": {"ApplNo": "21130", "Form": "TABLET;ORAL", "Drug": "ZYVOX", "ActiveIngredient": "LINEZOLID", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021130s043,021131s039,021132s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21130"}, "211302": {"ApplNo": "211302", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "CYSTADROPS", "ActiveIngredient": "CYSTEAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211302s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211302"}, "21131": {"ApplNo": "21131", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ZYVOX", "ActiveIngredient": "LINEZOLID", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021131s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21131"}, "21132": {"ApplNo": "21132", "Form": "FOR SUSPENSION;ORAL", "Drug": "ZYVOX", "ActiveIngredient": "LINEZOLID", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021130s043,021131s039,021132s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21132"}, "211321": {"ApplNo": "211321", "Form": "SPRAY;NASAL", "Drug": "NAYZILAM", "ActiveIngredient": "MIDAZOLAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211321s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211321"}, "21134": {"ApplNo": "21134", "Form": "TABLET;SUBLINGUAL", "Drug": "NITROSTAT", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021134s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21134"}, "211340": {"ApplNo": "211340", "Form": "SUSPENSION;ORAL", "Drug": "KATERZIA", "ActiveIngredient": "AMLODIPINE BENZOATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211340s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211340"}, "211349": {"ApplNo": "211349", "Form": "TABLET;ORAL", "Drug": "XOSPATA", "ActiveIngredient": "GILTERITINIB FUMARATE", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211349"}, "21135": {"ApplNo": "21135", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "VENOFER", "ActiveIngredient": "FERRIC OXYHYDROXIDE", "ApplType": "NDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021135Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21135"}, "211358": {"ApplNo": "211358", "Form": "GRANULE;ORAL", "Drug": "ORKAMBI", "ActiveIngredient": "IVACAFTOR; LUMACAFTOR", "ApplType": "NDA", "Sponsor": "VERTEX PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211358s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211358"}, "211363": {"ApplNo": "211363", "Form": "SOLUTION;INTRAVENOUS", "Drug": "EPINEPHRINE", "ActiveIngredient": "EPINEPHRINE", "ApplType": "NDA", "Sponsor": "INTL MEDICATION SYS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211363s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211363"}, "211367": {"ApplNo": "211367", "Form": "TABLET;ORAL", "Drug": "SLYND", "ActiveIngredient": "DROSPIRENONE", "ApplType": "NDA", "Sponsor": "EXELTIS USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211367"}, "21137": {"ApplNo": "21137", "Form": "TABLET;ORAL", "Drug": "LEVOLET", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "GENUS LIFESCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021137s002s003s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21137"}, "211371": {"ApplNo": "211371", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ZULRESSO", "ActiveIngredient": "BREXANOLONE", "ApplType": "NDA", "Sponsor": "SAGE THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211371"}, "211379": {"ApplNo": "211379", "Form": "TABLET;ORAL", "Drug": "HEMADY", "ActiveIngredient": "DEXAMETHASONE", "ApplType": "NDA", "Sponsor": "DEXCEL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211379s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211379"}, "21140": {"ApplNo": "21140", "Form": "TABLET;ORAL", "Drug": "IMODIUM MULTI-SYMPTOM RELIEF", "ActiveIngredient": "LOPERAMIDE HYDROCHLORIDE; SIMETHICONE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021140Orig1s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21140"}, "211415": {"ApplNo": "211415", "Form": "SOLUTION;INTRAVENOUS", "Drug": "QUZYTTIR", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JDP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211415s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211415"}, "21142": {"ApplNo": "21142", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "OLUX", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021142s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21142"}, "21143": {"ApplNo": "21143", "Form": "CREAM;VAGINAL", "Drug": "TRIVAGIZOLE 3", "ActiveIngredient": "CLOTRIMAZOLE", "ApplType": "NDA", "Sponsor": "TARO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021143Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21143"}, "21146": {"ApplNo": "21146", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ATROPINE SULFATE", "ActiveIngredient": "ATROPINE SULFATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021146Orig1s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21146"}, "21148": {"ApplNo": "21148", "Form": "INJECTABLE;INJECTION", "Drug": "NORDITROPIN FLEXPRO", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021148s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21148"}, "211488": {"ApplNo": "211488", "Form": "EMULSION;SUBCUTANEOUS", "Drug": "CAMCEVI KIT", "ActiveIngredient": "LEUPROLIDE MESYLATE", "ApplType": "NDA", "Sponsor": "ACCORD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211488s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211488"}, "21149": {"ApplNo": "21149", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "OVIDREL", "ActiveIngredient": "CHORIOGONADOTROPIN ALFA", "ApplType": "BLA", "Sponsor": "EMD SERONO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21149lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21149"}, "21150": {"ApplNo": "21150", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ZYRTEC-D 12 HOUR", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021150Orig1s021bl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21150"}, "21151": {"ApplNo": "21151", "Form": "TABLET;ORAL", "Drug": "BETAPACE AF", "ActiveIngredient": "SOTALOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LEGACY PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021151s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21151"}, "211527": {"ApplNo": "211527", "Form": "CREAM;TOPICAL", "Drug": "AKLIEF", "ActiveIngredient": "TRIFAROTENE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211527Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211527"}, "21153": {"ApplNo": "21153", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "NEXIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021153s059,021957s026,022101s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21153"}, "211530": {"ApplNo": "211530", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BENDAMUSTINE HYDROCHLORIDE", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211530s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211530"}, "21156": {"ApplNo": "21156", "Form": "CAPSULE;ORAL", "Drug": "CELEBREX", "ActiveIngredient": "CELECOXIB", "ApplType": "NDA", "Sponsor": "GD SEARLE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21156"}, "211580": {"ApplNo": "211580", "Form": "POWDER;INTRAVENOUS, INTERSTITIAL", "Drug": "SPY AGENT GREEN KIT", "ActiveIngredient": "INDOCYANINE GREEN", "ApplType": "NDA", "Sponsor": "NOVADAQ TECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211580Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211580"}, "21159": {"ApplNo": "21159", "Form": "SHAMPOO;TOPICAL", "Drug": "LOPROX", "ActiveIngredient": "CICLOPIROX", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021159s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21159"}, "21160": {"ApplNo": "21160", "Form": "CAPSULE;ORAL", "Drug": "PHOSLO GELCAPS", "ActiveIngredient": "CALCIUM ACETATE", "ApplType": "NDA", "Sponsor": "FRESENIUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021160s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21160"}, "211616": {"ApplNo": "211616", "Form": "TABLET;ORAL", "Drug": "NEXLETOL", "ActiveIngredient": "BEMPEDOIC ACID", "ApplType": "NDA", "Sponsor": "ESPERION THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211616s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211616"}, "211617": {"ApplNo": "211617", "Form": "TABLET;ORAL", "Drug": "NEXLIZET", "ActiveIngredient": "BEMPEDOIC ACID; EZETIMIBE", "ApplType": "NDA", "Sponsor": "ESPERION THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211617s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211617"}, "21162": {"ApplNo": "21162", "Form": "TABLET;ORAL", "Drug": "MICARDIS HCT", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; TELMISARTAN", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021162s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21162"}, "21163": {"ApplNo": "21163", "Form": "SOLUTION;INTRAVENOUS", "Drug": "INFUVITE ADULT", "ActiveIngredient": "ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K", "ApplType": "NDA", "Sponsor": "SANDOZ CANADA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021163s032,021559s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21163"}, "211635": {"ApplNo": "211635", "Form": "SPRAY;NASAL", "Drug": "VALTOCO", "ActiveIngredient": "DIAZEPAM", "ApplType": "NDA", "Sponsor": "NEURELIS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211635s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211635"}, "21165": {"ApplNo": "21165", "Form": "TABLET;ORAL", "Drug": "CLARINEX", "ActiveIngredient": "DESLORATADINE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021165s022,021300s019,021312s020,021563s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21165"}, "211651": {"ApplNo": "211651", "Form": "CAPSULE;ORAL", "Drug": "TALZENNA", "ActiveIngredient": "TALAZOPARIB TOSYLATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211651s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211651"}, "21166": {"ApplNo": "21166", "Form": "GEL, METERED;TRANSDERMAL", "Drug": "ESTROGEL", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "ASCEND THERAPS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021166s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21166"}, "21167": {"ApplNo": "21167", "Form": "FILM, EXTENDED RELEASE; TRANSDERMAL", "Drug": "VIVELLE", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20323S23lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21167"}, "211672": {"ApplNo": "211672", "Form": "TABLET;ORAL", "Drug": "XENLETA", "ActiveIngredient": "LEFAMULIN ACETATE", "ApplType": "NDA", "Sponsor": "NABRIVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211672s002,211673s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211672"}, "211673": {"ApplNo": "211673", "Form": "SOLUTION;INTRAVENOUS", "Drug": "XENLETA", "ActiveIngredient": "LEFAMULIN ACETATE", "ApplType": "NDA", "Sponsor": "NABRIVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211672s002,211673s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211673"}, "211675": {"ApplNo": "211675", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "RINVOQ", "ActiveIngredient": "UPADACITINIB", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211675s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211675"}, "21168": {"ApplNo": "21168", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "DEPAKOTE ER", "ActiveIngredient": "DIVALPROEX SODIUM", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021168s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21168"}, "21171": {"ApplNo": "21171", "Form": "INJECTABLE;INJECTION", "Drug": "DEMEROL", "ActiveIngredient": "MEPERIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021171Orig1s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21171"}, "211710": {"ApplNo": "211710", "Form": "SOLUTION;ORAL", "Drug": "VITRAKVI", "ActiveIngredient": "LAROTRECTINIB SULFATE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211710s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211710"}, "21172": {"ApplNo": "21172", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "NOVOLOG MIX 70/30", "ActiveIngredient": "INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021172s074lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21172"}, "211723": {"ApplNo": "211723", "Form": "TABLET;ORAL", "Drug": "TAZVERIK", "ActiveIngredient": "TAZEMETOSTAT HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "EPIZYME INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211723"}, "211728": {"ApplNo": "211728", "Form": "POWDER;PYELOCALYCEAL", "Drug": "JELMYTO", "ActiveIngredient": "MITOMYCIN", "ApplType": "NDA", "Sponsor": "UROGEN PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211728s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211728"}, "211733": {"ApplNo": "211733", "Form": "TABLET;ORAL", "Drug": "ADVIL DUAL ACTION WITH ACETAMINOPHEN", "ActiveIngredient": "ACETAMINOPHEN; IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211733Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211733"}, "211746": {"ApplNo": "211746", "Form": "SPRAY, METERED;NASAL", "Drug": "RYALTRIS", "ActiveIngredient": "MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLENMARK SPECIALTY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211746Orig1s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211746"}, "21176": {"ApplNo": "21176", "Form": "TABLET;ORAL", "Drug": "WELCHOL", "ActiveIngredient": "COLESEVELAM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022362s029,021176s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21176"}, "211765": {"ApplNo": "211765", "Form": "TABLET;ORAL", "Drug": "UBRELVY", "ActiveIngredient": "UBROGEPANT", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211765s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211765"}, "21179": {"ApplNo": "21179", "Form": "TABLET;ORAL", "Drug": "RENAGEL", "ActiveIngredient": "SEVELAMER HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021179s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21179"}, "211801": {"ApplNo": "211801", "Form": "TABLET;ORAL", "Drug": "IBSRELA", "ActiveIngredient": "TENAPANOR HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ARDELYX INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211801s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211801"}, "211810": {"ApplNo": "211810", "Form": "CAPSULE;ORAL", "Drug": "TURALIO", "ActiveIngredient": "PEXIDARTINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "DAIICHI SANKYO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211810s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211810"}, "21184": {"ApplNo": "21184", "Form": "CREAM;TOPICAL", "Drug": "TAZORAC", "ActiveIngredient": "TAZAROTENE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021184s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21184"}, "211843": {"ApplNo": "211843", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "THIOLA EC", "ActiveIngredient": "TIOPRONIN", "ApplType": "NDA", "Sponsor": "MISSION PHARMACAL CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211843s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211843"}, "211844": {"ApplNo": "211844", "Form": "SOLUTION;INTRAVENOUS", "Drug": "MIDAZOLAM IN 0.9% SODIUM CHLORIDE", "ActiveIngredient": "MIDAZOLAM", "ApplType": "NDA", "Sponsor": "INFORLIFE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211844s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211844"}, "211855": {"ApplNo": "211855", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "VUMERITY", "ActiveIngredient": "DIROXIMEL FUMARATE", "ApplType": "NDA", "Sponsor": "BIOGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211855Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211855"}, "21187": {"ApplNo": "21187", "Form": "RING;VAGINAL", "Drug": "NUVARING", "ActiveIngredient": "ETHINYL ESTRADIOL; ETONOGESTREL", "ApplType": "NDA", "Sponsor": "ORGANON USA ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021187s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21187"}, "211875": {"ApplNo": "211875", "Form": "POWDER;INTRAVENOUS", "Drug": "PACLITAXEL", "ActiveIngredient": "PACLITAXEL", "ApplType": "NDA", "Sponsor": "HBT LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211875s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211875"}, "211882": {"ApplNo": "211882", "Form": "LOTION;TOPICAL", "Drug": "ARAZLO", "ActiveIngredient": "TAZAROTENE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211882s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211882"}, "211911": {"ApplNo": "211911", "Form": "IMPLANT;OPHTHALMIC", "Drug": "DURYSTA", "ActiveIngredient": "BIMATOPROST", "ApplType": "NDA", "Sponsor": "ALLERGAN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211911s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211911"}, "211913": {"ApplNo": "211913", "Form": "CAPSULE;ORAL", "Drug": "ABSORICA LD", "ActiveIngredient": "ISOTRETINOIN", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211913Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211913"}, "21192": {"ApplNo": "21192", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "LESCOL XL", "ActiveIngredient": "FLUVASTATIN SODIUM", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021192s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21192"}, "211929": {"ApplNo": "211929", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "ORTIKOS", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211929s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211929"}, "211939": {"ApplNo": "211939", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "BONSITY", "ActiveIngredient": "TERIPARATIDE", "ApplType": "NDA", "Sponsor": "ALVOGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211939s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211939"}, "211950": {"ApplNo": "211950", "Form": "SUSPENSION;INJECTION", "Drug": "XIPERE", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211950Orig1s000correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211950"}, "21196": {"ApplNo": "21196", "Form": "SOLUTION;ORAL", "Drug": "XYREM", "ActiveIngredient": "SODIUM OXYBATE", "ApplType": "NDA", "Sponsor": "JAZZ PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021196s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21196"}, "211962": {"ApplNo": "211962", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "XELLIA PHARMS APS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211962s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211962"}, "211964": {"ApplNo": "211964", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "QELBREE", "ActiveIngredient": "VILOXAZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SUPERNUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211964s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211964"}, "21197": {"ApplNo": "21197", "Form": "POWDER;SUBCUTANEOUS", "Drug": "CETROTIDE", "ActiveIngredient": "CETRORELIX ACETATE", "ApplType": "NDA", "Sponsor": "EMD SERONO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021197s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21197"}, "211970": {"ApplNo": "211970", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VYONDYS 53", "ActiveIngredient": "GOLODIRSEN", "ApplType": "NDA", "Sponsor": "SAREPTA THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211970s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211970"}, "211988": {"ApplNo": "211988", "Form": "SOLUTION, EXTENDED RELEASE;PERIARTICULAR", "Drug": "ZYNRELEF KIT", "ActiveIngredient": "BUPIVACAINE; MELOXICAM", "ApplType": "NDA", "Sponsor": "HERON THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211988s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211988"}, "211994": {"ApplNo": "211994", "Form": "TABLET;ORAL", "Drug": "DOVATO", "ActiveIngredient": "DOLUTEGRAVIR SODIUM; LAMIVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211994s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211994"}, "211996": {"ApplNo": "211996", "Form": "CAPSULE;ORAL", "Drug": "VYNDAQEL", "ActiveIngredient": "TAFAMIDIS MEGLUMINE", "ApplType": "NDA", "Sponsor": "FOLDRX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211996s001,212161s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211996"}, "21201": {"ApplNo": "21201", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ASCLERA", "ActiveIngredient": "POLIDOCANOL", "ApplType": "NDA", "Sponsor": "CHEMISCH FBRK KRSSLR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021201s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21201"}, "212018": {"ApplNo": "212018", "Form": "TABLET;ORAL", "Drug": "BALVERSA", "ActiveIngredient": "ERDAFITINIB", "ApplType": "NDA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212018s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212018"}, "212020": {"ApplNo": "212020", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TRANEXAMIC ACID", "ActiveIngredient": "TRANEXAMIC ACID", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212020s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212020"}, "212028": {"ApplNo": "212028", "Form": "TABLET;ORAL", "Drug": "DAYVIGO", "ActiveIngredient": "LEMBOREXANT", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212028"}, "212035": {"ApplNo": "212035", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ARGATROBAN IN SODIUM CHLORIDE", "ActiveIngredient": "ARGATROBAN", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212035s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212035"}, "212045": {"ApplNo": "212045", "Form": "SPRAY;NASAL", "Drug": "KLOXXADO", "ActiveIngredient": "NALOXONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212045s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212045"}, "21205": {"ApplNo": "21205", "Form": "TABLET;ORAL", "Drug": "TRIZIVIR", "ActiveIngredient": "ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021205s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21205"}, "21208": {"ApplNo": "21208", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "REMERON SOLTAB", "ActiveIngredient": "MIRTAZAPINE", "ApplType": "NDA", "Sponsor": "ORGANON USA INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21208"}, "21209": {"ApplNo": "21209", "Form": "INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER", "Drug": "PORCINE SECRETIN", "ActiveIngredient": "PORCINE SECRETIN", "ApplType": "NDA", "Sponsor": "CHIRHOCLIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021136s012s013,021209s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21209"}, "212097": {"ApplNo": "212097", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "GVOKE PFS", "ActiveIngredient": "GLUCAGON", "ApplType": "NDA", "Sponsor": "XERIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212097Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212097"}, "212099": {"ApplNo": "212099", "Form": "TABLET;ORAL", "Drug": "NUBEQA", "ActiveIngredient": "DAROLUTAMIDE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212099s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212099"}, "21210": {"ApplNo": "21210", "Form": "TABLET;ORAL", "Drug": "UNITHROID", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "STEVENS J", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021210s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21210"}, "212102": {"ApplNo": "212102", "Form": "SOLUTION;ORAL", "Drug": "FINTEPLA", "ActiveIngredient": "FENFLURAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ZOGENIX INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212102s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212102"}, "21211": {"ApplNo": "21211", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "FOLLISTIM AQ", "ActiveIngredient": "FOLLITROPIN ALFA/BETA", "ApplType": "BLA", "Sponsor": "ORGANON USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021211s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21211"}, "21212": {"ApplNo": "21212", "Form": "INJECTABLE;INJECTION", "Drug": "CAVERJECT IMPULSE", "ActiveIngredient": "ALPROSTADIL", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021212s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21212"}, "212121": {"ApplNo": "212121", "Form": "SOLUTION;INTRAVENOUS", "Drug": "POTASSIUM PHOSPHATES", "ActiveIngredient": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC", "ApplType": "NDA", "Sponsor": "CMP DEV LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212121s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212121"}, "212122": {"ApplNo": "212122", "Form": "AEROSOL, METERED;INHALATION", "Drug": "BREZTRI AEROSPHERE", "ActiveIngredient": "BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212122s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212122"}, "212123": {"ApplNo": "212123", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TAUVID", "ActiveIngredient": "FLORTAUCIPIR F-18", "ApplType": "NDA", "Sponsor": "AVID RADIOPHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212123s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212123"}, "212154": {"ApplNo": "212154", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VILTEPSO", "ActiveIngredient": "VILTOLARSEN", "ApplType": "NDA", "Sponsor": "NIPPON SHINYAKU", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212154s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212154"}, "212155": {"ApplNo": "212155", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CERIANNA", "ActiveIngredient": "FLUOROESTRADIOL F-18", "ApplType": "NDA", "Sponsor": "ZIONEXA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212155s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212155"}, "212156": {"ApplNo": "212156", "Form": "POWDER;INTRAVENOUS", "Drug": "MICAFUNGIN", "ActiveIngredient": "MICAFUNGIN SODIUM", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212156Orig1s000Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212156"}, "21216": {"ApplNo": "21216", "Form": "SOLUTION; ORAL", "Drug": "NEURONTIN", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21216lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21216"}, "212161": {"ApplNo": "212161", "Form": "CAPSULE;ORAL", "Drug": "VYNDAMAX", "ActiveIngredient": "TAFAMIDIS", "ApplType": "NDA", "Sponsor": "FOLDRX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211996s001,212161s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212161"}, "212194": {"ApplNo": "212194", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "GIVLAARI", "ActiveIngredient": "GIVOSIRAN SODIUM", "ApplType": "NDA", "Sponsor": "ALNYLAM PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212194s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212194"}, "212209": {"ApplNo": "212209", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VIVIMUSTA", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SLAYBACK PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212209s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212209"}, "21223": {"ApplNo": "21223", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ZOMETA", "ActiveIngredient": "ZOLEDRONIC ACID", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021223s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21223"}, "21225": {"ApplNo": "21225", "Form": "INTRAUTERINE DEVICE;INTRAUTERINE", "Drug": "MIRENA", "ActiveIngredient": "LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021225s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21225"}, "212266": {"ApplNo": "212266", "Form": "SYRUP;ORAL", "Drug": "CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "QUAGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212266s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212266"}, "212268": {"ApplNo": "212268", "Form": "SYSTEM;TRANSDERMAL", "Drug": "SECUADO", "ActiveIngredient": "ASENAPINE", "ApplType": "NDA", "Sponsor": "HISAMITSU", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212268s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212268"}, "212269": {"ApplNo": "212269", "Form": "TABLET;ORAL", "Drug": "FERRIPROX", "ActiveIngredient": "DEFERIPRONE", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212269"}, "21227": {"ApplNo": "21227", "Form": "POWDER;INTRAVENOUS", "Drug": "CANCIDAS", "ActiveIngredient": "CASPOFUNGIN ACETATE", "ApplType": "NDA", "Sponsor": "MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021227Orig1s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21227"}, "212273": {"ApplNo": "212273", "Form": "TABLET;ORAL", "Drug": "TRIKAFTA (COPACKAGED)", "ActiveIngredient": "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR", "ApplType": "NDA", "Sponsor": "VERTEX PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212273s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212273"}, "212279": {"ApplNo": "212279", "Form": "FOAM;INTRAUTERINE", "Drug": "EXEM FOAM KIT", "ActiveIngredient": "AIR POLYMER-TYPE A", "ApplType": "NDA", "Sponsor": "GISKIT", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212279lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212279"}, "21228": {"ApplNo": "21228", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "DETROL LA", "ActiveIngredient": "TOLTERODINE TARTRATE", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021228s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21228"}, "21229": {"ApplNo": "21229", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "PRILOSEC OTC", "ActiveIngredient": "OMEPRAZOLE MAGNESIUM", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021229Orig1s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21229"}, "212295": {"ApplNo": "212295", "Form": "POWDER;INTRAVENOUS", "Drug": "BYFAVO", "ActiveIngredient": "REMIMAZOLAM BESYLATE", "ApplType": "NDA", "Sponsor": "ACACIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212295s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212295"}, "212304": {"ApplNo": "212304", "Form": "SYSTEM;TRANSDERMAL", "Drug": "ADLARITY", "ActiveIngredient": "DONEPEZIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CORIUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212304s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212304"}, "212306": {"ApplNo": "212306", "Form": "TABLET;ORAL", "Drug": "XPOVIO", "ActiveIngredient": "SELINEXOR", "ApplType": "NDA", "Sponsor": "KARYOPHARM THERAPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212306"}, "21231": {"ApplNo": "21231", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "ZOMIG-ZMT", "ActiveIngredient": "ZOLMITRIPTAN", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020768s023,021231s014,021450s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21231"}, "21232": {"ApplNo": "21232", "Form": "CAPSULE;ORAL", "Drug": "ORFADIN", "ActiveIngredient": "NITISINONE", "ApplType": "NDA", "Sponsor": "SWEDISH ORPHAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021232s023,206356s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21232"}, "212320": {"ApplNo": "212320", "Form": "CAPSULE;ORAL", "Drug": "ACCRUFER", "ActiveIngredient": "FERRIC MALTOL", "ApplType": "NDA", "Sponsor": "SHIELD TX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212320s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212320"}, "212327": {"ApplNo": "212327", "Form": "CAPSULE;ORAL", "Drug": "INREBIC", "ActiveIngredient": "FEDRATINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "IMPACT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212327s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212327"}, "21234": {"ApplNo": "21234", "Form": "SYSTEM;TOPICAL", "Drug": "FLECTOR", "ActiveIngredient": "DICLOFENAC EPOLAMINE", "ApplType": "NDA", "Sponsor": "INST BIOCHEM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021234s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21234"}, "212347": {"ApplNo": "212347", "Form": "INJECTABLE;INJECTION", "Drug": "POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%", "ActiveIngredient": "POTASSIUM CHLORIDE; SODIUM CHLORIDE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212347Orig1s000ltr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212347"}, "212379": {"ApplNo": "212379", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "AMZEEQ", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JOURNEY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212379Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212379"}, "21243": {"ApplNo": "21243", "Form": "TABLET; ORAL", "Drug": "AZULFIDINE EN-TABS", "ActiveIngredient": "SULFASALAZINE", "ApplType": "NDA", "Sponsor": "PHARMACIA UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/007073s133,020465s000,021243s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21243"}, "212436": {"ApplNo": "212436", "Form": "TABLET;ORAL", "Drug": "IBRANCE", "ActiveIngredient": "PALBOCICLIB", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212436s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212436"}, "21246": {"ApplNo": "21246", "Form": "FOR SUSPENSION;ORAL", "Drug": "TAMIFLU", "ActiveIngredient": "OSELTAMIVIR PHOSPHATE", "ApplType": "NDA", "Sponsor": "ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021087s071,021246s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21246"}, "212477": {"ApplNo": "212477", "Form": "PELLETS;ORAL", "Drug": "HARVONI", "ActiveIngredient": "LEDIPASVIR; SOFOSBUVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205834s032,212477s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212477"}, "212479": {"ApplNo": "212479", "Form": "SOLUTION;ORAL", "Drug": "JYLAMVO", "ActiveIngredient": "METHOTREXATE", "ApplType": "NDA", "Sponsor": "THERAKIND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212479s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212479"}, "21248": {"ApplNo": "21248", "Form": "INJECTABLE;INJECTION", "Drug": "TRISENOX", "ActiveIngredient": "ARSENIC TRIOXIDE", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021248s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21248"}, "212480": {"ApplNo": "212480", "Form": "PELLETS;ORAL", "Drug": "SOVALDI", "ActiveIngredient": "SOFOSBUVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204671s017,212480s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212480"}, "212489": {"ApplNo": "212489", "Form": "CAPSULE;ORAL", "Drug": "ONGENTYS", "ActiveIngredient": "OPICAPONE", "ApplType": "NDA", "Sponsor": "NEUROCRINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212489s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212489"}, "212501": {"ApplNo": "212501", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CYCLOPHOSPHAMIDE", "ActiveIngredient": "CYCLOPHOSPHAMIDE", "ApplType": "NDA", "Sponsor": "INGENUS PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212501s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212501"}, "21251": {"ApplNo": "21251", "Form": "SOLUTION;ORAL", "Drug": "KALETRA", "ActiveIngredient": "LOPINAVIR; RITONAVIR", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21251"}, "212516": {"ApplNo": "212516", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "DRIZALMA SPRINKLE", "ActiveIngredient": "DULOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212516s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212516"}, "21252": {"ApplNo": "21252", "Form": "SUPPOSITORY;RECTAL", "Drug": "CANASA", "ActiveIngredient": "MESALAMINE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021252s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21252"}, "212520": {"ApplNo": "212520", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "UPNEEQ", "ActiveIngredient": "OXYMETAZOLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "RVL PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212520s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212520"}, "212526": {"ApplNo": "212526", "Form": "TABLET;ORAL", "Drug": "PIQRAY", "ActiveIngredient": "ALPELISIB", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212526s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212526"}, "21253": {"ApplNo": "21253", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "ZYPREXA", "ActiveIngredient": "OLANZAPINE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21253"}, "21254": {"ApplNo": "21254", "Form": "AEROSOL, METERED;INHALATION", "Drug": "ADVAIR HFA", "ActiveIngredient": "FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE", "ApplType": "NDA", "Sponsor": "GLAXO GRP LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021254s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21254"}, "21256": {"ApplNo": "21256", "Form": "FOR SOLUTION;INTRAVENOUS", "Drug": "CHIRHOSTIM", "ActiveIngredient": "SECRETIN SYNTHETIC HUMAN", "ApplType": "NDA", "Sponsor": "CHIRHOCLIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021256s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21256"}, "212576": {"ApplNo": "212576", "Form": "TABLET;ORAL", "Drug": "INQOVI", "ActiveIngredient": "CEDAZURIDINE; DECITABINE", "ApplType": "NDA", "Sponsor": "OTSUKA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212576s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212576"}, "21258": {"ApplNo": "21258", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "CLIMARA PRO", "ActiveIngredient": "ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021258s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21258"}, "21259": {"ApplNo": "21259", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "METADATE CD", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AYTU BIOPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021259s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21259"}, "212593": {"ApplNo": "212593", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VASOPRESSIN", "ActiveIngredient": "VASOPRESSIN", "ApplType": "NDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212593s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212593"}, "212608": {"ApplNo": "212608", "Form": "TABLET;ORAL", "Drug": "AYVAKIT", "ActiveIngredient": "AVAPRITINIB", "ApplType": "NDA", "Sponsor": "BLUEPRINT MEDICINES", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212608s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212608"}, "21261": {"ApplNo": "21261", "Form": "CREAM;TOPICAL, VAGINAL", "Drug": "MONISTAT 3 COMBINATION PACK (PREFILLED)", "ActiveIngredient": "MICONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "MEDTECH PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017450Orig1s075,020670Orig1s036,021261Orig1s025,021308Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21261"}, "212614": {"ApplNo": "212614", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "TRIJARDY XR", "ActiveIngredient": "EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212614s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212614"}, "21262": {"ApplNo": "21262", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ALPHAGAN P", "ActiveIngredient": "BRIMONIDINE TARTRATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021262s020,021770s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21262"}, "21264": {"ApplNo": "21264", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "APOKYN", "ActiveIngredient": "APOMORPHINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MDD US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021264s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21264"}, "212640": {"ApplNo": "212640", "Form": "FILM;ORAL", "Drug": "EXSERVAN", "ActiveIngredient": "RILUZOLE", "ApplType": "NDA", "Sponsor": "AQUESTIVE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212640s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212640"}, "212642": {"ApplNo": "212642", "Form": "SOLUTION;INTRAVENOUS", "Drug": "GALLIUM GA 68 GOZETOTIDE", "ActiveIngredient": "GALLIUM GA-68 GOZETOTIDE", "ApplType": "NDA", "Sponsor": "UNIV CA LOS ANGELES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212642s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212642"}, "212643": {"ApplNo": "212643", "Form": "SOLUTION;INTRAVENOUS", "Drug": "GALLIUM GA 68 GOZETOTIDE", "ActiveIngredient": "GALLIUM GA-68 GOZETOTIDE", "ApplType": "NDA", "Sponsor": "UNIV OF CA SAN FRAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212643s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212643"}, "21265": {"ApplNo": "21265", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "INFUVITE PEDIATRIC", "ActiveIngredient": "ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K", "ApplType": "NDA", "Sponsor": "SANDOZ CANADA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021265s030,021646s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21265"}, "21266": {"ApplNo": "21266", "Form": "TABLET;ORAL", "Drug": "VFEND", "ActiveIngredient": "VORICONAZOLE", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021266s053,021267s063,021630s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21266"}, "21267": {"ApplNo": "21267", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "VFEND", "ActiveIngredient": "VORICONAZOLE", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021266s053,021267s063,021630s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21267"}, "21269": {"ApplNo": "21269", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CARDURA XL", "ActiveIngredient": "DOXAZOSIN MESYLATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021269Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21269"}, "212690": {"ApplNo": "212690", "Form": "SOLUTION;ORAL", "Drug": "XYWAV", "ActiveIngredient": "CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE", "ApplType": "NDA", "Sponsor": "JAZZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212690s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212690"}, "21272": {"ApplNo": "21272", "Form": "INJECTABLE;IV (INFUSION), SUBCUTANEOUS", "Drug": "REMODULIN", "ActiveIngredient": "TREPROSTINIL", "ApplType": "NDA", "Sponsor": "UNITED THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021272Orig1s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21272"}, "212725": {"ApplNo": "212725", "Form": "CAPSULE;ORAL", "Drug": "ROZLYTREK", "ActiveIngredient": "ENTRECTINIB", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212725s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212725"}, "212726": {"ApplNo": "212726", "Form": "CAPSULE;ORAL", "Drug": "ROZLYTREK", "ActiveIngredient": "ENTRECTINIB", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212726s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212726"}, "212728": {"ApplNo": "212728", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "NURTEC ODT", "ActiveIngredient": "RIMEGEPANT SULFATE", "ApplType": "NDA", "Sponsor": "BIOHAVEN IRELAND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212728s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212728"}, "21278": {"ApplNo": "21278", "Form": "TABLET;ORAL", "Drug": "FOCALIN", "ActiveIngredient": "DEXMETHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021278s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21278"}, "21279": {"ApplNo": "21279", "Form": "POWDER; INHALATION", "Drug": "FORADIL", "ActiveIngredient": "FORMOTEROL FUMARATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20831s2lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21279"}, "212801": {"ApplNo": "212801", "Form": "TABLET;ORAL", "Drug": "ISTURISA", "ActiveIngredient": "OSILODROSTAT PHOSPHATE", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212801s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212801"}, "212819": {"ApplNo": "212819", "Form": "POWDER;INTRAVENOUS", "Drug": "RECARBRIO", "ActiveIngredient": "CILASTATIN SODIUM; IMIPENEM; RELEBACTAM", "ApplType": "NDA", "Sponsor": "MSD MERCK CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212819s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212819"}, "21282": {"ApplNo": "21282", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MUCINEX", "ActiveIngredient": "GUAIFENESIN", "ApplType": "NDA", "Sponsor": "RB HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021282Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21282"}, "21283": {"ApplNo": "21283", "Form": "TABLET;ORAL", "Drug": "DIOVAN", "ActiveIngredient": "VALSARTAN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021283Orig1s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21283"}, "212832": {"ApplNo": "212832", "Form": "SOLUTION;INTRAVENOUS", "Drug": "POTASSIUM PHOSPHATES", "ActiveIngredient": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212832s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212832"}, "212839": {"ApplNo": "212839", "Form": "TABLET;ORAL", "Drug": "XCOPRI", "ActiveIngredient": "CENOBAMATE", "ApplType": "NDA", "Sponsor": "SK LIFE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212839s006s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212839"}, "21284": {"ApplNo": "21284", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "RITALIN LA", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021284s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21284"}, "212849": {"ApplNo": "212849", "Form": "FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "RYKINDO", "ActiveIngredient": "RISPERIDONE", "ApplType": "NDA", "Sponsor": "SHANDONG LUYE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212849s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212849"}, "21285": {"ApplNo": "21285", "Form": "SUSPENSION;ORAL", "Drug": "TRILEPTAL", "ActiveIngredient": "OXCARBAZEPINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021285s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21285"}, "212854": {"ApplNo": "212854", "Form": "SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS", "Drug": "ZIMHI", "ActiveIngredient": "NALOXONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ADAMIS PHARMS CORP", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212854s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212854"}, "21286": {"ApplNo": "21286", "Form": "TABLET;ORAL", "Drug": "BENICAR", "ActiveIngredient": "OLMESARTAN MEDOXOMIL", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021286s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21286"}, "212862": {"ApplNo": "212862", "Form": "TABLET;ORAL", "Drug": "PRETOMANID", "ActiveIngredient": "PRETOMANID", "ApplType": "NDA", "Sponsor": "MYLAN IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212862s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212862"}, "21287": {"ApplNo": "21287", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "UROXATRAL", "ActiveIngredient": "ALFUZOSIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021287s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21287"}, "21288": {"ApplNo": "21288", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "TRELSTAR", "ActiveIngredient": "TRIPTORELIN PAMOATE", "ApplType": "NDA", "Sponsor": "VERITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020715s040,021288s035,022427s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21288"}, "212887": {"ApplNo": "212887", "Form": "TABLET;ORAL", "Drug": "VOCABRIA", "ActiveIngredient": "CABOTEGRAVIR SODIUM", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212887s005s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212887"}, "212888": {"ApplNo": "212888", "Form": "SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "CABENUVA KIT", "ActiveIngredient": "CABOTEGRAVIR; RILPIVIRINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212888s005s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212888"}, "212895": {"ApplNo": "212895", "Form": "TABLET;ORAL", "Drug": "CONJUPRI", "ActiveIngredient": "LEVAMLODIPINE MALEATE", "ApplType": "NDA", "Sponsor": "CSPC OUYI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212895s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212895"}, "21290": {"ApplNo": "21290", "Form": "TABLET;ORAL", "Drug": "TRACLEER", "ActiveIngredient": "BOSENTAN", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021290Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21290"}, "212904": {"ApplNo": "212904", "Form": "CAPSULE;ORAL", "Drug": "FOTIVDA", "ActiveIngredient": "TIVOZANIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AVEO PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212904s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212904"}, "212909": {"ApplNo": "212909", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BIORPHEN", "ActiveIngredient": "PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "DR REDDYS LABS SA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212909Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212909"}, "21292": {"ApplNo": "21292", "Form": "TABLET;ORAL", "Drug": "EUTHYROX", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "PROVELL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021292Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21292"}, "212937": {"ApplNo": "212937", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PEDMARK", "ActiveIngredient": "SODIUM THIOSULFATE", "ApplType": "NDA", "Sponsor": "FENNEC PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212937s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212937"}, "212950": {"ApplNo": "212950", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "RUKOBIA", "ActiveIngredient": "FOSTEMSAVIR TROMETHAMINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212950s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212950"}, "21297": {"ApplNo": "21297", "Form": "Tablet; Oral", "Drug": "CLARINEX", "ActiveIngredient": "DESLORATADINE", "ApplType": "NDA", "Sponsor": "SCHERING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21297lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21297"}, "21299": {"ApplNo": "21299", "Form": "TABLET;ORAL", "Drug": "PEXEVA", "ActiveIngredient": "PAROXETINE MESYLATE", "ApplType": "NDA", "Sponsor": "SEBELA IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021299s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21299"}, "212994": {"ApplNo": "212994", "Form": "CAPSULE;ORAL", "Drug": "AZSTARYS", "ActiveIngredient": "DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE", "ApplType": "NDA", "Sponsor": "COMMAVE THERAP", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212994s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212994"}, "213004": {"ApplNo": "213004", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "TALICIA", "ActiveIngredient": "AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN", "ApplType": "NDA", "Sponsor": "REDHILL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213004s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213004"}, "213006": {"ApplNo": "213006", "Form": "TABLET;ORAL", "Drug": "GEMTESA", "ActiveIngredient": "VIBEGRON", "ApplType": "NDA", "Sponsor": "UROVANT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213006s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213006"}, "21301": {"ApplNo": "21301", "Form": "TABLET;ORAL", "Drug": "LEVOXYL", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "KING PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021301s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21301"}, "21302": {"ApplNo": "21302", "Form": "CREAM;TOPICAL", "Drug": "ELIDEL", "ActiveIngredient": "PIMECROLIMUS", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021302s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21302"}, "213026": {"ApplNo": "213026", "Form": "SOLUTION;INTRAVENOUS", "Drug": "AMONDYS 45", "ActiveIngredient": "CASIMERSEN", "ApplType": "NDA", "Sponsor": "SAREPTA THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213026"}, "21303": {"ApplNo": "21303", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "ADDERALL XR 10", "ActiveIngredient": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021303s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21303"}, "213036": {"ApplNo": "213036", "Form": "POWDER;INTRAVENOUS", "Drug": "ARTESUNATE", "ActiveIngredient": "ARTESUNATE", "ApplType": "NDA", "Sponsor": "AMIVAS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213036Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213036"}, "21304": {"ApplNo": "21304", "Form": "TABLET;ORAL", "Drug": "VALCYTE", "ActiveIngredient": "VALGANCICLOVIR HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOFFMANN LA ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021304.s17_22257s12lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21304"}, "21305": {"ApplNo": "21305", "Form": "CAPSULE;ORAL", "Drug": "SODIUM IODIDE I 131", "ActiveIngredient": "SODIUM IODIDE I-131", "ApplType": "NDA", "Sponsor": "JUBILANT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021305Orig1s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21305"}, "213051": {"ApplNo": "213051", "Form": "TABLET;ORAL", "Drug": "RYBELSUS", "ActiveIngredient": "SEMAGLUTIDE", "ApplType": "NDA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213051s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051"}, "21306": {"ApplNo": "21306", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "BUTRANS", "ActiveIngredient": "BUPRENORPHINE", "ApplType": "NDA", "Sponsor": "PURDUE PHARMA LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021306s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21306"}, "21307": {"ApplNo": "21307", "Form": "CREAM;TOPICAL", "Drug": "LOTRIMIN ULTRA", "ActiveIngredient": "BUTENAFINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021307Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21307"}, "21308": {"ApplNo": "21308", "Form": "CREAM, INSERT;TOPICAL, VAGINAL", "Drug": "MONISTAT 1 COMBINATION PACK", "ActiveIngredient": "MICONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "MEDTECH PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017450Orig1s075,020670Orig1s036,021261Orig1s025,021308Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21308"}, "213082": {"ApplNo": "213082", "Form": "SOLUTION;ORAL", "Drug": "XELJANZ", "ActiveIngredient": "TOFACITINIB CITRATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203214s028,208246s013,213082s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213082"}, "21313": {"ApplNo": "21313", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CLARINEX-D 12 HOUR", "ActiveIngredient": "DESLORATADINE; PSEUDOEPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "ORGANON LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021313s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21313"}, "213135": {"ApplNo": "213135", "Form": "TABLET;ORAL", "Drug": "SUTAB", "ActiveIngredient": "MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE", "ApplType": "NDA", "Sponsor": "BRAINTREE LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213135s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213135"}, "213137": {"ApplNo": "213137", "Form": "TABLET;ORAL", "Drug": "OXBRYTA", "ActiveIngredient": "VOXELOTOR", "ApplType": "NDA", "Sponsor": "GLOBAL BLOOD THERAPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213137s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213137"}, "213138": {"ApplNo": "213138", "Form": "FOR SUSPENSION;ORAL", "Drug": "DIFICID", "ActiveIngredient": "FIDAXOMICIN", "ApplType": "NDA", "Sponsor": "CUBIST PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201699s013,213138s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213138"}, "21314": {"ApplNo": "21314", "Form": "FOR SOLUTION, TABLET, FOR SOLUTION;ORAL", "Drug": "IDKIT:HP", "ActiveIngredient": "CITRIC ACID; UREA C-13", "ApplType": "NDA", "Sponsor": "MERIDIAN BIOSCIENCE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021314s004.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21314"}, "213150": {"ApplNo": "213150", "Form": "POWDER;SUBCUTANEOUS", "Drug": "FENSOLVI KIT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "TOLMAR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213150s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213150"}, "21316": {"ApplNo": "21316", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ALTOPREV", "ActiveIngredient": "LOVASTATIN", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021316s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21316"}, "21318": {"ApplNo": "21318", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "FORTEO", "ActiveIngredient": "TERIPARATIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021318Orig1s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21318"}, "213182": {"ApplNo": "213182", "Form": "TABLET;ORAL", "Drug": "RYBELSUS", "ActiveIngredient": "SEMAGLUTIDE", "ApplType": "NDA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213182"}, "213189": {"ApplNo": "213189", "Form": "OINTMENT;TOPICAL", "Drug": "KLISYRI", "ActiveIngredient": "TIRBANIBULIN", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213189s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213189"}, "21319": {"ApplNo": "21319", "Form": "CAPSULE;ORAL", "Drug": "AVODART", "ActiveIngredient": "DUTASTERIDE", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021319s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21319"}, "21321": {"ApplNo": "21321", "Form": "SOLUTION;INTRAPERITONEAL", "Drug": "EXTRANEAL", "ActiveIngredient": "ICODEXTRIN", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021321s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21321"}, "213217": {"ApplNo": "213217", "Form": "CAPSULE;ORAL", "Drug": "BRUKINSA", "ActiveIngredient": "ZANUBRUTINIB", "ApplType": "NDA", "Sponsor": "BEIGENE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213217s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213217"}, "213218": {"ApplNo": "213218", "Form": "TABLET;ORAL", "Drug": "SOAANZ", "ActiveIngredient": "TORSEMIDE", "ApplType": "NDA", "Sponsor": "SARFE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213218s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213218"}, "213224": {"ApplNo": "213224", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "BYNFEZIA PEN", "ActiveIngredient": "OCTREOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213224s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213224"}, "213227": {"ApplNo": "213227", "Form": "SOLUTION;INTRAVENOUS", "Drug": "DETECTNET", "ActiveIngredient": "COPPER CU-64 DOTATATE", "ApplType": "NDA", "Sponsor": "RADIOMEDIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213227s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213227"}, "21323": {"ApplNo": "21323", "Form": "TABLET;ORAL", "Drug": "LEXAPRO", "ActiveIngredient": "ESCITALOPRAM OXALATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021365s038,021323s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21323"}, "21324": {"ApplNo": "21324", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "ENTOCORT EC", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021324Orig1s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21324"}, "213246": {"ApplNo": "213246", "Form": "CAPSULE;ORAL", "Drug": "RETEVMO", "ActiveIngredient": "SELPERCATINIB", "ApplType": "NDA", "Sponsor": "LOXO ONCOL ELI LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213246s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213246"}, "21330": {"ApplNo": "21330", "Form": "TROCHE/LOZENGE;ORAL", "Drug": "NICORETTE", "ActiveIngredient": "NICOTINE POLACRILEX", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021330Orig1s024Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21330"}, "213312": {"ApplNo": "213312", "Form": "POWDER;INTRAVENOUS", "Drug": "FYARRO", "ActiveIngredient": "SIROLIMUS", "ApplType": "NDA", "Sponsor": "AADI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213312Orig1s000Corrected_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213312"}, "21332": {"ApplNo": "21332", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "SYMLIN", "ActiveIngredient": "PRAMLINTIDE ACETATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021332s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21332"}, "213330": {"ApplNo": "213330", "Form": "SOLUTION;INTRAVENOUS", "Drug": "LABETALOL HYDROCHLORIDE IN DEXTROSE", "ActiveIngredient": "LABETALOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213330s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213330"}, "21334": {"ApplNo": "21334", "Form": "Tablet; Oral", "Drug": "AVELOX", "ActiveIngredient": "MOXIFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAYER PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-085S010_Avelox_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21334"}, "21336": {"ApplNo": "21336", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "EMSAM", "ActiveIngredient": "SELEGILINE", "ApplType": "NDA", "Sponsor": "SOMERSET", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21336"}, "21337": {"ApplNo": "21337", "Form": "INJECTABLE;INTRAMUSCULAR, INTRAVENOUS", "Drug": "INVANZ", "ActiveIngredient": "ERTAPENEM SODIUM", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021337s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21337"}, "213378": {"ApplNo": "213378", "Form": "TABLET;ORAL", "Drug": "LYBALVI", "ActiveIngredient": "OLANZAPINE; SAMIDORPHAN L-MALATE", "ApplType": "NDA", "Sponsor": "ALKERMES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213378"}, "213388": {"ApplNo": "213388", "Form": "CAPSULE;ORAL", "Drug": "ORIAHNN (COPACKAGED)", "ActiveIngredient": "ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213388s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213388"}, "213400": {"ApplNo": "213400", "Form": "TABLET;ORAL", "Drug": "TAZVERIK", "ActiveIngredient": "TAZEMETOSTAT HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "EPIZYME INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213400"}, "213407": {"ApplNo": "213407", "Form": "SOLUTION;INTRAVENOUS", "Drug": "EMERPHED", "ActiveIngredient": "EPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "NEXUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213407s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213407"}, "213411": {"ApplNo": "213411", "Form": "TABLET;ORAL", "Drug": "TUKYSA", "ActiveIngredient": "TUCATINIB", "ApplType": "NDA", "Sponsor": "SEAGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213411s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213411"}, "21342": {"ApplNo": "21342", "Form": "TABLET;ORAL", "Drug": "LEVO-T", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "CEDIPROF INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021342s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21342"}, "213422": {"ApplNo": "213422", "Form": "CREAM;TOPICAL", "Drug": "WYNZORA", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE", "ApplType": "NDA", "Sponsor": "MC2", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213422s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213422"}, "213426": {"ApplNo": "213426", "Form": "TABLET;ORAL", "Drug": "SEGLENTIS", "ActiveIngredient": "CELECOXIB; TRAMADOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "KOWA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213426Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213426"}, "21343": {"ApplNo": "21343", "Form": "POWDER;SUBCUTANEOUS", "Drug": "ELIGARD KIT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "TOLMAR THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021343s039,021379s041,021488s036,021731s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21343"}, "213433": {"ApplNo": "213433", "Form": "CREAM;TOPICAL", "Drug": "WINLEVI", "ActiveIngredient": "CLASCOTERONE", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213433Orig1s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213433"}, "213436": {"ApplNo": "213436", "Form": "SPRAY, METERED;NASAL", "Drug": "TRUDHESA", "ActiveIngredient": "DIHYDROERGOTAMINE MESYLATE", "ApplType": "NDA", "Sponsor": "IMPEL PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213436"}, "21344": {"ApplNo": "21344", "Form": "SOLUTION;INTRAMUSCULAR", "Drug": "FASLODEX", "ActiveIngredient": "FULVESTRANT", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021344s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21344"}, "21345": {"ApplNo": "21345", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "ARIXTRA", "ActiveIngredient": "FONDAPARINUX SODIUM", "ApplType": "NDA", "Sponsor": "MYLAN IRELAND LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021345Orig1s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21345"}, "21346": {"ApplNo": "21346", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "RISPERDAL CONSTA", "ActiveIngredient": "RISPERIDONE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020272Orig1s083,020588Orig1s071,021444Orig1s057,021346Orig1s061lbl.pdf#page=60", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21346"}, "213464": {"ApplNo": "213464", "Form": "TABLET;ORAL", "Drug": "LAMPIT", "ActiveIngredient": "NIFURTIMOX", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213464s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213464"}, "213478": {"ApplNo": "213478", "Form": "GEL;TOPICAL", "Drug": "HYFTOR", "ActiveIngredient": "SIROLIMUS", "ApplType": "NDA", "Sponsor": "NOBELPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213478s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213478"}, "21348": {"ApplNo": "21348", "Form": "CAPSULE;ORAL", "Drug": "ZAVESCA", "ActiveIngredient": "MIGLUSTAT", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021348s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21348"}, "213491": {"ApplNo": "213491", "Form": "GRANULE, DELAYED RELEASE;ORAL", "Drug": "PROCYSBI", "ActiveIngredient": "CYSTEAMINE BITARTRATE", "ApplType": "NDA", "Sponsor": "HORIZON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203389s027,213491s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213491"}, "213498": {"ApplNo": "213498", "Form": "TABLET;ORAL", "Drug": "PONVORY", "ActiveIngredient": "PONESIMOD", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213498s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213498"}, "21350": {"ApplNo": "21350", "Form": "TABLET;ORAL", "Drug": "TRIGLIDE", "ActiveIngredient": "FENOFIBRATE", "ApplType": "NDA", "Sponsor": "SKYEPHARMA AG", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021350s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21350"}, "21351": {"ApplNo": "21351", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "OXYTROL", "ActiveIngredient": "OXYBUTYNIN", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021351s017s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21351"}, "213535": {"ApplNo": "213535", "Form": "FOR SOLUTION;ORAL", "Drug": "EVRYSDI", "ActiveIngredient": "RISDIPLAM", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213535Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213535"}, "213536": {"ApplNo": "213536", "Form": "SOLUTION;INTRAVENOUS", "Drug": "REZIPRES", "ActiveIngredient": "EPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "DR REDDYS LABS SA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213536s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213536"}, "21355": {"ApplNo": "21355", "Form": "TABLET;ORAL", "Drug": "ANGELIQ", "ActiveIngredient": "DROSPIRENONE; ESTRADIOL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021355s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21355"}, "21356": {"ApplNo": "21356", "Form": "TABLET;ORAL", "Drug": "VIREAD", "ActiveIngredient": "TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021356s058,022577s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21356"}, "21357": {"ApplNo": "21357", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "MULTIHANCE", "ActiveIngredient": "GADOBENATE DIMEGLUMINE", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021357s018,021358s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21357"}, "21358": {"ApplNo": "21358", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "MULTIHANCE MULTIPACK", "ActiveIngredient": "GADOBENATE DIMEGLUMINE", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021357s018,021358s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21358"}, "213581": {"ApplNo": "213581", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ATROPINE SULFATE", "ActiveIngredient": "ATROPINE SULFATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213581s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213581"}, "21359": {"ApplNo": "21359", "Form": "OINTMENT;INTRA-ANAL", "Drug": "RECTIV", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021359s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21359"}, "213591": {"ApplNo": "213591", "Form": "TABLET;ORAL", "Drug": "TABRECTA", "ActiveIngredient": "CAPMATINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213591s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213591"}, "213593": {"ApplNo": "213593", "Form": "FOR SUSPENSION;ORAL", "Drug": "KONVOMEP", "ActiveIngredient": "OMEPRAZOLE; SODIUM BICARBONATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213593s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213593"}, "21361": {"ApplNo": "21361", "Form": "TABLET;ORAL", "Drug": "XIFAXAN", "ActiveIngredient": "RIFAXIMIN", "ApplType": "NDA", "Sponsor": "SALIX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021361s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21361"}, "21363": {"ApplNo": "21363", "Form": "Tablet; Oral", "Drug": "CLARINEX", "ActiveIngredient": "DESLORATADINE", "ApplType": "NDA", "Sponsor": "SCHERING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21363lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21363"}, "21366": {"ApplNo": "21366", "Form": "TABLET;ORAL", "Drug": "CRESTOR", "ActiveIngredient": "ROSUVASTATIN CALCIUM", "ApplType": "NDA", "Sponsor": "IPR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021366s043s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21366"}, "21367": {"ApplNo": "21367", "Form": "INSERT, EXTENDED RELEASE;VAGINAL", "Drug": "FEMRING", "ActiveIngredient": "ESTRADIOL ACETATE", "ApplType": "NDA", "Sponsor": "MILLICENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021367s014s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21367"}, "213674": {"ApplNo": "213674", "Form": "TABLET;ORAL", "Drug": "XTANDI", "ActiveIngredient": "ENZALUTAMIDE", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203415s019,213674s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213674"}, "21368": {"ApplNo": "21368", "Form": "TABLET;ORAL", "Drug": "CIALIS", "ActiveIngredient": "TADALAFIL", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021368s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21368"}, "213687": {"ApplNo": "213687", "Form": "LIQUID;ORAL", "Drug": "DOJOLVI", "ActiveIngredient": "TRIHEPTANOIN", "ApplType": "NDA", "Sponsor": "ULTRAGENYX PHARM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213687s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213687"}, "213690": {"ApplNo": "213690", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "ZILXI", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "JOURNEY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213690s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213690"}, "213691": {"ApplNo": "213691", "Form": "LOTION;TOPICAL", "Drug": "IMPEKLO", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213691s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213691"}, "213702": {"ApplNo": "213702", "Form": "POWDER;INTRAVENOUS", "Drug": "ZEPZELCA", "ActiveIngredient": "LURBINECTEDIN", "ApplType": "NDA", "Sponsor": "JAZZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213702s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213702"}, "213716": {"ApplNo": "213716", "Form": "CAPSULE;ORAL", "Drug": "LUPKYNIS", "ActiveIngredient": "VOCLOSPORIN", "ApplType": "NDA", "Sponsor": "AURINIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213716"}, "213721": {"ApplNo": "213721", "Form": "CAPSULE;ORAL", "Drug": "GAVRETO", "ActiveIngredient": "PRALSETINIB", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213721s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213721"}, "21373": {"ApplNo": "21373", "Form": "SUSPENSION;ORAL", "Drug": "CHILDREN'S ADVIL COLD", "ActiveIngredient": "IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021373Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21373"}, "213736": {"ApplNo": "213736", "Form": "TABLET;ORAL", "Drug": "PEMAZYRE", "ActiveIngredient": "PEMIGATINIB", "ApplType": "NDA", "Sponsor": "INCYTE CORP", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213736s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213736"}, "21374": {"ApplNo": "21374", "Form": "CAPSULE;ORAL", "Drug": "ADVIL COLD AND SINUS", "ActiveIngredient": "IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021374orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21374"}, "21375": {"ApplNo": "21375", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "ALAVERT", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "FDN CONSUMER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/021375lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21375"}, "213756": {"ApplNo": "213756", "Form": "CAPSULE;ORAL", "Drug": "KOSELUGO", "ActiveIngredient": "SELUMETINIB SULFATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213756Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213756"}, "21379": {"ApplNo": "21379", "Form": "POWDER;SUBCUTANEOUS", "Drug": "ELIGARD KIT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "TOLMAR THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021343s039,021379s041,021488s036,021731s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21379"}, "213793": {"ApplNo": "213793", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "IMCIVREE", "ActiveIngredient": "SETMELANOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "RHYTHM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213793s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213793"}, "213801": {"ApplNo": "213801", "Form": "FOR SUSPENSION, EXTENDED RELEASE;ORAL", "Drug": "MYRBETRIQ GRANULES", "ActiveIngredient": "MIRABEGRON", "ApplType": "NDA", "Sponsor": "APGDI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213801s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213801"}, "21383": {"ApplNo": "21383", "Form": "INJECTABLE;INJECTION", "Drug": "CITANEST FORTE DENTAL", "ActiveIngredient": "EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "DENTSPLY PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021383Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21383"}, "21385": {"ApplNo": "21385", "Form": "CREAM;TOPICAL", "Drug": "ERTACZO", "ActiveIngredient": "SERTACONAZOLE NITRATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021385s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21385"}, "21386": {"ApplNo": "21386", "Form": "INJECTABLE; IV (INFUSION)", "Drug": "ZOMETA", "ActiveIngredient": "ZOLEDRONIC ACID", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021386s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21386"}, "213871": {"ApplNo": "213871", "Form": "TABLET;ORAL", "Drug": "CIBINQO", "ActiveIngredient": "ABROCITINIB", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213871s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213871"}, "213872": {"ApplNo": "213872", "Form": "SPRAY, METERED;NASAL", "Drug": "ASTEPRO ALLERGY", "ActiveIngredient": "AZELASTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213872Orig1s000Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213872"}, "213876": {"ApplNo": "213876", "Form": "GRANULE;ORAL", "Drug": "ALKINDI SPRINKLE", "ActiveIngredient": "HYDROCORTISONE", "ApplType": "NDA", "Sponsor": "ETON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213876s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213876"}, "21388": {"ApplNo": "21388", "Form": "POWDER;INTRAPLEURAL", "Drug": "TALC", "ActiveIngredient": "TALC", "ApplType": "NDA", "Sponsor": "SCIARRA LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021388s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21388"}, "213895": {"ApplNo": "213895", "Form": "SOLUTION;INTRAVENOUS, ORAL", "Drug": "VANCOMYCIN", "ActiveIngredient": "VANCOMYCIN", "ApplType": "NDA", "Sponsor": "XELLIA PHARMS APS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213895s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213895"}, "21392": {"ApplNo": "21392", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CARDIZEM LA", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021392s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21392"}, "21393": {"ApplNo": "21393", "Form": "CAPSULE;ORAL", "Drug": "ADVIL PM", "ActiveIngredient": "DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021393Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21393"}, "21394": {"ApplNo": "21394", "Form": "TABLET;ORAL", "Drug": "ADVIL PM", "ActiveIngredient": "DIPHENHYDRAMINE CITRATE; IBUPROFEN", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021394Orig1s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21394"}, "21395": {"ApplNo": "21395", "Form": "POWDER;INHALATION", "Drug": "SPIRIVA", "ActiveIngredient": "TIOTROPIUM BROMIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021395s048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21395"}, "213953": {"ApplNo": "213953", "Form": "CAPSULE;ORAL", "Drug": "KYZATREX", "ActiveIngredient": "TESTOSTERONE UNDECANOATE", "ApplType": "NDA", "Sponsor": "MARIUS PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213953s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213953"}, "21396": {"ApplNo": "21396", "Form": "Tablet; Oral", "Drug": "PREMPRO/PREMPHASE", "ActiveIngredient": "CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE", "ApplType": "NDA", "Sponsor": "WYETH AYERST", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21396_prempro_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21396"}, "213969": {"ApplNo": "213969", "Form": "CAPSULE;ORAL", "Drug": "ZOKINVY", "ActiveIngredient": "LONAFARNIB", "ApplType": "NDA", "Sponsor": "EIGER BIOPHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213969s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213969"}, "21397": {"ApplNo": "21397", "Form": "TABLET; ORAL", "Drug": "NEURONTIN", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-397.pdf_Neurontin_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21397"}, "213973": {"ApplNo": "213973", "Form": "TABLET;ORAL", "Drug": "QINLOCK", "ActiveIngredient": "RIPRETINIB", "ApplType": "NDA", "Sponsor": "DECIPHERA PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213973s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213973"}, "213978": {"ApplNo": "213978", "Form": "SPRAY;NASAL", "Drug": "TYRVAYA", "ActiveIngredient": "VARENICLINE TARTRATE", "ApplType": "NDA", "Sponsor": "OYSTER POINT PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213978s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213978"}, "21398": {"ApplNo": "21398", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "COMBIGAN", "ActiveIngredient": "BRIMONIDINE TARTRATE; TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021398s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21398"}, "213983": {"ApplNo": "213983", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "TIVICAY PD", "ActiveIngredient": "DOLUTEGRAVIR SODIUM", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204790s030,213983s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213983"}, "213994": {"ApplNo": "213994", "Form": "SOLUTION;INTRAVENOUS", "Drug": "EPHEDRINE SULFATE", "ActiveIngredient": "EPHEDRINE SULFATE", "ApplType": "NDA", "Sponsor": "ENDO VENTURES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213994s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213994"}, "214012": {"ApplNo": "214012", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "LEQVIO", "ActiveIngredient": "INCLISIRAN SODIUM", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214012Orig1s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214012"}, "214018": {"ApplNo": "214018", "Form": "POWDER;INTRAVENOUS", "Drug": "NULIBRY", "ActiveIngredient": "FOSDENOPTERIN HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "SENTYNL THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214018s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214018"}, "21402": {"ApplNo": "21402", "Form": "TABLET;ORAL", "Drug": "SYNTHROID", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021402Orig1s036Correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21402"}, "214028": {"ApplNo": "214028", "Form": "SOLUTION;OPHTHALMIC", "Drug": "VUITY", "ActiveIngredient": "PILOCARPINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214028s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214028"}, "214044": {"ApplNo": "214044", "Form": "SOLUTION;ORAL", "Drug": "QDOLO", "ActiveIngredient": "TRAMADOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ATHENA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214044s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214044"}, "214047": {"ApplNo": "214047", "Form": "SOLUTION;ORAL", "Drug": "THYQUIDITY", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214047s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214047"}, "214070": {"ApplNo": "214070", "Form": "AEROSOL, METERED;INHALATION", "Drug": "AIRSUPRA", "ActiveIngredient": "ALBUTEROL SULFATE; BUDESONIDE", "ApplType": "NDA", "Sponsor": "BOND", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214070s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214070"}, "21409": {"ApplNo": "21409", "Form": "GRANULE;ORAL", "Drug": "SINGULAIR", "ActiveIngredient": "MONTELUKAST SODIUM", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21409"}, "214094": {"ApplNo": "214094", "Form": "CAPSULE;ORAL", "Drug": "ORLADEYO", "ActiveIngredient": "BEROTRALSTAT HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BIOCRYST", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214094s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214094"}, "214096": {"ApplNo": "214096", "Form": "TABLET;ORAL", "Drug": "TEPMETKO", "ActiveIngredient": "TEPOTINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EMD SERONO INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214096s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214096"}, "214103": {"ApplNo": "214103", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "OXLUMO", "ActiveIngredient": "LUMASIRAN SODIUM", "ApplType": "NDA", "Sponsor": "ALNYLAM PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214103s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214103"}, "21411": {"ApplNo": "21411", "Form": "CAPSULE;ORAL", "Drug": "STRATTERA", "ActiveIngredient": "ATOMOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21411"}, "214120": {"ApplNo": "214120", "Form": "TABLET;ORAL", "Drug": "ONUREG", "ActiveIngredient": "AZACITIDINE", "ApplType": "NDA", "Sponsor": "BRISTOL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214120Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214120"}, "214133": {"ApplNo": "214133", "Form": "TABLET;ORAL", "Drug": "RECORLEV", "ActiveIngredient": "LEVOKETOCONAZOLE", "ApplType": "NDA", "Sponsor": "STRONGBRIDGE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214133s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214133"}, "214154": {"ApplNo": "214154", "Form": "TABLET;ORAL", "Drug": "NEXTSTELLIS", "ActiveIngredient": "DROSPIRENONE; ESTETROL", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214154s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214154"}, "214155": {"ApplNo": "214155", "Form": "POWDER;INTRAVENOUS", "Drug": "KIMYRSA", "ActiveIngredient": "ORITAVANCIN DIPHOSPHATE", "ApplType": "NDA", "Sponsor": "MELINTA THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214155s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214155"}, "21416": {"ApplNo": "21416", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "RYTHMOL SR", "ActiveIngredient": "PROPAFENONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021416s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21416"}, "21417": {"ApplNo": "21417", "Form": "TABLET; ORAL", "Drug": "PREMARIN", "ActiveIngredient": "ESTROGENS, CONJUGATED", "ApplType": "NDA", "Sponsor": "WYETH PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-417_Premarin_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21417"}, "214187": {"ApplNo": "214187", "Form": "PELLETS;ORAL", "Drug": "EPCLUSA", "ActiveIngredient": "SOFOSBUVIR; VELPATASVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214187s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214187"}, "21419": {"ApplNo": "21419", "Form": "SOLUTION;ORAL", "Drug": "METHYLIN", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SPECGX LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021419s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21419"}, "214200": {"ApplNo": "214200", "Form": "POWDER;INTRAVENOUS", "Drug": "COSELA", "ActiveIngredient": "TRILACICLIB DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "G1 THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214200s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214200"}, "214218": {"ApplNo": "214218", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PEMETREXED DISODIUM", "ActiveIngredient": "PEMETREXED DISODIUM", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214218Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214218"}, "21423": {"ApplNo": "21423", "Form": "CAPSULE; ORAL", "Drug": "NEURONTIN", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-397.pdf_Neurontin_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21423"}, "214231": {"ApplNo": "214231", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "ZEGALOGUE", "ActiveIngredient": "DASIGLUCAGON HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ZEALAND PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214231s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214231"}, "21424": {"ApplNo": "21424", "Form": "SOLUTION; ORAL", "Drug": "NEURONTIN", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "PARKE DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-397.pdf_Neurontin_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21424"}, "21425": {"ApplNo": "21425", "Form": "INJECTABLE;INJECTION", "Drug": "ULTRAVIST (PHARMACY BULK)", "ActiveIngredient": "IOPROMIDE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020220s052,021425s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21425"}, "214253": {"ApplNo": "214253", "Form": "SOLUTION;INTRAVENOUS", "Drug": "LEVOTHYROXINE SODIUM", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214253s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214253"}, "21426": {"ApplNo": "21426", "Form": "INJECTABLE;INJECTION", "Drug": "OMNITROPE", "ActiveIngredient": "SOMATROPIN", "ApplType": "BLA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021426s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21426"}, "21427": {"ApplNo": "21427", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "CYMBALTA", "ActiveIngredient": "DULOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021427s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21427"}, "214273": {"ApplNo": "214273", "Form": "SUSPENSION;ORAL", "Drug": "ZONISADE", "ActiveIngredient": "ZONISAMIDE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214273s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214273"}, "214275": {"ApplNo": "214275", "Form": "POWDER;INTRAVENOUS", "Drug": "UPTRAVI", "ActiveIngredient": "SELEXIPAG", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214275s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214275"}, "21428": {"ApplNo": "21428", "Form": "TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL", "Drug": "PREVACID", "ActiveIngredient": "LANSOPRAZOLE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020406s094,021428s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21428"}, "21430": {"ApplNo": "21430", "Form": "CAPSULE; ORAL", "Drug": "THALOMID", "ActiveIngredient": "THALIDOMIDE", "ApplType": "NDA", "Sponsor": "CELGENE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021430lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21430"}, "214313": {"ApplNo": "214313", "Form": "SOLUTION;INTRAVENOUS", "Drug": "NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE", "ActiveIngredient": "NOREPINEPHRINE BITARTRATE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214313Orig1s002Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214313"}, "214324": {"ApplNo": "214324", "Form": "POWDER;INHALATION", "Drug": "TYVASO DPI", "ActiveIngredient": "TREPROSTINIL", "ApplType": "NDA", "Sponsor": "UNITED THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214324s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214324"}, "21433": {"ApplNo": "21433", "Form": "AEROSOL, METERED;INHALATION", "Drug": "FLOVENT HFA", "ActiveIngredient": "FLUTICASONE PROPIONATE", "ApplType": "NDA", "Sponsor": "GLAXO GRP LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021433Orig1s040ReplacementLbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21433"}, "21434": {"ApplNo": "21434", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "XANAX XR", "ActiveIngredient": "ALPRAZOLAM", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21434"}, "214358": {"ApplNo": "214358", "Form": "PELLETS;ORAL", "Drug": "PRADAXA", "ActiveIngredient": "DABIGATRAN ETEXILATE MESYLATE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214358Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214358"}, "21436": {"ApplNo": "21436", "Form": "TABLET;ORAL", "Drug": "ABILIFY", "ActiveIngredient": "ARIPIPRAZOLE", "ApplType": "NDA", "Sponsor": "OTSUKA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021436s048lbledit.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21436"}, "21437": {"ApplNo": "21437", "Form": "TABLET;ORAL", "Drug": "INSPRA", "ActiveIngredient": "EPLERENONE", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021437s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21437"}, "214373": {"ApplNo": "214373", "Form": "TABLET;ORAL", "Drug": "BRENZAVVY", "ActiveIngredient": "BEXAGLIFLOZIN", "ApplType": "NDA", "Sponsor": "THERAXOSBIO LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214373"}, "214375": {"ApplNo": "214375", "Form": "GAS;INHALATION", "Drug": "XENOVIEW", "ActiveIngredient": "XENON XE-129 HYPERPOLARIZED", "ApplType": "NDA", "Sponsor": "POLAREAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214375s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214375"}, "214377": {"ApplNo": "214377", "Form": "TABLET;ORAL", "Drug": "VERQUVO", "ActiveIngredient": "VERICIGUAT", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214377Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214377"}, "21438": {"ApplNo": "21438", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "INNOPRAN XL", "ActiveIngredient": "PROPRANOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021438s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21438"}, "21440": {"ApplNo": "21440", "Form": "TABLET; ORAL", "Drug": "LEXAPRO", "ActiveIngredient": "ESCITALOPRAM OXALATE", "ApplType": "NDA", "Sponsor": "FOREST LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-440.pdf_Lexapro_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21440"}, "214408": {"ApplNo": "214408", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PEMETREXED DISODIUM", "ActiveIngredient": "PEMETREXED DISODIUM", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214408s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214408"}, "21441": {"ApplNo": "21441", "Form": "TABLET;ORAL", "Drug": "ADVIL ALLERGY SINUS", "ActiveIngredient": "CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021441Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21441"}, "214410": {"ApplNo": "214410", "Form": "FOR SUSPENSION;ORAL", "Drug": "XOFLUZA", "ActiveIngredient": "BALOXAVIR MARBOXIL", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214410Orig2s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214410"}, "214429": {"ApplNo": "214429", "Form": "TABLET;ORAL", "Drug": "FEXINIDAZOLE", "ActiveIngredient": "FEXINIDAZOLE", "ApplType": "NDA", "Sponsor": "SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214429s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214429"}, "214439": {"ApplNo": "214439", "Form": "SOLUTION;ORAL", "Drug": "NORLIQVA", "ActiveIngredient": "AMLODIPINE BESYLATE", "ApplType": "NDA", "Sponsor": "CMP DEV LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214439Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214439"}, "21445": {"ApplNo": "21445", "Form": "TABLET;ORAL", "Drug": "ZETIA", "ActiveIngredient": "EZETIMIBE", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/21445Orig1s040lbl1.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21445"}, "21446": {"ApplNo": "21446", "Form": "CAPSULE;ORAL", "Drug": "LYRICA", "ActiveIngredient": "PREGABALIN", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021446s040,%20022488s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21446"}, "214460": {"ApplNo": "214460", "Form": "SUSPENSION;ORAL", "Drug": "TEMBEXA", "ActiveIngredient": "BRINCIDOFOVIR", "ApplType": "NDA", "Sponsor": "EMERGENT BIODEFENSE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214460s001,214461s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214460"}, "214461": {"ApplNo": "214461", "Form": "TABLET;ORAL", "Drug": "TEMBEXA", "ActiveIngredient": "BRINCIDOFOVIR", "ApplType": "NDA", "Sponsor": "EMERGENT BIODEFENSE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214460s001,214461s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214461"}, "21447": {"ApplNo": "21447", "Form": "CAPSULE;ORAL", "Drug": "ZANAFLEX", "ActiveIngredient": "TIZANIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LEGACY PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021447s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21447"}, "214487": {"ApplNo": "214487", "Form": "CAPSULE;ORAL", "Drug": "TAVNEOS", "ActiveIngredient": "AVACOPAN", "ApplType": "NDA", "Sponsor": "CHEMOCENTRYX", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214487Orig1s001Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214487"}, "21449": {"ApplNo": "21449", "Form": "TABLET;ORAL", "Drug": "HEPSERA", "ActiveIngredient": "ADEFOVIR DIPIVOXIL", "ApplType": "NDA", "Sponsor": "GILEAD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021449s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21449"}, "21450": {"ApplNo": "21450", "Form": "SPRAY;NASAL", "Drug": "ZOMIG", "ActiveIngredient": "ZOLMITRIPTAN", "ApplType": "NDA", "Sponsor": "AMNEAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020768s023,021231s014,021450s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21450"}, "21451": {"ApplNo": "21451", "Form": "GEL;PERIODONTAL", "Drug": "ORAQIX", "ActiveIngredient": "LIDOCAINE; PRILOCAINE", "ApplType": "NDA", "Sponsor": "DENTSPLY PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021451s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21451"}, "214517": {"ApplNo": "214517", "Form": "SUSPENSION;ORAL", "Drug": "HETLIOZ LQ", "ActiveIngredient": "TASIMELTEON", "ApplType": "NDA", "Sponsor": "VANDA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214517s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214517"}, "214518": {"ApplNo": "214518", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TPOXX", "ActiveIngredient": "TECOVIRIMAT", "ApplType": "NDA", "Sponsor": "SIGA TECHNOLOGIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214518s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214518"}, "214522": {"ApplNo": "214522", "Form": "SUSPENSION;ORAL", "Drug": "TADLIQ", "ActiveIngredient": "TADALAFIL", "ApplType": "NDA", "Sponsor": "CMP DEV LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214522s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214522"}, "21454": {"ApplNo": "21454", "Form": "GEL;TRANSDERMAL", "Drug": "TESTIM", "ActiveIngredient": "TESTOSTERONE", "ApplType": "NDA", "Sponsor": "AUXILIUM PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021454s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21454"}, "21456": {"ApplNo": "21456", "Form": "Tablet, Delayed Release; Oral", "Drug": "ACIPHEX", "ActiveIngredient": "RABEPRAZOLE SODIUM", "ApplType": "NDA", "Sponsor": "EISAI MEDCL RES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20973S013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21456"}, "21457": {"ApplNo": "21457", "Form": "AEROSOL, METERED;INHALATION", "Drug": "PROAIR HFA", "ActiveIngredient": "ALBUTEROL SULFATE", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021457s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21457"}, "214581": {"ApplNo": "214581", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "NDA", "Sponsor": "NOVITIUM PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214581s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214581"}, "21462": {"ApplNo": "21462", "Form": "POWDER;INTRAVENOUS", "Drug": "ALIMTA", "ActiveIngredient": "PEMETREXED DISODIUM", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021462s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21462"}, "214621": {"ApplNo": "214621", "Form": "TABLET;ORAL", "Drug": "ORGOVYX", "ActiveIngredient": "RELUGOLIX", "ApplType": "NDA", "Sponsor": "MYOVANT SCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214621s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214621"}, "214622": {"ApplNo": "214622", "Form": "CAPSULE;ORAL", "Drug": "TRUSELTIQ", "ActiveIngredient": "INFIGRATINIB PHOSPHATE", "ApplType": "NDA", "Sponsor": "HELSINN HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214622"}, "21463": {"ApplNo": "21463", "Form": "GEL, METERED;TRANSDERMAL", "Drug": "FORTESTA", "ActiveIngredient": "TESTOSTERONE", "ApplType": "NDA", "Sponsor": "ENDO PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21463"}, "21464": {"ApplNo": "21464", "Form": "Tablet; Oral", "Drug": "VFEND", "ActiveIngredient": "VORICONAZOLE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021466lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21464"}, "214652": {"ApplNo": "214652", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ATROPINE SULFATE", "ActiveIngredient": "ATROPINE SULFATE", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214652s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214652"}, "214657": {"ApplNo": "214657", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PEMETREXED DISODIUM", "ActiveIngredient": "PEMETREXED DISODIUM", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214657s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214657"}, "21466": {"ApplNo": "21466", "Form": "Tablet; Oral", "Drug": "VFEND", "ActiveIngredient": "VORICONAZOLE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021466lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21466"}, "214662": {"ApplNo": "214662", "Form": "SOLUTION;ORAL", "Drug": "LIVMARLI", "ActiveIngredient": "MARALIXIBAT CHLORIDE", "ApplType": "NDA", "Sponsor": "MIRUM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214662s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214662"}, "214665": {"ApplNo": "214665", "Form": "TABLET;ORAL", "Drug": "LUMAKRAS", "ActiveIngredient": "SOTORASIB", "ApplType": "NDA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214665s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214665"}, "214679": {"ApplNo": "214679", "Form": "SOLUTION;ORAL", "Drug": "EPRONTIA", "ActiveIngredient": "TOPIRAMATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214679s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214679"}, "21468": {"ApplNo": "21468", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "FOSRENOL", "ActiveIngredient": "LANTHANUM CARBONATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021468s023,204734s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21468"}, "21470": {"ApplNo": "21470", "Form": "GEL;TOPICAL", "Drug": "FINACEA", "ActiveIngredient": "AZELAIC ACID", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021470s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21470"}, "214701": {"ApplNo": "214701", "Form": "CAPSULE;ORAL", "Drug": "GAVRETO", "ActiveIngredient": "PRALSETINIB", "ApplType": "NDA", "Sponsor": "BLUEPRINT MEDICINES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214701s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214701"}, "21471": {"ApplNo": "21471", "Form": "CREAM;TOPICAL", "Drug": "ANTHELIOS 20", "ActiveIngredient": "AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE", "ApplType": "NDA", "Sponsor": "LOREAL USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021471lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21471"}, "21472": {"ApplNo": "21472", "Form": "CAPSULE;ORAL", "Drug": "MIDOL LIQUID GELS", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "BIONPHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021472Orig1s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21472"}, "21476": {"ApplNo": "21476", "Form": "TABLET;ORAL", "Drug": "LUNESTA", "ActiveIngredient": "ESZOPICLONE", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21476"}, "214770": {"ApplNo": "214770", "Form": "FOR SUSPENSION, DELAYED RELEASE;ORAL", "Drug": "NOXAFIL POWDERMIX KIT", "ActiveIngredient": "POSACONAZOLE", "ApplType": "NDA", "Sponsor": "MSD MERCK CO", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214770Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214770"}, "21478": {"ApplNo": "21478", "Form": "CREAM;TOPICAL", "Drug": "ZOVIRAX", "ActiveIngredient": "ACYCLOVIR", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021478s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21478"}, "214783": {"ApplNo": "214783", "Form": "TABLET;ORAL", "Drug": "REZUROCK", "ActiveIngredient": "BELUMOSUDIL MESYLATE", "ApplType": "NDA", "Sponsor": "KADMON PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214783s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214783"}, "214787": {"ApplNo": "214787", "Form": "POWDER;INTRAVENOUS", "Drug": "VEKLURY", "ActiveIngredient": "REMDESIVIR", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214787Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214787"}, "21479": {"ApplNo": "21479", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "ZELAPAR", "ActiveIngredient": "SELEGILINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021479s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21479"}, "214793": {"ApplNo": "214793", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PYLARIFY", "ActiveIngredient": "PIFLUFOLASTAT F-18", "ApplType": "NDA", "Sponsor": "PROGENICS PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214793s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214793"}, "214801": {"ApplNo": "214801", "Form": "TABLET;ORAL", "Drug": "LYTGOBI", "ActiveIngredient": "FUTIBATINIB", "ApplType": "NDA", "Sponsor": "TAIHO ONCOLOGY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214801Orig1s000lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214801"}, "21481": {"ApplNo": "21481", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "FUZEON", "ActiveIngredient": "ENFUVIRTIDE", "ApplType": "NDA", "Sponsor": "ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021481s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21481"}, "214826": {"ApplNo": "214826", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "LOREEV XR", "ActiveIngredient": "LORAZEPAM", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214826s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214826"}, "21484": {"ApplNo": "21484", "Form": "Injectable; Subcutaneous", "Drug": "BRAVELLE", "ActiveIngredient": "UROFOLLITROPIN", "ApplType": "BLA", "Sponsor": "FERRING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21484_Bravelle_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21484"}, "214846": {"ApplNo": "214846", "Form": "TABLET;ORAL", "Drug": "MYFEMBREE", "ActiveIngredient": "ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX", "ApplType": "NDA", "Sponsor": "MYOVANT SCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214846s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214846"}, "21485": {"ApplNo": "21485", "Form": "TABLET;ORAL", "Drug": "STALEVO 50", "ActiveIngredient": "CARBIDOPA; ENTACAPONE; LEVODOPA", "ApplType": "NDA", "Sponsor": "ORION PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021485s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21485"}, "214860": {"ApplNo": "214860", "Form": "FOR SUSPENSION;ORAL", "Drug": "OLPRUVA", "ActiveIngredient": "SODIUM PHENYLBUTYRATE", "ApplType": "NDA", "Sponsor": "ACER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214860s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214860"}, "214869": {"ApplNo": "214869", "Form": "TABLET;ORAL", "Drug": "DHIVY", "ActiveIngredient": "CARBIDOPA; LEVODOPA", "ApplType": "NDA", "Sponsor": "AVION PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214869Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214869"}, "21487": {"ApplNo": "21487", "Form": "TABLET;ORAL", "Drug": "NAMENDA", "ActiveIngredient": "MEMANTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021487s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21487"}, "21488": {"ApplNo": "21488", "Form": "POWDER;SUBCUTANEOUS", "Drug": "ELIGARD KIT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "TOLMAR THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021343s039,021379s041,021488s036,021731s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21488"}, "21489": {"ApplNo": "21489", "Form": "INJECTABLE;INJECTION", "Drug": "PROHANCE MULTIPACK", "ActiveIngredient": "GADOTERIDOL", "ApplType": "NDA", "Sponsor": "BRACCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021489Orig1s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21489"}, "214900": {"ApplNo": "214900", "Form": "TABLET;ORAL", "Drug": "BREXAFEMME", "ActiveIngredient": "IBREXAFUNGERP CITRATE", "ApplType": "NDA", "Sponsor": "SCYNEXIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214900"}, "214902": {"ApplNo": "214902", "Form": "CREAM;TOPICAL", "Drug": "TWYNEO", "ActiveIngredient": "BENZOYL PEROXIDE; TRETINOIN", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214902s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214902"}, "214907": {"ApplNo": "214907", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CYTALUX", "ActiveIngredient": "PAFOLACIANINE SODIUM", "ApplType": "NDA", "Sponsor": "ON TARGET LABS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214907s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214907"}, "214916": {"ApplNo": "214916", "Form": "SOLUTION;INTRAVENOUS", "Drug": "KORSUVA", "ActiveIngredient": "DIFELIKEFALIN ACETATE", "ApplType": "NDA", "Sponsor": "CARA THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214916s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214916"}, "214919": {"ApplNo": "214919", "Form": "SOLUTION;INTRAMUSCULAR, INTRAVENOUS", "Drug": "GLYCOPYRROLATE", "ActiveIngredient": "GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214919s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214919"}, "21493": {"ApplNo": "21493", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ZYMAR", "ActiveIngredient": "GATIFLOXACIN", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021493s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21493"}, "214938": {"ApplNo": "214938", "Form": "POWDER;SUBCUTANEOUS", "Drug": "VOXZOGO", "ActiveIngredient": "VOSORITIDE", "ApplType": "NDA", "Sponsor": "BIOMARIN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214938Orig1s000Corrected_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214938"}, "214958": {"ApplNo": "214958", "Form": "TABLET;ORAL", "Drug": "SOTYKTU", "ActiveIngredient": "DEUCRAVACITINIB", "ApplType": "NDA", "Sponsor": "BRISTOL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214958s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214958"}, "214962": {"ApplNo": "214962", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "TASCENSO ODT", "ActiveIngredient": "FINGOLIMOD LAURYL SULFATE", "ApplType": "NDA", "Sponsor": "CYCLE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214962s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214962"}, "214965": {"ApplNo": "214965", "Form": "EMULSION;OPHTHALMIC", "Drug": "VERKAZIA", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "SANTEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214965s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214965"}, "21497": {"ApplNo": "21497", "Form": "TABLET;ORAL", "Drug": "ALINIA", "ActiveIngredient": "NITAZOXANIDE", "ApplType": "NDA", "Sponsor": "ROMARK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021497s018,021498s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21497"}, "21498": {"ApplNo": "21498", "Form": "FOR SUSPENSION;ORAL", "Drug": "ALINIA", "ActiveIngredient": "NITAZOXANIDE", "ApplType": "NDA", "Sponsor": "ROMARK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021497s018,021498s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21498"}, "214985": {"ApplNo": "214985", "Form": "TABLET;ORAL", "Drug": "QUVIVIQ", "ActiveIngredient": "DARIDOREXANT HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "IDORSIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214985s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214985"}, "214993": {"ApplNo": "214993", "Form": "POWDER;INTRAVENOUS", "Drug": "NEPHROSCAN", "ActiveIngredient": "TECHNETIUM TC-99M SUCCIMER", "ApplType": "NDA", "Sponsor": "THERAGNOSTICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214993s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214993"}, "214998": {"ApplNo": "214998", "Form": "CAPSULE;ORAL", "Drug": "CAMZYOS", "ActiveIngredient": "MAVACAMTEN", "ApplType": "NDA", "Sponsor": "BRISTOL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214998s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214998"}, "21500": {"ApplNo": "21500", "Form": "CAPSULE;ORAL", "Drug": "EMTRIVA", "ActiveIngredient": "EMTRICITABINE", "ApplType": "NDA", "Sponsor": "GILEAD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021500s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21500"}, "215000": {"ApplNo": "215000", "Form": "POWDER;INTRAVENOUS", "Drug": "CARMUSTINE", "ActiveIngredient": "CARMUSTINE", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215000s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215000"}, "21501": {"ApplNo": "21501", "Form": "CREAM;TOPICAL", "Drug": "CAPITAL SOLEIL 15", "ActiveIngredient": "AVOBENZONE; ECAMSULE; OCTOCRYLENE", "ApplType": "NDA", "Sponsor": "LOREAL USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021501s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21501"}, "215014": {"ApplNo": "215014", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "EMPAVELI", "ActiveIngredient": "PEGCETACOPLAN", "ApplType": "NDA", "Sponsor": "APELLIS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215014s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215014"}, "215019": {"ApplNo": "215019", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "DARTISLA ODT", "ActiveIngredient": "GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "EDENBRIDGE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215019s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215019"}, "21502": {"ApplNo": "21502", "Form": "CREAM;TOPICAL", "Drug": "ANTHELIOS SX", "ActiveIngredient": "AVOBENZONE; ECAMSULE; OCTOCRYLENE", "ApplType": "NDA", "Sponsor": "LOREAL USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021502s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21502"}, "215025": {"ApplNo": "215025", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SODIUM PHENYLACETATE AND SODIUM BENZOATE", "ActiveIngredient": "SODIUM BENZOATE; SODIUM PHENYLACETATE", "ApplType": "NDA", "Sponsor": "MAIA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215025s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215025"}, "21503": {"ApplNo": "21503", "Form": "TABLET;ORAL", "Drug": "VIRACEPT", "ActiveIngredient": "NELFINAVIR MESYLATE", "ApplType": "NDA", "Sponsor": "AGOURON PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020778s042,020779s063,021503s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21503"}, "215033": {"ApplNo": "215033", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BENDAMUSTINE HYDROCHLORIDE", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215033s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215033"}, "215039": {"ApplNo": "215039", "Form": "TABLET;ORAL", "Drug": "VIJOICE", "ActiveIngredient": "ALPELISIB", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215039s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215039"}, "21505": {"ApplNo": "21505", "Form": "SOLUTION;ORAL", "Drug": "KEPPRA", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021035s104,021505s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21505"}, "21506": {"ApplNo": "21506", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "MYCAMINE", "ActiveIngredient": "MICAFUNGIN SODIUM", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021506s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21506"}, "215092": {"ApplNo": "215092", "Form": "SOLUTION;OPHTHALMIC", "Drug": "OMLONTI", "ActiveIngredient": "OMIDENEPAG ISOPROPYL", "ApplType": "NDA", "Sponsor": "SANTEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215092s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215092"}, "215110": {"ApplNo": "215110", "Form": "PELLETS;ORAL", "Drug": "MAVYRET", "ActiveIngredient": "GLECAPREVIR; PIBRENTASVIR", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209394s014,215110s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215110"}, "215133": {"ApplNo": "215133", "Form": "CAPSULE;ORAL", "Drug": "SERTRALINE HYDROCHLORIDE", "ActiveIngredient": "SERTRALINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215133s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215133"}, "21514": {"ApplNo": "21514", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "DAYTRANA", "ActiveIngredient": "METHYLPHENIDATE", "ApplType": "NDA", "Sponsor": "NOVEN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021514s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21514"}, "215143": {"ApplNo": "215143", "Form": "SOLUTION;INTRAMUSCULAR, INTRAVENOUS", "Drug": "SUCCINYLCHOLINE CHLORIDE", "ActiveIngredient": "SUCCINYLCHOLINE CHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215143s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215143"}, "21515": {"ApplNo": "21515", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "WELLBUTRIN XL", "ActiveIngredient": "BUPROPION HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021515s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21515"}, "21516": {"ApplNo": "21516", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ISTALOL", "ActiveIngredient": "TIMOLOL MALEATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021516s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21516"}, "21518": {"ApplNo": "21518", "Form": "TABLET;ORAL", "Drug": "VESICARE", "ActiveIngredient": "SOLIFENACIN SUCCINATE", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021518s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21518"}, "21519": {"ApplNo": "21519", "Form": "TABLET;ORAL", "Drug": "LUVOX", "ActiveIngredient": "FLUVOXAMINE MALEATE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021519s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21519"}, "21520": {"ApplNo": "21520", "Form": "CAPSULE;ORAL", "Drug": "SYMBYAX", "ActiveIngredient": "FLUOXETINE HYDROCHLORIDE; OLANZAPINE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021520s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21520"}, "215206": {"ApplNo": "215206", "Form": "TABLET;ORAL", "Drug": "QULIPTA", "ActiveIngredient": "ATOGEPANT", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215206Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215206"}, "21524": {"ApplNo": "21524", "Form": "SWAB;TOPICAL", "Drug": "PREVANTICS SWAB", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL", "ApplType": "NDA", "Sponsor": "PROF DSPLS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021524Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21524"}, "21525": {"ApplNo": "21525", "Form": "Injectable; Injection", "Drug": "PHOTOFRIN", "ActiveIngredient": "PORFIMER SODIUM", "ApplType": "NDA", "Sponsor": "AXCAN SCANDIPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020451s029,021525s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21525"}, "215256": {"ApplNo": "215256", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "WEGOVY", "ActiveIngredient": "SEMAGLUTIDE", "ApplType": "NDA", "Sponsor": "NOVO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215256s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215256"}, "21526": {"ApplNo": "21526", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "RANEXA", "ActiveIngredient": "RANOLAZINE", "ApplType": "NDA", "Sponsor": "GILEAD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21526"}, "21527": {"ApplNo": "21527", "Form": "AEROSOL, METERED;INHALATION", "Drug": "ATROVENT HFA", "ActiveIngredient": "IPRATROPIUM BROMIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021527s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21527"}, "215272": {"ApplNo": "215272", "Form": "CREAM;TOPICAL", "Drug": "VTAMA", "ActiveIngredient": "TAPINAROF", "ApplType": "NDA", "Sponsor": "DERMAVANT SCI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215272s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215272"}, "21528": {"ApplNo": "21528", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ACULAR LS", "ActiveIngredient": "KETOROLAC TROMETHAMINE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021528s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21528"}, "21529": {"ApplNo": "21529", "Form": "IMPLANT;IMPLANTATION", "Drug": "NEXPLANON", "ActiveIngredient": "ETONOGESTREL", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021529s019s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21529"}, "21530": {"ApplNo": "21530", "Form": "SUSPENSION;ORAL", "Drug": "MELOXICAM", "ActiveIngredient": "MELOXICAM", "ApplType": "NDA", "Sponsor": "AVONDALE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021530s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21530"}, "215309": {"ApplNo": "215309", "Form": "CREAM;TOPICAL", "Drug": "OPZELURA", "ActiveIngredient": "RUXOLITINIB PHOSPHATE", "ApplType": "NDA", "Sponsor": "INCYTE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215309s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215309"}, "215310": {"ApplNo": "215310", "Form": "CAPSULE;ORAL", "Drug": "EXKIVITY", "ActiveIngredient": "MOBOCERTINIB SUCCINATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215310s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215310"}, "21532": {"ApplNo": "21532", "Form": "TABLET;ORAL", "Drug": "BENICAR HCT", "ActiveIngredient": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021532s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21532"}, "215331": {"ApplNo": "215331", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BORTEZOMIB", "ActiveIngredient": "BORTEZOMIB", "ApplType": "NDA", "Sponsor": "MAIA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215331s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215331"}, "215341": {"ApplNo": "215341", "Form": "TABLET;ORAL", "Drug": "KERENDIA", "ActiveIngredient": "FINERENONE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215341s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215341"}, "21535": {"ApplNo": "21535", "Form": "LOTION;TOPICAL", "Drug": "CLOBEX", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021535Orig1s003, 021644Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21535"}, "215358": {"ApplNo": "215358", "Form": "TABLET;ORAL", "Drug": "SCEMBLIX", "ActiveIngredient": "ASCIMINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215358s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215358"}, "21536": {"ApplNo": "21536", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "LEVEMIR", "ActiveIngredient": "INSULIN DETEMIR RECOMBINANT", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021536s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21536"}, "21537": {"ApplNo": "21537", "Form": "SUSPENSION/DROPS;OTIC", "Drug": "CIPRODEX", "ActiveIngredient": "CIPROFLOXACIN; DEXAMETHASONE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021537s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21537"}, "215383": {"ApplNo": "215383", "Form": "TABLET;ORAL", "Drug": "WELIREG", "ActiveIngredient": "BELZUTIFAN", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215383s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215383"}, "21539": {"ApplNo": "21539", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ACETADOTE", "ActiveIngredient": "ACETYLCYSTEINE", "ApplType": "NDA", "Sponsor": "CUMBERLAND PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021539s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21539"}, "215390": {"ApplNo": "215390", "Form": "FILM;BUCCAL, SUBLINGUAL", "Drug": "IGALMI", "ActiveIngredient": "DEXMEDETOMIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BIOXCEL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215390s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215390"}, "215395": {"ApplNo": "215395", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "LANREOTIDE ACETATE", "ActiveIngredient": "LANREOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "INVAGEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215395s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215395"}, "21540": {"ApplNo": "21540", "Form": "TABLET;ORAL", "Drug": "CADUET", "ActiveIngredient": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM", "ApplType": "NDA", "Sponsor": "PHARMACIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540Orig1s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21540"}, "215401": {"ApplNo": "215401", "Form": "SYSTEM;TRANSDERMAL", "Drug": "XELSTRYM", "ActiveIngredient": "DEXTROAMPHETAMINE", "ApplType": "NDA", "Sponsor": "NOVEN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215401s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215401"}, "215413": {"ApplNo": "215413", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "TRIUMEQ PD", "ActiveIngredient": "ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205551s029,215413s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215413"}, "215422": {"ApplNo": "215422", "Form": "GRANULES;ORAL", "Drug": "LYVISPAH", "ActiveIngredient": "BACLOFEN", "ApplType": "NDA", "Sponsor": "AMNEAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215422lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215422"}, "215423": {"ApplNo": "215423", "Form": "CAPSULE;ORAL", "Drug": "ENTADFI", "ActiveIngredient": "FINASTERIDE; TADALAFIL", "ApplType": "NDA", "Sponsor": "VERU", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215423s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215423"}, "215428": {"ApplNo": "215428", "Form": "CAPSULE;ORAL", "Drug": "CITALOPRAM HYDROBROMIDE", "ActiveIngredient": "CITALOPRAM HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215428s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215428"}, "215429": {"ApplNo": "215429", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "VENLAFAXINE BESYLATE", "ActiveIngredient": "VENLAFAXINE BESYLATE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215429s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215429"}, "215430": {"ApplNo": "215430", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "AUVELITY", "ActiveIngredient": "BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "AXSOME", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215430s000lblCorrect3.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215430"}, "21544": {"ApplNo": "21544", "Form": "TABLET;ORAL", "Drug": "SEASONALE", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021544s014s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21544"}, "215441": {"ApplNo": "215441", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BORTEZOMIB", "ActiveIngredient": "BORTEZOMIB", "ApplType": "NDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215441s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215441"}, "215446": {"ApplNo": "215446", "Form": "SUSPENSION;ORAL", "Drug": "RADICAVA ORS", "ActiveIngredient": "EDARAVONE", "ApplType": "NDA", "Sponsor": "MITSUBISHI TANABE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215446s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215446"}, "21545": {"ApplNo": "21545", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PATADAY ONCE DAILY RELIEF", "ActiveIngredient": "OLOPATADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021545Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21545"}, "21548": {"ApplNo": "21548", "Form": "TABLET;ORAL", "Drug": "LEXIVA", "ActiveIngredient": "FOSAMPRENAVIR CALCIUM", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021548s041,022116s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21548"}, "21549": {"ApplNo": "21549", "Form": "CAPSULE;ORAL", "Drug": "EMEND", "ActiveIngredient": "APREPITANT", "ApplType": "NDA", "Sponsor": "MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021549s030,207865s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21549"}, "215498": {"ApplNo": "215498", "Form": "CAPSULE, PELLETS;ORAL", "Drug": "BYLVAY", "ActiveIngredient": "ODEVIXIBAT", "ApplType": "NDA", "Sponsor": "ALBIREO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215498s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215498"}, "215499": {"ApplNo": "215499", "Form": "SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "APRETUDE", "ActiveIngredient": "CABOTEGRAVIR", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215499s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215499"}, "215515": {"ApplNo": "215515", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "AMVUTTRA", "ActiveIngredient": "VUTRISIRAN", "ApplType": "NDA", "Sponsor": "ALNYLAM PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215515s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215515"}, "21554": {"ApplNo": "21554", "Form": "TABLET, EXTENDED RELEASE; ORAL", "Drug": "CIPRO XR", "ActiveIngredient": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAYER PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21554_ciproXR_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21554"}, "21555": {"ApplNo": "21555", "Form": "SWAB;TOPICAL", "Drug": "CHLORAPREP ONE-STEP SEPP", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL", "ApplType": "NDA", "Sponsor": "BECTON DICKINSON CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021555Origs020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21555"}, "215596": {"ApplNo": "215596", "Form": "TABLET;ORAL", "Drug": "LIVTENCITY", "ActiveIngredient": "MARIBAVIR", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215596s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215596"}, "21560": {"ApplNo": "21560", "Form": "TABLET;ORAL", "Drug": "ZORTRESS", "ActiveIngredient": "EVEROLIMUS", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021560Orig1s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21560"}, "215602": {"ApplNo": "215602", "Form": "SUSPENSION;ORAL", "Drug": "FLEQSUVY", "ActiveIngredient": "BACLOFEN", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215602s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215602"}, "21563": {"ApplNo": "21563", "Form": "SYRUP; ORAL", "Drug": "CLARINEX", "ActiveIngredient": "DESLORATADINE", "ApplType": "NDA", "Sponsor": "SCHERING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021165s022,021300s019,021312s020,021563s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21563"}, "215650": {"ApplNo": "215650", "Form": "GEL;VAGINAL", "Drug": "XACIATO", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "DARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215650s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215650"}, "21567": {"ApplNo": "21567", "Form": "CAPSULE;ORAL", "Drug": "REYATAZ", "ActiveIngredient": "ATAZANAVIR SULFATE", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021567s044,206352s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21567"}, "21569": {"ApplNo": "21569", "Form": "INJECTABLE;INJECTION", "Drug": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "LIEBEL-FLARSHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021569s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21569"}, "215700": {"ApplNo": "215700", "Form": "SOLUTION;INTRAVENOUS", "Drug": "NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE", "ActiveIngredient": "NOREPINEPHRINE BITARTRATE", "ApplType": "NDA", "Sponsor": "INFORLIFE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215700s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215700"}, "215712": {"ApplNo": "215712", "Form": "SPRAY, METERED;NASAL", "Drug": "NASONEX 24HR ALLERGY", "ActiveIngredient": "MOMETASONE FUROATE", "ApplType": "NDA", "Sponsor": "PERRIGO PHARMA INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215712Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215712"}, "21572": {"ApplNo": "21572", "Form": "POWDER;INTRAVENOUS", "Drug": "CUBICIN", "ActiveIngredient": "DAPTOMYCIN", "ApplType": "NDA", "Sponsor": "CUBIST PHARMS LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021572s068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21572"}, "21574": {"ApplNo": "21574", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "FORTAMET", "ActiveIngredient": "METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ANDRX LABS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021574s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21574"}, "215760": {"ApplNo": "215760", "Form": "TABLET;ORAL", "Drug": "CUVRIOR", "ActiveIngredient": "TRIENTINE TETRAHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ORPHALAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215760s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215760"}, "215809": {"ApplNo": "215809", "Form": "SOLUTION;ORAL", "Drug": "ERMEZA", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215809s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215809"}, "215813": {"ApplNo": "215813", "Form": "SOLUTION;INTRAVENOUS", "Drug": "DOCETAXEL", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "MERIDIAN LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215813s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215813"}, "215814": {"ApplNo": "215814", "Form": "CAPSULE;ORAL", "Drug": "REZLIDHIA", "ActiveIngredient": "OLUTASIDENIB", "ApplType": "NDA", "Sponsor": "RIGEL PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215814s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215814"}, "21583": {"ApplNo": "21583", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "DEPO-SUBQ PROVERA 104", "ActiveIngredient": "MEDROXYPROGESTERONE ACETATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021583s033s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21583"}, "215833": {"ApplNo": "215833", "Form": "SOLUTION;INTRAVENOUS", "Drug": "PLUVICTO", "ActiveIngredient": "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN", "ApplType": "NDA", "Sponsor": "AAA USA NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215833s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215833"}, "215841": {"ApplNo": "215841", "Form": "POWDER;INTRAVENOUS", "Drug": "LOCAMETZ", "ActiveIngredient": "GALLIUM GA-68 GOZETOTIDE", "ApplType": "NDA", "Sponsor": "AAA USA NOVARTIS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215841s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215841"}, "21585": {"ApplNo": "21585", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MUCINEX D", "ActiveIngredient": "GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "RB HLTH", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021620Orig1s038,021585Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21585"}, "215859": {"ApplNo": "215859", "Form": "FOR SUSPENSION;ORAL", "Drug": "XARELTO", "ActiveIngredient": "RIVAROXABAN", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215859Orig1s000correctedLBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215859"}, "21586": {"ApplNo": "21586", "Form": "SPONGE;TOPICAL", "Drug": "DURAPREP", "ActiveIngredient": "IODINE POVACRYLEX; ISOPROPYL ALCOHOL", "ApplType": "NDA", "Sponsor": "3M", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021586Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21586"}, "215866": {"ApplNo": "215866", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "MOUNJARO", "ActiveIngredient": "TIRZEPATIDE", "ApplType": "NDA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215866"}, "215868": {"ApplNo": "215868", "Form": "SOLUTION;INTRAVENOUS", "Drug": "MIDAZOLAM IN 0.8% SODIUM CHLORIDE", "ActiveIngredient": "MIDAZOLAM", "ApplType": "NDA", "Sponsor": "EXELA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215868s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215868"}, "21587": {"ApplNo": "21587", "Form": "SUSPENSION;ORAL", "Drug": "CHILDREN'S ADVIL ALLERGY SINUS", "ActiveIngredient": "CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021587Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21587"}, "21588": {"ApplNo": "21588", "Form": "TABLET;ORAL", "Drug": "GLEEVEC", "ActiveIngredient": "IMATINIB MESYLATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021588s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21588"}, "215888": {"ApplNo": "215888", "Form": "CAPSULE;ORAL", "Drug": "VIVJOA", "ActiveIngredient": "OTESECONAZOLE", "ApplType": "NDA", "Sponsor": "MYCOVIA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215888s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215888"}, "215904": {"ApplNo": "215904", "Form": "SUSPENSION;ORAL", "Drug": "ZTALMY", "ActiveIngredient": "GANAXOLONE", "ApplType": "NDA", "Sponsor": "MARINUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215904s001s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215904"}, "215935": {"ApplNo": "215935", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "TARPEYO", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "CALLIDITAS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215935s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215935"}, "21597": {"ApplNo": "21597", "Form": "INJECTABLE;INJECTION", "Drug": "ZORBTIVE", "ActiveIngredient": "SOMATROPIN RECOMBINANT", "ApplType": "BLA", "Sponsor": "EMD SERONO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20604s026_zorbtive_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21597"}, "215973": {"ApplNo": "215973", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "SUNLENCA", "ActiveIngredient": "LENACAPAVIR SODIUM", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215973s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215973"}, "215974": {"ApplNo": "215974", "Form": "TABLET;ORAL", "Drug": "SUNLENCA", "ActiveIngredient": "LENACAPAVIR SODIUM", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215974s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215974"}, "21598": {"ApplNo": "21598", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "VIGAMOX", "ActiveIngredient": "MOXIFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/21598s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21598"}, "215985": {"ApplNo": "215985", "Form": "CREAM;TOPICAL", "Drug": "ZORYVE", "ActiveIngredient": "ROFLUMILAST", "ApplType": "NDA", "Sponsor": "ARCUTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215985s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215985"}, "216018": {"ApplNo": "216018", "Form": "GRANULES, EXTENDED RELEASE;ORAL", "Drug": "ASPRUZYO SPRINKLE", "ActiveIngredient": "RANOLAZINE", "ApplType": "NDA", "Sponsor": "SPIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216018s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216018"}, "21602": {"ApplNo": "21602", "Form": "INJECTABLE;INTRAVENOUS, SUBCUTANEOUS", "Drug": "VELCADE", "ActiveIngredient": "BORTEZOMIB", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021602s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21602"}, "21606": {"ApplNo": "21606", "Form": "CAPSULE;ORAL", "Drug": "ZEMPLAR", "ActiveIngredient": "PARICALCITOL", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021606s016s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21606"}, "216078": {"ApplNo": "216078", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BENDAMUSTINE HYDROCHLORIDE", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216078s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216078"}, "216109": {"ApplNo": "216109", "Form": "POWDER;INTRAVENOUS", "Drug": "CEFAZOLIN SODIUM", "ActiveIngredient": "CEFAZOLIN SODIUM", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216109s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216109"}, "216117": {"ApplNo": "216117", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "RELEXXII", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "OSMOTICA PHARM US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216117s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216117"}, "21612": {"ApplNo": "21612", "Form": "CAPSULE;ORAL", "Drug": "LIPOFEN", "ActiveIngredient": "FENOFIBRATE", "ApplType": "NDA", "Sponsor": "CIPHER PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021612s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21612"}, "21615": {"ApplNo": "21615", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "RAZADYNE ER", "ActiveIngredient": "GALANTAMINE HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021615s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21615"}, "216157": {"ApplNo": "216157", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "OXBRYTA", "ActiveIngredient": "VOXELOTOR", "ApplType": "NDA", "Sponsor": "GLOBAL BLOOD THERAPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/216157s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216157"}, "21618": {"ApplNo": "21618", "Form": "TABLET;ORAL", "Drug": "TINDAMAX", "ActiveIngredient": "TINIDAZOLE", "ApplType": "NDA", "Sponsor": "MISSION PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021618s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21618"}, "216196": {"ApplNo": "216196", "Form": "TABLET;ORAL", "Drug": "PYRUKYND", "ActiveIngredient": "MITAPIVAT SULFATE", "ApplType": "NDA", "Sponsor": "AGIOS PHARMS INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216196s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216196"}, "21620": {"ApplNo": "21620", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MUCINEX DM", "ActiveIngredient": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN", "ApplType": "NDA", "Sponsor": "RB HLTH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021282s054,021620s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21620"}, "21621": {"ApplNo": "21621", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "CHILDREN'S ZYRTEC ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021621Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21621"}, "216227": {"ApplNo": "216227", "Form": "GEL;OPHTHALMIC", "Drug": "IHEEZO", "ActiveIngredient": "CHLOROPROCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HARROW EYE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216227s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216227"}, "21624": {"ApplNo": "21624", "Form": "INJECTABLE;INJECTION", "Drug": "METHADONE HYDROCHLORIDE", "ActiveIngredient": "METHADONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "MYLAN INSTITUTIONAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021624Orig1s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21624"}, "21626": {"ApplNo": "21626", "Form": "CAPSULE;ORAL", "Drug": "RADIOGARDASE (PRUSSIAN BLUE)", "ActiveIngredient": "FERRIC HEXACYANOFERRATE(II)", "ApplType": "NDA", "Sponsor": "HEYL CHEMISCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021626s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21626"}, "216264": {"ApplNo": "216264", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BLUDIGO", "ActiveIngredient": "INDIGOTINDISULFONATE SODIUM", "ApplType": "NDA", "Sponsor": "PROVEPHARM SAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216264s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216264"}, "216285": {"ApplNo": "216285", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "DROSPIRENONE", "ActiveIngredient": "DROSPIRENONE", "ApplType": "NDA", "Sponsor": "EXELTIS USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216285s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216285"}, "21629": {"ApplNo": "21629", "Form": "INJECTABLE;INTRAVENOUS, SUBCUTANEOUS", "Drug": "APIDRA", "ActiveIngredient": "INSULIN GLULISINE RECOMBINANT", "ApplType": "BLA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021629s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21629"}, "21630": {"ApplNo": "21630", "Form": "FOR SUSPENSION;ORAL", "Drug": "VFEND", "ActiveIngredient": "VORICONAZOLE", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021266s053,021267s063,021630s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21630"}, "21632": {"ApplNo": "21632", "Form": "POWDER;INTRAVENOUS", "Drug": "ERAXIS", "ActiveIngredient": "ANIDULAFUNGIN", "ApplType": "NDA", "Sponsor": "VICURON HOLDINGS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021632s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21632"}, "216340": {"ApplNo": "216340", "Form": "TABLET;ORAL", "Drug": "KRAZATI", "ActiveIngredient": "ADAGRASIB", "ApplType": "NDA", "Sponsor": "MIRATI THERAPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216340Orig1s000Corrected_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216340"}, "21636": {"ApplNo": "21636", "Form": "FOR SUSPENSION;ORAL", "Drug": "ZEGERID", "ActiveIngredient": "OMEPRAZOLE; SODIUM BICARBONATE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021849s019,021636s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21636"}, "216387": {"ApplNo": "216387", "Form": "TABLET;ORAL", "Drug": "CALQUENCE", "ActiveIngredient": "ACALABRUTINIB MALEATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216387Orig1s000Correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216387"}, "21640": {"ApplNo": "21640", "Form": "INJECTABLE;INJECTION", "Drug": "VITRASE", "ActiveIngredient": "HYALURONIDASE", "ApplType": "BLA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21640_vitrase_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21640"}, "21641": {"ApplNo": "21641", "Form": "TABLET;ORAL", "Drug": "AZILECT", "ActiveIngredient": "RASAGILINE MESYLATE", "ApplType": "NDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021641s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21641"}, "21642": {"ApplNo": "21642", "Form": "SPRAY, METERED;NASAL", "Drug": "NASCOBAL", "ActiveIngredient": "CYANOCOBALAMIN", "ApplType": "NDA", "Sponsor": "ENDO PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021642s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21642"}, "21644": {"ApplNo": "21644", "Form": "SHAMPOO;TOPICAL", "Drug": "CLOBEX", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021535Orig1s003, 021644Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21644"}, "216457": {"ApplNo": "216457", "Form": "EMULSION;INTRAVENOUS", "Drug": "APONVIE", "ActiveIngredient": "APREPITANT", "ApplType": "NDA", "Sponsor": "HERON THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216457s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216457"}, "216472": {"ApplNo": "216472", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "IYUZEH", "ActiveIngredient": "LATANOPROST", "ApplType": "NDA", "Sponsor": "THEA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216472s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216472"}, "21648": {"ApplNo": "21648", "Form": "ELIXIR;ORAL", "Drug": "DIGOXIN", "ActiveIngredient": "DIGOXIN", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021648s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21648"}, "216513": {"ApplNo": "216513", "Form": "PELLETS;ORAL", "Drug": "PHEBURANE", "ActiveIngredient": "SODIUM PHENYLBUTYRATE", "ApplType": "NDA", "Sponsor": "MEDUNIK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216513s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216513"}, "21652": {"ApplNo": "21652", "Form": "TABLET;ORAL", "Drug": "EPZICOM", "ActiveIngredient": "ABACAVIR SULFATE; LAMIVUDINE", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21652"}, "21654": {"ApplNo": "21654", "Form": "CAPSULE;ORAL", "Drug": "LOVAZA", "ActiveIngredient": "OMEGA-3-ACID ETHYL ESTERS", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021654s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21654"}, "21656": {"ApplNo": "21656", "Form": "TABLET;ORAL", "Drug": "TRICOR", "ActiveIngredient": "FENOFIBRATE", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021656s030s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21656"}, "21658": {"ApplNo": "21658", "Form": "AEROSOL, METERED;INHALATION", "Drug": "ALVESCO", "ActiveIngredient": "CICLESONIDE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021658s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21658"}, "21660": {"ApplNo": "21660", "Form": "POWDER;INTRAVENOUS", "Drug": "ABRAXANE", "ActiveIngredient": "PACLITAXEL", "ApplType": "NDA", "Sponsor": "BRISTOL-MYERS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021660s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21660"}, "21663": {"ApplNo": "21663", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "MENOPUR", "ActiveIngredient": "MENOTROPINS (FSH;LH)", "ApplType": "BLA", "Sponsor": "FERRING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021663s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21663"}, "21665": {"ApplNo": "21665", "Form": "INJECTABLE;INJECTION", "Drug": "AMPHADASE", "ActiveIngredient": "HYALURONIDASE", "ApplType": "BLA", "Sponsor": "AMPHASTAR PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21665lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21665"}, "216660": {"ApplNo": "216660", "Form": "FOR SUSPENSION;ORAL", "Drug": "RELYVRIO", "ActiveIngredient": "SODIUM PHENYLBUTYRATE; TAURURSODIOL", "ApplType": "NDA", "Sponsor": "AMYLYX", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216660s000lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216660"}, "21669": {"ApplNo": "21669", "Form": "CLOTH;TOPICAL", "Drug": "CHLORHEXIDINE GLUCONATE", "ActiveIngredient": "CHLORHEXIDINE GLUCONATE", "ApplType": "NDA", "Sponsor": "SAGE PRODS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021669Orig1s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21669"}, "21670": {"ApplNo": "21670", "Form": "SOLUTION;OPHTHALMIC", "Drug": "VISIONBLUE", "ActiveIngredient": "TRYPAN BLUE", "ApplType": "NDA", "Sponsor": "DORC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021670s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21670"}, "21673": {"ApplNo": "21673", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CLOLAR", "ActiveIngredient": "CLOFARABINE", "ApplType": "NDA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021673s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21673"}, "21674": {"ApplNo": "21674", "Form": "SYSTEM;TRANSDERMAL", "Drug": "MENOSTAR", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21674_menostar_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21674"}, "21676": {"ApplNo": "21676", "Form": "TABLET;ORAL", "Drug": "YAZ", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021676s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21676"}, "21677": {"ApplNo": "21677", "Form": "INJECTABLE; INJECTION", "Drug": "ALIMTA", "ActiveIngredient": "PEMETREXED", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021677lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21677"}, "216820": {"ApplNo": "216820", "Form": "INJECTABLE;INJECTION", "Drug": "TECHNETIUM TC-99M MERTIATIDE KIT", "ActiveIngredient": "TECHNETIUM TC-99M MERTIATIDE KIT", "ApplType": "NDA", "Sponsor": "JUBILANT DRAXIMAGE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216820s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216820"}, "21684": {"ApplNo": "21684", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "GONAL-F RFF REDI-JECT", "ActiveIngredient": "FOLLITROPIN ALFA/BETA", "ApplType": "BLA", "Sponsor": "EMD SERONO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021684s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21684"}, "21687": {"ApplNo": "21687", "Form": "TABLET;ORAL", "Drug": "VYTORIN", "ActiveIngredient": "EZETIMIBE; SIMVASTATIN", "ApplType": "NDA", "Sponsor": "ORGANON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021687s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21687"}, "21688": {"ApplNo": "21688", "Form": "TABLET;ORAL", "Drug": "SENSIPAR", "ActiveIngredient": "CINACALCET HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AMGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021688s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21688"}, "21689": {"ApplNo": "21689", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "NEXIUM IV", "ActiveIngredient": "ESOMEPRAZOLE SODIUM", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021689s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21689"}, "21690": {"ApplNo": "21690", "Form": "TABLET; ORAL-21", "Drug": "ORTHO TRI-CYCLEN 21", "ActiveIngredient": "ETHINYL ESTRADIOL; NORGESTIMATE", "ApplType": "NDA", "Sponsor": "ORTHO MCNEIL PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019653s056,019697s052,021690s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21690"}, "21695": {"ApplNo": "21695", "Form": "CAPSULE;ORAL", "Drug": "ANTARA (MICRONIZED)", "ActiveIngredient": "FENOFIBRATE", "ApplType": "NDA", "Sponsor": "LUPIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021695s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21695"}, "21697": {"ApplNo": "21697", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER", "ActiveIngredient": "CONIVAPTAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CUMBERLAND PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021697s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21697"}, "216986": {"ApplNo": "216986", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ELUCIREM", "ActiveIngredient": "GADOPICLENOL", "ApplType": "NDA", "Sponsor": "GUERBET", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216986s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216986"}, "217003": {"ApplNo": "217003", "Form": "SUSPENSION;ORAL", "Drug": "IMBRUVICA", "ActiveIngredient": "IBRUTINIB", "ApplType": "NDA", "Sponsor": "PHARMACYCLICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/217003s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217003"}, "21703": {"ApplNo": "21703", "Form": "INJECTABLE;INJECTION", "Drug": "PRISMASOL BGK 2/0 IN PLASTIC CONTAINER", "ActiveIngredient": "CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021703Orig1s020, 207026Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21703"}, "21704": {"ApplNo": "21704", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION", "ActiveIngredient": "FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CHATTEM SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020786Origs035,021704Orig1s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21704"}, "21708": {"ApplNo": "21708", "Form": "SYSTEM; TRANSDERMAL", "Drug": "EMSAM", "ActiveIngredient": "SELEGILINE", "ApplType": "NDA", "Sponsor": "SOMERSET", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021336s005s010,021708s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21708"}, "21710": {"ApplNo": "21710", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "EQUETRO", "ActiveIngredient": "CARBAMAZEPINE", "ApplType": "NDA", "Sponsor": "VALIDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021710s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21710"}, "21717": {"ApplNo": "21717", "Form": "CREAM;TOPICAL", "Drug": "PLIAGLIS", "ActiveIngredient": "LIDOCAINE; TETRACAINE", "ApplType": "NDA", "Sponsor": "TARO PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021717s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21717"}, "21730": {"ApplNo": "21730", "Form": "AEROSOL, METERED;INHALATION", "Drug": "XOPENEX HFA", "ActiveIngredient": "LEVALBUTEROL TARTRATE", "ApplType": "NDA", "Sponsor": "LUPIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021730s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21730"}, "21731": {"ApplNo": "21731", "Form": "POWDER;SUBCUTANEOUS", "Drug": "ELIGARD KIT", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "NDA", "Sponsor": "TOLMAR THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021731s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21731"}, "21733": {"ApplNo": "21733", "Form": "CAPSULE, DELAYED REL PELLETS; ORAL", "Drug": "CYMBALTA", "ActiveIngredient": "DULOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21733lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21733"}, "21734": {"ApplNo": "21734", "Form": "SUSPENSION;ORAL", "Drug": "LORATADINE", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "TARO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021734lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21734"}, "21735": {"ApplNo": "21735", "Form": "CREAM;VAGINAL", "Drug": "TERCONAZOLE", "ActiveIngredient": "TERCONAZOLE", "ApplType": "NDA", "Sponsor": "FOUGERA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021735s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21735"}, "21737": {"ApplNo": "21737", "Form": "IMPLANT;INTRAVITREAL", "Drug": "RETISERT", "ActiveIngredient": "FLUOCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021737s019.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21737"}, "21738": {"ApplNo": "21738", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "EXTINA", "ActiveIngredient": "KETOCONAZOLE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021738s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21738"}, "217415": {"ApplNo": "217415", "Form": "POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER", "Drug": "DAPTOMYCIN", "ActiveIngredient": "DAPTOMYCIN", "ApplType": "NDA", "Sponsor": "XELLIA PHARMS APS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217415s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217415"}, "21742": {"ApplNo": "21742", "Form": "TABLET;ORAL", "Drug": "BYSTOLIC", "ActiveIngredient": "NEBIVOLOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021742s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21742"}, "21743": {"ApplNo": "21743", "Form": "TABLET;ORAL", "Drug": "TARCEVA", "ActiveIngredient": "ERLOTINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "OSI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021743s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21743"}, "21747": {"ApplNo": "21747", "Form": "SPRAY, METERED;INHALATION", "Drug": "COMBIVENT RESPIMAT", "ActiveIngredient": "ALBUTEROL SULFATE; IPRATROPIUM BROMIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021747s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21747"}, "21748": {"ApplNo": "21748", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "GLUMETZA", "ActiveIngredient": "METFORMIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SANTARUS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021748s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21748"}, "21752": {"ApplNo": "21752", "Form": "TABLET;ORAL", "Drug": "TRUVADA", "ActiveIngredient": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021752s061lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21752"}, "21753": {"ApplNo": "21753", "Form": "GEL;TOPICAL", "Drug": "DIFFERIN", "ActiveIngredient": "ADAPALENE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021753s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21753"}, "21754": {"ApplNo": "21754", "Form": "INJECTABLE; INJECTION", "Drug": "MYCAMINE", "ActiveIngredient": "MICAFUNGIN SODIUM", "ApplType": "NDA", "Sponsor": "FUJISAWA HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21506,21754lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21754"}, "21758": {"ApplNo": "21758", "Form": "CREAM;TOPICAL", "Drug": "VANOS", "ActiveIngredient": "FLUOCINONIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021758s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21758"}, "21759": {"ApplNo": "21759", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ELOXATIN", "ActiveIngredient": "OXALIPLATIN", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021759s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21759"}, "21762": {"ApplNo": "21762", "Form": "TABLET;ORAL", "Drug": "FOSAMAX PLUS D", "ActiveIngredient": "ALENDRONATE SODIUM; CHOLECALCIFEROL", "ApplType": "NDA", "Sponsor": "ORGANON LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21762"}, "21763": {"ApplNo": "21763", "Form": "TABLET; ORALLY DISINTEGRATING", "Drug": "CITALOPRAM HYDROBROMIDE", "ActiveIngredient": "CITALOPRAM HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "BIOVAIL LABS INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021763lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21763"}, "217639": {"ApplNo": "217639", "Form": "TABLET;ORAL", "Drug": "ORSERDU", "ActiveIngredient": "ELACESTRANT", "ApplType": "NDA", "Sponsor": "STEMLINE THERAPEUTICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217639s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217639"}, "21764": {"ApplNo": "21764", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "QOLIANA", "ActiveIngredient": "BRIMONIDINE TARTRATE", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021764s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21764"}, "21765": {"ApplNo": "21765", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "GONAL-F RFF", "ActiveIngredient": "FOLLITROPIN ALFA/BETA", "ApplType": "BLA", "Sponsor": "EMD SERONO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020021765s013s014s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21765"}, "21770": {"ApplNo": "21770", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ALPHAGAN P", "ActiveIngredient": "BRIMONIDINE TARTRATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021262s020,021770s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21770"}, "21773": {"ApplNo": "21773", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "BYETTA", "ActiveIngredient": "EXENATIDE SYNTHETIC", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021773s048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21773"}, "21774": {"ApplNo": "21774", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "AMBIEN CR", "ActiveIngredient": "ZOLPIDEM TARTRATE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21774"}, "21775": {"ApplNo": "21775", "Form": "CAPSULE;ORAL", "Drug": "ENTEREG", "ActiveIngredient": "ALVIMOPAN", "ApplType": "NDA", "Sponsor": "CUBIST PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021775s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21775"}, "21777": {"ApplNo": "21777", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "AMRIX", "ActiveIngredient": "CYCLOBENZAPRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TEVA PHARMS INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021777s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21777"}, "21778": {"ApplNo": "21778", "Form": "SUSPENSION;ORAL", "Drug": "MEGACE ES", "ActiveIngredient": "MEGESTROL ACETATE", "ApplType": "NDA", "Sponsor": "ENDO PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021778s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21778"}, "21779": {"ApplNo": "21779", "Form": "SOLUTION;INHALATION", "Drug": "VENTAVIS", "ActiveIngredient": "ILOPROST", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021779s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21779"}, "21780": {"ApplNo": "21780", "Form": "AEROSOL, METERED;SUBLINGUAL", "Drug": "NITROMIST", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "NDA", "Sponsor": "EVUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021780s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21780"}, "21782": {"ApplNo": "21782", "Form": "TABLET;ORAL", "Drug": "ROZEREM", "ActiveIngredient": "RAMELTEON", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021782s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21782"}, "21789": {"ApplNo": "21789", "Form": "GEL;TOPICAL", "Drug": "METROGEL", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021789s009s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21789"}, "21794": {"ApplNo": "21794", "Form": "GEL;TOPICAL", "Drug": "ACZONE", "ActiveIngredient": "DAPSONE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021794s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21794"}, "21797": {"ApplNo": "21797", "Form": "TABLET;ORAL", "Drug": "BARACLUDE", "ActiveIngredient": "ENTECAVIR", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021797s023,021798s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21797"}, "21798": {"ApplNo": "21798", "Form": "SOLUTION;ORAL", "Drug": "BARACLUDE", "ActiveIngredient": "ENTECAVIR", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021797s023,021798s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21798"}, "21799": {"ApplNo": "21799", "Form": "CAPSULE;ORAL", "Drug": "QUALAQUIN", "ActiveIngredient": "QUININE SULFATE", "ApplType": "NDA", "Sponsor": "SUN PHARM INDUSTRIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21799"}, "21802": {"ApplNo": "21802", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "FOCALIN XR", "ActiveIngredient": "DEXMETHYLPHENIDATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021802s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21802"}, "21806": {"ApplNo": "21806", "Form": "GEL;VAGINAL", "Drug": "VANDAZOLE", "ActiveIngredient": "METRONIDAZOLE", "ApplType": "NDA", "Sponsor": "TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021806s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21806"}, "21807": {"ApplNo": "21807", "Form": "SOLUTION;ORAL", "Drug": "SOLTAMOX", "ActiveIngredient": "TAMOXIFEN CITRATE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21807"}, "21812": {"ApplNo": "21812", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "MEN'S ROGAINE", "ActiveIngredient": "MINOXIDIL", "ApplType": "NDA", "Sponsor": "JOHNSON AND JOHNSON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021812Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21812"}, "21813": {"ApplNo": "21813", "Form": "GEL, METERED;TRANSDERMAL", "Drug": "ELESTRIN", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021813s007s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21813"}, "21814": {"ApplNo": "21814", "Form": "CAPSULE;ORAL", "Drug": "APTIVUS", "ActiveIngredient": "TIPRANAVIR", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021814s021,022292s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21814"}, "21817": {"ApplNo": "21817", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "RECLAST", "ActiveIngredient": "ZOLEDRONIC ACID", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21817"}, "21818": {"ApplNo": "21818", "Form": "TABLET; ORAL", "Drug": "ALINIA", "ActiveIngredient": "NITAZOXANIDE", "ApplType": "NDA", "Sponsor": "ROMARK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021818lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21818"}, "21821": {"ApplNo": "21821", "Form": "POWDER;INTRAVENOUS", "Drug": "TYGACIL", "ActiveIngredient": "TIGECYCLINE", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021821s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21821"}, "21822": {"ApplNo": "21822", "Form": "SOLUTION; ORAL", "Drug": "APTIVUS", "ActiveIngredient": "TIPRANAVIR", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021822LBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21822"}, "21825": {"ApplNo": "21825", "Form": "TABLET;ORAL", "Drug": "FERRIPROX", "ActiveIngredient": "DEFERIPRONE", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21825"}, "21829": {"ApplNo": "21829", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "NEUPRO", "ActiveIngredient": "ROTIGOTINE", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021829s021s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21829"}, "21835": {"ApplNo": "21835", "Form": "SPRAY;TOPICAL", "Drug": "CLOBEX", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021835s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21835"}, "21839": {"ApplNo": "21839", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "INCRELEX", "ActiveIngredient": "MECASERMIN RECOMBINANT", "ApplType": "BLA", "Sponsor": "IPSEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021839s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21839"}, "21840": {"ApplNo": "21840", "Form": "TABLET;ORAL", "Drug": "SEASONIQUE", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021840s012s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21840"}, "21842": {"ApplNo": "21842", "Form": "TABLET;ORAL", "Drug": "ACTOPLUS MET", "ActiveIngredient": "METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21842"}, "21845": {"ApplNo": "21845", "Form": "TABLET;ORAL", "Drug": "REVATIO", "ActiveIngredient": "SILDENAFIL CITRATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021845s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21845"}, "21849": {"ApplNo": "21849", "Form": "CAPSULE;ORAL", "Drug": "ZEGERID", "ActiveIngredient": "OMEPRAZOLE; SODIUM BICARBONATE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021849s019,021636s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21849"}, "21852": {"ApplNo": "21852", "Form": "OINTMENT;TOPICAL", "Drug": "TACLONEX", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021852s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21852"}, "21855": {"ApplNo": "21855", "Form": "CAPSULE;ORAL", "Drug": "LOPERAMIDE HYDROCHLORIDE", "ActiveIngredient": "LOPERAMIDE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BIONPHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021855Orig1s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21855"}, "21856": {"ApplNo": "21856", "Form": "TABLET;ORAL", "Drug": "ULORIC", "ActiveIngredient": "FEBUXOSTAT", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021856s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21856"}, "21859": {"ApplNo": "21859", "Form": "INJECTABLE;INJECTION", "Drug": "HYLENEX RECOMBINANT", "ActiveIngredient": "HYALURONIDASE RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "HALOZYME THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021859lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21859"}, "21861": {"ApplNo": "21861", "Form": "SPRAY, METERED;NASAL", "Drug": "PATANASE", "ActiveIngredient": "OLOPATADINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021861s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21861"}, "21862": {"ApplNo": "21862", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "NEVANAC", "ActiveIngredient": "NEPAFENAC", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021862s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21862"}, "21870": {"ApplNo": "21870", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "FLUDEOXYGLUCOSE F18", "ActiveIngredient": "FLUDEOXYGLUCOSE F-18", "ApplType": "NDA", "Sponsor": "FEINSTEIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021870s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21870"}, "21872": {"ApplNo": "21872", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "KEPPRA", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021872s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21872"}, "21873": {"ApplNo": "21873", "Form": "TABLET; ORAL", "Drug": "YAZ", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021873lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21873"}, "21875": {"ApplNo": "21875", "Form": "TABLET;ORAL", "Drug": "NUVIGIL", "ActiveIngredient": "ARMODAFINIL", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21875"}, "21876": {"ApplNo": "21876", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "DICLEGIS", "ActiveIngredient": "DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "DUCHESNAY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021876s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21876"}, "21877": {"ApplNo": "21877", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ARRANON", "ActiveIngredient": "NELARABINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021877Orig1s012correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21877"}, "21878": {"ApplNo": "21878", "Form": "INJECTABLE; INJECTION", "Drug": "LEVEMIR", "ActiveIngredient": "INSULIN DETEMIR", "ApplType": "BLA", "Sponsor": "NOVO NORDISK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021878lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21878"}, "21879": {"ApplNo": "21879", "Form": "CAPSULE;ORAL", "Drug": "NUEDEXTA", "ActiveIngredient": "DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE", "ApplType": "NDA", "Sponsor": "AVANIR PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021879s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21879"}, "21880": {"ApplNo": "21880", "Form": "CAPSULE;ORAL", "Drug": "REVLIMID", "ActiveIngredient": "LENALIDOMIDE", "ApplType": "NDA", "Sponsor": "CELGENE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021880s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21880"}, "21881": {"ApplNo": "21881", "Form": "FOR SOLUTION;ORAL", "Drug": "MOVIPREP", "ActiveIngredient": "ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE", "ApplType": "NDA", "Sponsor": "SALIX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021881Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21881"}, "21882": {"ApplNo": "21882", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "EXJADE", "ActiveIngredient": "DEFERASIROX", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021882Orig1s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21882"}, "21883": {"ApplNo": "21883", "Form": "POWDER;INTRAVENOUS", "Drug": "DALVANCE", "ActiveIngredient": "DALBAVANCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021883s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21883"}, "21885": {"ApplNo": "21885", "Form": "SYSTEM; TRANSDERMAL", "Drug": "CLIMARA PRO", "ActiveIngredient": "ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "BERLEX LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021885lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21885"}, "21887": {"ApplNo": "21887", "Form": "CAPSULE;ORAL", "Drug": "ALLI", "ActiveIngredient": "ORLISTAT", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021887Orig1s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21887"}, "21891": {"ApplNo": "21891", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "CHILDREN'S CLARITIN", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021891Orig1s043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21891"}, "21892": {"ApplNo": "21892", "Form": "TABLET;ORAL", "Drug": "OSMOPREP", "ActiveIngredient": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "ApplType": "NDA", "Sponsor": "SALIX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21892"}, "21894": {"ApplNo": "21894", "Form": "TABLET;ORAL", "Drug": "XENAZINE", "ActiveIngredient": "TETRABENAZINE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21894"}, "21896": {"ApplNo": "21896", "Form": "SOLUTION;ORAL", "Drug": "EMTRIVA", "ActiveIngredient": "EMTRICITABINE", "ApplType": "NDA", "Sponsor": "GILEAD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021896s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21896"}, "21897": {"ApplNo": "21897", "Form": "FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "VIVITROL", "ActiveIngredient": "NALTREXONE", "ApplType": "NDA", "Sponsor": "ALKERMES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021897s057lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21897"}, "21902": {"ApplNo": "21902", "Form": "OINTMENT;TOPICAL", "Drug": "VEREGEN", "ActiveIngredient": "SINECATECHINS", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021902s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21902"}, "21903": {"ApplNo": "21903", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "NEOPROFEN", "ActiveIngredient": "IBUPROFEN LYSINE", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021903s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21903"}, "21906": {"ApplNo": "21906", "Form": "TABLET;ORAL", "Drug": "KALETRA", "ActiveIngredient": "LOPINAVIR; RITONAVIR", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21906"}, "21908": {"ApplNo": "21908", "Form": "CAPSULE;ORAL", "Drug": "AMITIZA", "ActiveIngredient": "LUBIPROSTONE", "ApplType": "NDA", "Sponsor": "SUCAMPO PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021908s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21908"}, "21910": {"ApplNo": "21910", "Form": "SOLUTION;INJECTION", "Drug": "NORMOCARB HF 25", "ActiveIngredient": "MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE", "ApplType": "NDA", "Sponsor": "DIALYSIS SUPS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021910s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21910"}, "21911": {"ApplNo": "21911", "Form": "TABLET;ORAL", "Drug": "BANZEL", "ActiveIngredient": "RUFINAMIDE", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21911"}, "21912": {"ApplNo": "21912", "Form": "SOLUTION;INHALATION", "Drug": "BROVANA", "ActiveIngredient": "ARFORMOTEROL TARTRATE", "ApplType": "NDA", "Sponsor": "LUPIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021912Orig1s032lblrpl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21912"}, "21918": {"ApplNo": "21918", "Form": "SOLUTION/DROPS;OTIC", "Drug": "CETRAXAL", "ActiveIngredient": "CIPROFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "WRASER PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021918lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21918"}, "21919": {"ApplNo": "21919", "Form": "INJECTABLE; SUBCUTANEOUS", "Drug": "BYETTA", "ActiveIngredient": "EXENATIDE SYNTHETIC", "ApplType": "NDA", "Sponsor": "AMYLIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21919"}, "21920": {"ApplNo": "21920", "Form": "CAPSULE;ORAL", "Drug": "NAPROXEN SODIUM", "ActiveIngredient": "NAPROXEN SODIUM", "ApplType": "NDA", "Sponsor": "BIONPHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021920Orig1s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21920"}, "21923": {"ApplNo": "21923", "Form": "TABLET;ORAL", "Drug": "NEXAVAR", "ActiveIngredient": "SORAFENIB TOSYLATE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021923Orig1s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21923"}, "21924": {"ApplNo": "21924", "Form": "CAPSULE;ORAL", "Drug": "TIROSINT", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "NDA", "Sponsor": "INSTITUT BIOCHIMIQUE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021924Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21924"}, "21925": {"ApplNo": "21925", "Form": "TABLET;ORAL", "Drug": "DUETACT", "ActiveIngredient": "GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21925"}, "21926": {"ApplNo": "21926", "Form": "TABLET;ORAL", "Drug": "TREXIMET", "ActiveIngredient": "NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE", "ApplType": "NDA", "Sponsor": "CURRAX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021926s017s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21926"}, "21929": {"ApplNo": "21929", "Form": "AEROSOL, METERED;INHALATION", "Drug": "SYMBICORT", "ActiveIngredient": "BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021929s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21929"}, "21936": {"ApplNo": "21936", "Form": "SPRAY, METERED;INHALATION", "Drug": "SPIRIVA RESPIMAT", "ActiveIngredient": "TIOTROPIUM BROMIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021936s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21936"}, "21937": {"ApplNo": "21937", "Form": "TABLET;ORAL", "Drug": "ATRIPLA", "ActiveIngredient": "EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021937s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21937"}, "21938": {"ApplNo": "21938", "Form": "CAPSULE;ORAL", "Drug": "SUTENT", "ActiveIngredient": "SUNITINIB MALATE", "ApplType": "NDA", "Sponsor": "CPPI CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21938"}, "21945": {"ApplNo": "21945", "Form": "SOLUTION;INTRAMUSCULAR", "Drug": "MAKENA", "ActiveIngredient": "HYDROXYPROGESTERONE CAPROATE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021945s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21945"}, "21947": {"ApplNo": "21947", "Form": "TABLET;BUCCAL, SUBLINGUAL", "Drug": "FENTORA", "ActiveIngredient": "FENTANYL CITRATE", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021947s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21947"}, "21948": {"ApplNo": "21948", "Form": "INJECTABLE; INJECTION", "Drug": "ERAXIS", "ActiveIngredient": "ANIDULAFUNGIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021632s000,021948s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21948"}, "21949": {"ApplNo": "21949", "Form": "POWDER, METERED;INHALATION", "Drug": "PULMICORT FLEXHALER", "ActiveIngredient": "BUDESONIDE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021949s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21949"}, "21951": {"ApplNo": "21951", "Form": "CAPSULE;ORAL", "Drug": "ABSORICA", "ActiveIngredient": "ISOTRETINOIN", "ApplType": "NDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21951"}, "21952": {"ApplNo": "21952", "Form": "CAPSULE;ORAL", "Drug": "CLARITIN", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019658Orig1s055,021952Orig1s018Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21952"}, "21957": {"ApplNo": "21957", "Form": "FOR SUSPENSION, DELAYED RELEASE;ORAL", "Drug": "NEXIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "021153s059,021957s026,022101s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21957"}, "21958": {"ApplNo": "21958", "Form": "GEL;TOPICAL", "Drug": "LAMISIL AT", "ActiveIngredient": "TERBINAFINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021958lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21958"}, "21959": {"ApplNo": "21959", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "ORAPRED ODT", "ActiveIngredient": "PREDNISOLONE SODIUM PHOSPHATE", "ApplType": "NDA", "Sponsor": "CONCORDIA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021959s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21959"}, "21964": {"ApplNo": "21964", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "RELISTOR", "ActiveIngredient": "METHYLNALTREXONE BROMIDE", "ApplType": "NDA", "Sponsor": "SALIX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21964"}, "21968": {"ApplNo": "21968", "Form": "CAPSULE; ORAL", "Drug": "SUTENT", "ActiveIngredient": "SUNITINIB MALATE", "ApplType": "NDA", "Sponsor": "CPPI CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021968s002s003s004s005s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21968"}, "21976": {"ApplNo": "21976", "Form": "TABLET;ORAL", "Drug": "PREZISTA", "ActiveIngredient": "DARUNAVIR", "ApplType": "NDA", "Sponsor": "JANSSEN PRODS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021976s067,202895s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21976"}, "21977": {"ApplNo": "21977", "Form": "CAPSULE;ORAL", "Drug": "VYVANSE", "ActiveIngredient": "LISDEXAMFETAMINE DIMESYLATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021977s048,208510s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21977"}, "21978": {"ApplNo": "21978", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "VERDESO", "ActiveIngredient": "DESONIDE", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021978s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21978"}, "21980": {"ApplNo": "21980", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "FLUORESCITE", "ActiveIngredient": "FLUORESCEIN SODIUM", "ApplType": "NDA", "Sponsor": "ALCON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021980Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21980"}, "21983": {"ApplNo": "21983", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "DUODOTE", "ActiveIngredient": "ATROPINE; PRALIDOXIME CHLORIDE", "ApplType": "NDA", "Sponsor": "MMT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021983Orig1s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21983"}, "21985": {"ApplNo": "21985", "Form": "TABLET;ORAL", "Drug": "TEKTURNA", "ActiveIngredient": "ALISKIREN HEMIFUMARATE", "ApplType": "NDA", "Sponsor": "NODEN PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021985s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21985"}, "21986": {"ApplNo": "21986", "Form": "TABLET;ORAL", "Drug": "SPRYCEL", "ActiveIngredient": "DASATINIB", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021986s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21986"}, "21990": {"ApplNo": "21990", "Form": "TABLET;ORAL", "Drug": "EXFORGE", "ActiveIngredient": "AMLODIPINE BESYLATE; VALSARTAN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021990s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21990"}, "21991": {"ApplNo": "21991", "Form": "CAPSULE;ORAL", "Drug": "ZOLINZA", "ActiveIngredient": "VORINOSTAT", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021991s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21991"}, "21992": {"ApplNo": "21992", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "PRISTIQ", "ActiveIngredient": "DESVENLAFAXINE SUCCINATE", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21992"}, "21993": {"ApplNo": "21993", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "CLARITIN REDITABS", "ActiveIngredient": "LORATADINE", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020704Orig1s034,021993Orig1s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21993"}, "21994": {"ApplNo": "21994", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "TRAVATAN Z", "ActiveIngredient": "TRAVOPROST", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021994s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21994"}, "21995": {"ApplNo": "21995", "Form": "TABLET;ORAL", "Drug": "JANUVIA", "ActiveIngredient": "SITAGLIPTIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21995"}, "21996": {"ApplNo": "21996", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ALAWAY", "ActiveIngredient": "KETOTIFEN FUMARATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021996Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21996"}, "21997": {"ApplNo": "21997", "Form": "TABLET;SUBLINGUAL", "Drug": "EDLUAR", "ActiveIngredient": "ZOLPIDEM TARTRATE", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21997"}, "21998": {"ApplNo": "21998", "Form": "TABLET;ORAL", "Drug": "PLAN B ONE-STEP", "ActiveIngredient": "LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "FDN CONSUMER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021998Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21998"}, "21999": {"ApplNo": "21999", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "INVEGA", "ActiveIngredient": "PALIPERIDONE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021999Orig1s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21999"}, "22000": {"ApplNo": "22000", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "LIALDA", "ActiveIngredient": "MESALAMINE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022000s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22000"}, "22001": {"ApplNo": "22001", "Form": "TABLET; ORAL", "Drug": "ACTIVELLA", "ActiveIngredient": "ESTRADIOL; NORETHINDRONE ACETATE", "ApplType": "NDA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/022001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22001"}, "22003": {"ApplNo": "22003", "Form": "SUSPENSION;ORAL", "Drug": "NOXAFIL", "ActiveIngredient": "POSACONAZOLE", "ApplType": "NDA", "Sponsor": "SCHERING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022003Orig1s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22003"}, "22004": {"ApplNo": "22004", "Form": "SPRAY, METERED;NASAL", "Drug": "OMNARIS", "ActiveIngredient": "CICLESONIDE", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022004s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22004"}, "22006": {"ApplNo": "22006", "Form": "FOR SOLUTION;ORAL", "Drug": "SABRIL", "ActiveIngredient": "VIGABATRIN", "ApplType": "NDA", "Sponsor": "LUNDBECK PHARMS LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22006"}, "22007": {"ApplNo": "22007", "Form": "SOLUTION;INHALATION", "Drug": "PERFOROMIST", "ActiveIngredient": "FORMOTEROL FUMARATE", "ApplType": "NDA", "Sponsor": "MYLAN SPECLT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022007s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22007"}, "22012": {"ApplNo": "22012", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "COREG CR", "ActiveIngredient": "CARVEDILOL PHOSPHATE", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22012"}, "22013": {"ApplNo": "22013", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "OLUX E", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022013s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22013"}, "22014": {"ApplNo": "22014", "Form": "SPRAY;TRANSDERMAL", "Drug": "EVAMIST", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022014s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22014"}, "22015": {"ApplNo": "22015", "Form": "FOR SOLUTION;ORAL", "Drug": "MIRALAX", "ActiveIngredient": "POLYETHYLENE GLYCOL 3350", "ApplType": "NDA", "Sponsor": "BAYER HEALTHCARE LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022015Orig1s043Correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22015"}, "22020": {"ApplNo": "22020", "Form": "FOR SUSPENSION, DELAYED RELEASE;ORAL", "Drug": "PROTONIX", "ActiveIngredient": "PANTOPRAZOLE SODIUM", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020987s058,022020s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22020"}, "22023": {"ApplNo": "22023", "Form": "POWDER;INTRAVENOUS", "Drug": "EMEND", "ActiveIngredient": "FOSAPREPITANT DIMEGLUMINE", "ApplType": "NDA", "Sponsor": "MERCK AND CO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022023s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22023"}, "22027": {"ApplNo": "22027", "Form": "SUSPENSION; ORAL", "Drug": "NOXAFIL", "ActiveIngredient": "POSACONAZOLE", "ApplType": "NDA", "Sponsor": "SCHERING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022003s011s012,022027s002s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22027"}, "22029": {"ApplNo": "22029", "Form": "PATCH;TOPICAL", "Drug": "SALONPAS", "ActiveIngredient": "MENTHOL; METHYL SALICYLATE", "ApplType": "NDA", "Sponsor": "HISAMITSU PHARM CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022029Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22029"}, "22030": {"ApplNo": "22030", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "TOVIAZ", "ActiveIngredient": "FESOTERODINE FUMARATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022030s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22030"}, "22032": {"ApplNo": "22032", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "OMEPRAZOLE", "ActiveIngredient": "OMEPRAZOLE", "ApplType": "NDA", "Sponsor": "DEXCEL PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022032Orig1s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22032"}, "22036": {"ApplNo": "22036", "Form": "TABLET;ORAL", "Drug": "SILENOR", "ActiveIngredient": "DOXEPIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CURRAX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022036s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22036"}, "22037": {"ApplNo": "22037", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "INTUNIV", "ActiveIngredient": "GUANFACINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22037"}, "22038": {"ApplNo": "22038", "Form": "GEL;TRANSDERMAL", "Drug": "DIVIGEL", "ActiveIngredient": "ESTRADIOL", "ApplType": "NDA", "Sponsor": "VERTICAL PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022038s005s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22038"}, "22041": {"ApplNo": "22041", "Form": "INJECTABLE;INJECTION", "Drug": "CYANOKIT", "ActiveIngredient": "HYDROXOCOBALAMIN", "ApplType": "NDA", "Sponsor": "BTG INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022041s019, 020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22041"}, "22042": {"ApplNo": "22042", "Form": "TABLET; ORAL", "Drug": "EVISTA", "ActiveIngredient": "RALOXIFENE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22042"}, "22043": {"ApplNo": "22043", "Form": "TABLET, EXTENDED RELEASE; ORAL", "Drug": "INVEGA", "ActiveIngredient": "PALIPERIDONE", "ApplType": "NDA", "Sponsor": "JANSSEN LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022043lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22043"}, "22044": {"ApplNo": "22044", "Form": "TABLET;ORAL", "Drug": "JANUMET", "ActiveIngredient": "METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022044s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22044"}, "22046": {"ApplNo": "22046", "Form": "INJECTABLE; INJECTION", "Drug": "BUPIVACAINE HYDROCHLORIDE", "ActiveIngredient": "BUPIVACAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022046s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22046"}, "22047": {"ApplNo": "22047", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "SEROQUEL XR", "ActiveIngredient": "QUETIAPINE FUMARATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022047s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22047"}, "22048": {"ApplNo": "22048", "Form": "INJECTABLE;INTRAVITREAL", "Drug": "TRIESENCE", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022223,022048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22048"}, "22051": {"ApplNo": "22051", "Form": "SPRAY, METERED;NASAL", "Drug": "FLONASE SENSIMIST ALLERGY RELIEF", "ActiveIngredient": "FLUTICASONE FUROATE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022051Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22051"}, "22055": {"ApplNo": "22055", "Form": "OINTMENT;TOPICAL", "Drug": "ALTABAX", "ActiveIngredient": "RETAPAMULIN", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022055s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22055"}, "22056": {"ApplNo": "22056", "Form": "FOR SUSPENSION, DELAYED RELEASE;ORAL", "Drug": "PRILOSEC", "ActiveIngredient": "OMEPRAZOLE MAGNESIUM", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022056s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22056"}, "22057": {"ApplNo": "22057", "Form": "INSERT;VAGINAL", "Drug": "ENDOMETRIN", "ActiveIngredient": "PROGESTERONE", "ApplType": "NDA", "Sponsor": "FERRING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022057s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22057"}, "22058": {"ApplNo": "22058", "Form": "IMPLANT;SUBCUTANEOUS", "Drug": "SUPPRELIN LA", "ActiveIngredient": "HISTRELIN ACETATE", "ApplType": "NDA", "Sponsor": "ENDO PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022058s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22058"}, "22059": {"ApplNo": "22059", "Form": "TABLET;ORAL", "Drug": "TYKERB", "ActiveIngredient": "LAPATINIB DITOSYLATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022059s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22059"}, "22063": {"ApplNo": "22063", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "MYDAYIS", "ActiveIngredient": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022063s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22063"}, "22065": {"ApplNo": "22065", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "IXEMPRA KIT", "ActiveIngredient": "IXABEPILONE", "ApplType": "NDA", "Sponsor": "R-PHARM US LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022065s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22065"}, "22066": {"ApplNo": "22066", "Form": "INJECTABLE;INJECTION", "Drug": "OMNISCAN", "ActiveIngredient": "GADODIAMIDE", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022066s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22066"}, "22068": {"ApplNo": "22068", "Form": "CAPSULE;ORAL", "Drug": "TASIGNA", "ActiveIngredient": "NILOTINIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22068"}, "22070": {"ApplNo": "22070", "Form": "GEL;TOPICAL", "Drug": "ATRALIN", "ActiveIngredient": "TRETINOIN", "ApplType": "NDA", "Sponsor": "DOW PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022070s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22070"}, "22072": {"ApplNo": "22072", "Form": "TABLET; ORAL", "Drug": "SPRYCEL", "ActiveIngredient": "DASATINIB", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/022072lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22072"}, "22074": {"ApplNo": "22074", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "SOMATULINE DEPOT", "ActiveIngredient": "LANREOTIDE ACETATE", "ApplType": "NDA", "Sponsor": "IPSEN PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022074Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22074"}, "22075": {"ApplNo": "22075", "Form": "TABLET;ORAL", "Drug": "NOURIANZ", "ActiveIngredient": "ISTRADEFYLLINE", "ApplType": "NDA", "Sponsor": "KYOWA KIRIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022075s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22075"}, "22076": {"ApplNo": "22076", "Form": "LOTION;TOPICAL", "Drug": "LOCOID", "ActiveIngredient": "HYDROCORTISONE BUTYRATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022076s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22076"}, "22080": {"ApplNo": "22080", "Form": "INJECTABLE; INJECTION", "Drug": "RECLAST", "ActiveIngredient": "ZOLEDRONIC ACID", "ApplType": "NDA", "Sponsor": "NOVARTIS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022080lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22080"}, "22081": {"ApplNo": "22081", "Form": "TABLET;ORAL", "Drug": "LETAIRIS", "ActiveIngredient": "AMBRISENTAN", "ApplType": "NDA", "Sponsor": "GILEAD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22081"}, "22083": {"ApplNo": "22083", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "EXELON", "ActiveIngredient": "RIVASTIGMINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022083s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22083"}, "22087": {"ApplNo": "22087", "Form": "OINTMENT;TOPICAL", "Drug": "VECTICAL", "ActiveIngredient": "CALCITRIOL", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022087s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22087"}, "22088": {"ApplNo": "22088", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TORISEL", "ActiveIngredient": "TEMSIROLIMUS", "ApplType": "NDA", "Sponsor": "PF PRISM CV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022088s021s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22088"}, "22090": {"ApplNo": "22090", "Form": "SOLUTION;INTRAVENOUS", "Drug": "EOVIST", "ActiveIngredient": "GADOXETATE DISODIUM", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022090s020lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22090"}, "22100": {"ApplNo": "22100", "Form": "TABLET;ORAL", "Drug": "AZOR", "ActiveIngredient": "AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022100s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22100"}, "22101": {"ApplNo": "22101", "Form": "FOR SUSPENSION, DELAYED RELEASE;ORAL", "Drug": "NEXIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021153s059,021957s026,022101s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22101"}, "22104": {"ApplNo": "22104", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "VENLAFAXINE HYDROCHLORIDE", "ActiveIngredient": "VENLAFAXINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "OSMOTICA PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022104s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22104"}, "22108": {"ApplNo": "22108", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "APLENZIN", "ActiveIngredient": "BUPROPION HYDROBROMIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022108s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22108"}, "22110": {"ApplNo": "22110", "Form": "POWDER;INTRAVENOUS", "Drug": "VIBATIV", "ActiveIngredient": "TELAVANCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CUMBERLAND PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022110s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22110"}, "22113": {"ApplNo": "22113", "Form": "TABLET;ORAL", "Drug": "ADVIL ALLERGY AND CONGESTION RELIEF", "ActiveIngredient": "CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022113Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22113"}, "22114": {"ApplNo": "22114", "Form": "SYSTEM;INTRADERMAL", "Drug": "ZINGO", "ActiveIngredient": "LIDOCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "POWDER PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022114s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22114"}, "22115": {"ApplNo": "22115", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "LAMICTAL XR", "ActiveIngredient": "LAMOTRIGINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022115s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22115"}, "22116": {"ApplNo": "22116", "Form": "SUSPENSION;ORAL", "Drug": "LEXIVA", "ActiveIngredient": "FOSAMPRENAVIR CALCIUM", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021548s041,022116s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22116"}, "22117": {"ApplNo": "22117", "Form": "TABLET;SUBLINGUAL", "Drug": "SAPHRIS", "ActiveIngredient": "ASENAPINE MALEATE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022117s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22117"}, "22118": {"ApplNo": "22118", "Form": "TABLET;ORAL", "Drug": "FENOGLIDE", "ActiveIngredient": "FENOFIBRATE", "ApplType": "NDA", "Sponsor": "SALIX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022118s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22118"}, "22119": {"ApplNo": "22119", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "AMMONIA N 13", "ActiveIngredient": "AMMONIA N-13", "ApplType": "NDA", "Sponsor": "FEINSTEIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022119s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22119"}, "22122": {"ApplNo": "22122", "Form": "GEL;TOPICAL", "Drug": "VOLTAREN ARTHRITIS PAIN", "ActiveIngredient": "DICLOFENAC SODIUM", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE CONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022122Orig1s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22122"}, "22124": {"ApplNo": "22124", "Form": "SPRAY; NASAL", "Drug": "OMNARIS", "ActiveIngredient": "CICLESONIDE", "ApplType": "NDA", "Sponsor": "NYCOMED US INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022124lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22124"}, "22127": {"ApplNo": "22127", "Form": "TABLET;ORAL", "Drug": "RENVELA", "ActiveIngredient": "SEVELAMER CARBONATE", "ApplType": "NDA", "Sponsor": "SANOFI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022127s019,022318s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22127"}, "22128": {"ApplNo": "22128", "Form": "TABLET;ORAL", "Drug": "SELZENTRY", "ActiveIngredient": "MARAVIROC", "ApplType": "NDA", "Sponsor": "VIIV HLTHCARE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128Orig1s019,208984Orig1s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22128"}, "22134": {"ApplNo": "22134", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "LASTACAFT", "ActiveIngredient": "ALCAFTADINE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022134Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22134"}, "22137": {"ApplNo": "22137", "Form": "INJECTABLE;INJECTION", "Drug": "FLUDARABINE PHOSPHATE", "ActiveIngredient": "FLUDARABINE PHOSPHATE", "ApplType": "NDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022137s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22137"}, "22138": {"ApplNo": "22138", "Form": "INJECTABLE; INJECTION", "Drug": "LOVENOX", "ActiveIngredient": "ENOXAPARIN SODIUM", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022138,020164s075lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22138"}, "22141": {"ApplNo": "22141", "Form": "TABLET;ORAL", "Drug": "CIMDUO", "ActiveIngredient": "LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "MYLAN LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022141s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22141"}, "22142": {"ApplNo": "22142", "Form": "TABLET;ORAL", "Drug": "SYMFI", "ActiveIngredient": "EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "MYLAN LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022142s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22142"}, "22145": {"ApplNo": "22145", "Form": "TABLET;ORAL", "Drug": "ISENTRESS", "ActiveIngredient": "RALTEGRAVIR POTASSIUM", "ApplType": "NDA", "Sponsor": "MSD SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022145s044,203045s017,205786s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22145"}, "22148": {"ApplNo": "22148", "Form": "CAPSULE, DELAYED REL PELLETS; ORAL", "Drug": "CYMBALTA", "ActiveIngredient": "DULOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022148lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22148"}, "22150": {"ApplNo": "22150", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "FIRAZYR", "ActiveIngredient": "ICATIBANT ACETATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022150Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22150"}, "22155": {"ApplNo": "22155", "Form": "SYRUP;ORAL", "Drug": "CHILDREN'S ZYRTEC HIVES RELIEF", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022155Orig1015Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22155"}, "22156": {"ApplNo": "22156", "Form": "EMULSION;INTRAVENOUS", "Drug": "CLEVIPREX", "ActiveIngredient": "CLEVIDIPINE", "ApplType": "NDA", "Sponsor": "CHIESI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022156s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22156"}, "22159": {"ApplNo": "22159", "Form": "INJECTABLE;INJECTION", "Drug": "ORAVERSE", "ActiveIngredient": "PHENTOLAMINE MESYLATE", "ApplType": "NDA", "Sponsor": "SEPTODONT HOLDING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022159s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22159"}, "22160": {"ApplNo": "22160", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "OXALIPLATIN", "ActiveIngredient": "OXALIPLATIN", "ApplType": "NDA", "Sponsor": "TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022160s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22160"}, "22161": {"ApplNo": "22161", "Form": "SOLUTION;INTRAVENOUS", "Drug": "LEXISCAN", "ActiveIngredient": "REGADENOSON", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022161s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22161"}, "22165": {"ApplNo": "22165", "Form": "FOR SOLUTION;ORAL", "Drug": "CAMBIA", "ActiveIngredient": "DICLOFENAC POTASSIUM", "ApplType": "NDA", "Sponsor": "ASSERTIO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022165s013s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22165"}, "22172": {"ApplNo": "22172", "Form": "TABLET, EXTENDED RELEASE; ORAL", "Drug": "SEROQUEL XR", "ActiveIngredient": "QUETIAPINE FUMARATE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022172lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22172"}, "22173": {"ApplNo": "22173", "Form": "SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "ZYPREXA RELPREVV", "ActiveIngredient": "OLANZAPINE PAMOATE", "ApplType": "NDA", "Sponsor": "ELI LILLY CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22173"}, "22175": {"ApplNo": "22175", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "PERTZYE", "ActiveIngredient": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)", "ApplType": "BLA", "Sponsor": "DIGESTIVE CARE INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22175"}, "22180": {"ApplNo": "22180", "Form": "SOLUTION;INTRAVENOUS", "Drug": "FERAHEME", "ActiveIngredient": "FERUMOXYTOL", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022180s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22180"}, "22181": {"ApplNo": "22181", "Form": "TABLET;ORAL", "Drug": "KUVAN", "ActiveIngredient": "SAPROPTERIN DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BIOMARIN PHARM", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022181s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22181"}, "22184": {"ApplNo": "22184", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "LUMIGAN", "ActiveIngredient": "BIMATOPROST", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022184s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22184"}, "22185": {"ApplNo": "22185", "Form": "SUSPENSION;TOPICAL", "Drug": "TACLONEX", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022185s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22185"}, "22187": {"ApplNo": "22187", "Form": "TABLET;ORAL", "Drug": "INTELENCE", "ActiveIngredient": "ETRAVIRINE", "ApplType": "NDA", "Sponsor": "JANSSEN R AND D", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022187s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22187"}, "22192": {"ApplNo": "22192", "Form": "TABLET;ORAL", "Drug": "FANAPT", "ActiveIngredient": "ILOPERIDONE", "ApplType": "NDA", "Sponsor": "VANDA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022192s018s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22192"}, "22195": {"ApplNo": "22195", "Form": "SOLUTION;ORAL", "Drug": "MORPHINE SULFATE", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22195"}, "22198": {"ApplNo": "22198", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "SANCUSO", "ActiveIngredient": "GRANISETRON", "ApplType": "NDA", "Sponsor": "KYOWA KIRIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022198s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22198"}, "22201": {"ApplNo": "22201", "Form": "POWDER;SUBCUTANEOUS", "Drug": "FIRMAGON", "ActiveIngredient": "DEGARELIX ACETATE", "ApplType": "NDA", "Sponsor": "FERRING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022201s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22201"}, "22202": {"ApplNo": "22202", "Form": "CAPSULE;ORAL", "Drug": "ZIPSOR", "ActiveIngredient": "DICLOFENAC POTASSIUM", "ApplType": "NDA", "Sponsor": "ASSERTIO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022202s013s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22202"}, "22204": {"ApplNo": "22204", "Form": "GEL;TRANSDERMAL", "Drug": "GELNIQUE", "ActiveIngredient": "OXYBUTYNIN CHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022204s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22204"}, "22206": {"ApplNo": "22206", "Form": "CAPSULE;ORAL", "Drug": "RAPAFLO", "ActiveIngredient": "SILODOSIN", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022206s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22206"}, "22207": {"ApplNo": "22207", "Form": "TABLET;ORAL", "Drug": "MORPHINE SULFATE", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022207s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22207"}, "22210": {"ApplNo": "22210", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "ZENPEP", "ActiveIngredient": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)", "ApplType": "BLA", "Sponsor": "EURAND PHARMA LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022210Orig1s024_CorrectedLbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22210"}, "22211": {"ApplNo": "22211", "Form": "GEL;OPHTHALMIC", "Drug": "ZIRGAN", "ActiveIngredient": "GANCICLOVIR", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022211lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22211"}, "22212": {"ApplNo": "22212", "Form": "EMULSION;OPHTHALMIC", "Drug": "DUREZOL", "ActiveIngredient": "DIFLUPREDNATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022212s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22212"}, "22219": {"ApplNo": "22219", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "AVEED", "ActiveIngredient": "TESTOSTERONE UNDECANOATE", "ApplType": "NDA", "Sponsor": "ENDO PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022219s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22219"}, "22221": {"ApplNo": "22221", "Form": "GEL;OPHTHALMIC", "Drug": "AKTEN", "ActiveIngredient": "LIDOCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "THEA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022221s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22221"}, "22223": {"ApplNo": "22223", "Form": "INJECTABLE; SUSPENSION", "Drug": "TRIESENCE", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "NDA", "Sponsor": "ALCON RES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022223,022048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22223"}, "22224": {"ApplNo": "22224", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "TRILIPIX", "ActiveIngredient": "CHOLINE FENOFIBRATE", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022224s016s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22224"}, "22225": {"ApplNo": "22225", "Form": "SOLUTION;INTRAVENOUS", "Drug": "BRIDION", "ActiveIngredient": "SUGAMMADEX SODIUM", "ApplType": "NDA", "Sponsor": "ORGANON SUB MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022225Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22225"}, "22231": {"ApplNo": "22231", "Form": "POWDER;INTRAVENOUS", "Drug": "TERLIVAZ", "ActiveIngredient": "TERLIPRESSIN ACETATE", "ApplType": "NDA", "Sponsor": "MALLINCKRODT IRELAND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022231s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22231"}, "22234": {"ApplNo": "22234", "Form": "INJECTABLE;INJECTION", "Drug": "DOCETAXEL", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022234s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22234"}, "22235": {"ApplNo": "22235", "Form": "TABLET; ORAL", "Drug": "LUVOX", "ActiveIngredient": "FLUVOXAMINE MALEATE", "ApplType": "NDA", "Sponsor": "JAZZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022235lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22235"}, "22247": {"ApplNo": "22247", "Form": "TABLET;ORAL", "Drug": "DUAVEE", "ActiveIngredient": "BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022247s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22247"}, "22249": {"ApplNo": "22249", "Form": "POWDER;IV (INFUSION)", "Drug": "TREANDA", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022249s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22249"}, "22250": {"ApplNo": "22250", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "AMPYRA", "ActiveIngredient": "DALFAMPRIDINE", "ApplType": "NDA", "Sponsor": "ACORDA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22250"}, "22251": {"ApplNo": "22251", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "LAMICTAL ODT", "ActiveIngredient": "LAMOTRIGINE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22251"}, "22252": {"ApplNo": "22252", "Form": "TABLET;ORAL", "Drug": "NATAZIA", "ActiveIngredient": "DIENOGEST; ESTRADIOL VALERATE", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022252s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22252"}, "22253": {"ApplNo": "22253", "Form": "TABLET;ORAL", "Drug": "VIMPAT", "ActiveIngredient": "LACOSAMIDE", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022253s055,022254s045,022255s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22253"}, "22254": {"ApplNo": "22254", "Form": "SOLUTION;INTRAVENOUS", "Drug": "VIMPAT", "ActiveIngredient": "LACOSAMIDE", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022253s055,022254s045,022255s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22254"}, "22255": {"ApplNo": "22255", "Form": "SOLUTION;ORAL", "Drug": "VIMPAT", "ActiveIngredient": "LACOSAMIDE", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022253s055,022254s045,022255s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22255"}, "22256": {"ApplNo": "22256", "Form": "TABLET;ORAL", "Drug": "SAVELLA", "ActiveIngredient": "MILNACIPRAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022256s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22256"}, "22257": {"ApplNo": "22257", "Form": "FOR SOLUTION;ORAL", "Drug": "VALCYTE", "ActiveIngredient": "VALGANCICLOVIR HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOFFMANN LA ROCHE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021304.s17_22257s12lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22257"}, "22259": {"ApplNo": "22259", "Form": "CREAM;TOPICAL", "Drug": "TOLAK", "ActiveIngredient": "FLUOROURACIL", "ApplType": "NDA", "Sponsor": "HILL DERMACEUTICALS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022259Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22259"}, "22260": {"ApplNo": "22260", "Form": "INJECTABLE;INJECTION", "Drug": "VELETRI", "ActiveIngredient": "EPOPROSTENOL SODIUM", "ApplType": "NDA", "Sponsor": "ACTELION", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022260s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22260"}, "22262": {"ApplNo": "22262", "Form": "TABLET;ORAL", "Drug": "LOSEASONIQUE", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "NDA", "Sponsor": "TEVA BRANDED PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022262s003s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22262"}, "22264": {"ApplNo": "22264", "Form": "SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR", "Drug": "INVEGA SUSTENNA", "ActiveIngredient": "PALIPERIDONE PALMITATE", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022264s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22264"}, "22267": {"ApplNo": "22267", "Form": "TABLET, EXTENDED RELEASE; ORAL", "Drug": "DEPAKOTE ER", "ActiveIngredient": "DIVALPROEX SODIUM", "ApplType": "NDA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022267s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22267"}, "22268": {"ApplNo": "22268", "Form": "TABLET;ORAL", "Drug": "COARTEM", "ActiveIngredient": "ARTEMETHER; LUMEFANTRINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022268s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22268"}, "22271": {"ApplNo": "22271", "Form": "TABLET;ORAL", "Drug": "NESINA", "ActiveIngredient": "ALOGLIPTIN BENZOATE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022271s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22271"}, "22272": {"ApplNo": "22272", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "OXYCONTIN", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PURDUE PHARMA LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022272s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22272"}, "22275": {"ApplNo": "22275", "Form": "TABLET;ORAL", "Drug": "SAMSCA", "ActiveIngredient": "TOLVAPTAN", "ApplType": "NDA", "Sponsor": "OTSUKA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22275"}, "22276": {"ApplNo": "22276", "Form": "INJECTABLE;INJECTION", "Drug": "NICARDIPINE HYDROCHLORIDE", "ActiveIngredient": "NICARDIPINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HIKMA INTL PHARMS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022276Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22276"}, "22277": {"ApplNo": "22277", "Form": "POWDER;INTRAVENOUS", "Drug": "TEMODAR", "ActiveIngredient": "TEMOZOLOMIDE", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022277s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22277"}, "22281": {"ApplNo": "22281", "Form": "CAPSULE;ORAL", "Drug": "ZEGERID OTC", "ActiveIngredient": "OMEPRAZOLE; SODIUM BICARBONATE", "ApplType": "NDA", "Sponsor": "RILEY CONSUMER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022281Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22281"}, "22283": {"ApplNo": "22283", "Form": "FOR SUSPENSION;ORAL", "Drug": "ZEGERID OTC", "ActiveIngredient": "OMEPRAZOLE; SODIUM BICARBONATE", "ApplType": "NDA", "Sponsor": "RILEY CONSUMER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022283Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22283"}, "22285": {"ApplNo": "22285", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "KEPPRA XR", "ActiveIngredient": "LEVETIRACETAM", "ApplType": "NDA", "Sponsor": "UCB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022285s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22285"}, "22287": {"ApplNo": "22287", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "DEXILANT", "ActiveIngredient": "DEXLANSOPRAZOLE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022287s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22287"}, "22288": {"ApplNo": "22288", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "BEPREVE", "ActiveIngredient": "BEPOTASTINE BESILATE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022288s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22288"}, "22290": {"ApplNo": "22290", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ADREVIEW", "ActiveIngredient": "IOBENGUANE SULFATE I-123", "ApplType": "NDA", "Sponsor": "GE HEALTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022290s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22290"}, "22291": {"ApplNo": "22291", "Form": "TABLET;ORAL", "Drug": "PROMACTA", "ActiveIngredient": "ELTROMBOPAG OLAMINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022291Orig1s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22291"}, "22301": {"ApplNo": "22301", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "APRISO", "ActiveIngredient": "MESALAMINE", "ApplType": "NDA", "Sponsor": "VALEANT PHARMS INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022301s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22301"}, "22303": {"ApplNo": "22303", "Form": "INJECTABLE; INJECTION", "Drug": "TREANDA", "ActiveIngredient": "BENDAMUSTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CEPHALON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022303lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22303"}, "22304": {"ApplNo": "22304", "Form": "TABLET;ORAL", "Drug": "NUCYNTA", "ActiveIngredient": "TAPENTADOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "COLLEGIUM PHARM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022304s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22304"}, "22306": {"ApplNo": "22306", "Form": "SOLUTION;INTRAVENOUS", "Drug": "SOTALOL HYDROCHLORIDE", "ActiveIngredient": "SOTALOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALTATHERA PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022306s005lblrpl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22306"}, "22307": {"ApplNo": "22307", "Form": "TABLET;ORAL", "Drug": "EFFIENT", "ActiveIngredient": "PRASUGREL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22307"}, "22308": {"ApplNo": "22308", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "BESIVANCE", "ActiveIngredient": "BESIFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022308s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22308"}, "22309": {"ApplNo": "22309", "Form": "GEL, METERED;TRANSDERMAL", "Drug": "ANDROGEL", "ActiveIngredient": "TESTOSTERONE", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22309"}, "22310": {"ApplNo": "22310", "Form": "TABLET; ORAL", "Drug": "CASODEX", "ActiveIngredient": "BICALUTAMIDE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022310lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22310"}, "22311": {"ApplNo": "22311", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "MOZOBIL", "ActiveIngredient": "PLERIXAFOR", "ApplType": "NDA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022311s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22311"}, "22314": {"ApplNo": "22314", "Form": "TABLET;ORAL", "Drug": "EXFORGE HCT", "ActiveIngredient": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022314Orig1s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22314"}, "22315": {"ApplNo": "22315", "Form": "IMPLANT;INTRAVITREAL", "Drug": "OZURDEX", "ActiveIngredient": "DEXAMETHASONE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022315s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22315"}, "22318": {"ApplNo": "22318", "Form": "FOR SUSPENSION;ORAL", "Drug": "RENVELA", "ActiveIngredient": "SEVELAMER CARBONATE", "ApplType": "NDA", "Sponsor": "GENZYME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022127s019,022318s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22318"}, "22320": {"ApplNo": "22320", "Form": "GEL;TOPICAL", "Drug": "EPIDUO", "ActiveIngredient": "ADAPALENE; BENZOYL PEROXIDE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022320s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22320"}, "22325": {"ApplNo": "22325", "Form": "INJECTABLE;INJECTION", "Drug": "NEXTERONE", "ActiveIngredient": "AMIODARONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022325s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22325"}, "22327": {"ApplNo": "22327", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "PREVACID 24 HR", "ActiveIngredient": "LANSOPRAZOLE", "ApplType": "NDA", "Sponsor": "PERRIGO PHARMA INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022327Orig1s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22327"}, "22331": {"ApplNo": "22331", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "KAPVAY", "ActiveIngredient": "CLONIDINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CONCORDIA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022331s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22331"}, "22332": {"ApplNo": "22332", "Form": "TABLET;ORAL", "Drug": "ADCIRCA", "ActiveIngredient": "TADALAFIL", "ApplType": "NDA", "Sponsor": "ELI LILLY CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022332Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22332"}, "22334": {"ApplNo": "22334", "Form": "TABLET;ORAL", "Drug": "AFINITOR", "ActiveIngredient": "EVEROLIMUS", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203985s023,022334s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22334"}, "22341": {"ApplNo": "22341", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "VICTOZA", "ActiveIngredient": "LIRAGLUTIDE RECOMBINANT", "ApplType": "NDA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022341s037s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22341"}, "22348": {"ApplNo": "22348", "Form": "SOLUTION;INTRAVENOUS", "Drug": "CALDOLOR", "ActiveIngredient": "IBUPROFEN", "ApplType": "NDA", "Sponsor": "CUMBERLAND PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022348Orig1s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22348"}, "22350": {"ApplNo": "22350", "Form": "TABLET;ORAL", "Drug": "ONGLYZA", "ActiveIngredient": "SAXAGLIPTIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22350"}, "22351": {"ApplNo": "22351", "Form": "TABLET; ORAL", "Drug": "COLCRYS", "ActiveIngredient": "COLCHICINE", "ApplType": "NDA", "Sponsor": "AR HOLDING CO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022351lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22351"}, "22352": {"ApplNo": "22352", "Form": "TABLET;ORAL", "Drug": "COLCRYS", "ActiveIngredient": "COLCHICINE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22352"}, "22353": {"ApplNo": "22353", "Form": "TABLET; ORAL", "Drug": "COLCRYS", "ActiveIngredient": "COLCHICINE", "ApplType": "NDA", "Sponsor": "AR HOLDING CO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22353"}, "22360": {"ApplNo": "22360", "Form": "TROCHE/LOZENGE;ORAL", "Drug": "NICORETTE", "ActiveIngredient": "NICOTINE POLACRILEX", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022360Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22360"}, "22362": {"ApplNo": "22362", "Form": "FOR SUSPENSION;ORAL", "Drug": "WELCHOL", "ActiveIngredient": "COLESEVELAM HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "COSETTE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022362s029,021176s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22362"}, "22363": {"ApplNo": "22363", "Form": "TABLET;ORAL", "Drug": "LIVALO", "ActiveIngredient": "PITAVASTATIN CALCIUM", "ApplType": "NDA", "Sponsor": "KOWA CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022363s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22363"}, "22368": {"ApplNo": "22368", "Form": "POWDER;INHALATION", "Drug": "ARIDOL KIT", "ActiveIngredient": "MANNITOL", "ApplType": "NDA", "Sponsor": "PHARMAXIS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022368s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22368"}, "22369": {"ApplNo": "22369", "Form": "SOLUTION/DROPS;TOPICAL", "Drug": "LATISSE", "ActiveIngredient": "BIMATOPROST", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022369s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22369"}, "22370": {"ApplNo": "22370", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "CONZIP", "ActiveIngredient": "TRAMADOL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CIPHER PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022370s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22370"}, "22372": {"ApplNo": "22372", "Form": "SOLUTION;ORAL", "Drug": "SUPREP BOWEL PREP KIT", "ActiveIngredient": "MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE", "ApplType": "NDA", "Sponsor": "BRAINTREE LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22372"}, "22382": {"ApplNo": "22382", "Form": "SPRAY, METERED;NASAL", "Drug": "SPRIX", "ActiveIngredient": "KETOROLAC TROMETHAMINE", "ApplType": "NDA", "Sponsor": "ZYLA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022382s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22382"}, "22387": {"ApplNo": "22387", "Form": "SOLUTION;INHALATION", "Drug": "TYVASO", "ActiveIngredient": "TREPROSTINIL", "ApplType": "NDA", "Sponsor": "UNITED THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022387s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22387"}, "22388": {"ApplNo": "22388", "Form": "DRUG-ELUTING CONTACT LENS;OPHTHALMIC", "Drug": "ACUVUE THERAVISION WITH KETOTIFEN", "ActiveIngredient": "KETOTIFEN FUMARATE", "ApplType": "NDA", "Sponsor": "JOHNSON JOHNSON VISN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022388s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22388"}, "22393": {"ApplNo": "22393", "Form": "POWDER;INTRAVENOUS", "Drug": "ISTODAX", "ActiveIngredient": "ROMIDEPSIN", "ApplType": "NDA", "Sponsor": "CELGENE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022393s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22393"}, "22395": {"ApplNo": "22395", "Form": "PATCH;TOPICAL", "Drug": "QUTENZA", "ActiveIngredient": "CAPSAICIN", "ApplType": "NDA", "Sponsor": "AVERITAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022395s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22395"}, "22399": {"ApplNo": "22399", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "HORIZANT", "ActiveIngredient": "GABAPENTIN ENACARBIL", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22399"}, "22402": {"ApplNo": "22402", "Form": "TABLET;ORAL", "Drug": "CODEINE SULFATE", "ActiveIngredient": "CODEINE SULFATE", "ApplType": "NDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022402s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22402"}, "22404": {"ApplNo": "22404", "Form": "TABLET;BUCCAL", "Drug": "ORAVIG", "ActiveIngredient": "MICONAZOLE", "ApplType": "NDA", "Sponsor": "GALT PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022404s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22404"}, "22405": {"ApplNo": "22405", "Form": "TABLET;ORAL", "Drug": "CAPRELSA", "ActiveIngredient": "VANDETANIB", "ApplType": "NDA", "Sponsor": "GENZYME CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022405s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22405"}, "22406": {"ApplNo": "22406", "Form": "TABLET;ORAL", "Drug": "XARELTO", "ActiveIngredient": "RIVAROXABAN", "ApplType": "NDA", "Sponsor": "JANSSEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406Orig1s039,202439Orig1s038correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22406"}, "22407": {"ApplNo": "22407", "Form": "INJECTABLE; INJECTION", "Drug": "VIBATIV", "ActiveIngredient": "TELAVANCIN", "ApplType": "NDA", "Sponsor": "THERAVANCE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022407s000,022110s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22407"}, "22408": {"ApplNo": "22408", "Form": "SUSPENSION;TOPICAL", "Drug": "NATROBA", "ActiveIngredient": "SPINOSAD", "ApplType": "NDA", "Sponsor": "PARAPRO LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022408Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22408"}, "22410": {"ApplNo": "22410", "Form": "FILM;BUCCAL, SUBLINGUAL", "Drug": "SUBOXONE", "ActiveIngredient": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "INDIVIOR INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022410s046s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22410"}, "22416": {"ApplNo": "22416", "Form": "TABLET;ORAL", "Drug": "APTIOM", "ActiveIngredient": "ESLICARBAZEPINE ACETATE", "ApplType": "NDA", "Sponsor": "SUNOVION PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22416"}, "22417": {"ApplNo": "22417", "Form": "TABLET;ORAL", "Drug": "NORVIR", "ActiveIngredient": "RITONAVIR", "ApplType": "NDA", "Sponsor": "ABBVIE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022417Orig1s025,020659Orig1s073,209512Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22417"}, "22421": {"ApplNo": "22421", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MIRAPEX ER", "ActiveIngredient": "PRAMIPEXOLE DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022421s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22421"}, "22425": {"ApplNo": "22425", "Form": "TABLET;ORAL", "Drug": "MULTAQ", "ActiveIngredient": "DRONEDARONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022425s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22425"}, "22426": {"ApplNo": "22426", "Form": "TABLET;ORAL", "Drug": "OSENI", "ActiveIngredient": "ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TAKEDA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022426s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22426"}, "22427": {"ApplNo": "22427", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ACUVAIL", "ActiveIngredient": "KETOROLAC TROMETHAMINE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022427s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22427"}, "22428": {"ApplNo": "22428", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "MOXEZA", "ActiveIngredient": "MOXIFLOXACIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "IMPRIMIS PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022428s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22428"}, "22429": {"ApplNo": "22429", "Form": "CAPSULE;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BIONPHARMA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022429Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22429"}, "22430": {"ApplNo": "22430", "Form": "TABLET;ORAL", "Drug": "LYSTEDA", "ActiveIngredient": "TRANEXAMIC ACID", "ApplType": "NDA", "Sponsor": "AMRING PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022430s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22430"}, "22432": {"ApplNo": "22432", "Form": "INJECTABLE; INJECTION", "Drug": "H.P. ACTHAR GEL", "ActiveIngredient": "REPOSITORY CORTICOTROPIN", "ApplType": "NDA", "Sponsor": "QUESTCOR PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022432s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22432"}, "22433": {"ApplNo": "22433", "Form": "TABLET;ORAL", "Drug": "BRILINTA", "ActiveIngredient": "TICAGRELOR", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022433s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22433"}, "22436": {"ApplNo": "22436", "Form": "CREAM;TOPICAL", "Drug": "XERESE", "ActiveIngredient": "ACYCLOVIR; HYDROCORTISONE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022436s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22436"}, "22437": {"ApplNo": "22437", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "TRELSTAR", "ActiveIngredient": "TRIPTORELIN PAMOATE", "ApplType": "NDA", "Sponsor": "VERITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020715s040,021288s035,022427s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22437"}, "22445": {"ApplNo": "22445", "Form": "INJECTION, EXTENDED RELEASE;SUBCUTANEOUS", "Drug": "SUSTOL", "ActiveIngredient": "GRANISETRON", "ApplType": "NDA", "Sponsor": "HERON THERAPS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022445s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22445"}, "22453": {"ApplNo": "22453", "Form": "SOLUTION;INTRAVENOUS", "Drug": "TOPOTECAN HYDROCHLORIDE", "ActiveIngredient": "TOPOTECAN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022453s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22453"}, "22454": {"ApplNo": "22454", "Form": "SOLUTION;INTRAVENOUS", "Drug": "DATSCAN", "ActiveIngredient": "IOFLUPANE I-123", "ApplType": "NDA", "Sponsor": "GE HLTHCARE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022454Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22454"}, "22458": {"ApplNo": "22458", "Form": "POWDER;INTRAVENOUS", "Drug": "ELELYSO", "ActiveIngredient": "TALIGLUCERASE ALFA", "ApplType": "BLA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022458s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22458"}, "22460": {"ApplNo": "22460", "Form": "CAPSULE;ORAL", "Drug": "JALYN", "ActiveIngredient": "DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "WOODWARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022460Orig1s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22460"}, "22462": {"ApplNo": "22462", "Form": "INJECTABLE;INTRATHECAL", "Drug": "GABLOFEN", "ActiveIngredient": "BACLOFEN", "ApplType": "NDA", "Sponsor": "PIRAMAL CRITICAL", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022462Orig1s015Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22462"}, "22465": {"ApplNo": "22465", "Form": "TABLET;ORAL", "Drug": "VOTRIENT", "ActiveIngredient": "PAZOPANIB HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022465Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22465"}, "22466": {"ApplNo": "22466", "Form": "INJECTABLE;INJECTION", "Drug": "ORABLOC", "ActiveIngredient": "ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE", "ApplType": "NDA", "Sponsor": "PIERREL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022466s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22466"}, "22468": {"ApplNo": "22468", "Form": "SOLUTION;INTRAVENOUS", "Drug": "FOLOTYN", "ActiveIngredient": "PRALATREXATE", "ApplType": "NDA", "Sponsor": "ACROTECH BIOPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022468s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22468"}, "22472": {"ApplNo": "22472", "Form": "POWDER;INHALATION", "Drug": "AFREZZA", "ActiveIngredient": "INSULIN RECOMBINANT HUMAN", "ApplType": "BLA", "Sponsor": "MANNKIND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22472"}, "22473": {"ApplNo": "22473", "Form": "SOLUTION;INTRAVENOUS", "Drug": "REVATIO", "ActiveIngredient": "SILDENAFIL CITRATE", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022473s012,203109s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22473"}, "22474": {"ApplNo": "22474", "Form": "TABLET;ORAL", "Drug": "ELLA", "ActiveIngredient": "ULIPRISTAL ACETATE", "ApplType": "NDA", "Sponsor": "LAB HRA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022474s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22474"}, "22483": {"ApplNo": "22483", "Form": "CREAM;TOPICAL", "Drug": "ZYCLARA", "ActiveIngredient": "IMIQUIMOD", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022483s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22483"}, "22485": {"ApplNo": "22485", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ARGATROBAN IN SODIUM CHLORIDE", "ActiveIngredient": "ARGATROBAN", "ApplType": "NDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022485s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22485"}, "22488": {"ApplNo": "22488", "Form": "SOLUTION;ORAL", "Drug": "LYRICA", "ActiveIngredient": "PREGABALIN", "ApplType": "NDA", "Sponsor": "UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021446s040, 022488s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22488"}, "22496": {"ApplNo": "22496", "Form": "INJECTABLE, LIPOSOMAL;INJECTION", "Drug": "EXPAREL", "ActiveIngredient": "BUPIVACAINE", "ApplType": "NDA", "Sponsor": "PACIRA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022496Orig1s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22496"}, "22497": {"ApplNo": "22497", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "FORFIVO XL", "ActiveIngredient": "BUPROPION HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22497"}, "22500": {"ApplNo": "22500", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "NEXICLON XR", "ActiveIngredient": "CLONIDINE", "ApplType": "NDA", "Sponsor": "ATHENA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022500s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22500"}, "22501": {"ApplNo": "22501", "Form": "TABLET;ORAL", "Drug": "LO LOESTRIN FE", "ActiveIngredient": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE", "ApplType": "NDA", "Sponsor": "APIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022501s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22501"}, "22502": {"ApplNo": "22502", "Form": "LOTION;TOPICAL", "Drug": "DIFFERIN", "ActiveIngredient": "ADAPALENE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022502s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22502"}, "22505": {"ApplNo": "22505", "Form": "POWDER;SUBCUTANEOUS", "Drug": "EGRIFTA", "ActiveIngredient": "TESAMORELIN ACETATE", "ApplType": "BLA", "Sponsor": "THERATECHNOLOGIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022505s001s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22505"}, "22509": {"ApplNo": "22509", "Form": "TABLET, EXTENDED RELEASE; ORAL", "Drug": "LAMICTAL XR", "ActiveIngredient": "LAMOTRIGINE", "ApplType": "NDA", "Sponsor": "SMITHKLINE BEECHAM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22509"}, "22511": {"ApplNo": "22511", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "VIMOVO", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN", "ApplType": "NDA", "Sponsor": "HORIZON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022511s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22511"}, "22512": {"ApplNo": "22512", "Form": "CAPSULE;ORAL", "Drug": "PRADAXA", "ActiveIngredient": "DABIGATRAN ETEXILATE MESYLATE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022512s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22512"}, "22514": {"ApplNo": "22514", "Form": "TABLET, EXTENDED RELEASE; ORAL", "Drug": "MIRAPEX ER", "ActiveIngredient": "PRAMIPEXOLE DIHYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022514lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22514"}, "22516": {"ApplNo": "22516", "Form": "CAPSULE, DELAYED REL PELLETS; ORAL", "Drug": "CYMBALTA", "ActiveIngredient": "DULOXETINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "LILLY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022516lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22516"}, "22517": {"ApplNo": "22517", "Form": "TABLET;SUBLINGUAL", "Drug": "NOCDURNA", "ActiveIngredient": "DESMOPRESSIN ACETATE", "ApplType": "NDA", "Sponsor": "FERRING PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22517"}, "22518": {"ApplNo": "22518", "Form": "AEROSOL, METERED;INHALATION", "Drug": "DULERA", "ActiveIngredient": "FORMOTEROL FUMARATE; MOMETASONE FUROATE", "ApplType": "NDA", "Sponsor": "ORGANON LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022518s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22518"}, "22519": {"ApplNo": "22519", "Form": "TABLET;ORAL", "Drug": "DUEXIS", "ActiveIngredient": "FAMOTIDINE; IBUPROFEN", "ApplType": "NDA", "Sponsor": "HORIZON", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022519s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22519"}, "22522": {"ApplNo": "22522", "Form": "TABLET;ORAL", "Drug": "DALIRESP", "ActiveIngredient": "ROFLUMILAST", "ApplType": "NDA", "Sponsor": "ASTRAZENECA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22522"}, "22523": {"ApplNo": "22523", "Form": "CAPSULE, DELAYED RELEASE;ORAL", "Drug": "PANCREAZE", "ActiveIngredient": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)", "ApplType": "BLA", "Sponsor": "VIVUS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022523s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22523"}, "22525": {"ApplNo": "22525", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "NAMENDA XR", "ActiveIngredient": "MEMANTINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022525s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22525"}, "22526": {"ApplNo": "22526", "Form": "TABLET;ORAL", "Drug": "ADDYI", "ActiveIngredient": "FLIBANSERIN", "ApplType": "NDA", "Sponsor": "SPROUT PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022526s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22526"}, "22527": {"ApplNo": "22527", "Form": "CAPSULE;ORAL", "Drug": "GILENYA", "ActiveIngredient": "FINGOLIMOD HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022527s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22527"}, "22532": {"ApplNo": "22532", "Form": "TABLET;ORAL", "Drug": "BEYAZ", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022532s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22532"}, "22534": {"ApplNo": "22534", "Form": "INJECTABLE;INJECTION", "Drug": "DOCETAXEL", "ActiveIngredient": "DOCETAXEL", "ApplType": "NDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022534s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22534"}, "22535": {"ApplNo": "22535", "Form": "CAPSULE;ORAL", "Drug": "ESBRIET", "ActiveIngredient": "PIRFENIDONE", "ApplType": "NDA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022535s015,208780s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22535"}, "22536": {"ApplNo": "22536", "Form": "INJECTABLE;INJECTION", "Drug": "INDOMETHACIN", "ActiveIngredient": "INDOMETHACIN", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022536Orig1s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22536"}, "22542": {"ApplNo": "22542", "Form": "TABLET;ORAL", "Drug": "VIOKACE", "ActiveIngredient": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)", "ApplType": "BLA", "Sponsor": "VIOKACE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022542Orig1s007CorrectedLbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22542"}, "22544": {"ApplNo": "22544", "Form": "TABLET;ORAL", "Drug": "GRALISE", "ActiveIngredient": "GABAPENTIN", "ApplType": "NDA", "Sponsor": "ALMATICA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022544Orig1s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22544"}, "22548": {"ApplNo": "22548", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "ZYMAXID", "ActiveIngredient": "GATIFLOXACIN", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022548s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22548"}, "22549": {"ApplNo": "22549", "Form": "POWDER;INHALATION", "Drug": "ADASUVE", "ActiveIngredient": "LOXAPINE", "ApplType": "NDA", "Sponsor": "ALEXZA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022549s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22549"}, "22554": {"ApplNo": "22554", "Form": "TABLET;ORAL", "Drug": "XIFAXAN", "ActiveIngredient": "RIFAXIMIN", "ApplType": "NDA", "Sponsor": "SALIX PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022554lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22554"}, "22555": {"ApplNo": "22555", "Form": "FOR SOLUTION;INTRAVESICAL", "Drug": "CYSVIEW KIT", "ActiveIngredient": "HEXAMINOLEVULINATE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PHOTOCURE ASA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022555s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22555"}, "22556": {"ApplNo": "22556", "Form": "SUSPENSION, EXTENDED RELEASE;ORAL", "Drug": "KARBINAL ER", "ActiveIngredient": "CARBINOXAMINE MALEATE", "ApplType": "NDA", "Sponsor": "AYTU", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022556s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22556"}, "22560": {"ApplNo": "22560", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "ATELVIA", "ActiveIngredient": "RISEDRONATE SODIUM", "ApplType": "NDA", "Sponsor": "APIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22560"}, "22561": {"ApplNo": "22561", "Form": "TABLET;ORAL", "Drug": "MAVENCLAD", "ActiveIngredient": "CLADRIBINE", "ApplType": "NDA", "Sponsor": "EMD SERONO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022561s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22561"}, "22562": {"ApplNo": "22562", "Form": "TABLET, FOR SUSPENSION;ORAL", "Drug": "CARBAGLU", "ActiveIngredient": "CARGLUMIC ACID", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022562s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22562"}, "22563": {"ApplNo": "22563", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "SORILUX", "ActiveIngredient": "CALCIPOTRIENE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022563s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22563"}, "22565": {"ApplNo": "22565", "Form": "TABLET;ORAL", "Drug": "ADVIL CONGESTION RELIEF", "ActiveIngredient": "IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022565orig1s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22565"}, "22567": {"ApplNo": "22567", "Form": "TABLET;ORAL", "Drug": "VIIBRYD", "ActiveIngredient": "VILAZODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022567s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22567"}, "22568": {"ApplNo": "22568", "Form": "TABLET;ORAL", "Drug": "ARICEPT", "ActiveIngredient": "DONEPEZIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "EISAI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22568"}, "22571": {"ApplNo": "22571", "Form": "SOLUTION;ORAL", "Drug": "CUVPOSA", "ActiveIngredient": "GLYCOPYRROLATE", "ApplType": "NDA", "Sponsor": "MERZ PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022571s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22571"}, "22572": {"ApplNo": "22572", "Form": "FOR SOLUTION;TOPICAL", "Drug": "MITOSOL", "ActiveIngredient": "MITOMYCIN", "ApplType": "NDA", "Sponsor": "MOBIUS THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022572s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22572"}, "22573": {"ApplNo": "22573", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE", "ActiveIngredient": "ETHINYL ESTRADIOL; NORETHINDRONE", "ApplType": "NDA", "Sponsor": "APIL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022573s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22573"}, "22574": {"ApplNo": "22574", "Form": "TABLET;ORAL", "Drug": "SAFYRAL", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM", "ApplType": "NDA", "Sponsor": "BAYER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022574s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22574"}, "22575": {"ApplNo": "22575", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "VPRIV", "ActiveIngredient": "VELAGLUCERASE ALFA", "ApplType": "BLA", "Sponsor": "SHIRE HUMAN GENETIC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022575s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22575"}, "22577": {"ApplNo": "22577", "Form": "POWDER;ORAL", "Drug": "VIREAD", "ActiveIngredient": "TENOFOVIR DISOPROXIL FUMARATE", "ApplType": "NDA", "Sponsor": "GILEAD SCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021356s058,022577s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22577"}, "22578": {"ApplNo": "22578", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "ZYRTEC ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "J AND J CONSUMER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022578Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22578"}, "22580": {"ApplNo": "22580", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "QSYMIA", "ActiveIngredient": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE", "ApplType": "NDA", "Sponsor": "VIVUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022580s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22580"}, "22581": {"ApplNo": "22581", "Form": "SOLUTION;ORAL", "Drug": "PHOSLYRA", "ActiveIngredient": "CALCIUM ACETATE", "ApplType": "NDA", "Sponsor": "FRESENIUS MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022581s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22581"}, "40054": {"ApplNo": "40054", "Form": "TABLET;ORAL", "Drug": "METHOTREXATE SODIUM", "ActiveIngredient": "METHOTREXATE SODIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/040054s015,s016,s017.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40054"}, "40056": {"ApplNo": "40056", "Form": "INJECTABLE;INJECTION", "Drug": "LEUCOVORIN CALCIUM PRESERVATIVE FREE", "ActiveIngredient": "LEUCOVORIN CALCIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040347s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40056"}, "40104": {"ApplNo": "40104", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/040104Orig1s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40104"}, "40136": {"ApplNo": "40136", "Form": "INJECTABLE;INJECTION", "Drug": "HYDRALAZINE HYDROCHLORIDE", "ActiveIngredient": "HYDRALAZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/040136s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40136"}, "40183": {"ApplNo": "40183", "Form": "TABLET;ORAL", "Drug": "METHYLPREDNISOLONE", "ActiveIngredient": "METHYLPREDNISOLONE", "ApplType": "ANDA", "Sponsor": "VINTAGE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/40183_Methylprednisolone_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40183"}, "40226": {"ApplNo": "40226", "Form": "TABLET;ORAL", "Drug": "PERPHENAZINE", "ActiveIngredient": "PERPHENAZINE", "ApplType": "ANDA", "Sponsor": "VINTAGE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/40226_Perphenazaine_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40226"}, "40230": {"ApplNo": "40230", "Form": "TABLET;ORAL", "Drug": "DICYCLOMINE HYDROCHLORIDE", "ActiveIngredient": "DICYCLOMINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "LANNETT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40230_Dicyclomine%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40230"}, "40249": {"ApplNo": "40249", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ORPHENADRINE CITRATE", "ActiveIngredient": "ORPHENADRINE CITRATE", "ApplType": "ANDA", "Sponsor": "RISING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40249_Orphenadrine%20Citrate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40249"}, "40251": {"ApplNo": "40251", "Form": "ELIXIR;ORAL", "Drug": "TRIHEXYPHENIDYL HYDROCHLORIDE", "ActiveIngredient": "TRIHEXYPHENIDYL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "MIKART", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40251_Trihexyphenidyl%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40251"}, "40253": {"ApplNo": "40253", "Form": "SYRUP;ORAL", "Drug": "ETHOSUXIMIDE", "ActiveIngredient": "ETHOSUXIMIDE", "ApplType": "ANDA", "Sponsor": "PHARM ASSOC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/40253_Ethosuximide_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40253"}, "40254": {"ApplNo": "40254", "Form": "TABLET;ORAL", "Drug": "TRIHEXYPHENIDYL HYDROCHLORIDE", "ActiveIngredient": "TRIHEXYPHENIDYL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "NOVITIUM PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/40254_Trihexyphenidyl%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40254"}, "40263": {"ApplNo": "40263", "Form": "INJECTABLE;INJECTION", "Drug": "METHOTREXATE SODIUM", "ActiveIngredient": "METHOTREXATE SODIUM", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40263_Methotrexate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40263"}, "40266": {"ApplNo": "40266", "Form": "INJECTABLE;INJECTION", "Drug": "METHOTREXATE PRESERVATIVE FREE", "ActiveIngredient": "METHOTREXATE SODIUM", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40266_Methotrexate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40266"}, "40274": {"ApplNo": "40274", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "AUROBINDO PHARMA USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/040274Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40274"}, "40275": {"ApplNo": "40275", "Form": "TABLET;ORAL", "Drug": "ESTRADIOL", "ActiveIngredient": "ESTRADIOL", "ApplType": "ANDA", "Sponsor": "EPIC PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/40-275_Estradiol_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40275"}, "40277": {"ApplNo": "40277", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "PROPARACAINE HYDROCHLORIDE", "ActiveIngredient": "PROPARACAINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/40277_Proparacaine%20Hydrochloride%20Ophthalmic_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40277"}, "40278": {"ApplNo": "40278", "Form": "INJECTABLE;INJECTION", "Drug": "FLUOROURACIL", "ActiveIngredient": "FLUOROURACIL", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/40278_Fluorouracil_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40278"}, "40279": {"ApplNo": "40279", "Form": "INJECTABLE;INJECTION", "Drug": "FLUOROURACIL", "ActiveIngredient": "FLUOROURACIL", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/40279_Fluorouracil_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40279"}, "40298": {"ApplNo": "40298", "Form": "CAPSULE;ORAL", "Drug": "EXTENDED PHENYTOIN SODIUM", "ActiveIngredient": "PHENYTOIN SODIUM", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/40298lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40298"}, "40300": {"ApplNo": "40300", "Form": "TABLET;ORAL", "Drug": "METHYLPHENIDATE HYDROCHLORIDE", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "SPECGX LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/40-300_Methylphenidate%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40300"}, "40301": {"ApplNo": "40301", "Form": "TABLET;ORAL", "Drug": "WARFARIN SODIUM", "ActiveIngredient": "WARFARIN SODIUM", "ApplType": "ANDA", "Sponsor": "TARO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40301_Warfarin%20Sodium_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40301"}, "40323": {"ApplNo": "40323", "Form": "SYRUP;ORAL", "Drug": "PREDNISOLONE", "ActiveIngredient": "PREDNISOLONE", "ApplType": "ANDA", "Sponsor": "CHARTWELL RX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/40323lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40323"}, "40330": {"ApplNo": "40330", "Form": "TABLET;ORAL", "Drug": "PERCOCET", "ActiveIngredient": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "VINTAGE PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40330"}, "40335": {"ApplNo": "40335", "Form": "INJECTABLE;INJECTION", "Drug": "LEUCOVORIN CALCIUM PRESERVATIVE FREE", "ActiveIngredient": "LEUCOVORIN CALCIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040347s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40335"}, "40347": {"ApplNo": "40347", "Form": "INJECTABLE;INJECTION", "Drug": "LEUCOVORIN CALCIUM PRESERVATIVE FREE", "ActiveIngredient": "LEUCOVORIN CALCIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040347s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40347"}, "40350": {"ApplNo": "40350", "Form": "TABLET;ORAL", "Drug": "METHIMAZOLE", "ActiveIngredient": "METHIMAZOLE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040350s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40350"}, "40361": {"ApplNo": "40361", "Form": "TABLET;ORAL", "Drug": "DEXTROAMPHETAMINE SULFATE", "ActiveIngredient": "DEXTROAMPHETAMINE SULFATE", "ApplType": "ANDA", "Sponsor": "BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/040361Orig1s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40361"}, "40378": {"ApplNo": "40378", "Form": "TABLET;ORAL", "Drug": "NIACOR", "ActiveIngredient": "NIACIN", "ApplType": "ANDA", "Sponsor": "AVONDALE PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/40378_Niacor_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40378"}, "40422": {"ApplNo": "40422", "Form": "TABLET;ORAL", "Drug": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE", "ActiveIngredient": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE", "ApplType": "ANDA", "Sponsor": "BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/040422s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40422"}, "40424": {"ApplNo": "40424", "Form": "TABLET;ORAL", "Drug": "SPIRONOLACTONE", "ActiveIngredient": "SPIRONOLACTONE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/40-424_Spironolactone_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40424"}, "40432": {"ApplNo": "40432", "Form": "TABLET;ORAL", "Drug": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN", "ActiveIngredient": "ACETAMINOPHEN; HYDROCODONE BITARTRATE", "ApplType": "ANDA", "Sponsor": "CHARTWELL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/040432s006,40556s012,40658s006, 40846s005, 89699s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40432"}, "40491": {"ApplNo": "40491", "Form": "INJECTABLE;INJECTION", "Drug": "DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE", "ActiveIngredient": "DEXAMETHASONE SODIUM PHOSPHATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/040491s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40491"}, "40572": {"ApplNo": "40572", "Form": "INJECTABLE;INJECTION", "Drug": "DEXAMETHASONE SODIUM PHOSPHATE", "ActiveIngredient": "DEXAMETHASONE SODIUM PHOSPHATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/40572s002lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40572"}, "40657": {"ApplNo": "40657", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "ZYDUS PHARMS USA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/040657Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40657"}, "40658": {"ApplNo": "40658", "Form": "TABLET;ORAL", "Drug": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN", "ActiveIngredient": "ACETAMINOPHEN; HYDROCODONE BITARTRATE", "ApplType": "ANDA", "Sponsor": "CHARTWELL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/040432s006,40556s012,40658s006, 40846s005, 89699s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40658"}, "40745": {"ApplNo": "40745", "Form": "INJECTABLE;INJECTION", "Drug": "CYCLOPHOSPHAMIDE", "ActiveIngredient": "CYCLOPHOSPHAMIDE", "ApplType": "ANDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/040745Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40745"}, "40766": {"ApplNo": "40766", "Form": "TABLET;ORAL", "Drug": "HYDROXYCHLOROQUINE SULFATE", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "ANDA", "Sponsor": "IPCA LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/040766Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40766"}, "40903": {"ApplNo": "40903", "Form": "TABLET;ORAL", "Drug": "IMIPRAMINE HYDROCHLORIDE", "ActiveIngredient": "IMIPRAMINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "LEADING", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040903lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=40903"}, "4782": {"ApplNo": "4782", "Form": "TABLET;ORAL", "Drug": "PREMARIN", "ActiveIngredient": "ESTROGENS, CONJUGATED", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/004782s176lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=4782"}, "50006": {"ApplNo": "50006", "Form": "FOR SUSPENSION;ORAL", "Drug": "VIBRAMYCIN", "ActiveIngredient": "DOXYCYCLINE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050006s092,050007s034,050480s058,050533s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50006"}, "50007": {"ApplNo": "50007", "Form": "CAPSULE;ORAL", "Drug": "VIBRAMYCIN", "ActiveIngredient": "DOXYCYCLINE HYCLATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050006s092,050007s034,050480s058,050533s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50007"}, "50023": {"ApplNo": "50023", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "MAXITROL", "ActiveIngredient": "DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE", "ApplType": "NDA", "Sponsor": "IMPRIMIS PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050023s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50023"}, "50065": {"ApplNo": "50065", "Form": "OINTMENT;OPHTHALMIC", "Drug": "MAXITROL", "ActiveIngredient": "DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050065s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50065"}, "50108": {"ApplNo": "50108", "Form": "INJECTABLE;INJECTION", "Drug": "COLY-MYCIN M", "ActiveIngredient": "COLISTIMETHATE SODIUM", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050108s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50108"}, "50114": {"ApplNo": "50114", "Form": "INJECTABLE;INJECTION", "Drug": "PRE-PEN", "ActiveIngredient": "BENZYLPENICILLOYL POLYLYSINE", "ApplType": "BLA", "Sponsor": "ALLERQUEST", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050114s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50114"}, "50138": {"ApplNo": "50138", "Form": "INJECTABLE;INJECTION", "Drug": "BICILLIN C-R", "ActiveIngredient": "PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE", "ApplType": "NDA", "Sponsor": "KING PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050138s242lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50138"}, "50141": {"ApplNo": "50141", "Form": "INJECTABLE;INJECTION", "Drug": "BICILLIN L-A", "ActiveIngredient": "PENICILLIN G BENZATHINE", "ApplType": "NDA", "Sponsor": "KING PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050141Orig1s240lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50141"}, "50162": {"ApplNo": "50162", "Form": "CAPSULE;ORAL", "Drug": "CLEOCIN HYDROCHLORIDE", "ActiveIngredient": "CLINDAMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050162s104lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50162"}, "50207": {"ApplNo": "50207", "Form": "GRANULE;ORAL", "Drug": "E.E.S.", "ActiveIngredient": "ERYTHROMYCIN ETHYLSUCCINATE", "ApplType": "NDA", "Sponsor": "AZURITY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050207s074,050611s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50207"}, "50278": {"ApplNo": "50278", "Form": "CAPSULE;ORAL", "Drug": "ACHROMYCIN V", "ActiveIngredient": "TETRACYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "AVET", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050278s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50278"}, "50317": {"ApplNo": "50317", "Form": "INJECTABLE;INJECTION", "Drug": "LINCOCIN", "ActiveIngredient": "LINCOMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050317Orig1s187lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50317"}, "50356": {"ApplNo": "50356", "Form": "SUSPENSION/DROPS;OTIC", "Drug": "COLY-MYCIN S", "ActiveIngredient": "COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE", "ApplType": "NDA", "Sponsor": "ENDO PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050356s059lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50356"}, "50417": {"ApplNo": "50417", "Form": "OINTMENT;OPHTHALMIC", "Drug": "LUMI-SPORYN", "ActiveIngredient": "BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE", "ApplType": "NDA", "Sponsor": "CASPER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050417s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50417"}, "50429": {"ApplNo": "50429", "Form": "CAPSULE;ORAL", "Drug": "RIMACTANE", "ActiveIngredient": "RIFAMPIN", "ApplType": "NDA", "Sponsor": "OXFORD PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050429s086lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50429"}, "50441": {"ApplNo": "50441", "Form": "INJECTABLE;INJECTION", "Drug": "CLEOCIN PHOSPHATE", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050441s085lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50441"}, "50444": {"ApplNo": "50444", "Form": "INJECTABLE;INJECTION", "Drug": "MINOCIN", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "REMPEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050444s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50444"}, "50475": {"ApplNo": "50475", "Form": "TABLET;ORAL", "Drug": "GRIS-PEG", "ActiveIngredient": "GRISEOFULVIN, ULTRAMICROSIZE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050475s057lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50475"}, "50480": {"ApplNo": "50480", "Form": "SUSPENSION;ORAL", "Drug": "VIBRAMYCIN", "ActiveIngredient": "DOXYCYCLINE CALCIUM", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050006s092,050007s034,050480s058,050533s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50480"}, "50514": {"ApplNo": "50514", "Form": "SUSPENSION;OPHTHALMIC", "Drug": "NATACYN", "ActiveIngredient": "NATAMYCIN", "ApplType": "NDA", "Sponsor": "EYEVANCE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050514s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50514"}, "50536": {"ApplNo": "50536", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "ERYC", "ActiveIngredient": "ERYTHROMYCIN", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050536s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50536"}, "50541": {"ApplNo": "50541", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "TOBREX", "ActiveIngredient": "TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050541s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50541"}, "50555": {"ApplNo": "50555", "Form": "OINTMENT;OPHTHALMIC", "Drug": "TOBREX", "ActiveIngredient": "TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050555s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50555"}, "50557": {"ApplNo": "50557", "Form": "GEL;TOPICAL", "Drug": "BENZAMYCIN", "ActiveIngredient": "BENZOYL PEROXIDE; ERYTHROMYCIN", "ApplType": "NDA", "Sponsor": "VALEANT INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/050557s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50557"}, "50558": {"ApplNo": "50558", "Form": "INJECTABLE;INTRAMUSCULAR, INTRAVENOUS", "Drug": "ZINACEF", "ActiveIngredient": "CEFUROXIME SODIUM", "ApplType": "NDA", "Sponsor": "PAI HOLDINGS PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050558s076lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50558"}, "50573": {"ApplNo": "50573", "Form": "INJECTABLE;INJECTION", "Drug": "SANDIMMUNE", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050573s041,050574s051,050625s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50573"}, "50574": {"ApplNo": "50574", "Form": "SOLUTION;ORAL", "Drug": "SANDIMMUNE", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050573s041,050574s051,050625s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50574"}, "50575": {"ApplNo": "50575", "Form": "FOR SUSPENSION;ORAL", "Drug": "AUGMENTIN '125'", "ActiveIngredient": "AMOXICILLIN; CLAVULANATE POTASSIUM", "ApplType": "NDA", "Sponsor": "US ANTIBIOTICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050564Orig1s059,050575Orig1s048,050597Orig1s051,050720Orig1s033,050725Orig1s035,050726Orig1s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50575"}, "50578": {"ApplNo": "50578", "Form": "INJECTABLE;INJECTION", "Drug": "FORTAZ", "ActiveIngredient": "CEFTAZIDIME", "ApplType": "NDA", "Sponsor": "PAI HOLDINGS PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050578s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50578"}, "50580": {"ApplNo": "50580", "Form": "INJECTABLE;INJECTION", "Drug": "AZACTAM", "ActiveIngredient": "AZTREONAM", "ApplType": "NDA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050580Orig1s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50580"}, "50587": {"ApplNo": "50587", "Form": "POWDER;INTRAVENOUS", "Drug": "PRIMAXIN", "ActiveIngredient": "CILASTATIN SODIUM; IMIPENEM", "ApplType": "NDA", "Sponsor": "MERCK", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050587Orig1s083lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50587"}, "50588": {"ApplNo": "50588", "Form": "INJECTABLE;INJECTION", "Drug": "CEFOTAN", "ActiveIngredient": "CEFOTETAN DISODIUM", "ApplType": "NDA", "Sponsor": "PAI HOLDINGS PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050588s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50588"}, "50592": {"ApplNo": "50592", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "TOBRADEX", "ActiveIngredient": "DEXAMETHASONE; TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050592s044s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50592"}, "50600": {"ApplNo": "50600", "Form": "LOTION;TOPICAL", "Drug": "CLEOCIN T", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050537s041,050600s018,050615s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50600"}, "50606": {"ApplNo": "50606", "Form": "CAPSULE;ORAL", "Drug": "VANCOCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050606s039lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50606"}, "50608": {"ApplNo": "50608", "Form": "INJECTABLE;INJECTION", "Drug": "UNASYN", "ActiveIngredient": "AMPICILLIN SODIUM; SULBACTAM SODIUM", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050608s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50608"}, "50609": {"ApplNo": "50609", "Form": "INJECTABLE;INJECTION", "Drug": "ERYTHROCIN", "ActiveIngredient": "ERYTHROMYCIN LACTOBIONATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050609s051lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50609"}, "50615": {"ApplNo": "50615", "Form": "GEL;TOPICAL", "Drug": "CLEOCIN T", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050537s041,050600s018,050615s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50615"}, "50616": {"ApplNo": "50616", "Form": "OINTMENT;OPHTHALMIC", "Drug": "TOBRADEX", "ActiveIngredient": "DEXAMETHASONE; TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050616s040s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50616"}, "50625": {"ApplNo": "50625", "Form": "CAPSULE;ORAL", "Drug": "SANDIMMUNE", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050625Orig1s060lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50625"}, "50627": {"ApplNo": "50627", "Form": "INJECTABLE;INJECTION", "Drug": "RIFADIN", "ActiveIngredient": "RIFAMPIN", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050420s087,050627s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50627"}, "50629": {"ApplNo": "50629", "Form": "INJECTABLE;INJECTION", "Drug": "DOXORUBICIN HYDROCHLORIDE", "ActiveIngredient": "DOXORUBICIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050467s078,050629s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50629"}, "50638": {"ApplNo": "50638", "Form": "INJECTABLE;INJECTION", "Drug": "PENICILLIN G POTASSIUM IN PLASTIC CONTAINER", "ActiveIngredient": "PENICILLIN G POTASSIUM", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050638s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50638"}, "50640": {"ApplNo": "50640", "Form": "INJECTABLE;INJECTION", "Drug": "BACTOCILL IN PLASTIC CONTAINER", "ActiveIngredient": "OXACILLIN SODIUM", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050640s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50640"}, "50641": {"ApplNo": "50641", "Form": "CAPSULE;ORAL", "Drug": "MONODOX", "ActiveIngredient": "DOXYCYCLINE", "ApplType": "NDA", "Sponsor": "CHARTWELL RX", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050641Orig1s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50641"}, "50649": {"ApplNo": "50649", "Form": "CAPSULE;ORAL", "Drug": "MINOCIN", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050649s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50649"}, "50655": {"ApplNo": "50655", "Form": "INJECTABLE;INJECTION", "Drug": "NALLPEN IN PLASTIC CONTAINER", "ActiveIngredient": "NAFCILLIN SODIUM", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050655s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50655"}, "50671": {"ApplNo": "50671", "Form": "INJECTABLE;INJECTION", "Drug": "VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050671s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50671"}, "50679": {"ApplNo": "50679", "Form": "INJECTABLE;INJECTION", "Drug": "MAXIPIME", "ActiveIngredient": "CEFEPIME HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050679s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50679"}, "50680": {"ApplNo": "50680", "Form": "CREAM;VAGINAL", "Drug": "CLEOCIN", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050680s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50680"}, "50682": {"ApplNo": "50682", "Form": "INJECTABLE;INJECTION", "Drug": "COSMEGEN", "ActiveIngredient": "DACTINOMYCIN", "ApplType": "NDA", "Sponsor": "RECORDATI RARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050682s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50682"}, "50689": {"ApplNo": "50689", "Form": "CAPSULE;ORAL", "Drug": "MYCOBUTIN", "ActiveIngredient": "RIFABUTIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050689s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50689"}, "50693": {"ApplNo": "50693", "Form": "FOR SUSPENSION;ORAL", "Drug": "ZITHROMAX", "ActiveIngredient": "AZITHROMYCIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050730s043,050693s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50693"}, "50706": {"ApplNo": "50706", "Form": "INJECTABLE;INJECTION", "Drug": "MERREM", "ActiveIngredient": "MEROPENEM", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050706s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50706"}, "50708": {"ApplNo": "50708", "Form": "CAPSULE;ORAL", "Drug": "PROGRAF", "ActiveIngredient": "TACROLIMUS", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50708"}, "50709": {"ApplNo": "50709", "Form": "INJECTABLE;INJECTION", "Drug": "PROGRAF", "ActiveIngredient": "TACROLIMUS", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50709"}, "50710": {"ApplNo": "50710", "Form": "FOR SUSPENSION;ORAL", "Drug": "ZITHROMAX", "ActiveIngredient": "AZITHROMYCIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050670Orig1s036;050710Orig1s051;050711Orig1s050;050784Orig1s037ltr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50710"}, "50711": {"ApplNo": "50711", "Form": "TABLET;ORAL", "Drug": "ZITHROMAX", "ActiveIngredient": "AZITHROMYCIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050670s036,050710s051,050784s037,050711s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50711"}, "50715": {"ApplNo": "50715", "Form": "CAPSULE;ORAL", "Drug": "NEORAL", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050715s035,050716s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50715"}, "50716": {"ApplNo": "50716", "Form": "SOLUTION;ORAL", "Drug": "NEORAL", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050715s035,050716s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50716"}, "50717": {"ApplNo": "50717", "Form": "FOR SOLUTION;ORAL", "Drug": "MONUROL", "ActiveIngredient": "FOSFOMYCIN TROMETHAMINE", "ApplType": "NDA", "Sponsor": "ZAMBON SPA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050717s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50717"}, "50718": {"ApplNo": "50718", "Form": "INJECTABLE, LIPOSOMAL;INJECTION", "Drug": "DOXIL (LIPOSOMAL)", "ActiveIngredient": "DOXORUBICIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE CORP", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050718Orig1s060lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50718"}, "50720": {"ApplNo": "50720", "Form": "TABLET;ORAL", "Drug": "AUGMENTIN '875'", "ActiveIngredient": "AMOXICILLIN; CLAVULANATE POTASSIUM", "ApplType": "NDA", "Sponsor": "US ANTIBIOTICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050564Orig1s059,050575Orig1s048,050597Orig1s051,050720Orig1s033,050725Orig1s035,050726Orig1s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50720"}, "50722": {"ApplNo": "50722", "Form": "CAPSULE;ORAL", "Drug": "CELLCEPT", "ActiveIngredient": "MYCOPHENOLATE MOFETIL", "ApplType": "NDA", "Sponsor": "ROCHE PALO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50722"}, "50723": {"ApplNo": "50723", "Form": "TABLET;ORAL", "Drug": "CELLCEPT", "ActiveIngredient": "MYCOPHENOLATE MOFETIL", "ApplType": "NDA", "Sponsor": "ROCHE PALO", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50723"}, "50733": {"ApplNo": "50733", "Form": "INJECTABLE;INJECTION", "Drug": "ZITHROMAX", "ActiveIngredient": "AZITHROMYCIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050733Orig1s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50733"}, "50734": {"ApplNo": "50734", "Form": "INJECTABLE;INJECTION", "Drug": "IDAMYCIN PFS", "ActiveIngredient": "IDARUBICIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050734s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50734"}, "50740": {"ApplNo": "50740", "Form": "INJECTABLE, LIPOSOMAL;INJECTION", "Drug": "AMBISOME", "ActiveIngredient": "AMPHOTERICIN B", "ApplType": "NDA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050740Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50740"}, "50741": {"ApplNo": "50741", "Form": "GEL;TOPICAL", "Drug": "DUAC", "ActiveIngredient": "BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "STIEFEL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050741s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50741"}, "50742": {"ApplNo": "50742", "Form": "TABLET;ORAL", "Drug": "STROMECTOL", "ActiveIngredient": "IVERMECTIN", "ApplType": "NDA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050742s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50742"}, "50747": {"ApplNo": "50747", "Form": "INJECTABLE; INJECTION", "Drug": "SYNERCID", "ActiveIngredient": "QUINUPRISTIN; DALFOPRISTIN", "ApplType": "NDA", "Sponsor": "KING PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050747s015,050748s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50747"}, "50748": {"ApplNo": "50748", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "SYNERCID", "ActiveIngredient": "DALFOPRISTIN; QUINUPRISTIN", "ApplType": "NDA", "Sponsor": "KING PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050747s015,050748s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50748"}, "50750": {"ApplNo": "50750", "Form": "INJECTABLE;INJECTION", "Drug": "ZOSYN IN PLASTIC CONTAINER", "ActiveIngredient": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM", "ApplType": "NDA", "Sponsor": "WYETH PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050750s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50750"}, "50753": {"ApplNo": "50753", "Form": "SOLUTION;INHALATION", "Drug": "TOBI", "ActiveIngredient": "TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "MYLAN SPECIALITY LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050753s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50753"}, "50755": {"ApplNo": "50755", "Form": "FOR SUSPENSION;ORAL", "Drug": "AUGMENTIN ES-600", "ActiveIngredient": "AMOXICILLIN; CLAVULANATE POTASSIUM", "ApplType": "NDA", "Sponsor": "US ANTIBIOTICS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050755s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50755"}, "50756": {"ApplNo": "50756", "Form": "GEL;TOPICAL", "Drug": "BENZACLIN", "ActiveIngredient": "BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050756s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50756"}, "50758": {"ApplNo": "50758", "Form": "INJECTABLE;INJECTION", "Drug": "CELLCEPT", "ActiveIngredient": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ROCHE PALO", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50758"}, "50759": {"ApplNo": "50759", "Form": "FOR SUSPENSION;ORAL", "Drug": "CELLCEPT", "ActiveIngredient": "MYCOPHENOLATE MOFETIL", "ApplType": "NDA", "Sponsor": "ROCHE PALO", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50759"}, "50767": {"ApplNo": "50767", "Form": "SUPPOSITORY;VAGINAL", "Drug": "CLEOCIN", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050767Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50767"}, "50777": {"ApplNo": "50777", "Form": "OINTMENT;TOPICAL", "Drug": "PROTOPIC", "ActiveIngredient": "TACROLIMUS", "ApplType": "NDA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050777s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50777"}, "50778": {"ApplNo": "50778", "Form": "INJECTABLE;INJECTION", "Drug": "ELLENCE", "ActiveIngredient": "EPIRUBICIN HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050778s024s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50778"}, "50779": {"ApplNo": "50779", "Form": "INJECTABLE;INJECTION", "Drug": "CEFAZOLIN AND DEXTROSE", "ActiveIngredient": "CEFAZOLIN SODIUM", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050779s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50779"}, "50780": {"ApplNo": "50780", "Form": "INJECTABLE;INJECTION", "Drug": "CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER", "ActiveIngredient": "CEFUROXIME SODIUM", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050780s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50780"}, "50781": {"ApplNo": "50781", "Form": "POWDER, EXTENDED RELEASE;DENTAL", "Drug": "ARESTIN", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ORAPHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050781s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50781"}, "50782": {"ApplNo": "50782", "Form": "GEL;TOPICAL", "Drug": "CLINDAGEL", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/50782lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50782"}, "50784": {"ApplNo": "50784", "Form": "TABLET;ORAL", "Drug": "ZITHROMAX", "ActiveIngredient": "AZITHROMYCIN", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050670s036,050710s051,050784s037,050711s050lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50784"}, "50786": {"ApplNo": "50786", "Form": "CAPSULE;ORAL", "Drug": "PYLERA", "ActiveIngredient": "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050786s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50786"}, "50788": {"ApplNo": "50788", "Form": "OINTMENT;TOPICAL", "Drug": "CENTANY", "ActiveIngredient": "MUPIROCIN", "ApplType": "NDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050788Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50788"}, "50789": {"ApplNo": "50789", "Form": "INJECTABLE;INJECTION", "Drug": "TOBRAMYCIN SULFATE", "ActiveIngredient": "TOBRAMYCIN SULFATE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050789s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50789"}, "50790": {"ApplNo": "50790", "Form": "EMULSION;OPHTHALMIC", "Drug": "RESTASIS", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050790s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50790"}, "50791": {"ApplNo": "50791", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "MYFORTIC", "ActiveIngredient": "MYCOPHENOLIC SODIUM", "ApplType": "NDA", "Sponsor": "NOVARTIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050791s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50791"}, "50793": {"ApplNo": "50793", "Form": "CREAM;VAGINAL", "Drug": "CLINDESSE", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050793s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50793"}, "50794": {"ApplNo": "50794", "Form": "POWDER;INTRAVENOUS, SUBCUTANEOUS", "Drug": "VIDAZA", "ActiveIngredient": "AZACITIDINE", "ApplType": "NDA", "Sponsor": "BRISTOL-MYERS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050794s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50794"}, "50795": {"ApplNo": "50795", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "DORYX", "ActiveIngredient": "DOXYCYCLINE HYCLATE", "ApplType": "NDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050795s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50795"}, "50796": {"ApplNo": "50796", "Form": "INJECTABLE;INJECTION", "Drug": "CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER", "ActiveIngredient": "CEFTRIAXONE SODIUM", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050796s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50796"}, "50801": {"ApplNo": "50801", "Form": "AEROSOL, FOAM;TOPICAL", "Drug": "EVOCLIN", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050801s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50801"}, "50802": {"ApplNo": "50802", "Form": "GEL;TOPICAL", "Drug": "ZIANA", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE; TRETINOIN", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050802lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50802"}, "50803": {"ApplNo": "50803", "Form": "GEL;TOPICAL", "Drug": "VELTIN", "ActiveIngredient": "CLINDAMYCIN PHOSPHATE; TRETINOIN", "ApplType": "NDA", "Sponsor": "ALMIRALL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050803s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50803"}, "50804": {"ApplNo": "50804", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "ZYLET", "ActiveIngredient": "LOTEPREDNOL ETABONATE; TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050804s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50804"}, "50805": {"ApplNo": "50805", "Form": "CAPSULE;ORAL", "Drug": "ORACEA", "ActiveIngredient": "DOXYCYCLINE", "ApplType": "NDA", "Sponsor": "GALDERMA LABS LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050805s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50805"}, "50808": {"ApplNo": "50808", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "SOLODYN", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050808s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50808"}, "50810": {"ApplNo": "50810", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "AZASITE", "ActiveIngredient": "AZITHROMYCIN", "ApplType": "NDA", "Sponsor": "THEA PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050810Orig1s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50810"}, "50814": {"ApplNo": "50814", "Form": "FOR SOLUTION;INHALATION", "Drug": "CAYSTON", "ActiveIngredient": "AZTREONAM", "ApplType": "NDA", "Sponsor": "GILEAD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050814s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50814"}, "50817": {"ApplNo": "50817", "Form": "INJECTABLE;INJECTION", "Drug": "CEFEPIME IN PLASTIC CONTAINER", "ActiveIngredient": "CEFEPIME HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050817s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50817"}, "50818": {"ApplNo": "50818", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "TOBRADEX ST", "ActiveIngredient": "DEXAMETHASONE; TOBRAMYCIN", "ApplType": "NDA", "Sponsor": "EYEVANCE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050818s007s008s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50818"}, "50819": {"ApplNo": "50819", "Form": "GEL;TOPICAL", "Drug": "ACANYA", "ActiveIngredient": "BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050819s023s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50819"}, "50821": {"ApplNo": "50821", "Form": "INJECTABLE;INJECTION", "Drug": "CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER", "ActiveIngredient": "CEFEPIME HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050821s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50821"}, "5213": {"ApplNo": "5213", "Form": "TABLET;ORAL", "Drug": "HYCODAN", "ActiveIngredient": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE", "ApplType": "NDA", "Sponsor": "GENUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/005213Orig1s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=5213"}, "5378": {"ApplNo": "5378", "Form": "TABLET;ORAL", "Drug": "DESOXYN", "ActiveIngredient": "METHAMPHETAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "KEY THERAP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/005378s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=5378"}, "5939": {"ApplNo": "5939", "Form": "INJECTABLE;INJECTION", "Drug": "BAL", "ActiveIngredient": "DIMERCAPROL", "ApplType": "NDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/005939s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=5939"}, "6035": {"ApplNo": "6035", "Form": "INJECTABLE;INJECTION", "Drug": "METHERGINE", "ActiveIngredient": "METHYLERGONOVINE MALEATE", "ApplType": "NDA", "Sponsor": "EDISON THERAPS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/006035s078lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=6035"}, "60359": {"ApplNo": "60359", "Form": "TABLET;ORAL", "Drug": "ERYTHROCIN STEARATE", "ActiveIngredient": "ERYTHROMYCIN STEARATE", "ApplType": "ANDA", "Sponsor": "ARBOR PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/060359s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=60359"}, "60613": {"ApplNo": "60613", "Form": "SUSPENSION/DROPS;OTIC", "Drug": "CASPORYN HC", "ActiveIngredient": "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE", "ApplType": "NDA", "Sponsor": "CASPER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/060613s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=60613"}, "61621": {"ApplNo": "61621", "Form": "TABLET;ORAL", "Drug": "ERYTHROMYCIN", "ActiveIngredient": "ERYTHROMYCIN", "ApplType": "ANDA", "Sponsor": "ARBOR PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/061621Orig1s043LBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=61621"}, "6188": {"ApplNo": "6188", "Form": "TABLET;ORAL", "Drug": "PROPYLTHIOURACIL", "ActiveIngredient": "PROPYLTHIOURACIL", "ApplType": "NDA", "Sponsor": "DAVA PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=6188"}, "61904": {"ApplNo": "61904", "Form": "TABLET;ORAL", "Drug": "ERYTHROMYCIN ETHYLSUCCINATE", "ActiveIngredient": "ERYTHROMYCIN ETHYLSUCCINATE", "ApplType": "ANDA", "Sponsor": "ARBOR PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/061904Orig1s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=61904"}, "61905": {"ApplNo": "61905", "Form": "TABLET;ORAL", "Drug": "E.E.S. 400", "ActiveIngredient": "ERYTHROMYCIN ETHYLSUCCINATE", "ApplType": "ANDA", "Sponsor": "ARBOR PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/061639s032,061905s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=61905"}, "62298": {"ApplNo": "62298", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "ERY-TAB", "ActiveIngredient": "ERYTHROMYCIN", "ApplType": "ANDA", "Sponsor": "ARBOR PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62298"}, "62366": {"ApplNo": "62366", "Form": "INJECTABLE;INJECTION", "Drug": "GENTAMICIN SULFATE", "ActiveIngredient": "GENTAMICIN SULFATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/062366s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62366"}, "62475": {"ApplNo": "62475", "Form": "INJECTABLE;INJECTION", "Drug": "DOXY 100", "ActiveIngredient": "DOXYCYCLINE HYCLATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/062475s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62475"}, "62638": {"ApplNo": "62638", "Form": "INJECTABLE;INJECTION", "Drug": "ERYTHROCIN", "ActiveIngredient": "ERYTHROMYCIN LACTOBIONATE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062638s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62638"}, "62644": {"ApplNo": "62644", "Form": "FOR SOLUTION;ORAL", "Drug": "CLEOCIN", "ActiveIngredient": "CLINDAMYCIN PALMITATE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/062644s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62644"}, "62774": {"ApplNo": "62774", "Form": "TABLET;ORAL", "Drug": "CEFADROXIL", "ActiveIngredient": "CEFADROXIL/CEFADROXIL HEMIHYDRATE", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/062774s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62774"}, "62911": {"ApplNo": "62911", "Form": "INJECTABLE;INJECTION", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/062911s035lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62911"}, "62912": {"ApplNo": "62912", "Form": "INJECTABLE;INJECTION", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/062912s049lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62912"}, "62921": {"ApplNo": "62921", "Form": "INJECTABLE;INJECTION", "Drug": "DOXORUBICIN HYDROCHLORIDE", "ActiveIngredient": "DOXORUBICIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/062921s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62921"}, "62931": {"ApplNo": "62931", "Form": "INJECTABLE;INJECTION", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/062931s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62931"}, "62933": {"ApplNo": "62933", "Form": "INJECTABLE;INJECTION", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/062933s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62933"}, "62975": {"ApplNo": "62975", "Form": "INJECTABLE;INJECTION", "Drug": "DOXORUBICIN HYDROCHLORIDE", "ActiveIngredient": "DOXORUBICIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/062975s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=62975"}, "63009": {"ApplNo": "63009", "Form": "CAPSULE;ORAL", "Drug": "MINOCYCLINE HYDROCHLORIDE", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "ZYDUS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/063009s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=63009"}, "63024": {"ApplNo": "63024", "Form": "TABLET;ORAL", "Drug": "CEPHALEXIN", "ActiveIngredient": "CEPHALEXIN", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/063024s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=63024"}, "63065": {"ApplNo": "63065", "Form": "CAPSULE;ORAL", "Drug": "MINOCYCLINE HYDROCHLORIDE", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "WATSON LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/63065S015_Minocycline%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=63065"}, "63076": {"ApplNo": "63076", "Form": "INJECTABLE;INJECTION", "Drug": "VANCOMYCIN HYDROCHLORIDE", "ActiveIngredient": "VANCOMYCIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/063076s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=63076"}, "63081": {"ApplNo": "63081", "Form": "INJECTABLE;INJECTION", "Drug": "TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER", "ActiveIngredient": "TOBRAMYCIN SULFATE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/063081s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=63081"}, "63111": {"ApplNo": "63111", "Form": "INJECTABLE;INJECTION", "Drug": "TOBRAMYCIN SULFATE", "ActiveIngredient": "TOBRAMYCIN SULFATE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/063111s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=63111"}, "63112": {"ApplNo": "63112", "Form": "INJECTABLE;INJECTION", "Drug": "TOBRAMYCIN SULFATE", "ActiveIngredient": "TOBRAMYCIN SULFATE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/063112Orig1s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=63112"}, "64071": {"ApplNo": "64071", "Form": "TABLET;ORAL", "Drug": "PENICILLIN V POTASSIUM", "ActiveIngredient": "PENICILLIN V POTASSIUM", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/064071s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=64071"}, "64097": {"ApplNo": "64097", "Form": "INJECTABLE;INJECTION", "Drug": "DOXORUBICIN HYDROCHLORIDE", "ActiveIngredient": "DOXORUBICIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/064097s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=64097"}, "64134": {"ApplNo": "64134", "Form": "SUSPENSION/DROPS;OPHTHALMIC", "Drug": "TOBRAMYCIN AND DEXAMETHASONE", "ActiveIngredient": "DEXAMETHASONE; TOBRAMYCIN", "ApplType": "ANDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/64-134_Tobramycin%20and%20Dexamethasone_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=64134"}, "64142": {"ApplNo": "64142", "Form": "SUSPENSION;ORAL", "Drug": "NYSTATIN", "ActiveIngredient": "NYSTATIN", "ApplType": "ANDA", "Sponsor": "VISTAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/64142ap_appltr_prntlbl_chemr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=64142"}, "64210": {"ApplNo": "64210", "Form": "INJECTABLE;INJECTION", "Drug": "STREPTOMYCIN SULFATE", "ActiveIngredient": "STREPTOMYCIN SULFATE", "ApplType": "ANDA", "Sponsor": "XGEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/064210s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=64210"}, "64217": {"ApplNo": "64217", "Form": "INJECTABLE;INJECTION", "Drug": "RIFAMPIN", "ActiveIngredient": "RIFAMPIN", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/64-217_Rifampin_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=64217"}, "6488": {"ApplNo": "6488", "Form": "INJECTABLE;INJECTION", "Drug": "XYLOCAINE", "ActiveIngredient": "LIDOCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006488s097lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=6488"}, "65005": {"ApplNo": "65005", "Form": "CAPSULE;ORAL", "Drug": "MINOCYCLINE HYDROCHLORIDE", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "IMPAX LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/65-005_Minocycline%20Hydrochloride_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65005"}, "65013": {"ApplNo": "65013", "Form": "INJECTABLE;INJECTION", "Drug": "TOBRAMYCIN SULFATE", "ActiveIngredient": "TOBRAMYCIN SULFATE", "ApplType": "ANDA", "Sponsor": "XGEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065013s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65013"}, "65017": {"ApplNo": "65017", "Form": "CAPSULE;ORAL", "Drug": "CYCLOSPORINE", "ActiveIngredient": "CYCLOSPORINE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/65017a_Cyclosporine_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65017"}, "65055": {"ApplNo": "65055", "Form": "CAPSULE;ORAL", "Drug": "DOXYCYCLINE", "ActiveIngredient": "DOXYCYCLINE", "ApplType": "ANDA", "Sponsor": "STRIDES PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065055Orig1s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65055"}, "65056": {"ApplNo": "65056", "Form": "TABLET;ORAL", "Drug": "AMOXICILLIN", "ActiveIngredient": "AMOXICILLIN", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/065056s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65056"}, "65068": {"ApplNo": "65068", "Form": "INJECTABLE;INTRAMUSCULAR, INTRAVENOUS", "Drug": "PENICILLIN G SODIUM", "ActiveIngredient": "PENICILLIN G SODIUM", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065068s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65068"}, "65095": {"ApplNo": "65095", "Form": "TABLET;ORAL", "Drug": "DOXYCYCLINE HYCLATE", "ActiveIngredient": "DOXYCYCLINE HYCLATE", "ApplType": "ANDA", "Sponsor": "HIKMA INTL PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065095Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65095"}, "65119": {"ApplNo": "65119", "Form": "FOR SUSPENSION;ORAL", "Drug": "AMOXICILLIN", "ActiveIngredient": "AMOXICILLIN", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065119s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65119"}, "65122": {"ApplNo": "65122", "Form": "INJECTABLE;INJECTION", "Drug": "TOBRAMYCIN SULFATE", "ActiveIngredient": "TOBRAMYCIN SULFATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065122s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65122"}, "65131": {"ApplNo": "65131", "Form": "TABLET;ORAL", "Drug": "MINOCYCLINE HYDROCHLORIDE", "ActiveIngredient": "MINOCYCLINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "STRIDES PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065131s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65131"}, "65141": {"ApplNo": "65141", "Form": "INJECTABLE;INJECTION", "Drug": "CEFAZOLIN SODIUM", "ActiveIngredient": "CEFAZOLIN SODIUM", "ApplType": "ANDA", "Sponsor": "SAMSON MEDCL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/065141s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65141"}, "65162": {"ApplNo": "65162", "Form": "FOR SUSPENSION;ORAL", "Drug": "AMOXICILLIN AND CLAVULANATE POTASSIUM", "ActiveIngredient": "AMOXICILLIN; CLAVULANATE POTASSIUM", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/065162s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65162"}, "65168": {"ApplNo": "65168", "Form": "INJECTABLE;INJECTION", "Drug": "CEFTRIAXONE", "ActiveIngredient": "CEFTRIAXONE SODIUM", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065168s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65168"}, "65169": {"ApplNo": "65169", "Form": "INJECTABLE;INTRAMUSCULAR, INTRAVENOUS", "Drug": "CEFTRIAXONE", "ActiveIngredient": "CEFTRIAXONE SODIUM", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065169s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65169"}, "65214": {"ApplNo": "65214", "Form": "INJECTABLE;INJECTION", "Drug": "CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER", "ActiveIngredient": "CEFOXITIN SODIUM", "ApplType": "NDA", "Sponsor": "B BRAUN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/065214s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65214"}, "65396": {"ApplNo": "65396", "Form": "FOR SUSPENSION;ORAL", "Drug": "CEFADROXIL", "ActiveIngredient": "CEFADROXIL/CEFADROXIL HEMIHYDRATE", "ApplType": "ANDA", "Sponsor": "LUPIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065396Orig1s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65396"}, "65410": {"ApplNo": "65410", "Form": "CAPSULE;ORAL", "Drug": "MYCOPHENOLATE MOFETIL", "ActiveIngredient": "MYCOPHENOLATE MOFETIL", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/065410s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65410"}, "65413": {"ApplNo": "65413", "Form": "TABLET;ORAL", "Drug": "MYCOPHENOLATE MOFETIL", "ActiveIngredient": "MYCOPHENOLATE MOFETIL", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/065413s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65413"}, "65454": {"ApplNo": "65454", "Form": "FOR SUSPENSION;ORAL", "Drug": "DOXYCYCLINE", "ActiveIngredient": "DOXYCYCLINE", "ApplType": "ANDA", "Sponsor": "CHARTWELL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/065454s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65454"}, "65461": {"ApplNo": "65461", "Form": "CAPSULE;ORAL", "Drug": "TACROLIMUS", "ActiveIngredient": "TACROLIMUS", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/065461s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65461"}, "65462": {"ApplNo": "65462", "Form": "TABLET;ORAL", "Drug": "CEFPODOXIME PROXETIL", "ActiveIngredient": "CEFPODOXIME PROXETIL", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065462s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=65462"}, "70434": {"ApplNo": "70434", "Form": "SOLUTION;ORAL", "Drug": "FUROSEMIDE", "ActiveIngredient": "FUROSEMIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/070434s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=70434"}, "7073": {"ApplNo": "7073", "Form": "TABLET;ORAL", "Drug": "AZULFIDINE", "ActiveIngredient": "SULFASALAZINE", "ApplType": "NDA", "Sponsor": "PFIZER", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/007073s133lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=7073"}, "70791": {"ApplNo": "70791", "Form": "CAPSULE;ORAL", "Drug": "DOXEPIN HYDROCHLORIDE", "ActiveIngredient": "DOXEPIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "MYLAN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/070791s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=70791"}, "71165": {"ApplNo": "71165", "Form": "INJECTABLE;INJECTION", "Drug": "BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE", "ActiveIngredient": "BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/071165s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71165"}, "71168": {"ApplNo": "71168", "Form": "INJECTABLE;INJECTION", "Drug": "BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE", "ActiveIngredient": "BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/071168s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71168"}, "71196": {"ApplNo": "71196", "Form": "TABLET;ORAL", "Drug": "TRAZODONE HYDROCHLORIDE", "ActiveIngredient": "TRAZODONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "APOTEX INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71196"}, "71258": {"ApplNo": "71258", "Form": "TABLET;ORAL", "Drug": "TRAZODONE HYDROCHLORIDE", "ActiveIngredient": "TRAZODONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71258"}, "71297": {"ApplNo": "71297", "Form": "TABLET;ORAL", "Drug": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE", "ActiveIngredient": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE", "ApplType": "ANDA", "Sponsor": "MYLAN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/071297s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71297"}, "71413": {"ApplNo": "71413", "Form": "INJECTABLE;INJECTION", "Drug": "FLUPHENAZINE DECANOATE", "ActiveIngredient": "FLUPHENAZINE DECANOATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/071413s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71413"}, "71443": {"ApplNo": "71443", "Form": "TABLET;ORAL", "Drug": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE", "ActiveIngredient": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/071443s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71443"}, "71484": {"ApplNo": "71484", "Form": "INJECTABLE;INJECTION", "Drug": "VINCRISTINE SULFATE PFS", "ActiveIngredient": "VINCRISTINE SULFATE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/071484s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71484"}, "71868": {"ApplNo": "71868", "Form": "INJECTABLE;INJECTION", "Drug": "CYTARABINE", "ActiveIngredient": "CYTARABINE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/071868s032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=71868"}, "72691": {"ApplNo": "72691", "Form": "TABLET;ORAL", "Drug": "AMOXAPINE", "ActiveIngredient": "AMOXAPINE", "ApplType": "ANDA", "Sponsor": "WATSON LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/072691s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=72691"}, "73193": {"ApplNo": "73193", "Form": "CREAM;TOPICAL", "Drug": "TOPICORT", "ActiveIngredient": "DESOXIMETASONE", "ApplType": "ANDA", "Sponsor": "TARO PHARM INDS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/073193SOrig1s33Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=73193"}, "73210": {"ApplNo": "73210", "Form": "CREAM;TOPICAL", "Drug": "TOPICORT", "ActiveIngredient": "DESOXIMETASONE", "ApplType": "ANDA", "Sponsor": "TARO PHARM INDS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/073210Orig1s029Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=73210"}, "73303": {"ApplNo": "73303", "Form": "INJECTABLE;INJECTION", "Drug": "SULFAMETHOXAZOLE AND TRIMETHOPRIM", "ActiveIngredient": "SULFAMETHOXAZOLE; TRIMETHOPRIM", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/073303s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=73303"}, "7337": {"ApplNo": "7337", "Form": "TABLET;ORAL", "Drug": "PERCODAN", "ActiveIngredient": "ASPIRIN; OXYCODONE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ENDO PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=7337"}, "74507": {"ApplNo": "74507", "Form": "GUM, CHEWING;BUCCAL", "Drug": "NICOTINE POLACRILEX", "ActiveIngredient": "NICOTINE POLACRILEX", "ApplType": "ANDA", "Sponsor": "P AND L", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/74-507_Nicotine_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74507"}, "74538": {"ApplNo": "74538", "Form": "TABLET;ORAL-28", "Drug": "TRIVORA-28", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "ANDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/074538s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74538"}, "74650": {"ApplNo": "74650", "Form": "SUSPENSION;ORAL", "Drug": "SULFAMETHOXAZOLE AND TRIMETHOPRIM", "ActiveIngredient": "SULFAMETHOXAZOLE; TRIMETHOPRIM", "ApplType": "ANDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/074650s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74650"}, "74707": {"ApplNo": "74707", "Form": "GUM, CHEWING;BUCCAL", "Drug": "NICOTINE POLACRILEX", "ActiveIngredient": "NICOTINE POLACRILEX", "ApplType": "ANDA", "Sponsor": "P AND L", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/74-707_Nicotine%20Polacrilex_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74707"}, "74726": {"ApplNo": "74726", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "KLOR-CON M20", "ActiveIngredient": "POTASSIUM CHLORIDE", "ApplType": "ANDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74726_KLOR-CON_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74726"}, "74728": {"ApplNo": "74728", "Form": "INJECTABLE;INJECTION", "Drug": "LEUPROLIDE ACETATE", "ActiveIngredient": "LEUPROLIDE ACETATE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/074728s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74728"}, "74739": {"ApplNo": "74739", "Form": "TABLET;ORAL", "Drug": "AMIODARONE HYDROCHLORIDE", "ActiveIngredient": "AMIODARONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74-739_Amiodarone_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74739"}, "74752": {"ApplNo": "74752", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "CARTIA XT", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "ACTAVIS LABS FL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/74752lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74752"}, "74769": {"ApplNo": "74769", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MORPHINE SULFATE", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "ANDA", "Sponsor": "RHODES PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74769ap_appltr_prntlbl_chemr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74769"}, "74787": {"ApplNo": "74787", "Form": "TABLET;ORAL", "Drug": "LABETALOL HYDROCHLORIDE", "ActiveIngredient": "LABETALOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HERITAGE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74787_Labetalol%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74787"}, "74802": {"ApplNo": "74802", "Form": "INJECTABLE;INJECTION", "Drug": "KETOROLAC TROMETHAMINE", "ActiveIngredient": "KETOROLAC TROMETHAMINE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/074802s038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74802"}, "74862": {"ApplNo": "74862", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "MORPHINE SULFATE", "ActiveIngredient": "MORPHINE SULFATE", "ApplType": "ANDA", "Sponsor": "RHODES PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74862ap_appltr_prntlbl_chemr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74862"}, "74904": {"ApplNo": "74904", "Form": "GEL;TOPICAL", "Drug": "TOPICORT", "ActiveIngredient": "DESOXIMETASONE", "ApplType": "ANDA", "Sponsor": "TARO PHARM INDS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/074904Orig1s015Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74904"}, "74926": {"ApplNo": "74926", "Form": "CREAM, SUPPOSITORY;TOPICAL, VAGINAL", "Drug": "M-ZOLE 3 COMBINATION PACK", "ActiveIngredient": "MICONAZOLE NITRATE", "ApplType": "ANDA", "Sponsor": "P AND L", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/74-926_Miconazole%20Nitrate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74926"}, "74928": {"ApplNo": "74928", "Form": "CAPSULE;ORAL", "Drug": "NICARDIPINE HYDROCHLORIDE", "ActiveIngredient": "NICARDIPINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "EPIC PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74928ap_appltr_prntlbl_chemr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74928"}, "74937": {"ApplNo": "74937", "Form": "SUSPENSION;ORAL", "Drug": "CHILDREN'S IBUPROFEN", "ActiveIngredient": "IBUPROFEN", "ApplType": "ANDA", "Sponsor": "PERRIGO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74-937_Ibuprofen_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74937"}, "74941": {"ApplNo": "74941", "Form": "INJECTABLE;INJECTION", "Drug": "DILTIAZEM HYDROCHLORIDE", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/74-941_Diltiazem_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74941"}, "74943": {"ApplNo": "74943", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "DILTIAZEM HYDROCHLORIDE", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74943_Diltiazem%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74943"}, "74978": {"ApplNo": "74978", "Form": "SUSPENSION;ORAL", "Drug": "IBUPROFEN", "ActiveIngredient": "IBUPROFEN", "ApplType": "ANDA", "Sponsor": "ACTAVIS MID ATLANTIC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/074978Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=74978"}, "75014": {"ApplNo": "75014", "Form": "LOTION;TOPICAL", "Drug": "PERMETHRIN", "ActiveIngredient": "PERMETHRIN", "ApplType": "ANDA", "Sponsor": "ACTAVIS MID ATLANTIC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75014_Permethrin_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75014"}, "75036": {"ApplNo": "75036", "Form": "INJECTABLE;INJECTION", "Drug": "CISPLATIN", "ActiveIngredient": "CISPLATIN", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-036_Cisplatin_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75036"}, "75042": {"ApplNo": "75042", "Form": "CREAM;TOPICAL", "Drug": "HYDROCORTISONE VALERATE", "ActiveIngredient": "HYDROCORTISONE VALERATE", "ApplType": "ANDA", "Sponsor": "TARO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/75-042_prntlbl.PDF", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75042"}, "75043": {"ApplNo": "75043", "Form": "OINTMENT;TOPICAL", "Drug": "HYDROCORTISONE VALERATE", "ActiveIngredient": "HYDROCORTISONE VALERATE", "ApplType": "ANDA", "Sponsor": "TARO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75043_Hydrocortisone%20Valerate_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75043"}, "75049": {"ApplNo": "75049", "Form": "CAPSULE;ORAL", "Drug": "FLUOXETINE HYDROCHLORIDE", "ActiveIngredient": "FLUOXETINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "APNAR PHARMA LP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75049_FLUOXETINE_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75049"}, "75051": {"ApplNo": "75051", "Form": "SOLUTION;ORAL", "Drug": "METOCLOPRAMIDE HYDROCHLORIDE", "ActiveIngredient": "METOCLOPRAMIDE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "VISTAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-051_Metoclopramide_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75051"}, "75072": {"ApplNo": "75072", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "VERAPAMIL HYDROCHLORIDE", "ActiveIngredient": "VERAPAMIL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "STRIDES PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/75072_Verapamil_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75072"}, "75086": {"ApplNo": "75086", "Form": "INJECTABLE;INJECTION", "Drug": "DILTIAZEM HYDROCHLORIDE", "ActiveIngredient": "DILTIAZEM HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "AKORN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75086_Diltiazem%20Hydrochloride_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75086"}, "75091": {"ApplNo": "75091", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CARBIDOPA AND LEVODOPA", "ActiveIngredient": "CARBIDOPA; LEVODOPA", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75-091_Carbidopa%20and%20Levodopa_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75091"}, "7513": {"ApplNo": "7513", "Form": "INJECTABLE;INJECTION", "Drug": "LEVOPHED", "ActiveIngredient": "NOREPINEPHRINE BITARTRATE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/007513s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=7513"}, "75135": {"ApplNo": "75135", "Form": "TABLET;ORAL", "Drug": "PACERONE", "ActiveIngredient": "AMIODARONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/75135ap_appltr_prntlbl_chemr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75135"}, "75138": {"ApplNo": "75138", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "VERAPAMIL HYDROCHLORIDE", "ActiveIngredient": "VERAPAMIL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75-138_Verapamil%20Hydrochloride_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75138"}, "75155": {"ApplNo": "75155", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "ISOSORBIDE MONONITRATE", "ActiveIngredient": "ISOSORBIDE MONONITRATE", "ApplType": "ANDA", "Sponsor": "CHARTWELL MOLECULAR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/075155Orig1s034lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75155"}, "75184": {"ApplNo": "75184", "Form": "INJECTABLE;INJECTION", "Drug": "PACLITAXEL", "ActiveIngredient": "PACLITAXEL", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2002/75184_Paclitaxel_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75184"}, "75203": {"ApplNo": "75203", "Form": "TABLET;ORAL", "Drug": "PROPAFENONE HYDROCHLORIDE", "ActiveIngredient": "PROPAFENONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "WATSON LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75203_Propafenone%20Hydrochloride_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75203"}, "75213": {"ApplNo": "75213", "Form": "CREAM;TOPICAL", "Drug": "TRETINOIN", "ActiveIngredient": "TRETINOIN", "ApplType": "ANDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75213_Tretinoin_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75213"}, "75217": {"ApplNo": "75217", "Form": "SUSPENSION/DROPS;ORAL", "Drug": "IBUPROFEN", "ActiveIngredient": "IBUPROFEN", "ApplType": "ANDA", "Sponsor": "L PERRIGO CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/75-217_Ibuprofen_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75217"}, "75232": {"ApplNo": "75232", "Form": "TABLET;ORAL", "Drug": "LOPERAMIDE HYDROCHLORIDE", "ActiveIngredient": "LOPERAMIDE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "L PERRIGO CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-232_Loperamide_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75232"}, "75239": {"ApplNo": "75239", "Form": "INJECTABLE;INJECTION", "Drug": "LABETALOL HYDROCHLORIDE", "ActiveIngredient": "LABETALOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/075239s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75239"}, "75241": {"ApplNo": "75241", "Form": "INJECTABLE;INJECTION", "Drug": "FUROSEMIDE", "ActiveIngredient": "FUROSEMIDE", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75-241_Furosemide_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75241"}, "75256": {"ApplNo": "75256", "Form": "TABLET;ORAL-28", "Drug": "DESOGESTREL AND ETHINYL ESTRADIOL", "ActiveIngredient": "DESOGESTREL; ETHINYL ESTRADIOL", "ApplType": "ANDA", "Sponsor": "DURAMED PHARMS BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75256_Desogestrel%20and%20Ethinyl%20Estradiol_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75256"}, "75264": {"ApplNo": "75264", "Form": "CREAM;TOPICAL", "Drug": "TRETINOIN", "ActiveIngredient": "TRETINOIN", "ApplType": "ANDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75264_Tretinoin_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75264"}, "75265": {"ApplNo": "75265", "Form": "CREAM;TOPICAL", "Drug": "TRETINOIN", "ActiveIngredient": "TRETINOIN", "ApplType": "ANDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75265_Tretinoin_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75265"}, "75271": {"ApplNo": "75271", "Form": "SOLUTION;INHALATION", "Drug": "CROMOLYN SODIUM", "ActiveIngredient": "CROMOLYN SODIUM", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-271_Cromolyn%20Sodium_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75271"}, "75276": {"ApplNo": "75276", "Form": "GEL, AUGMENTED;TOPICAL", "Drug": "BETAMETHASONE DIPROPIONATE", "ActiveIngredient": "BETAMETHASONE DIPROPIONATE", "ApplType": "ANDA", "Sponsor": "FOUGERA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2003/75276_Betamethasone%20Dipropionate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75276"}, "75288": {"ApplNo": "75288", "Form": "TABLET;ORAL-28", "Drug": "LOW-OGESTREL-28", "ActiveIngredient": "ETHINYL ESTRADIOL; NORGESTREL", "ApplType": "ANDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75288_Norgestrel%20And%20Ethinyl%20Estradiol_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75288"}, "75290": {"ApplNo": "75290", "Form": "INJECTABLE;INJECTION", "Drug": "PAMIDRONATE DISODIUM", "ActiveIngredient": "PAMIDRONATE DISODIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-290_Pamidronate%20Disodium_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75290"}, "75329": {"ApplNo": "75329", "Form": "CREAM, SUPPOSITORY;TOPICAL, VAGINAL", "Drug": "MICONAZOLE NITRATE COMBINATION PACK", "ActiveIngredient": "MICONAZOLE NITRATE", "ApplType": "ANDA", "Sponsor": "L PERRIGO CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75-329_Miconazole%20Nitrate_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75329"}, "75374": {"ApplNo": "75374", "Form": "OINTMENT;TOPICAL", "Drug": "DIFLORASONE DIACETATE", "ActiveIngredient": "DIFLORASONE DIACETATE", "ApplType": "ANDA", "Sponsor": "FOUGERA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75-374_Diflorasone%20Diacetate_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75374"}, "75429": {"ApplNo": "75429", "Form": "TABLET;ORAL", "Drug": "SOTALOL HYDROCHLORIDE", "ActiveIngredient": "SOTALOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-429_Sotalol%20Hydrochloride_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75429"}, "75458": {"ApplNo": "75458", "Form": "INJECTABLE;INJECTION", "Drug": "ENALAPRILAT", "ActiveIngredient": "ENALAPRILAT", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/075458s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75458"}, "75465": {"ApplNo": "75465", "Form": "CAPSULE;ORAL", "Drug": "FLUOXETINE HYDROCHLORIDE", "ActiveIngredient": "FLUOXETINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "MARKSANS PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2002/75465_Fluoxetine_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75465"}, "75541": {"ApplNo": "75541", "Form": "TABLET;ORAL", "Drug": "BETAXOLOL HYDROCHLORIDE", "ActiveIngredient": "BETAXOLOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "EPIC PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/075541Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75541"}, "75547": {"ApplNo": "75547", "Form": "INJECTABLE;INJECTION", "Drug": "THIOTEPA", "ActiveIngredient": "THIOTEPA", "ApplType": "ANDA", "Sponsor": "WEST-WARD PHARMS INT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/075547Orig1s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75547"}, "75549": {"ApplNo": "75549", "Form": "INJECTABLE;INJECTION", "Drug": "VECURONIUM BROMIDE", "ActiveIngredient": "VECURONIUM BROMIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/075549s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75549"}, "75567": {"ApplNo": "75567", "Form": "INJECTABLE;INJECTION", "Drug": "LEVOCARNITINE", "ActiveIngredient": "LEVOCARNITINE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-567_Levocarnitine_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75567"}, "75581": {"ApplNo": "75581", "Form": "CREAM;TOPICAL", "Drug": "KETOCONAZOLE", "ActiveIngredient": "KETOCONAZOLE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/75-581_Ketoconazole_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75581"}, "75611": {"ApplNo": "75611", "Form": "TABLET;ORAL", "Drug": "FAMOTIDINE", "ActiveIngredient": "FAMOTIDINE", "ApplType": "ANDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75611_Famotidine_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75611"}, "75660": {"ApplNo": "75660", "Form": "INJECTABLE;INJECTION", "Drug": "MILRINONE LACTATE", "ActiveIngredient": "MILRINONE LACTATE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/75660_Milrinone%20Lactate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75660"}, "75661": {"ApplNo": "75661", "Form": "TABLET;ORAL", "Drug": "IBUPROFEN", "ActiveIngredient": "IBUPROFEN", "ApplType": "ANDA", "Sponsor": "DR REDDYS LA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75661_Ibuprofen_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75661"}, "75702": {"ApplNo": "75702", "Form": "SPRAY, METERED;NASAL", "Drug": "CROMOLYN SODIUM", "ActiveIngredient": "CROMOLYN SODIUM", "ApplType": "ANDA", "Sponsor": "BAUSCH AND LOMB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-702_Cromolyn%20Sodium_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75702"}, "75706": {"ApplNo": "75706", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "LORATADINE AND PSEUDOEPHEDRINE SULFATE", "ActiveIngredient": "LORATADINE; PSEUDOEPHEDRINE SULFATE", "ApplType": "ANDA", "Sponsor": "P AND L", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/75706_Loratadine And Pseudoephedrine Sulfate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75706"}, "75733": {"ApplNo": "75733", "Form": "CREAM;TOPICAL", "Drug": "CLOBETASOL PROPIONATE (EMOLLIENT)", "ActiveIngredient": "CLOBETASOL PROPIONATE", "ApplType": "ANDA", "Sponsor": "ANI PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75733_Clobetasol Propionate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75733"}, "75753": {"ApplNo": "75753", "Form": "CAPSULE;ORAL", "Drug": "FENOFIBRATE (MICRONIZED)", "ActiveIngredient": "FENOFIBRATE", "ApplType": "ANDA", "Sponsor": "RHODES PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/075753s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75753"}, "75796": {"ApplNo": "75796", "Form": "TABLET;ORAL-28", "Drug": "AVIANE-28", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "ANDA", "Sponsor": "DURAMED PHARMS BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-796_Aviane-21%20and%20Aviane-28_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75796"}, "75803": {"ApplNo": "75803", "Form": "TABLET;ORAL-28", "Drug": "LESSINA-28", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "ANDA", "Sponsor": "BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/75803_Levonorgestrel And Ethinyl Estradiol_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75803"}, "75811": {"ApplNo": "75811", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "MESNA", "ActiveIngredient": "MESNA", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-811_Mesna_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75811"}, "75834": {"ApplNo": "75834", "Form": "INJECTABLE;INJECTION", "Drug": "MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER", "ActiveIngredient": "MILRINONE LACTATE", "ApplType": "ANDA", "Sponsor": "BAXTER HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/75834_Milrinone%20Lactate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75834"}, "75906": {"ApplNo": "75906", "Form": "INJECTABLE;INJECTION", "Drug": "PROGESTERONE", "ActiveIngredient": "PROGESTERONE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-906_Progesterone_prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75906"}, "75909": {"ApplNo": "75909", "Form": "TABLET;ORAL", "Drug": "ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE", "ActiveIngredient": "ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE", "ApplType": "ANDA", "Sponsor": "DR REDDYS LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75-909_Enalapril%20Maleate%20and%20Hydrochlorothiazide_Prntlb", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75909"}, "75951": {"ApplNo": "75951", "Form": "TABLET;ORAL", "Drug": "NORETHINDRONE ACETATE", "ActiveIngredient": "NORETHINDRONE ACETATE", "ApplType": "ANDA", "Sponsor": "BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/75951_Norethindrone Acetate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75951"}, "75964": {"ApplNo": "75964", "Form": "TABLET;ORAL", "Drug": "TRAMADOL HYDROCHLORIDE", "ActiveIngredient": "TRAMADOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/N75964lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75964"}, "75977": {"ApplNo": "75977", "Form": "TABLET;ORAL", "Drug": "TRAMADOL HYDROCHLORIDE", "ActiveIngredient": "TRAMADOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/75977lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=75977"}, "76003": {"ApplNo": "76003", "Form": "TABLET;ORAL", "Drug": "TRAMADOL HYDROCHLORIDE", "ActiveIngredient": "TRAMADOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "AMNEAL PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/76003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76003"}, "76005": {"ApplNo": "76005", "Form": "CREAM;TOPICAL", "Drug": "ECONAZOLE NITRATE", "ActiveIngredient": "ECONAZOLE NITRATE", "ApplType": "ANDA", "Sponsor": "TARO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/76005_Econazole Nirate_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76005"}, "76037": {"ApplNo": "76037", "Form": "TABLET;ORAL", "Drug": "NEFAZODONE HYDROCHLORIDE", "ActiveIngredient": "NEFAZODONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/076037s011lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76037"}, "76047": {"ApplNo": "76047", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "CONTRACT PHARMACAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/076047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76047"}, "76067": {"ApplNo": "76067", "Form": "OINTMENT;TOPICAL", "Drug": "MOMETASONE FUROATE", "ActiveIngredient": "MOMETASONE FUROATE", "ApplType": "ANDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/2002/76067_Mometasone Furoate_Approv.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76067"}, "761024": {"ApplNo": "761024", "Form": "INJECTABLE;INJECTION", "Drug": "AMJEVITA", "ActiveIngredient": "ADALIMUMAB-ATTO", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761024s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761024"}, "761025": {"ApplNo": "761025", "Form": "INJECTABLE;INJECTION", "Drug": "PRAXBIND", "ActiveIngredient": "IDARUCIZUMAB", "ApplType": "BLA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761025s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761025"}, "761028": {"ApplNo": "761028", "Form": "INJECTABLE; INJECTION", "Drug": "MVASI", "ActiveIngredient": "BEVACIZUMAB-AWWB", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761028s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761028"}, "761029": {"ApplNo": "761029", "Form": "INJECTABLE;INJECTION", "Drug": "ZINBRYTA", "ActiveIngredient": "DACLIZUMAB", "ApplType": "BLA", "Sponsor": "BIOGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761029"}, "761032": {"ApplNo": "761032", "Form": "INJECTABLE;INJECTION", "Drug": "SILIQ", "ActiveIngredient": "BRODALUMAB", "ApplType": "BLA", "Sponsor": "VALEANT LUXEMBOURG", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032"}, "761033": {"ApplNo": "761033", "Form": "INJECTABLE;INJECTION", "Drug": "CINQAIR", "ActiveIngredient": "RESLIZUMAB", "ApplType": "BLA", "Sponsor": "TEVA RESPIRATORY LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/0761033s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761033"}, "761034": {"ApplNo": "761034", "Form": "INJECTABLE;INJECTION", "Drug": "TECENTRIQ", "ActiveIngredient": "ATEZOLIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761034s047lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761034"}, "761035": {"ApplNo": "761035", "Form": "INJECTABLE;INJECTION", "Drug": "EMPLICITI", "ActiveIngredient": "ELOTUZUMAB", "ApplType": "BLA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761035s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761035"}, "761036": {"ApplNo": "761036", "Form": "INJECTABLE;INJECTION", "Drug": "DARZALEX", "ActiveIngredient": "DARATUMUMAB", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761036s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761036"}, "761037": {"ApplNo": "761037", "Form": "INJECTABLE;INJECTION", "Drug": "KEVZARA", "ActiveIngredient": "SARILUMAB", "ApplType": "BLA", "Sponsor": "SANOFI SYNTHELABO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761037s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761037"}, "761038": {"ApplNo": "761038", "Form": "INJECTABLE; INJECTION", "Drug": "LARTRUVO", "ActiveIngredient": "OLARATUMAB", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761038lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761038"}, "761039": {"ApplNo": "761039", "Form": "INJECTABLE;INJECTION", "Drug": "UDENYCA", "ActiveIngredient": "PEGFILGRASTIM-CBQV", "ApplType": "BLA", "Sponsor": "COHERUS BIOSCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761039s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761039"}, "761040": {"ApplNo": "761040", "Form": "POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER", "Drug": "BESPONSA", "ActiveIngredient": "INOTUZUMAB OZOGAMICIN", "ApplType": "BLA", "Sponsor": "WYETH PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761040s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761040"}, "761041": {"ApplNo": "761041", "Form": "INJECTABLE; INJECTION", "Drug": "TECENTRIQ", "ActiveIngredient": "ATEZOLIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761041"}, "761042": {"ApplNo": "761042", "Form": "INJECTABLE; INJECTION", "Drug": "ERELZI", "ActiveIngredient": "ETANERCEPT-SZZS", "ApplType": "BLA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761042s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761042"}, "761043": {"ApplNo": "761043", "Form": "INJECTABLE;INJECTION", "Drug": "BENLYSTA", "ActiveIngredient": "BELIMUMAB", "ApplType": "BLA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761043s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761043"}, "761044": {"ApplNo": "761044", "Form": "INJECTABLE;INJECTION", "Drug": "STELARA", "ActiveIngredient": "USTEKINUMAB", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761044s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761044"}, "761045": {"ApplNo": "761045", "Form": "INJECTABLE;INJECTION", "Drug": "ZIEXTENZO", "ActiveIngredient": "PEGFILGRASTIM-BMEZ", "ApplType": "BLA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761045s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761045"}, "761046": {"ApplNo": "761046", "Form": "INJECTABLE;INJECTION", "Drug": "ZINPLAVA", "ActiveIngredient": "BEZLOTOXUMAB", "ApplType": "BLA", "Sponsor": "MERCK SHARP DOHME", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761046"}, "761047": {"ApplNo": "761047", "Form": "INJECTABLE;INJECTION", "Drug": "MEPSEVII", "ActiveIngredient": "VESTRONIDASE ALFA-VJBK", "ApplType": "BLA", "Sponsor": "ULTRAGENYX PHARM INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761047s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761047"}, "761049": {"ApplNo": "761049", "Form": "INJECTABLE;INJECTION", "Drug": "BAVENCIO", "ActiveIngredient": "AVELUMAB", "ApplType": "BLA", "Sponsor": "EMD SERONO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761049s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761049"}, "761051": {"ApplNo": "761051", "Form": "INJECTABLE;INJECTION", "Drug": "POTELIGEO", "ActiveIngredient": "MOGAMULIZUMAB-KPKC", "ApplType": "BLA", "Sponsor": "KYOWA KIRIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761051s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761051"}, "761052": {"ApplNo": "761052", "Form": "INJECTABLE;INJECTION", "Drug": "BRINEURA", "ActiveIngredient": "CERLIPONASE ALFA", "ApplType": "BLA", "Sponsor": "BIOMARIN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761052s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052"}, "761053": {"ApplNo": "761053", "Form": "INJECTABLE;INJECTION", "Drug": "OCREVUS", "ActiveIngredient": "OCRELIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761053s029s030lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761053"}, "761054": {"ApplNo": "761054", "Form": "INJECTABLE;INJECTION", "Drug": "RENFLEXIS", "ActiveIngredient": "INFLIXIMAB-ABDA", "ApplType": "BLA", "Sponsor": "SAMSUNG BIOEPIS CO LTD", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761054Orig1s029lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761054"}, "761055": {"ApplNo": "761055", "Form": "INJECTABLE; INJECTION", "Drug": "DUPIXENT", "ActiveIngredient": "DUPILUMAB", "ApplType": "BLA", "Sponsor": "REGENERON PHARMACEUTICALS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761055s046lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761055"}, "761058": {"ApplNo": "761058", "Form": "INJECTABLE;INJECTION", "Drug": "CYLTEZO", "ActiveIngredient": "ADALIMUMAB-ADBM", "ApplType": "BLA", "Sponsor": "BOEHRINGER INGELHEIM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761058Orig1s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761058"}, "761059": {"ApplNo": "761059", "Form": "INJECTABLE;INJECTION", "Drug": "HADLIMA", "ActiveIngredient": "ADALIMUMAB-BWWD", "ApplType": "BLA", "Sponsor": "SAMSUNG BIOEPIS CO LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761059Orig1s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761059"}, "761060": {"ApplNo": "761060", "Form": "VIAL;SINGLE-DOSE", "Drug": "MYLOTARG", "ActiveIngredient": "GEMTUZUMAB OZOGAMICIN", "ApplType": "BLA", "Sponsor": "WYETH PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761060s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761060"}, "761061": {"ApplNo": "761061", "Form": "INJECTABLE;INJECTION", "Drug": "TREMFYA", "ActiveIngredient": "GUSELKUMAB", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761061"}, "761062": {"ApplNo": "761062", "Form": "INJECTABLE;INJECTION", "Drug": "EVENITY", "ActiveIngredient": "ROMOSOZUMAB-AQQG", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761062"}, "761063": {"ApplNo": "761063", "Form": "INJECTABLE;INJECTION", "Drug": "EMGALITY", "ActiveIngredient": "GALCANEZUMAB-GNLM", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761063s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761063"}, "761064": {"ApplNo": "761064", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "RITUXAN HYCELA", "ActiveIngredient": "RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761064"}, "761065": {"ApplNo": "761065", "Form": "INJECTABLE;INJECTION", "Drug": "TROGARZO", "ActiveIngredient": "IBALIZUMAB-UIYK", "ApplType": "BLA", "Sponsor": "THERATECHNOLOGIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761065s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761065"}, "761066": {"ApplNo": "761066", "Form": "INJECTABLE;INJECTION", "Drug": "ETICOVO", "ActiveIngredient": "ETANERCEPT-YKRO", "ApplType": "BLA", "Sponsor": "SAMSUNG BIOEPIS CO LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761066"}, "761067": {"ApplNo": "761067", "Form": "INJECTABLE;INJECTION", "Drug": "ILUMYA", "ActiveIngredient": "TILDRAKIZUMAB-ASMN", "ApplType": "BLA", "Sponsor": "SUN PHARMA GLOBAL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761067s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761067"}, "761068": {"ApplNo": "761068", "Form": "INJECTABLE;INJECTION", "Drug": "CRYSVITA", "ActiveIngredient": "BUROSUMAB-TWZA", "ApplType": "BLA", "Sponsor": "KYOWA KIRIN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761068s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761068"}, "761069": {"ApplNo": "761069", "Form": "INJECTABLE;INJECTION", "Drug": "IMFINZI", "ActiveIngredient": "DURVALUMAB", "ApplType": "BLA", "Sponsor": "ASTRAZENECA UK LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761069Orig1s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761069"}, "761070": {"ApplNo": "761070", "Form": "INJECTABLE;INJECTION", "Drug": "FASENRA", "ActiveIngredient": "BENRALIZUMAB", "ApplType": "BLA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761070s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761070"}, "761071": {"ApplNo": "761071", "Form": "INJECTABLE;INJECTION", "Drug": "HYRIMOZ", "ActiveIngredient": "ADALIMUMAB-ADAZ", "ApplType": "BLA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761071s010s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761071"}, "761072": {"ApplNo": "761072", "Form": "INJECTABLE;INJECTION", "Drug": "IXIFI", "ActiveIngredient": "INFLIXIMAB-QBTX", "ApplType": "BLA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761072s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761072"}, "761073": {"ApplNo": "761073", "Form": "VIAL; MULTIDOSE", "Drug": "KANJINTI", "ActiveIngredient": "TRASTUZUMAB-ANNS", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761073Orig1s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761073"}, "761074": {"ApplNo": "761074", "Form": "INJECTABLE;INJECTION", "Drug": "OGIVRI", "ActiveIngredient": "TRASTUZUMAB-DKST", "ApplType": "BLA", "Sponsor": "MYLAN GMBH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761074s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761074"}, "761075": {"ApplNo": "761075", "Form": "INJECTABLE;INJECTION", "Drug": "FULPHILA", "ActiveIngredient": "PEGFILGRASTIM-JMDB", "ApplType": "BLA", "Sponsor": "MYLAN GMBH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761075s012lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761075"}, "761077": {"ApplNo": "761077", "Form": "INJECTABLE;INJECTION", "Drug": "AIMOVIG", "ActiveIngredient": "ERENUMAB-AOOE", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761077s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077"}, "761078": {"ApplNo": "761078", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "BAVENCIO", "ActiveIngredient": "AVELUMAB", "ApplType": "BLA", "Sponsor": "EMD SERONO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761078"}, "761079": {"ApplNo": "761079", "Form": "INJECTABLE;INJECTION", "Drug": "PALYNZIQ", "ActiveIngredient": "PEGVALIASE-PQPZ", "ApplType": "BLA", "Sponsor": "BIOMARIN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761079s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079"}, "761080": {"ApplNo": "761080", "Form": "VIAL;SINGLE-DOSE", "Drug": "NIVESTYM", "ActiveIngredient": "FILGRASTIM-AAFI", "ApplType": "BLA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761080s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761080"}, "761081": {"ApplNo": "761081", "Form": "INJECTABLE;INJECTION", "Drug": "TRAZIMERA", "ActiveIngredient": "TRASTUZUMAB-QYYP", "ApplType": "BLA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761081s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761081"}, "761082": {"ApplNo": "761082", "Form": "SOLUTION;INTRAVENOUS, SUBCUTANEOUS", "Drug": "RELEUKO", "ActiveIngredient": "FILGRASTIM-AYOW", "ApplType": "BLA", "Sponsor": "KASHIV BIOSCIENCES LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761082s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761082"}, "761083": {"ApplNo": "761083", "Form": "INJECTABLE;INJECTION", "Drug": "HEMLIBRA", "ActiveIngredient": "EMICIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761083s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761083"}, "761084": {"ApplNo": "761084", "Form": "INJECTABLE;INJECTION", "Drug": "FYLNETRA", "ActiveIngredient": "PEGFILGRASTIM-PBBK", "ApplType": "BLA", "Sponsor": "KASHIV BIOSCIENCES LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761084s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761084"}, "761085": {"ApplNo": "761085", "Form": "INJECTABLE;INJECTION", "Drug": "JEUVEAU", "ActiveIngredient": "PRABOTULINUMTOXINA-XVFS", "ApplType": "BLA", "Sponsor": "EVOLUS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761085"}, "761086": {"ApplNo": "761086", "Form": "INJECTABLE;INJECTION", "Drug": "AVSOLA", "ActiveIngredient": "INFLIXIMAB-AXXQ", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761086s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761086"}, "761088": {"ApplNo": "761088", "Form": "INJECTABLE;INJECTION", "Drug": "TRUXIMA", "ActiveIngredient": "RITUXIMAB-ABBS", "ApplType": "BLA", "Sponsor": "CELLTRION INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761088s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761088"}, "761089": {"ApplNo": "761089", "Form": "INJECTABLE;INJECTION", "Drug": "AJOVY", "ActiveIngredient": "FREMANEZUMAB-VFRM", "ApplType": "BLA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761089s013lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761089"}, "761090": {"ApplNo": "761090", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "TAKHZYRO", "ActiveIngredient": "LANDELUMAB-FLYO", "ApplType": "BLA", "Sponsor": "DYAX CORP.", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761090s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761090"}, "761091": {"ApplNo": "761091", "Form": "INJECTABLE;INJECTION", "Drug": "HERZUMA", "ActiveIngredient": "TRASTUZUMAB-PKRB", "ApplType": "BLA", "Sponsor": "CELLTRION INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761091s001s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761091"}, "761092": {"ApplNo": "761092", "Form": "INJECTABLE;INJECTION", "Drug": "REVCOVI", "ActiveIngredient": "ELAPEGADEMASE-LVLR", "ApplType": "BLA", "Sponsor": "LEADIANT BIOSCI INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761092s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761092"}, "761094": {"ApplNo": "761094", "Form": "SOLUTION;OPHTHALMIC", "Drug": "OXERVATE", "ActiveIngredient": "CENEGERMIN-BKBJ", "ApplType": "BLA", "Sponsor": "DOMPE FARMACEUTICI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761094s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761094"}, "761097": {"ApplNo": "761097", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "LIBTAYO", "ActiveIngredient": "CEMIPLIMAB-RWLC", "ApplType": "BLA", "Sponsor": "REGENERON PHARMACEUTICALS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761097s014lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761097"}, "761099": {"ApplNo": "761099", "Form": "INJECTABLE;INJECTION", "Drug": "ZIRABEV", "ActiveIngredient": "BEVACIZUMAB-BVZR", "ApplType": "BLA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761099s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761099"}, "761100": {"ApplNo": "761100", "Form": "POWDER;IV (INFUSION)", "Drug": "ONTRUZANT", "ActiveIngredient": "TRASTUZUMAB-DTTB", "ApplType": "BLA", "Sponsor": "SAMSUNG BIOEPIS CO LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761100Orig1s005Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761100"}, "761102": {"ApplNo": "761102", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "ASPARLAS", "ActiveIngredient": "CALASPARGASE PEGOL-MKNL", "ApplType": "BLA", "Sponsor": "SERVIER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761102s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761102"}, "761103": {"ApplNo": "761103", "Form": "INJECTABLE;INJECTION", "Drug": "RUXIENCE", "ActiveIngredient": "RITUXIMAB-PVVR", "ApplType": "BLA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761103s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761103"}, "761104": {"ApplNo": "761104", "Form": "INJECTABLE;INJECTION", "Drug": "LUMOXITI", "ActiveIngredient": "MOXETUMOMAB PASUDOTOX-TDFK", "ApplType": "BLA", "Sponsor": "INNATE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761104"}, "761105": {"ApplNo": "761105", "Form": "INJECTABLE;INJECTION", "Drug": "SKYRIZI", "ActiveIngredient": "RISANKIZUMAB-RZAA", "ApplType": "BLA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761105s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761105"}, "761106": {"ApplNo": "761106", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "HERCEPTIN HYLECTA", "ActiveIngredient": "TRASTUZUMAB; HYALURONIDASE-OYSK", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761106Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761106"}, "761107": {"ApplNo": "761107", "Form": "INJECTABLE;INJECTION", "Drug": "GAMIFANT", "ActiveIngredient": "EMAPALUMAB-LZSG", "ApplType": "BLA", "Sponsor": "NOVIMMUNE S.A.", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761107s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761107"}, "761108": {"ApplNo": "761108", "Form": "INJECTABLE;INJECTION", "Drug": "ULTOMIRIS", "ActiveIngredient": "RAVULIZUMAB-CWVZ", "ApplType": "BLA", "Sponsor": "ALEXION PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761108s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761108"}, "761109": {"ApplNo": "761109", "Form": "INJECTABLE;INJECTION", "Drug": "LYUMJEV", "ActiveIngredient": "INSULIN LISPRO-AABC", "ApplType": "BLA", "Sponsor": "ELI LILLY AND CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761109s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761109"}, "761111": {"ApplNo": "761111", "Form": "INJECTABLE;INJECTION", "Drug": "NYVEPRIA", "ActiveIngredient": "PEGFILGRASTIM-APGF", "ApplType": "BLA", "Sponsor": "HOSPIRA INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761111s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761111"}, "761112": {"ApplNo": "761112", "Form": "INJECTABLE;INJECTION", "Drug": "CABLIVI", "ActiveIngredient": "CAPLACIZUMAB-YHDP", "ApplType": "BLA", "Sponsor": "ABLYNX NV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761112s009lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761112"}, "761113": {"ApplNo": "761113", "Form": "INJECTABLE;INJECTION", "Drug": "SARCLISA", "ActiveIngredient": "ISATUXIMAB-IRFC", "ApplType": "BLA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761113s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761113"}, "761115": {"ApplNo": "761115", "Form": "INJECTABLE;INJECTION", "Drug": "TRODELVY", "ActiveIngredient": "SACITUZUMAB GOVITECAN-HZIY", "ApplType": "BLA", "Sponsor": "IMMUNOMEDICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761115Orig1s031Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761115"}, "761116": {"ApplNo": "761116", "Form": "SOLUTION;INJECTION", "Drug": "ELZONRIS", "ActiveIngredient": "TAGRAXOFUSP-ERZS", "ApplType": "BLA", "Sponsor": "STEMLINE THERAPEUTICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761116s007lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761116"}, "761118": {"ApplNo": "761118", "Form": "INJECTABLE;INJECTION", "Drug": "ABRILADA", "ActiveIngredient": "ADALIMUMAB-AFZB", "ApplType": "BLA", "Sponsor": "PFIZER INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761118s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761118"}, "761119": {"ApplNo": "761119", "Form": "INJECTABLE;INJECTION", "Drug": "VYEPTI", "ActiveIngredient": "EPTINEZUMAB-JJMR", "ApplType": "BLA", "Sponsor": "Lundbeck Seattle BioPharmaceuticals, Inc.", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761119s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761119"}, "761121": {"ApplNo": "761121", "Form": "POWDER;INTRAVENOUS", "Drug": "POLIVY", "ActiveIngredient": "POLATUZUMAB VEDOTIN-PIIQ", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761121"}, "761122": {"ApplNo": "761122", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "NUCALA", "ActiveIngredient": "MEPOLIZUMAB", "ApplType": "BLA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761122s008,125526s019lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761122"}, "761123": {"ApplNo": "761123", "Form": "INJECTABLE;INJECTION", "Drug": "SAPHNELO", "ActiveIngredient": "ANIFROLUMAB-FNIA", "ApplType": "BLA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761123s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761123"}, "761125": {"ApplNo": "761125", "Form": "INJECTABLE; INTRAVITREAL", "Drug": "BEOVU", "ActiveIngredient": "brolucizumab-dbll", "ApplType": "BLA", "Sponsor": "NOVARTIS PHARMS CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761125s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761125"}, "761127": {"ApplNo": "761127", "Form": "INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS", "Drug": "DAXXIFY", "ActiveIngredient": "DAXIBOTULINUMTOXINA-LANM", "ApplType": "BLA", "Sponsor": "REVANCE THERAPEUTICS, INC.", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761127s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761127"}, "761128": {"ApplNo": "761128", "Form": "INJECTABLE; INJECTION", "Drug": "ADAKVEO", "ActiveIngredient": "CRIZANLIZUMAB-TMCA", "ApplType": "BLA", "Sponsor": "NOVARTIS PHARMS CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761128s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761128"}, "761136": {"ApplNo": "761136", "Form": "POWDER;SUBCUTANEOUS", "Drug": "REBLOZYL", "ActiveIngredient": "LUSPATERCEPT-AAMT", "ApplType": "BLA", "Sponsor": "CELGENE CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761136s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761136"}, "761137": {"ApplNo": "761137", "Form": "INJECTABLE;INJECTION", "Drug": "PADCEV", "ActiveIngredient": "ENFORTUMAB VEDOTIN-EJFV", "ApplType": "BLA", "Sponsor": "ASTELLAS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761137s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761137"}, "761139": {"ApplNo": "761139", "Form": "INJECTABLE;INJECTION", "Drug": "ENHERTU", "ActiveIngredient": "FAM-TRASTUZUMAB DERUXTECAN-NXKI", "ApplType": "BLA", "Sponsor": "DAIICHI SANKYO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761139s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761139"}, "761140": {"ApplNo": "761140", "Form": "INJECTABLE;INJECTION", "Drug": "RIABNI", "ActiveIngredient": "RITUXIMAB-ARRX", "ApplType": "BLA", "Sponsor": "AMGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761140s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761140"}, "761142": {"ApplNo": "761142", "Form": "INJECTABLE;INJECTION", "Drug": "UPLIZNA", "ActiveIngredient": "INEBILIZUMAB-CDON", "ApplType": "BLA", "Sponsor": "VIELA BIO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761142"}, "761143": {"ApplNo": "761143", "Form": "INJECTABLE;INJECTION", "Drug": "TEPEZZA", "ActiveIngredient": "TEPROTUMUMAB-TRBW", "ApplType": "BLA", "Sponsor": "HORIZON THERAPEUTICS IRELAND", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761143s021lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761143"}, "761145": {"ApplNo": "761145", "Form": "INJECTABLE;INJECTION", "Drug": "DARZALEX FASPRO", "ActiveIngredient": "DARATUMUMAB;HYALURONIDASE-FIHJ", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761145s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761145"}, "761146": {"ApplNo": "761146", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "QWO", "ActiveIngredient": "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES", "ApplType": "BLA", "Sponsor": "ENDO GLOBAL AESTHETICS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761146s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761146"}, "761148": {"ApplNo": "761148", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "ROLVEDON", "ActiveIngredient": "EFLAPEGRASTIM-XNST", "ApplType": "BLA", "Sponsor": "SPECTRUM PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761148Orig1s000Corrected_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761148"}, "761149": {"ApplNo": "761149", "Form": "INJECTABLE;INJECTION", "Drug": "ENSPRYNG", "ActiveIngredient": "SATRALIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761149s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761149"}, "761150": {"ApplNo": "761150", "Form": "INJECTABLE;INJECTION", "Drug": "MARGENZA", "ActiveIngredient": "MARGETUXIMAB-CMKB", "ApplType": "BLA", "Sponsor": "MACROGENICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761150s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761150"}, "761154": {"ApplNo": "761154", "Form": "INJECTABLE;INJECTION", "Drug": "HULIO", "ActiveIngredient": "ADALIMUMAB-FKJP", "ApplType": "BLA", "Sponsor": "MYLAN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761154s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761154"}, "761156": {"ApplNo": "761156", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "SOGROYA", "ActiveIngredient": "SOMAPACITAN-BECO", "ApplType": "BLA", "Sponsor": "NOVO NORDISK INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761156s001s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761156"}, "761158": {"ApplNo": "761158", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "BLENREP", "ActiveIngredient": "BELANTAMAB MAFODOTIN-BLMF", "ApplType": "BLA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761158s006lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761158"}, "761163": {"ApplNo": "761163", "Form": "SOLUTION;INTRAVENOUS", "Drug": "MONJUVI", "ActiveIngredient": "TAFASITAMAB-CXIX", "ApplType": "BLA", "Sponsor": "MORPHOSYS US INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761163s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761163"}, "761164": {"ApplNo": "761164", "Form": "INJECTABLE;INJECTION", "Drug": "ENJAYMO", "ActiveIngredient": "SUTIMLIMAB-JOME", "ApplType": "BLA", "Sponsor": "BIOVERATIV THERAPEUTICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761164s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761164"}, "761165": {"ApplNo": "761165", "Form": "INJECTABLE;INJECTION", "Drug": "CIMERLI", "ActiveIngredient": "RANIBIZUMAB-EQRN", "ApplType": "BLA", "Sponsor": "COHERUS BIOSCIENCES INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761165s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761165"}, "761166": {"ApplNo": "761166", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "BESREMI", "ActiveIngredient": "ROPEGINTERFERON ALFA-2B-NJFT", "ApplType": "BLA", "Sponsor": "PHARMAESSENTIA CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761166s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761166"}, "761169": {"ApplNo": "761169", "Form": "SOLUTION; INJECTION", "Drug": "INMAZEB", "ActiveIngredient": "ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB", "ApplType": "BLA", "Sponsor": "REGENERON PHARMACEUTICALS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761169s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761169"}, "761170": {"ApplNo": "761170", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "PHESGO", "ActiveIngredient": "PERTUZUMAB;TRASTUZUMAB;HYALURONIDASE-ZZXF", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761170s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761170"}, "761171": {"ApplNo": "761171", "Form": "SOLUTION;INTRAVENOUS", "Drug": "DANYELZA", "ActiveIngredient": "NAXITAMAB-GQGK", "ApplType": "BLA", "Sponsor": "Y-MABS THERAPEUTICS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761171lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761171"}, "761172": {"ApplNo": "761172", "Form": "POWDER;IV (INFUSION)", "Drug": "EBANGA", "ActiveIngredient": "ANSUVIMAB-ZYKL", "ApplType": "BLA", "Sponsor": "RIDGEBACK BIOTHERAPEUTICS", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761172Orig1s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761172"}, "761173": {"ApplNo": "761173", "Form": "SOLUTION; INJECTION", "Drug": "STIMUFEND", "ActiveIngredient": "PEGFILGRASTIM-FPGK", "ApplType": "BLA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761173Orig1s000correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761173"}, "761174": {"ApplNo": "761174", "Form": "INJECTABLE;INJECTION", "Drug": "JEMPERLI", "ActiveIngredient": "DOSTARLIMAB-GXLY", "ApplType": "BLA", "Sponsor": "GLAXOSMITHKLINE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761174s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761174"}, "761177": {"ApplNo": "761177", "Form": "INJECTABLE;INJECTION", "Drug": "SKYTROFA", "ActiveIngredient": "LONAPEGSOMATROPIN-TCGD", "ApplType": "BLA", "Sponsor": "ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761177s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761177"}, "761178": {"ApplNo": "761178", "Form": "INJECTABLE;INJECTION", "Drug": "ADUHELM", "ActiveIngredient": "ADUCANUMAB-AVWA", "ApplType": "BLA", "Sponsor": "BIOGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761178s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761178"}, "761179": {"ApplNo": "761179", "Form": "INJECTABLE;INTRAMUSCULAR", "Drug": "RYLAZE", "ActiveIngredient": "ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN", "ApplType": "BLA", "Sponsor": "JAZZ PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761179s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761179"}, "761180": {"ApplNo": "761180", "Form": "INJECTABLE;INJECTION", "Drug": "ADBRY", "ActiveIngredient": "TRALOKINUMAB", "ApplType": "BLA", "Sponsor": "LEO PHARMA AS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761180s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761180"}, "761181": {"ApplNo": "761181", "Form": "SOLUTION; INJECTION", "Drug": "EVKEEZA", "ActiveIngredient": "EVINACUMAB-DGNB", "ApplType": "BLA", "Sponsor": "REGENERON PHARMACEUTICALS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761181s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761181"}, "761183": {"ApplNo": "761183", "Form": "INJECTABLE;INJECTION", "Drug": "TZIELD", "ActiveIngredient": "TEPLIZUMAB-MZWV", "ApplType": "BLA", "Sponsor": "PROVENTION BIO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761183Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761183"}, "761192": {"ApplNo": "761192", "Form": "GEL;TOPICAL", "Drug": "NEXOBRID", "ActiveIngredient": "ANACAULASE-BCDB", "ApplType": "BLA", "Sponsor": "MEDIWOUND, LTD", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761192s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761192"}, "761194": {"ApplNo": "761194", "Form": "INJECTABLE;INJECTION", "Drug": "NEXVIAZYME", "ActiveIngredient": "AVALGLUCOSIDASE ALFA-NGPT", "ApplType": "BLA", "Sponsor": "GENZYME CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761194s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761194"}, "761195": {"ApplNo": "761195", "Form": "INJECTABLE;INJECTION", "Drug": "VYVGART", "ActiveIngredient": "EFGARTIGIMOD ALFA", "ApplType": "BLA", "Sponsor": "ARGENX BV", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761195s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761195"}, "761196": {"ApplNo": "761196", "Form": "INJECTABLE;INJECTION", "Drug": "ZYNLONTA", "ActiveIngredient": "LONCASTUXIMAB TESIRINE-LPYL", "ApplType": "BLA", "Sponsor": "ADC Therapeutics SA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761196s004s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761196"}, "761197": {"ApplNo": "761197", "Form": "SOLUTION;INJECTION", "Drug": "SUSVIMO", "ActiveIngredient": "RANIBIZUMAB", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761197s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761197"}, "761201": {"ApplNo": "761201", "Form": "INJECTABLE;INJECTION", "Drug": "SEMGLEE", "ActiveIngredient": "INSULIN GLARGINE-YFGN", "ApplType": "BLA", "Sponsor": "MYLAN PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761201Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761201"}, "761202": {"ApplNo": "761202", "Form": "INJECTABLE;INJECTION", "Drug": "BYOOVIZ", "ActiveIngredient": "RANIBIZUMAB-NUNA", "ApplType": "BLA", "Sponsor": "SAMSUNG BIOEPIS CO LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761202s004lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761202"}, "761208": {"ApplNo": "761208", "Form": "INJECTABLE;INJECTION", "Drug": "TIVDAK", "ActiveIngredient": "TISOTUMAB VEDOTIN-TFTV", "ApplType": "BLA", "Sponsor": "SEAGEN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761208Orig1s000lbledt.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761208"}, "761210": {"ApplNo": "761210", "Form": "INJECTABLE;INJECTION", "Drug": "RYBREVANT", "ActiveIngredient": "AMIVANTAMAB-VMJW", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761210s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761210"}, "761215": {"ApplNo": "761215", "Form": "INJECTABLE;INJECTION", "Drug": "REZVOGLAR", "ActiveIngredient": "INSULIN GLARGINE-AGLR", "ApplType": "BLA", "Sponsor": "ELI LILLY CO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761215s000Orig2s000.lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761215"}, "761216": {"ApplNo": "761216", "Form": "INJECTABLE;INJECTION", "Drug": "YUSIMRY", "ActiveIngredient": "ADALIMUMAB-AQVH", "ApplType": "BLA", "Sponsor": "COHERUS BIOSCIENCES INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761216s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761216"}, "761223": {"ApplNo": "761223", "Form": "INJECTABLE;INJECTION", "Drug": "JEMPERLI", "ActiveIngredient": "DOSTARLIMAB-GXLY", "ApplType": "BLA", "Sponsor": "GLAXOSMITHKLINE LLC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761223"}, "761224": {"ApplNo": "761224", "Form": "SOLUTION;SUBCUTANEOUS", "Drug": "TEZSPIRE", "ActiveIngredient": "TEZEPELUMAB-EKKO", "ApplType": "BLA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761224s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761224"}, "761228": {"ApplNo": "761228", "Form": "INJECTABLE;INJECTION", "Drug": "KIMMTRAK", "ActiveIngredient": "TEBENTAFUSP-TEBN", "ApplType": "BLA", "Sponsor": "IMMUNOCORE LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761228s002lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761228"}, "761231": {"ApplNo": "761231", "Form": "INJECTABLE;INJECTION", "Drug": "ALYMSYS", "ActiveIngredient": "BEVACIZUMAB-MALY", "ApplType": "BLA", "Sponsor": "AMNEAL PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761231s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761231"}, "761234": {"ApplNo": "761234", "Form": "SOLUTION;INTRAVENOUS", "Drug": "OPDUALAG", "ActiveIngredient": "NIVOLUMAB;RELATLIMAB-RMBW", "ApplType": "BLA", "Sponsor": "BRISTOL MYERS SQUIBB", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761234s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761234"}, "761235": {"ApplNo": "761235", "Form": "INJECTABLE; INTRAVITREAL", "Drug": "VABYSMO", "ActiveIngredient": "FARICIMAB-SVOA", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761235s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761235"}, "761238": {"ApplNo": "761238", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "BRIUMVI", "ActiveIngredient": "UBLITUXIMAB-XIIY", "ApplType": "BLA", "Sponsor": "TG THERAPEUTICS, INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761238s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761238"}, "761244": {"ApplNo": "761244", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "SPEVIGO", "ActiveIngredient": "SPESOLIMAB-SBZO", "ApplType": "BLA", "Sponsor": "BOEHRINGER INGELHEIM PHARMACEUTICALS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761244s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761244"}, "761255": {"ApplNo": "761255", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "IDACIO", "ActiveIngredient": "ADALIMUMAB-AACF", "ApplType": "BLA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761255s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761255"}, "761261": {"ApplNo": "761261", "Form": "INJECTABLE;INJECTION", "Drug": "XENPOZYME", "ActiveIngredient": "OLIPUDASE ALFA-RPCP", "ApplType": "BLA", "Sponsor": "GENZYME CORP", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761261s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761261"}, "761262": {"ApplNo": "761262", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "SKYRIZI", "ActiveIngredient": "RISANKIZUMAB-RZAA", "ApplType": "BLA", "Sponsor": "ABBVIE INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761262s000lblUpdated.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761262"}, "761263": {"ApplNo": "761263", "Form": "INJECTABLE;INJECTION", "Drug": "LUNSUMIO", "ActiveIngredient": "MOSUNETUZUMAB-AXGB", "ApplType": "BLA", "Sponsor": "GENENTECH INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761263s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761263"}, "761268": {"ApplNo": "761268", "Form": "INJECTABLE;INJECTION", "Drug": "VEGZELMA", "ActiveIngredient": "BEVACIZUMAB-ADCD", "ApplType": "BLA", "Sponsor": "CELLTRION", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761268Orig1s000Correctedlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761268"}, "761269": {"ApplNo": "761269", "Form": "INJECTABLE;INJECTION", "Drug": "LEQEMBI", "ActiveIngredient": "LECANEMAB-IRMB", "ApplType": "BLA", "Sponsor": "EISAI INC", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761269"}, "761270": {"ApplNo": "761270", "Form": "INJECTABLE;INTRAVENOUS, SUBCUTANEOUS", "Drug": "IMJUDO", "ActiveIngredient": "TREMELIMUMAB-ACTL", "ApplType": "BLA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761270s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761270"}, "761289": {"ApplNo": "761289", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "IMJUDO", "ActiveIngredient": "TREMELIMUMAB-ACTL  ", "ApplType": "BLA", "Sponsor": "ASTRAZENECA AB", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761289s001lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761289"}, "761291": {"ApplNo": "761291", "Form": "INJECTABLE;INJECTION", "Drug": "TECVAYLI", "ActiveIngredient": "TECLISTAMAB-CQYV", "ApplType": "BLA", "Sponsor": "JANSSEN BIOTECH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761291s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761291"}, "76131": {"ApplNo": "76131", "Form": "INJECTABLE;INJECTION", "Drug": "PACLITAXEL", "ActiveIngredient": "PACLITAXEL", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/076131s022lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76131"}, "761310": {"ApplNo": "761310", "Form": "INJECTABLE;INJECTION", "Drug": "ELAHERE", "ActiveIngredient": "MIRVETUXIMAB SORAVTANSINE-GYNX", "ApplType": "BLA", "Sponsor": "IMMUNOGEN INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761310s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761310"}, "76168": {"ApplNo": "76168", "Form": "TABLET, EXTENDED RELEASE; ORAL", "Drug": "OXYCODONE HYDROCHLORIDE", "ActiveIngredient": "OXYCODONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/76168lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76168"}, "76182": {"ApplNo": "76182", "Form": "TABLET;ORAL", "Drug": "OFLOXACIN", "ActiveIngredient": "OFLOXACIN", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/076182Orig1s012ltr.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76182"}, "76187": {"ApplNo": "76187", "Form": "TABLET;ORAL", "Drug": "LEVOTHYROXINE SODIUM", "ActiveIngredient": "LEVOTHYROXINE SODIUM", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/076187lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76187"}, "76268": {"ApplNo": "76268", "Form": "TABLET;ORAL", "Drug": "DIGOXIN", "ActiveIngredient": "DIGOXIN", "ApplType": "ANDA", "Sponsor": "STEVENS J", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/76268_Digoxin_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76268"}, "76392": {"ApplNo": "76392", "Form": "TABLET;ORAL", "Drug": "MEFLOQUINE HYDROCHLORIDE", "ActiveIngredient": "MEFLOQUINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/076392s008lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76392"}, "76523": {"ApplNo": "76523", "Form": "TABLET;ORAL", "Drug": "MEFLOQUINE HYDROCHLORIDE", "ActiveIngredient": "MEFLOQUINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/076523s007lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76523"}, "76625": {"ApplNo": "76625", "Form": "TABLET;ORAL-28", "Drug": "LEVONORGESTREL AND ETHINYL ESTRADIOL", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "ANDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/076625Orig1s10Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76625"}, "76657": {"ApplNo": "76657", "Form": "INJECTABLE;INJECTION", "Drug": "IFOSFAMIDE", "ActiveIngredient": "IFOSFAMIDE", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/076657s017s021s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76657"}, "76677": {"ApplNo": "76677", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/076677lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76677"}, "76690": {"ApplNo": "76690", "Form": "TABLET;ORAL", "Drug": "VENLAFAXINE HYDROCHLORIDE", "ActiveIngredient": "VENLAFAXINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/076690s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76690"}, "76761": {"ApplNo": "76761", "Form": "TABLET;ORAL", "Drug": "OXANDROLONE", "ActiveIngredient": "OXANDROLONE", "ApplType": "ANDA", "Sponsor": "UPSHER SMITH LABS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/076761lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=76761"}, "77043": {"ApplNo": "77043", "Form": "SOLUTION;ORAL", "Drug": "CITALOPRAM HYDROBROMIDE", "ActiveIngredient": "CITALOPRAM HYDROBROMIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/077043s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77043"}, "77132": {"ApplNo": "77132", "Form": "TABLET;ORAL", "Drug": "RISEDRONATE SODIUM", "ActiveIngredient": "RISEDRONATE SODIUM", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077132s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77132"}, "77170": {"ApplNo": "77170", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "IVAX SUB TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/077170_s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77170"}, "77284": {"ApplNo": "77284", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "BUPROPION HYDROCHLORIDE", "ActiveIngredient": "BUPROPION HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "ANCHEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/077284lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77284"}, "77297": {"ApplNo": "77297", "Form": "INJECTABLE;INJECTION", "Drug": "GRANISETRON HYDROCHLORIDE", "ActiveIngredient": "GRANISETRON HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "DR REDDYS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/077963Orig1s016, 077297Orig1s016, 078392Orig1s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77297"}, "77322": {"ApplNo": "77322", "Form": "TABLET;ORAL", "Drug": "ZOLPIDEM TARTRATE", "ActiveIngredient": "ZOLPIDEM TARTRATE", "ApplType": "ANDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077322s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77322"}, "77328": {"ApplNo": "77328", "Form": "TABLET, ORALLY DISINTEGRATING;ORAL", "Drug": "RISPERIDONE", "ActiveIngredient": "RISPERIDONE", "ApplType": "ANDA", "Sponsor": "DR REDDYS LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077328ls000lb.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77328"}, "77419": {"ApplNo": "77419", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "POTASSIUM CHLORIDE", "ActiveIngredient": "POTASSIUM CHLORIDE", "ApplType": "ANDA", "Sponsor": "ACTAVIS LABS FL INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/077419lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77419"}, "77425": {"ApplNo": "77425", "Form": "SOLUTION;INTRAVENOUS", "Drug": "ADENOSINE", "ActiveIngredient": "ADENOSINE", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/077425Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77425"}, "77463": {"ApplNo": "77463", "Form": "TABLET;ORAL", "Drug": "NATEGLINIDE", "ActiveIngredient": "NATEGLINIDE", "ApplType": "ANDA", "Sponsor": "STRIDES PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077463s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77463"}, "77481": {"ApplNo": "77481", "Form": "INJECTABLE;INJECTION", "Drug": "FOSPHENYTOIN SODIUM", "ActiveIngredient": "FOSPHENYTOIN SODIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077481s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77481"}, "77492": {"ApplNo": "77492", "Form": "TABLET;ORAL", "Drug": "VALSARTAN", "ActiveIngredient": "VALSARTAN", "ApplType": "ANDA", "Sponsor": "OHM LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/077492Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77492"}, "77498": {"ApplNo": "77498", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "SUN PHARM INDS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077498lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77498"}, "77567": {"ApplNo": "77567", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "DIVALPROEX SODIUM", "ActiveIngredient": "DIVALPROEX SODIUM", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077567s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77567"}, "77571": {"ApplNo": "77571", "Form": "TABLET; ORAL", "Drug": "REPAGLINIDE", "ActiveIngredient": "REPAGLINIDE", "ApplType": "ANDA", "Sponsor": "SUN PHARM INDS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/077571s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77571"}, "77605": {"ApplNo": "77605", "Form": "TABLET;ORAL", "Drug": "GALANTAMINE HYDROBROMIDE", "ActiveIngredient": "GALANTAMINE HYDROBROMIDE", "ApplType": "ANDA", "Sponsor": "BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/077605s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77605"}, "77612": {"ApplNo": "77612", "Form": "SUSPENSION;ORAL", "Drug": "SULFAMETHOXAZOLE AND TRIMETHOPRIM", "ActiveIngredient": "SULFAMETHOXAZOLE; TRIMETHOPRIM", "ApplType": "ANDA", "Sponsor": "PRASCO", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/077612s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77612"}, "77681": {"ApplNo": "77681", "Form": "TABLET;ORAL-28", "Drug": "LEVONORGESTREL AND ETHINYL ESTRADIOL", "ActiveIngredient": "ETHINYL ESTRADIOL; LEVONORGESTREL", "ApplType": "ANDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/077681Orig1s000Lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77681"}, "77794": {"ApplNo": "77794", "Form": "TABLET;ORAL", "Drug": "OXCARBAZEPINE", "ActiveIngredient": "OXCARBAZEPINE", "ApplType": "ANDA", "Sponsor": "SUN PHARM INDS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077794s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77794"}, "77802": {"ApplNo": "77802", "Form": "TABLET;ORAL", "Drug": "OXCARBAZEPINE", "ActiveIngredient": "OXCARBAZEPINE", "ApplType": "ANDA", "Sponsor": "GLENMARK PHARMS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077802s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77802"}, "77946": {"ApplNo": "77946", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "PLD ACQUISITIONS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077946lbl_rc.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77946"}, "77989": {"ApplNo": "77989", "Form": "INJECTABLE;INJECTION", "Drug": "FOSPHENYTOIN SODIUM", "ActiveIngredient": "FOSPHENYTOIN SODIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/077989s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=77989"}, "78003": {"ApplNo": "78003", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "ESOMEPRAZOLE MAGNESIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "ANDA", "Sponsor": "IVAX SUB TEVA PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/078003Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78003"}, "78052": {"ApplNo": "78052", "Form": "INJECTABLE;INJECTION", "Drug": "FOSPHENYTOIN SODIUM", "ActiveIngredient": "FOSPHENYTOIN SODIUM", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/078052s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78052"}, "78065": {"ApplNo": "78065", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "PROPRANOLOL HYDROCHLORIDE", "ActiveIngredient": "PROPRANOLOL HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "NORTEC DEV ASSOC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/078065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78065"}, "78090": {"ApplNo": "78090", "Form": "INJECTABLE;INJECTION", "Drug": "GRANISETRON HYDROCHLORIDE", "ActiveIngredient": "GRANISETRON HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/078096Orig1s005,078090Orig1s005,078522Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78090"}, "78096": {"ApplNo": "78096", "Form": "INJECTABLE;INJECTION", "Drug": "GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE", "ActiveIngredient": "GRANISETRON HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/078096Orig1s005,078090Orig1s005,078522Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78096"}, "78104": {"ApplNo": "78104", "Form": "SPRAY, METERED;NASAL", "Drug": "TRIAMCINOLONE ACETONIDE", "ActiveIngredient": "TRIAMCINOLONE ACETONIDE", "ApplType": "ANDA", "Sponsor": "PERRIGO PHARMA INTL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078104lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78104"}, "78137": {"ApplNo": "78137", "Form": "INJECTABLE;INJECTION", "Drug": "FOSPHENYTOIN SODIUM", "ActiveIngredient": "FOSPHENYTOIN SODIUM", "ApplType": "ANDA", "Sponsor": "WOCKHARDT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/078137s0000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78137"}, "78185": {"ApplNo": "78185", "Form": "SOLUTION;ORAL", "Drug": "GALANTAMINE HYDROBROMIDE", "ActiveIngredient": "GALANTAMINE HYDROBROMIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078185s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78185"}, "78279": {"ApplNo": "78279", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "ESOMEPRAZOLE MAGNESIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "ANDA", "Sponsor": "DR REDDYS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/078279Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78279"}, "78317": {"ApplNo": "78317", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "APOTEX INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/078317lbl_rc.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78317"}, "78336": {"ApplNo": "78336", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "PERRIGO R AND D", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/078336lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78336"}, "78343": {"ApplNo": "78343", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE HIVES", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "DR REDDYS LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/078343s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78343"}, "78392": {"ApplNo": "78392", "Form": "INJECTABLE;INJECTION", "Drug": "GRANISETRON HYDROCHLORIDE", "ActiveIngredient": "GRANISETRON HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "DR REDDYS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/077963Orig1s016, 077297Orig1s016, 078392Orig1s017lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78392"}, "78427": {"ApplNo": "78427", "Form": "TABLET;ORAL", "Drug": "CETIRIZINE HYDROCHLORIDE ALLERGY", "ActiveIngredient": "CETIRIZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "GLENMARK PHARMS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/078427lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78427"}, "78458": {"ApplNo": "78458", "Form": "CAPSULE, EXTENDED RELEASE;ORAL", "Drug": "METHYLPHENIDATE HYDROCHLORIDE", "ActiveIngredient": "METHYLPHENIDATE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "MAYNE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/078458Orig1s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78458"}, "78515": {"ApplNo": "78515", "Form": "TABLET;ORAL", "Drug": "DROSPIRENONE AND ETHINYL ESTRADIOL", "ActiveIngredient": "DROSPIRENONE; ETHINYL ESTRADIOL", "ApplType": "ANDA", "Sponsor": "BARR", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078515s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78515"}, "78522": {"ApplNo": "78522", "Form": "INJECTABLE;INJECTION", "Drug": "GRANISETRON HYDROCHLORIDE", "ActiveIngredient": "GRANISETRON HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/078096Orig1s005,078090Orig1s005,078522Orig1s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78522"}, "78575": {"ApplNo": "78575", "Form": "TABLET;ORAL", "Drug": "BICALUTAMIDE", "ActiveIngredient": "BICALUTAMIDE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078575s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78575"}, "78593": {"ApplNo": "78593", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "SUMATRIPTAN SUCCINATE", "ActiveIngredient": "SUMATRIPTAN SUCCINATE", "ApplType": "ANDA", "Sponsor": "WOCKHARDT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078593Orig1s000LBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78593"}, "78830": {"ApplNo": "78830", "Form": "SYSTEM;TRANSDERMAL", "Drug": "SCOPOLAMINE", "ActiveIngredient": "SCOPOLAMINE", "ApplType": "ANDA", "Sponsor": "PADAGIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/078830Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78830"}, "78917": {"ApplNo": "78917", "Form": "TABLET;ORAL", "Drug": "BICALUTAMIDE", "ActiveIngredient": "BICALUTAMIDE", "ApplType": "ANDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078917s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78917"}, "78936": {"ApplNo": "78936", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "ESOMEPRAZOLE MAGNESIUM", "ActiveIngredient": "ESOMEPRAZOLE MAGNESIUM", "ApplType": "ANDA", "Sponsor": "MYLAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/078936Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78936"}, "78964": {"ApplNo": "78964", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "RABEPRAZOLE SODIUM", "ActiveIngredient": "RABEPRAZOLE SODIUM", "ApplType": "ANDA", "Sponsor": "LUPIN LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/078964Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=78964"}, "79016": {"ApplNo": "79016", "Form": "CAPSULE;ORAL", "Drug": "ATOMOXETINE HYDROCHLORIDE", "ActiveIngredient": "ATOMOXETINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "AUROBINDO PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/079016Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=79016"}, "79089": {"ApplNo": "79089", "Form": "TABLET;ORAL", "Drug": "BICALUTAMIDE", "ActiveIngredient": "BICALUTAMIDE", "ApplType": "ANDA", "Sponsor": "PINNACLE LIFE SCI", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/079089s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=79089"}, "79110": {"ApplNo": "79110", "Form": "TABLET;ORAL", "Drug": "BICALUTAMIDE", "ActiveIngredient": "BICALUTAMIDE", "ApplType": "ANDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/079110s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=79110"}, "79167": {"ApplNo": "79167", "Form": "TABLET;ORAL", "Drug": "ROSUVASTATIN CALCIUM", "ActiveIngredient": "ROSUVASTATIN CALCIUM", "ApplType": "ANDA", "Sponsor": "WATSON LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/079167Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=79167"}, "79242": {"ApplNo": "79242", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "SUMATRIPTAN SUCCINATE", "ActiveIngredient": "SUMATRIPTAN SUCCINATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/079242Orig1s000LBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=79242"}, "80258": {"ApplNo": "80258", "Form": "SYRUP;ORAL", "Drug": "ZARONTIN", "ActiveIngredient": "ETHOSUXIMIDE", "ApplType": "ANDA", "Sponsor": "PARKE-DAVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/080258Orig1s031.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=80258"}, "80737": {"ApplNo": "80737", "Form": "INJECTABLE;INJECTION", "Drug": "CYANOCOBALAMIN", "ActiveIngredient": "CYANOCOBALAMIN", "ApplType": "ANDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/080737Orig1s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=80737"}, "8316": {"ApplNo": "8316", "Form": "TABLET;ORAL", "Drug": "PRIMAQUINE", "ActiveIngredient": "PRIMAQUINE PHOSPHATE", "ApplType": "NDA", "Sponsor": "SANOFI AVENTIS US", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/008316s023lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8316"}, "83220": {"ApplNo": "83220", "Form": "TABLET;ORAL", "Drug": "OGEN 5", "ActiveIngredient": "ESTROPIPATE", "ApplType": "ANDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/083220s041lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=83220"}, "8370": {"ApplNo": "8370", "Form": "INJECTABLE;INJECTION", "Drug": "BENTYL", "ActiveIngredient": "DICYCLOMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/007409s042,008370s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8370"}, "8372": {"ApplNo": "8372", "Form": "INJECTABLE;INJECTION", "Drug": "ACTHAR GEL", "ActiveIngredient": "CORTICOTROPIN", "ApplType": "NDA", "Sponsor": "MALLINCKRODT ARD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/008372s071lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8372"}, "84349": {"ApplNo": "84349", "Form": "CAPSULE;ORAL", "Drug": "DILANTIN", "ActiveIngredient": "PHENYTOIN SODIUM", "ApplType": "ANDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=84349"}, "84427": {"ApplNo": "84427", "Form": "TABLET, CHEWABLE;ORAL", "Drug": "DILANTIN", "ActiveIngredient": "PHENYTOIN", "ApplType": "ANDA", "Sponsor": "PHARMACIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/084427s042lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=84427"}, "8453": {"ApplNo": "8453", "Form": "INJECTABLE;INJECTION", "Drug": "ANECTINE", "ActiveIngredient": "SUCCINYLCHOLINE CHLORIDE", "ApplType": "NDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008453s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8453"}, "84916": {"ApplNo": "84916", "Form": "INJECTABLE;INJECTION", "Drug": "DEXAMETHASONE SODIUM PHOSPHATE", "ActiveIngredient": "DEXAMETHASONE SODIUM PHOSPHATE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/084916s066lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=84916"}, "85128": {"ApplNo": "85128", "Form": "TABLET;ORAL", "Drug": "ADIPEX-P", "ActiveIngredient": "PHENTERMINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/085128s065lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=85128"}, "85470": {"ApplNo": "85470", "Form": "INJECTABLE;INJECTION", "Drug": "DEPO-ESTRADIOL", "ActiveIngredient": "ESTRADIOL CYPIONATE", "ApplType": "ANDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/085470s015lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=85470"}, "85635": {"ApplNo": "85635", "Form": "INJECTABLE;INJECTION", "Drug": "DEPO-TESTOSTERONE", "ActiveIngredient": "TESTOSTERONE CYPIONATE", "ApplType": "ANDA", "Sponsor": "PFIZER", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=85635"}, "8578": {"ApplNo": "8578", "Form": "TABLET;ORAL", "Drug": "DARAPRIM", "ActiveIngredient": "PYRIMETHAMINE", "ApplType": "NDA", "Sponsor": "VYERA PHARMS LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/008578s020lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8578"}, "85968": {"ApplNo": "85968", "Form": "TABLET;ORAL", "Drug": "AMITRIPTYLINE HYDROCHLORIDE", "ActiveIngredient": "AMITRIPTYLINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/085966s095,085969s084,085968s096,085971s075,085967s076,085970s072lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=85968"}, "85970": {"ApplNo": "85970", "Form": "TABLET;ORAL", "Drug": "AMITRIPTYLINE HYDROCHLORIDE", "ActiveIngredient": "AMITRIPTYLINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/085966s095,085969s084,085968s096,085971s075,085967s076,085970s072lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=85970"}, "86069": {"ApplNo": "86069", "Form": "CREAM;VAGINAL", "Drug": "ESTRACE", "ActiveIngredient": "ESTRADIOL", "ApplType": "ANDA", "Sponsor": "ALLERGAN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/86069s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=86069"}, "8697": {"ApplNo": "8697", "Form": "TABLET;ORAL", "Drug": "CORTEF", "ActiveIngredient": "HYDROCORTISONE", "ApplType": "NDA", "Sponsor": "PHARMACIA AND UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/008697s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8697"}, "87056": {"ApplNo": "87056", "Form": "TABLET;ORAL", "Drug": "CYPROHEPTADINE HYDROCHLORIDE", "ActiveIngredient": "CYPROHEPTADINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HERITAGE PHARMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/087056s045lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=87056"}, "8708": {"ApplNo": "8708", "Form": "CAPSULE;ORAL", "Drug": "DIBENZYLINE", "ActiveIngredient": "PHENOXYBENZAMINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/008708s025lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8708"}, "87294": {"ApplNo": "87294", "Form": "SYRUP;ORAL", "Drug": "HYDROXYZINE HYDROCHLORIDE", "ActiveIngredient": "HYDROXYZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "WOCKHARDT BIO AG", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087294Orig1s026lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=87294"}, "87393": {"ApplNo": "87393", "Form": "SOLUTION;ORAL", "Drug": "METHADONE HYDROCHLORIDE", "ActiveIngredient": "METHADONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087393Orig1s033lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=87393"}, "8762": {"ApplNo": "8762", "Form": "SUSPENSION;ORAL", "Drug": "DILANTIN-125", "ActiveIngredient": "PHENYTOIN", "ApplType": "NDA", "Sponsor": "VIATRIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8762"}, "87846": {"ApplNo": "87846", "Form": "TABLET;ORAL", "Drug": "TOFRANIL", "ActiveIngredient": "IMIPRAMINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "SPECGX LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=87846"}, "87997": {"ApplNo": "87997", "Form": "SOLUTION;ORAL", "Drug": "METHADONE HYDROCHLORIDE", "ActiveIngredient": "METHADONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087997Orig1s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=87997"}, "88023": {"ApplNo": "88023", "Form": "CAPSULE;ORAL", "Drug": "ADIPEX-P", "ActiveIngredient": "PHENTERMINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "TEVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/088023s037lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=88023"}, "8845": {"ApplNo": "8845", "Form": "INJECTABLE;INJECTION", "Drug": "QUELICIN", "ActiveIngredient": "SUCCINYLCHOLINE CHLORIDE", "ApplType": "NDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008845s080lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8845"}, "88617": {"ApplNo": "88617", "Form": "TABLET;ORAL", "Drug": "HYDROXYZINE HYDROCHLORIDE", "ActiveIngredient": "HYDROXYZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "PLIVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/088617Orig1s043,088618Orig1s043,088619Orig1s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=88617"}, "88618": {"ApplNo": "88618", "Form": "TABLET;ORAL", "Drug": "HYDROXYZINE HYDROCHLORIDE", "ActiveIngredient": "HYDROXYZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "PLIVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/088617Orig1s043,088618Orig1s043,088619Orig1s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=88618"}, "88619": {"ApplNo": "88619", "Form": "TABLET;ORAL", "Drug": "HYDROXYZINE HYDROCHLORIDE", "ActiveIngredient": "HYDROXYZINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "PLIVA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/088617Orig1s043,088618Orig1s043,088619Orig1s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=88619"}, "8922": {"ApplNo": "8922", "Form": "INJECTABLE;INJECTION", "Drug": "CALCIUM DISODIUM VERSENATE", "ActiveIngredient": "EDETATE CALCIUM DISODIUM", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/008922s016lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=8922"}, "89338": {"ApplNo": "89338", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "QUINIDINE GLUCONATE", "ActiveIngredient": "QUINIDINE GLUCONATE", "ApplType": "ANDA", "Sponsor": "SUN PHARM INDUSTRIES", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/089338s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89338"}, "89384": {"ApplNo": "89384", "Form": "INJECTABLE;INJECTION", "Drug": "LEUCOVORIN CALCIUM", "ActiveIngredient": "LEUCOVORIN CALCIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040347s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89384"}, "89683": {"ApplNo": "89683", "Form": "TABLET;ORAL", "Drug": "PERPHENAZINE", "ActiveIngredient": "PERPHENAZINE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/089683s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89683"}, "89684": {"ApplNo": "89684", "Form": "TABLET;ORAL", "Drug": "PERPHENAZINE", "ActiveIngredient": "PERPHENAZINE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/089683s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89684"}, "89685": {"ApplNo": "89685", "Form": "TABLET;ORAL", "Drug": "PERPHENAZINE", "ActiveIngredient": "PERPHENAZINE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/089683s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89685"}, "89686": {"ApplNo": "89686", "Form": "TABLET;ORAL", "Drug": "PERPHENAZINE", "ActiveIngredient": "PERPHENAZINE", "ApplType": "ANDA", "Sponsor": "SANDOZ", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/089683s024lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89686"}, "89717": {"ApplNo": "89717", "Form": "INJECTABLE;INJECTION", "Drug": "LEUCOVORIN CALCIUM", "ActiveIngredient": "LEUCOVORIN CALCIUM", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040347s010lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89717"}, "89884": {"ApplNo": "89884", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "NITROGLYCERIN", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "ANDA", "Sponsor": "ZYDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/89884_Nitroglycerin%20Transdermal_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89884"}, "89885": {"ApplNo": "89885", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "NITROGLYCERIN", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "ANDA", "Sponsor": "ZYDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/89885_Nitroglycerin%20Transdermal_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89885"}, "89886": {"ApplNo": "89886", "Form": "FILM, EXTENDED RELEASE;TRANSDERMAL", "Drug": "NITROGLYCERIN", "ActiveIngredient": "NITROGLYCERIN", "ApplType": "ANDA", "Sponsor": "ZYDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/89886_Nitroglycerin%20Transdermal_Prntlbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89886"}, "89897": {"ApplNo": "89897", "Form": "CONCENTRATE;ORAL", "Drug": "METHADONE HYDROCHLORIDE INTENSOL", "ActiveIngredient": "METHADONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/089897Orig1s028lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89897"}, "89903": {"ApplNo": "89903", "Form": "INJECTABLE;INJECTION", "Drug": "PROCHLORPERAZINE EDISYLATE", "ActiveIngredient": "PROCHLORPERAZINE EDISYLATE", "ApplType": "ANDA", "Sponsor": "HIKMA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/089903s018lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=89903"}, "90170": {"ApplNo": "90170", "Form": "TABLET;ORAL", "Drug": "LAMOTRIGINE", "ActiveIngredient": "LAMOTRIGINE", "ApplType": "ANDA", "Sponsor": "UNICHEM LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/090170Orig1s000LBL.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90170"}, "90193": {"ApplNo": "90193", "Form": "INJECTABLE;INJECTION", "Drug": "METHYLERGONOVINE MALEATE", "ActiveIngredient": "METHYLERGONOVINE MALEATE", "ApplType": "ANDA", "Sponsor": "AM REGENT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/090193s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90193"}, "90218": {"ApplNo": "90218", "Form": "INJECTABLE;SUBCUTANEOUS", "Drug": "GLATOPA", "ActiveIngredient": "GLATIRAMER ACETATE", "ApplType": "ANDA", "Sponsor": "SANDOZ INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/090218Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90218"}, "90449": {"ApplNo": "90449", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "BIMATOPROST", "ActiveIngredient": "BIMATOPROST", "ApplType": "ANDA", "Sponsor": "APOTEX", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/090449Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90449"}, "90482": {"ApplNo": "90482", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "QUETIAPINE FUMARATE", "ActiveIngredient": "QUETIAPINE FUMARATE", "ApplType": "ANDA", "Sponsor": "PAR PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/090482Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90482"}, "9053": {"ApplNo": "9053", "Form": "TABLET;ORAL", "Drug": "PURINETHOL", "ActiveIngredient": "MERCAPTOPURINE", "ApplType": "NDA", "Sponsor": "STASON PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009053s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9053"}, "90610": {"ApplNo": "90610", "Form": "TABLET;ORAL", "Drug": "CHLOROQUINE PHOSPHATE", "ActiveIngredient": "CHLOROQUINE PHOSPHATE", "ApplType": "ANDA", "Sponsor": "IPCA LABS LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/090610Orig1s004,s005lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90610"}, "90678": {"ApplNo": "90678", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "RABEPRAZOLE SODIUM", "ActiveIngredient": "RABEPRAZOLE SODIUM", "ApplType": "ANDA", "Sponsor": "LANNETT CO INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/090678Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90678"}, "90681": {"ApplNo": "90681", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "QUETIAPINE FUMARATE", "ActiveIngredient": "QUETIAPINE FUMARATE", "ApplType": "ANDA", "Sponsor": "ACCORD HLTHCARE", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/090681Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90681"}, "90707": {"ApplNo": "90707", "Form": "SOLUTION;ORAL", "Drug": "METHADONE HYDROCHLORIDE", "ActiveIngredient": "METHADONE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "VISTAPHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/090707Orig1s003lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90707"}, "90780": {"ApplNo": "90780", "Form": "CAPSULE, DELAYED REL PELLETS;ORAL", "Drug": "DULOXETINE HYDROCHLORIDE", "ActiveIngredient": "DULOXETINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "ANCHEN PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/090780s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90780"}, "90811": {"ApplNo": "90811", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "BIVALIRUDIN", "ActiveIngredient": "BIVALIRUDIN", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/090811s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90811"}, "90816": {"ApplNo": "90816", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "BIVALIRUDIN", "ActiveIngredient": "BIVALIRUDIN", "ApplType": "ANDA", "Sponsor": "HOSPIRA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/090816s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90816"}, "90848": {"ApplNo": "90848", "Form": "SOLUTION/DROPS;OPHTHALMIC", "Drug": "OLOPATADINE HYDROCHLORIDE", "ActiveIngredient": "OLOPATADINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "BARR LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/090848Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90848"}, "90853": {"ApplNo": "90853", "Form": "INJECTABLE;INTRAVENOUS", "Drug": "IBANDRONATE SODIUM", "ActiveIngredient": "IBANDRONATE SODIUM", "ApplType": "ANDA", "Sponsor": "SUN PHARM", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/090853Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=90853"}, "91077": {"ApplNo": "91077", "Form": "FOR SOLUTION;ORAL", "Drug": "POLYETHYLENE GLYCOL 3350", "ActiveIngredient": "POLYETHYLENE GLYCOL 3350", "ApplType": "ANDA", "Sponsor": "NOVEL LABS INC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/091077s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=91077"}, "9112": {"ApplNo": "9112", "Form": "LOTION;TOPICAL", "Drug": "EURAX", "ActiveIngredient": "CROTAMITON", "ApplType": "NDA", "Sponsor": "JOURNEY", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/06927slr030,09112slr021_eurax_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9112"}, "91526": {"ApplNo": "91526", "Form": "INJECTABLE;INJECTION", "Drug": "DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE", "ActiveIngredient": "DIPHENHYDRAMINE HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/091526lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=91526"}, "91589": {"ApplNo": "91589", "Form": "SOLUTION;INHALATION", "Drug": "TOBRAMYCIN", "ActiveIngredient": "TOBRAMYCIN", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/091589Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=91589"}, "91640": {"ApplNo": "91640", "Form": "TABLET, DELAYED RELEASE;ORAL", "Drug": "MESALAMINE", "ActiveIngredient": "MESALAMINE", "ApplType": "ANDA", "Sponsor": "ZYDUS PHARMS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/091640Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=91640"}, "91649": {"ApplNo": "91649", "Form": "TABLET;ORAL", "Drug": "CAPECITABINE", "ActiveIngredient": "CAPECITABINE", "ApplType": "ANDA", "Sponsor": "TEVA PHARMS USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/091649Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=91649"}, "91664": {"ApplNo": "91664", "Form": "TABLET, EXTENDED RELEASE;ORAL", "Drug": "METFORMIN HYDROCHLORIDE", "ActiveIngredient": "METFORMIN HYDROCHLORIDE", "ApplType": "ANDA", "Sponsor": "LUPIN LTD", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/091664Orig1s000lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=91664"}, "9170": {"ApplNo": "9170", "Form": "TABLET;ORAL", "Drug": "MYSOLINE", "ActiveIngredient": "PRIMIDONE", "ApplType": "NDA", "Sponsor": "VALEANT", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9170"}, "9175": {"ApplNo": "9175", "Form": "SUSPENSION;ORAL", "Drug": "FURADANTIN", "ActiveIngredient": "NITROFURANTOIN", "ApplType": "NDA", "Sponsor": "CASPER PHARMA LLC", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009175Orig1s048lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9175"}, "9190": {"ApplNo": "9190", "Form": "OIL;INTRALYMPHATIC, INTRAUTERINE", "Drug": "LIPIODOL", "ActiveIngredient": "ETHIODIZED OIL", "ApplType": "NDA", "Sponsor": "GUERBET", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009190s029s031lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9190"}, "9330": {"ApplNo": "9330", "Form": "INJECTABLE;INJECTION", "Drug": "LANOXIN", "ActiveIngredient": "DIGOXIN", "ApplType": "NDA", "Sponsor": "COVIS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009330Orig1s036lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9330"}, "9386": {"ApplNo": "9386", "Form": "TABLET;ORAL", "Drug": "MYLERAN", "ActiveIngredient": "BUSULFAN", "ApplType": "NDA", "Sponsor": "WOODWARD SPECL", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/09386slr023_myleran_lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9386"}, "9402": {"ApplNo": "9402", "Form": "INJECTABLE;INJECTION", "Drug": "DELESTROGEN", "ActiveIngredient": "ESTRADIOL VALERATE", "ApplType": "NDA", "Sponsor": "PAR STERILE PRODUCTS", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/009402Orig1s060lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9402"}, "9435": {"ApplNo": "9435", "Form": "INJECTABLE;INJECTION", "Drug": "NESACAINE", "ActiveIngredient": "CHLOROPROCAINE HYDROCHLORIDE", "ApplType": "NDA", "Sponsor": "FRESENIUS KABI USA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/009435s044lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9435"}, "9768": {"ApplNo": "9768", "Form": "TABLET;ORAL", "Drug": "PLAQUENIL", "ActiveIngredient": "HYDROXYCHLOROQUINE SULFATE", "ApplType": "NDA", "Sponsor": "CONCORDIA", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/009768s056lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9768"}, "9829": {"ApplNo": "9829", "Form": "TABLET;ORAL", "Drug": "MESTINON", "ActiveIngredient": "PYRIDOSTIGMINE BROMIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/15193s18lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9829"}, "9830": {"ApplNo": "9830", "Form": "INJECTABLE;INJECTION", "Drug": "MESTINON", "ActiveIngredient": "PYRIDOSTIGMINE BROMIDE", "ApplType": "NDA", "Sponsor": "BAUSCH", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/09829s9lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9830"}, "9866": {"ApplNo": "9866", "Form": "INJECTABLE;INJECTION", "Drug": "SOLU-CORTEF", "ActiveIngredient": "HYDROCORTISONE SODIUM SUCCINATE", "ApplType": "NDA", "Sponsor": "PHARMACIA AND UPJOHN", "LatestLabel": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/009866s115lbl.pdf", "LinkToFDA": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=9866"}}